0001641172-25-001000.txt : 20250328 0001641172-25-001000.hdr.sgml : 20250328 20250327194334 ACCESSION NUMBER: 0001641172-25-001000 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 104 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250328 DATE AS OF CHANGE: 20250327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHY CHOICE WELLNESS CORP. CENTRAL INDEX KEY: 0001948864 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-GROCERY STORES [5411] ORGANIZATION NAME: 07 Trade & Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42274 FILM NUMBER: 25781096 BUSINESS ADDRESS: STREET 1: 3800 NORTH 28TH WAY, UNIT 1 CITY: HOLLYWOOD STATE: FL ZIP: 33020 BUSINESS PHONE: (305) 600-5004 MAIL ADDRESS: STREET 1: 3800 NORTH 28TH WAY, UNIT 1 CITY: HOLLYWOOD STATE: FL ZIP: 33020 10-K 1 form10-k.htm
false FY 0001948864 P2Y 0001948864 2024-01-01 2024-12-31 0001948864 2024-09-30 0001948864 2025-03-27 0001948864 2023-01-01 2023-12-31 0001948864 2024-12-31 0001948864 2023-12-31 0001948864 us-gaap:RelatedPartyMember 2024-12-31 0001948864 us-gaap:RelatedPartyMember 2023-12-31 0001948864 HCWC:SeriesAConvertiblePreferredStockMember 2024-12-31 0001948864 HCWC:SeriesAConvertiblePreferredStockMember 2023-12-31 0001948864 us-gaap:CommonStockMember 2022-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2022-12-31 0001948864 us-gaap:RetainedEarningsMember 2022-12-31 0001948864 2022-12-31 0001948864 us-gaap:CommonStockMember 2023-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2023-12-31 0001948864 us-gaap:RetainedEarningsMember 2023-12-31 0001948864 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2023-01-01 2023-12-31 0001948864 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001948864 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2024-01-01 2024-12-31 0001948864 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001948864 us-gaap:CommonStockMember 2024-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2024-12-31 0001948864 us-gaap:RetainedEarningsMember 2024-12-31 0001948864 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember HCWC:OneVendorMember 2024-01-01 2024-12-31 0001948864 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember HCWC:OneVendorMember 2023-01-01 2023-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:CommonStockMember 2024-09-08 2024-09-09 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:CommonClassAMember 2024-09-08 2024-09-09 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:CommonClassBMember 2024-09-08 2024-09-09 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:SeriesEPreferredStockMember 2024-09-13 0001948864 HCWC:HealthierChoicesManagementCorpMember HCWC:SecuritiesPurchaseAgreementMember us-gaap:SeriesEPreferredStockMember 2024-09-13 0001948864 2024-07-18 2024-07-18 0001948864 2024-07-18 0001948864 us-gaap:BuildingMember 2024-07-24 2024-07-24 0001948864 HCWC:HealthierChoicesManagementCorpMember HCWC:SeriesEConvertiblePreferredStockMember 2022-08-18 0001948864 HCWC:HealthierChoicesManagementCorpMember 2022-08-18 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:SeriesAPreferredStockMember 2022-08-18 2022-08-18 0001948864 HCWC:HealthierChoicesManagementCorpMember 2022-08-18 2022-08-18 0001948864 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-12-31 0001948864 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-12-31 0001948864 srt:MinimumMember 2024-12-31 0001948864 srt:MaximumMember 2024-12-31 0001948864 HCWC:GreenAcresMarketMember 2024-07-31 0001948864 2024-09-16 2024-09-16 0001948864 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember HCWC:SuppliersMember 2024-01-01 2024-12-31 0001948864 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember HCWC:SuppliersMember 2023-01-01 2023-12-31 0001948864 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember HCWC:PurchaseMember 2024-01-01 2024-12-31 0001948864 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember HCWC:PurchaseMember 2023-01-01 2023-12-31 0001948864 us-gaap:OperatingSegmentsMember 2024-01-01 2024-12-31 0001948864 us-gaap:OperatingSegmentsMember 2023-01-01 2023-12-31 0001948864 HCWC:SegmentNetOperatingIncomeLossMember 2024-01-01 2024-12-31 0001948864 HCWC:SegmentNetOperatingIncomeLossMember 2023-01-01 2023-12-31 0001948864 HCWC:UnallocatedAmountMember 2024-01-01 2024-12-31 0001948864 HCWC:UnallocatedAmountMember 2023-01-01 2023-12-31 0001948864 HCWC:TotalReportingSegmentAssetsMember 2024-12-31 0001948864 HCWC:TotalReportingSegmentAssetsMember 2023-12-31 0001948864 HCWC:UnallocatedAmountMember 2024-12-31 0001948864 HCWC:UnallocatedAmountMember 2023-12-31 0001948864 HCWC:RetailGroceryMember 2024-01-01 2024-12-31 0001948864 HCWC:RetailGroceryMember 2023-01-01 2023-12-31 0001948864 HCWC:FoodServiceRestaurantMember 2024-01-01 2024-12-31 0001948864 HCWC:FoodServiceRestaurantMember 2023-01-01 2023-12-31 0001948864 HCWC:OnlineECommerceMember 2024-01-01 2024-12-31 0001948864 HCWC:OnlineECommerceMember 2023-01-01 2023-12-31 0001948864 2023-01-01 0001948864 HCWC:AssetPurchaseAgreementMember HCWC:EllwoodThompsonMember 2023-10-01 2023-10-01 0001948864 HCWC:AssetPurchaseAgreementMember HCWC:EllwoodThompsonMember 2023-10-01 0001948864 HCWC:AssetPurchaseAgreementMember HCWC:EllwoodThompsonMember 2024-01-01 2024-12-31 0001948864 HCWC:EllwoodThompsonMember 2023-10-01 2023-10-01 0001948864 HCWC:AssetPurchaseAgreementMember HCWC:GreenAcresMarketMember 2024-07-18 2024-07-18 0001948864 HCWC:AssetPurchaseAgreementMember HCWC:GreenAcresMarketMember 2024-07-18 0001948864 HCWC:EllwoodThompsonMember 2023-10-01 0001948864 HCWC:EllwoodThompsonMember us-gaap:TradeNamesMember 2023-10-01 0001948864 HCWC:GreenAcresMarketMember 2024-07-18 2024-07-18 0001948864 HCWC:GreenAcresMarketMember 2024-07-18 0001948864 HCWC:GreenAcresMarketMember us-gaap:TradeNamesMember 2024-07-18 0001948864 HCWC:GreenAcresMarketMember HCWC:NonCompeteAgreementMember 2024-07-18 0001948864 us-gaap:TradeNamesMember HCWC:EllwoodThompsonMember 2024-07-18 0001948864 HCWC:EllwoodThompsonMember 2024-01-01 2024-12-31 0001948864 HCWC:EllwoodThompsonMember 2023-01-01 2023-12-31 0001948864 us-gaap:BuildingMember 2024-02-07 0001948864 us-gaap:BuildingMember 2024-07-24 0001948864 HCWC:DisplaysMember 2024-12-31 0001948864 HCWC:DisplaysMember 2023-12-31 0001948864 us-gaap:BuildingMember 2024-12-31 0001948864 us-gaap:BuildingMember 2023-12-31 0001948864 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001948864 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001948864 us-gaap:LeaseholdImprovementsMember 2024-12-31 0001948864 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001948864 us-gaap:ComputerEquipmentMember 2024-12-31 0001948864 us-gaap:ComputerEquipmentMember 2023-12-31 0001948864 us-gaap:OtherMachineryAndEquipmentMember 2024-12-31 0001948864 us-gaap:OtherMachineryAndEquipmentMember 2023-12-31 0001948864 us-gaap:PropertyPlantAndEquipmentMember 2024-01-01 2024-12-31 0001948864 us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-12-31 0001948864 us-gaap:TradeNamesMember srt:MinimumMember 2024-12-31 0001948864 us-gaap:TradeNamesMember srt:MaximumMember 2024-12-31 0001948864 us-gaap:TradeNamesMember 2024-12-31 0001948864 HCWC:CustomerRelationshipMember srt:MinimumMember 2024-12-31 0001948864 HCWC:CustomerRelationshipMember srt:MaximumMember 2024-12-31 0001948864 HCWC:CustomerRelationshipMember 2024-12-31 0001948864 HCWC:NonCompeteMember srt:MinimumMember 2024-12-31 0001948864 HCWC:NonCompeteMember srt:MaximumMember 2024-12-31 0001948864 HCWC:NonCompeteMember 2024-12-31 0001948864 us-gaap:TradeNamesMember srt:MinimumMember 2023-12-31 0001948864 us-gaap:TradeNamesMember srt:MaximumMember 2023-12-31 0001948864 us-gaap:TradeNamesMember 2023-12-31 0001948864 HCWC:CustomerRelationshipMember srt:MinimumMember 2023-12-31 0001948864 HCWC:CustomerRelationshipMember srt:MaximumMember 2023-12-31 0001948864 HCWC:CustomerRelationshipMember 2023-12-31 0001948864 HCWC:NonCompeteMember srt:MinimumMember 2023-12-31 0001948864 HCWC:NonCompeteMember srt:MaximumMember 2023-12-31 0001948864 HCWC:NonCompeteMember 2023-12-31 0001948864 HCWC:PromissoryNotesMember 2022-10-14 0001948864 HCWC:PromissoryNotesMember 2024-01-01 2024-12-31 0001948864 HCWC:PromissoryNotesMember 2023-01-01 2023-12-31 0001948864 HCWC:SecuredPromissoryNotesMember 2023-10-01 0001948864 HCWC:SecuredPromissoryNotesMember 2024-12-31 0001948864 HCWC:SecuredPromissoryNotesMember 2023-12-31 0001948864 HCWC:SecuredPromissoryNotesMember 2024-01-01 2024-12-31 0001948864 HCWC:SecuredPromissoryNotesMember 2023-01-01 2023-12-31 0001948864 HCWC:SecuritiesPurchaseAgreementMember HCWC:UnsecuredPromissoryNoteMember us-gaap:IPOMember 2024-01-18 2024-01-18 0001948864 HCWC:SecuritiesPurchaseAgreementMember HCWC:UnsecuredPromissoryNoteMember 2024-01-18 2024-01-18 0001948864 us-gaap:IPOMember HCWC:SecuritiesPurchaseAgreementMember 2024-01-18 2024-01-18 0001948864 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-01-18 2024-01-18 0001948864 HCWC:SecuritiesPurchaseAgreementMember HCWC:UnsecuredPromissoryNoteMember 2024-01-18 0001948864 HCWC:BridgeWarrantSharesMember us-gaap:CommonClassAMember 2024-04-08 0001948864 HCWC:SecuritiesPurchaseAgreementMember 2024-12-31 0001948864 HCWC:SecuritiesPurchaseAgreementMember 2024-01-01 2024-12-31 0001948864 HCWC:BridgeWarrantSharesMember us-gaap:CommonClassAMember 2024-09-16 0001948864 HCWC:BridgeWarrantSharesMember us-gaap:CommonClassAMember 2024-09-17 0001948864 HCWC:BridgeWarrantSharesMember us-gaap:CommonClassAMember 2024-09-16 2024-09-17 0001948864 HCWC:LoanAndSecurityAgreementMember HCWC:GreenAcresMarketMember 2024-07-18 0001948864 HCWC:LoanAndSecurityAgreementMember HCWC:GreenAcresMarketMember 2024-07-18 2024-07-18 0001948864 HCWC:FirstAnniversaryMember 2024-07-18 2024-07-18 0001948864 HCWC:SecondAnniversaryMember 2024-07-18 2024-07-18 0001948864 HCWC:AcquisitionLoanAndSecurityAgreementMember HCWC:SecuredPromissoryNotesMember 2024-08-23 0001948864 HCWC:AcquisitionLoanAndSecurityAgreementMember HCWC:SecuredPromissoryNotesMember 2024-01-01 2024-12-31 0001948864 HCWC:AcquisitionLoanAndSecurityAgreementMember HCWC:SecuredPromissoryNotesMember 2023-01-01 2023-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember 2024-09-13 0001948864 HCWC:HealthierChoicesManagementCorpMember HCWC:SecuritiesPurchaseAgreementMember 2024-09-13 0001948864 HCWC:HealthierChoicesManagementCorpMember 2024-01-01 2024-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember 2023-01-01 2023-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember 2024-01-01 2024-09-13 0001948864 HCWC:HealthierChoicesManagementCorpMember 2024-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember 2023-09-13 0001948864 HCWC:TransitionServicesAgreementMember 2024-01-01 2024-12-31 0001948864 2022-06-12 2022-06-12 0001948864 2022-12-31 2022-12-31 0001948864 us-gaap:SubsequentEventMember 2025-03-02 0001948864 HCWC:LoanAndSecurityAgreementMember 2024-07-18 0001948864 us-gaap:SubsequentEventMember HCWC:LoanAndSecurityAgreementMember us-gaap:CommonClassAMember 2025-02-28 0001948864 us-gaap:SubsequentEventMember HCWC:LoanAndSecurityAgreementMember 2025-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure HCWC:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended: December 31, 2024

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from: _____________ to _____________

 

HEALTHY CHOICE WELLNESS CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   001-42274   88-4128927

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

Address of Principal Executive Office: 3800 North 28th Way, Unit#1, Hollywood, Florida 33020

 

Registrant’s telephone number, including area code: (305) 330-3839

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, par value $0.001 per share   HCWC   NYSE American

 

Securities registered pursuant to Section 12(g) of the Act:

None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer
Non-accelerated filer   Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management assessment of the effectiveness of its internal controls over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes No

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business day of the registrant’s most recently completed third fiscal quarter was approximately $24.4 million based on the September 30, 2024 closing price of $2.49 per share.

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: 10,565,749 shares outstanding as of March 27, 2025.

 

 

 

 

 

 

INDEX

 

  Page
   
PART I  
   
Item 1. Business 1
   
Item 1A. Risk Factors 8
   
Item 1B. Unresolved Staff Comments 8
   
Item 1C. Cybersecurity 8
   
Item 2. Properties 9
   
Item 3. Legal Proceedings 9
   
Item 4. Mine Safety Disclosures 9
   
PART II  
   
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 10
   
Item 6. Selected Financial Data 10
   
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 10
   
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 16
   
Item 8. Financial Statements and Supplementary Data 16
   
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 16
   
Item 9A. Controls and Procedures 16
   
Item 9B. Other Information 17
   
PART III  
   
Item 10. Directors, Executive Officers and Corporate Governance 18
   
Item 11. Executive Compensation 21
   
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters 25
   
Item 13. Certain Relationships and Related Transactions, and Director Independence 26
   
Item 14. Principal Accounting Fees and Services 27
   
PART IV  
   
Item 15. Exhibits, Financial Statement Schedules 27
   
Exhibit Index 28
   
SIGNATURES 30

 

 

 

 

PART I

Item 1. Business.

 

Healthy Choice Wellness Corp. (the “Company” or “HCWC” or “we” or “our” or “us”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives.

 

Through its wholly owned subsidiaries, the Company operates:

 

Healthy Choice Markets, Inc. (DBA Ada’s Natural Market), a natural and organic grocery store offering fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
   
Healthy Choice Markets II, LLC (DBA Paradise Health & Nutrition), operating three stores that likewise offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
   
Healthy Choice Markets III, LLC (DBA Mother Earth’s Storehouse), an organic and health food and vitamin chain in New York’s Hudson Valley, which has been in existence for over 40 years.
   
Healthy Choice Markets IV, LLC (DBA Greens Natural Foods), managing eight stores in New York and New Jersey, offering a selection of 100% organic produce, all-natural and non-GMO groceries & bulk foods; a wide selection of local products; an organic juice and smoothie bar; a fresh foods department, which offers fresh and healthy “grab & go” foods; a full selection of vitamins & supplements; as well as health and beauty products.
   
Healthy Choice Markets V, LLC (DBA Ellwood Thompson’s), an organic and natural health food and vitamin store located in Richmond, Virginia.
   
Healthy Choice Markets VI, LLC (DBA GreenAcres Market), an organic and natural health food and vitamin chain with five store locations in Kansas and Oklahoma. GreenAcres Market offers organic and all natural products and vitamins from both top national brands as well as locally sourced specialty brands.

 

Through its wholly owned subsidiary, Healthy U Wholesale, the Company sells vitamins and supplements, as well as health, beauty, and personal care products on its website www.TheVitaminStore.com.

 

SPIN-OFF

 

Healthier Choices Management Corp. (“HCMC” or the “Parent”) announced on August 22, 2022 that its Board of Directors approved the separation of the grocery business, including wellness business, into an independent, publicly traded company (the “Spin-Off” or “Separation”). Prior to the Spin-Off, HCWC was a subsidiary under HCMC.

 

On September 13, 2024 (the “Spin-Off Date”), after the NYSE American (“NYSEAM”) market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock commenced trading on the NYSEAM under the stock ticker “HCWC.”

 

HCMC distributed all the outstanding shares of HCMC common stock held by it on a pro rata basis to holders of HCMC’s common stock. For each 208,632 shares of HCMC common stock held as of 5:00 p.m., New York City time, on September 9, 2024, the record date for the Spin-Off (the “Record Date”), a HCMC stockholder was entitled to receive one (1) share of Class A common stock and three (3) shares of Class B common stock. The Distribution was made in book-entry form by a distribution agent as soon as practicable after the date of the Distribution.

 

HCMC has secured binding commitments of $13.25 million in equity financing for HCWC from the same group of investors that invested $13.25 million in HCMC Series E Preferred Stock. Pursuant to the Securities Purchase Agreement for the HCMC Series E Stock (“HCMC Series E SPA”), the purchasers of HCMC Series E Stock will also be required to purchase Series A Preferred Stock of HCWC in the same subscription amounts that the Purchasers paid for the HCMC Series E Stock (regardless of whether or not such HCMC Series E Stock has been converted into HCMC common stock).

 

NATURAL AND ORGANIC GROCERIES AND DIETARY SUPPLEMENTS BUSINESS

 

Local. Organic. Fresh. Three words that define Healthy Choice Markets! With Ada’s Natural Market, a full-service grocery store and Greenleaf Grill, Ada’s flagship fast casual in-store restaurant, serving Fort Myers, FL, along with the eight Greens Natural Foods Stores in New Jersey and New York, three Paradise Health & Nutrition locations in the greater Melbourne, FL area, one Mother Earth’s Storehouse location in Hudson Valley, NY, one Ellwood Thompson store located in Richmond Virginia, five GreenAcres Market stores located in Oklahoma and Kansas, all serving their respective local communities, our stores provide all-natural and organic products in a friendly and helpful atmosphere, with aisles of traditional grocery complete with frozen, healthy home, vitamins & supplements, health & beauty, fresh produce, hormone and antibiotic free meats and bulk foods. Ada’s Natural Market, Greens Natural Foods, Paradise Health & Nutrition, Mother Earth’s Storehouse, Ellwood Thompson’s and GreenAcres Market all offer chef-prepared ready-to-go foods and fresh-baked-daily baked goods.

 

1

 

 

Collectively, we focus on providing high-quality products at affordable prices, exceptional customer service, nutrition education and community outreach. We strive to generate long-term relationships with our customers based on quality and service by:

 

  selling only all-natural and organic groceries;
     
  offering affordable prices and a shopper-friendly retail environment; and
     
  providing dine-in options at our Greenleaf Grill, Organic Juice Bar, and our free-trade coffee bar.

 

Our History and Founding Principles

 

We are committed to maintaining the following founding principles, which have helped foster our growth:

 

  Quality. Every product on our shelves must go through a rigorous screening and approval process. Our mission includes providing the highest quality groceries and supplements, Natural Grocers branded products, European and United States Department of Agriculture (USDA) certified organic and fresh produce at the best prices in the industry.
     
  Community. The Ada’s, Paradise, Mother Earth’s Storehouse, Green’s Natural Foods, Ellwood Thompson’s and now GreenAcres Market brands have each been serving their respective communities for approximately 40+ years.
     
  Employees. Our employees make our companies great. We work hard to ensure that our employees are able to live a healthy, balanced lifestyle. We support them with free nutrition education programs, competitive pay and excellent benefits.

 

Our Market

 

We operate within the natural products retail industry, which is a subset of the United States grocery industry and the dietary supplement business. This industry includes conventional supermarkets, natural, gourmet and specialty food markets, mass and discount retailers, warehouse clubs, independent health food stores, dietary supplement retailers, drug stores, farmers’ markets, food co-ops, mail order and online retailers and multi-level marketers. Industry-wide sales of natural and organic foods and dietary supplements have experienced meaningful growth over the past several years, and we believe that growth will continue for the foreseeable future.

 

We believe the growth in sales of natural and organic foods and dietary supplements continues to be driven by numerous factors, including:

 

  greater consumer focus on high-quality nutritional products;
     
  an increased awareness of the importance of good nutrition to long-term wellness;
     
  aging communities that are seeking healthy lifestyle alternatives;
     
  heightened consumer awareness about the importance of food quality and a desire to avoid pesticide residues, growth hormones, artificial ingredients and genetically engineered ingredients in foods;
     
  growing consumer concerns over the use of harmful chemical additives in body care and household cleaning supplies;
     
  well-established natural and organic brands, which generate additional industry awareness and credibility with consumers; and
     
  the growth in the number of consumers with special dietary requirements as a result of allergies, chemical sensitivities, auto-immune disorders and other conditions.

 

2

 

 

Our Competitive Strengths

 

We are well-positioned to capitalize on favorable natural and organic grocery and dietary supplement industry dynamics as a result of the following competitive strengths:

 

Strict focus on high-quality natural and organic grocery products. We offer high-quality products and brands, including an extensive selection of widely-recognized natural and organic food, dietary supplements, body care products, pet care products and books. We offer our customers approximately 10,000 Stock Keeping Units (SKUs) of natural and organic products. We believe our broad product offering enables our customers to shop our stores for substantially all of their grocery and dietary supplement purchases. In our grocery departments, we primarily sell USDA certified organic produce and do not approve for sale grocery products that are known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils. In addition, we only sell pasture-raised, humanely-raised dairy products. Consistent with this strategy, our product selection does not include items that do not meet our strict quality guidelines. Our store managers enhance our robust product offering by customizing their stores’ selections to address the preferences of local customers.

 

Engaging customer service experience based on education and empowerment. We strive to offer consistently exceptional customer service in a shopper-friendly environment, which we believe creates a differentiated shopping experience, enhances customer loyalty and generates repeat visits from our clientele. A key aspect of our customer service model is to provide free nutrition education to our customers. We believe this focus provides an engaging retail experience while also empowering our customers to make informed decisions about their health. We offer our science-based nutrition education through our trained employees, our newsletter and sales flyer, community out-reach programs, one-on-one nutrition health coaching, nutrition classes and cooking demonstrations.

 

Our Growth Strategies

 

We expect to pursue several strategies to help return the overall business to profitable growth, including:

 

Expand our store base. We intend to expand our store base through the acquisition of new stores.

 

Increase sales from existing customers. In order to increase our average ticket and the number of customer transactions, we plan to continue offering an engaging customer experience by providing science-based nutrition education and a differentiated merchandising strategy that delivers affordable, high-quality natural and organic grocery products and dietary supplements. We also plan to continue to utilize targeted marketing efforts to reach our existing customers, which we anticipate will drive customer transactions and convert occasional, single-category customers into core, multi-category customers.

 

Create new revenue streams. The Company has initiated the implementation of new in-house baking commissaries at the following banners: Mother Earth’s Storehouse (serving Mother Earth’s Storehouse and all 8 Green’s Natural Foods Stores), Ada’s Natural Market (serving Ada’s Natural Market and all 3 Paradise Stores), and GreenAcres Market Bradley Fair (serving all 5 GreenAcres Market stores). These commissaries will generate new revenue while driving additional traffic to retail locations. Additionally, the Company intends to launch a wholesale business to supply bread and pies to local restaurants and businesses, further establishing its commitment to serving local communities.

 

Grow our customer base. We plan to implement several measures aimed at building our brand awareness and growing our customer base, including: (i) continuously improving the design of all our websites to enhance functionality, create a more engaging user experience and increase its reach and effectiveness; (ii) introducing customer appreciation programs at all our stores; and (iii) developing new collateral marketing materials. We believe offering nutrition education has historically been one of our most effective marketing strategies for reaching new customers and increasing the demand for natural and organic groceries and dietary supplements in our markets.

 

Improve operating margins. We expect to continue to improve our operating margins as we benefit from investments we have made or are making in fixed overhead and information technology. As we add additional stores, we expect to achieve greater economies of scale through sourcing and distribution. To achieve additional operating margin expansion, we intend to further optimize performance, maintain appropriate store labor levels and effectively manage product selection and pricing.

 

3

 

 

Our Products

 

Product Selection Guidelines. We have a set of strict quality guidelines covering all products we sell. For example:

 

  we do not approve for sale food known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils or phthalates or parabens, regardless of the proportion of its natural or organic ingredients;
     
  we sell USDA certified organic produce; and
     
  we sell meats naturally raised without hormones, antibiotics or treatments and that were not fed animal by-products.

 

Our product review team analyzes all new products and approves them for sale based on ingredients, price and uniqueness within the current product set. We actively research new products in the marketplace through our product vendors, private label manufacturers, scientific findings, customer requests and general trends in popular media. Our stores are able to fully merchandise all departments by providing an extensive assortment of natural and organic products. We do not believe we need to sell conventional products to fill our selection, increase our margins or attract more customers.

 

What We Sell. We operate both a full-service natural and organic grocery stores and dietary supplement stores within our retail locations. The following is a breakdown of our product mix:

 

  Grocery. We offer a broad selection of natural and organic grocery products with an emphasis on minimally processed and single ingredient products that are not known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils. Additionally, we carry a wide variety of products associated with special diets such as gluten free, vegetarian and non-dairy.
     
  Produce. We sell USDA-certified organic produce and source from local, organic producers whenever feasible. Our selection varies based on seasonal availability, and we offer a variety of organic produce offerings that are not typically found at conventional food retailers.
     
  Bulk Food and Private Label Products. We sell a wide selection of private label repackaged bulk and other products, including nuts, water, pasta, canned seafood, dried fruits, grains, granolas, honey, eggs, herbs, spices and teas.
     
  Dry, Frozen and Canned Groceries. We offer a wide variety of natural and organic dry, frozen and canned groceries, including cereals, soups, baby foods, frozen entrees and snack items. We offer a broad selection of natural chocolate bars, and energy, protein and food bars.
     
  Meats and Seafood. We offer naturally-raised or organic meat products. The meat products we offer come from animals that have never been treated with antibiotics or hormones or fed animal by-products. Additionally, we only buy from companies we believe employ humane animal-raising practices. Our seafood items are generally frozen at the time of processing and sold from our freezer section, thereby ensuring freshness and reducing food spoilage and safety issues.
     
  Dairy Products and Dairy Substitutes. We offer a broad selection of natural and organic dairy products such as milk, eggs, cheeses, yogurts and beverages, as well as non-dairy substitutes made from almonds, coconuts, rice and soy.
     
  Prepared Foods. Our stores have a convenient selection of refrigerated prepared fresh food items, including salads, sandwiches, salsa, hummus and wraps. The size of this offering varies by location.
     
  Bread and Baked Goods. We receive regular deliveries of a wide selection of bakery products for our bakery section, which includes an extensive selection of gluten-free items.
     
  Beverages. We offer a wide variety of non-alcoholic and alcoholic beverages containing natural and organic ingredients.

 

4

 

 

  Dietary Supplements. We offer a wide selection of vitamins, supplements and natural remedies. Our staff is well educated and trained on multiple aspects of natural medicine.
     
  Health, Beauty, and Personal Care. We offer a full range of cosmetics, skin care, hair care, fragrance and personal care products containing natural and organic ingredients. Our body care offerings range from bargain-priced basics to high-end formulations.
     
  Household and General Merchandise. Our offerings include sustainable, hypo-allergenic and fragrance-free household products, including cleaning supplies, paper products, dish and laundry soap and other common household products, including diapers.

 

Quality Assurance. We endeavor to ensure the quality of the products we sell. We work with reputable suppliers we believe are compliant with established regulatory and industry guidelines. Our purchasing department requires a complete supplier and product profile as part of the approval process. Our dietary supplement suppliers must follow Food and Drug Administration (FDA) current good manufacturing practices supported by quality assurance testing for both the base ingredients and the finished product. We expect our suppliers to comply with the industry’s best practices for food safety.

 

Many of our suppliers are inspected and certified under the USDA National Organic Program, voluntary industry associations, and other third-party auditing programs with regards to additional ingredients, manufacturing and handling standards. We operate all our stores in compliance with the National Organic Program standards, which restricts the use of certain substances for cleaning and pest control and requires rigorous recordkeeping, among other requirements.

 

Our Pricing Strategy

 

We believe our pricing strategy allows our customers to shop our stores on a regular basis for their groceries and dietary supplements.

 

The key elements of our pricing strategy include:

 

  heavily advertised discounts supported by manufacturer participation;

 

  in-store specials generally lasting for 30 days and not advertised outside the store;

 

  managers’ specials, such as clearance, overstock, short-dated or promotional incentives; and

 

  specials on seasonally harvested produce.

 

As we expand our store base, we believe there are opportunities for increased leverage in fixed costs, such as administrative expenses, as well as increased economies of scale in sourcing products. We strive to keep our product, operating and general and administrative costs low, which allows us to continue to offer attractive pricing for our customers.

 

Store Management and Staffing. Our store staffing includes a manager and assistant manager, with department managers in each of the dietary supplement, grocery, dairy and frozen, produce, body care and receiving departments, as well as several non-management employees. Our regional manager is responsible for monthly store profit and loss, including labor, merchandising and inventory costs.

 

To ensure a high level of service, all employees receive training and guidance on customer service skills, product attributes and nutrition education. Employees are carefully trained and evaluated based on a requirement that they present nutrition information in an appropriate and legally compliant educational context while interacting with customers. Additionally, store employees are cross-trained in various functions, including cashier duties, stocking and receiving product.

 

5

 

 

Inventory. We use a robust merchandise management and perpetual inventory system that values goods at the lower of cost and net realizable value using the average cost method. We manage shelf stock based on weeks-on-hand relative to sales, resupply time and minimum economic order quantity.

 

Sourcing and Vendors. We source from approximately 1,000 suppliers and offer over 4,000 brands. These suppliers range from small independent businesses to multi-national conglomerates. For the years ended December 31, 2024 and 2023, approximately 25% and 41% of our total purchases were from one vendor. We maintain good relations with all our suppliers and believe we have adequate alternative supply methods, including self-distribution.

 

We have longstanding relationships with our suppliers, and we require disclosure from them regarding quality, freshness, potency and safety data information. Our bulk food private label products are packaged by us in pre-packed sealed bags to help prevent contamination while in transit and in our stores. Unlike most of our competitors, most of our private label nuts, trail mix and flour are refrigerated in our warehouse and stores to maintain freshness.

 

New Reward Program. In August 2024, the Company transitioned its customer loyalty program from a points-based system to a VIP membership structure. Under the original loyalty program, customers earned redeemable loyalty points based on qualifying purchases, which have been discontinued. Existing unredeemed loyalty points remain valid for redemption until January 31, 2025. The new VIP program provides members with immediate discounts on qualifying purchases, replacing the accrual of future points. This modification did not require a restatement of prior-period revenue. However, the elimination of future loyalty point accruals reduces the Company’s ongoing contract liability obligations, as discounts under the VIP program are recognized as reductions to revenue at the time of sale.

 

New Marketing Program. HCWC has established a robust COOP marketing revenue program generated through a collaborative approach that emphasizes community engagement and shared values. The revenue in this context is driven by promoting national and locally sourced, organic, and sustainable products, which align with the priorities of the HCWC.

 

Our Employees

 

As of December 31, 2024, HCWC employed approximately 450 employees across its retail, warehouse, and corporate operations. Our employees are central to delivering our mission of providing exceptional service and products to our customers. Commitment to our employees is one of our founding principles. Employees are eligible for health, long-term disability, vision and dental insurance coverage, as well as Company paid short-term disability and life insurance benefits, after they meet eligibility requirements. Additionally, our employees are offered a 401(k) retirement savings plan with discretionary contribution matching opportunities. This further offers our employees the opportunity to become more familiar with our products, which we believe improves the customer service our employees are able to provide. We believe these and other factors result in higher retention rates and encourage our employees to appreciate our culture, which helps them better promote our brand.

 

Our Customers

 

The growth in the natural and organic grocery and dietary supplement industries and growing consumer interest in health and nutrition have led to an increase in our core customer base. We believe the demands for affordable, nutritious food and dietary supplements are shared attributes of our core customers, regardless of their socio-economic status. Additionally, we believe our core customers prefer a retail store environment that offers carefully selected natural and organic products and dietary supplements. Our customers tend to be interested in health and nutrition, and expect our store employees to be highly knowledgeable about these topics and related products.

 

Competition

 

The grocery and dietary supplement retail business is a large, fragmented and highly competitive industry, with few barriers to entry. Our competition varies by market and includes conventional supermarkets such as Publix and Winn-Dixie, mass or discount retailers such as Sprout’s Farmers Market, Wal-Mart and Target, natural and gourmet markets such as Whole Foods and The Fresh Market, specialty food retailers such as Trader Joe’s, independent health food stores, dietary supplement retailers, drug stores, farmers’ markets, food co-ops, mail order and online retailers and multi-level marketers. These businesses compete with us for customers on the basis of price, selection, quality, customer service, shopping experience or any combination of these or other factors. They also compete with us for products and locations. In addition, some of our competitors are expanding to offer a greater range of natural and organic foods. We believe our commitment to carrying only carefully vetted, affordably priced and high-quality natural and organic products and dietary supplements, as well as our focus on providing nutritional education, differentiate us in the industry and provide a competitive advantage.

 

6

 

 

Online Sales

 

HCWC is your online source for the leading products in the all-natural vitamin and supplement, and health, beauty, and personal care categories of Healthier Living.

 

Backed by 30+ years of combined experience in the health and nutrition industry, we provide our customers with only the best products on the market — Try our exclusive offering of Ada’s Naturals brand products or any of the top products from the most recognized national natural health brands in the industry.

 

  VITAMINS & SUPPLEMENTS:

 

  Product categories include, but are not limited to: Vitamins, Minerals & Herbals, Immunity, Multivitamins, Sports Nutrition, Protein Powders, Collagen, Stress & Anxiety, Sleep & Relax, Brain Health, Pain & Inflammation, Probiotics, Energy & Stamina, Joint & Bone Support, Digestion, Fish Oils, Just for Men, Kids/Children/Teens, and more.
     
  Product varieties include, but are not limited to: Apple Cider Vinegar, BCAA, Biotin, Calcium, Chlorophyll, CLA, Collagen Peptides, Creatine, Elderberry, Omega-3’s, Garlin, Glucosamine, Iron, Magnesium, Melatonin, Potassium, Prenatals, Probiotics, Protein Powders (Plant and Whey), Ashwaghanda Turmeric, Ginseng, Vitamin B,C,D,E,K+, Zinc, and more.
     
  Product brands include, but are not limited to: Ada’s Naturals, Enzymedica, Garden of Life, Natural Vitality, New Chapter, Renew Life, Solgar, and more.

 

  HEALTH, BEAUTY, AND PERSONAL CARE:

 

  Product categories include, but are not limited to: Oral Care, Hair Care, Body Wash, Skin & Face, Deodorant, Suncare, Soaps, Shaving, Feminine Hygiene, Lip Balms, Ear Candles, Lotions, Hand Sanitizers, Essential Oils, and more.
     
  Product varieties include, but are not limited to: Body Wash, Deodorant, Ear Candles, Shampoos, Conditioners, Toothpaste, Mouthwashes, Shaving, Bar Soaps, Liquid Soaps, Suncare, and more.

 

  Product brands include, but are not limited to: Ada’s Naturals, Alba Botanica, Aura Cacia, Derma-E, Desert Essence, Dr. Bronners, Every Man Jack, Heritage Store, Himalaya Botanique, Life-Flo, Lily of the Desert, Natracare, Naturally Fresh, Oral Essentials, South of France, Tea Tree Therapy, Thai Deodorant Stone, Thayers, and more.

 

Seasonality

 

Our business is active throughout the calendar year and does not experience significant fluctuation caused by seasonal changes in consumer purchasing.

 

Insurance and Risk Management

 

We use a combination of insurance and self-insurance to cover workers’ compensation, general liability, product liability, director and officers’ liability, employment practices liability, associate healthcare benefits and other casualty and property risks. Changes in legal trends and interpretations, variability in inflation rates, changes in the nature and method of claims settlement, benefit level changes due to changes in applicable laws, insolvency of insurance carriers and changes in discount rates could all affect ultimate settlements of claims. We evaluate our insurance requirements and providers on an ongoing basis.

 

Information Technology Systems

 

We have made significant investments in overhead and information technology infrastructure, including purchasing, receiving, inventory, point of sale, accounting automation, reporting and financial systems.

 

7

 

 

Segment Information

 

The Company has two operating segments: Grocery and Wellness. The Company’s operations are managed as one integrated business unit with similar economic characteristics and are similar in the nature of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment. In accordance with ASC 280 Segment Reporting, the Company has aggregated its Grocery and Wellness operating segments into a single reportable segment, as management reviews financial results and allocates resources at the consolidated level.

 

The Company’s Chief Operating Decision Maker (CODM) reviews financial results and allocates resources at the consolidated level, as the aggregated segments operate as one integrated business unit. There were no inter-segment revenues during the period.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate the continuation of the Company as a going concern for the next twelve months from the issuance of this Form 10-K and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the consolidated financial statements do not necessarily purport to represent realizable or settlement values.

 

The Company currently and historically has reported net losses and cash outflows from operations. Cash and cash equivalents increased to approximately $2.1 million as of December 31, 2024, compared to $1.4 million as of December 31, 2023, driven by increased sales and improved sales margin. Working capital deficit decreased from negative $2.6 million as of December 31, 2023, to negative $2.2 million as of December 31, 2024, primarily due to improvements in cash reserves and inventory management. Net losses improved to $4.5 million for the year ending December 31, 2024 from $9.9 million for the year ended December 31, 2023. Net cash used in operating activities increased to $3.1 million in 2024 from $2.5 million cash used in operations in 2023, respectively.

 

The Company’s liquidity needs through December 31, 2024 have been satisfied through the initial public offering and financing agreement with private lenders.

 

Management has made plans to reduce certain costs and raise needed capital, however there can be no assurance the Company can successfully implement these plans. The Company contracted a third-party consultant, whose expertise is streamlining operations, to identify areas of improvement and cost savings. The Company will enact the consultant’s recommendations in anticipation of realizing savings and achieving profitability. The Company plans on evaluating non-performing stores and continuing to expand via acquisition which will help achieve profitability. Also, the Company is formulating plans to raise capital from outside investors and from equity offerings, as it has done in the past, to fund operating losses and also provide capital for further business acquisitions.

 

On July 18, 2024, HCWC entered into a $7.5 million loan and security agreement with a private lender to support its expansion plans and funding of any working capital needs, of which $4.2 million was used for the July 18, 2024 purchase of GreenAcres Market. The face amount of the loan is $7,500,000 with 12% annual interest and has a maturity date of July 17, 2027. On July 24, 2024, the Company finalized the closing of Saugerties building sale with all parties involved and received net proceeds of $695,000.

 

On August 18, 2022, HCMC entered into a Securities Purchase Agreement (“HCMC Preferred Stock”) pursuant to which HCMC sold and issued 14,722 shares of its Series E Convertible Preferred Stock to institutional investors for $1,000 per share or an aggregate subscription of $13.25 million. This same group of investors committed to invest $13.25 million in HCWC after the Spin-Off and IPO transactions were completed. As such, HCWC entered into an agreement to sell shares of its Series A Convertible Preferred Stock (the “Series A Preferred Stock”), with the gross proceeds from such offering expected to be $13.25 million. The institutional investors that acquired HCMC Series E Preferred Stock are contractually required to purchase the Series A Preferred Stock in the same dollar amounts as they invested in the HCMC Series E Preferred Stock (regardless of whether or not such HCMC Series E Preferred Stock has been converted into HCMC common stock).

 

The Company believes its cash on hand and the commitment of $13.25 million anticipated to be raised by May 31, 2025 through its security offering (as noted above) will enable the Company to meet its obligations and capital requirements for at least the twelve months from the date these consolidated financial statements are issued. Accordingly, no adjustment has been made to the consolidated financial statements to account for this uncertainty.

 

Item 1A. Risk Factors.

 

Not applicable to smaller reporting companies.

 

Item 1B. Unresolved Staff Comments.

 

None

 

Item 1C. Cybersecurity

 

We recognize that cybersecurity is of critical importance to our success. We are susceptible to a number of significant and persistent cybersecurity threats, including those common to most industries as well as those we face as a retailer, operating in an industry characterized by a high volume of customer transactions and collection of sensitive data. These threats, which are constantly evolving, include data breaches, ransomware, and phishing attacks. We, and our vendors and suppliers, regularly face attempts by malicious actors to breach our security and compromise our information technology systems. A cybersecurity incident impacting us or any vendor or supplier could significantly disrupt our operations and result in damage to our reputation, costly litigation and/or government enforcement action. Accordingly, we are committed to maintaining robust cybersecurity and data protection and continuously evaluating the impact of cybersecurity threats, considering both immediate and potential long-term effects of these threats on our business strategy, operations, and financial condition.

 

8

 

 

Our Chief Operating Officer is primarily responsible for managing material risks from cybersecurity threats, and is supported by third party cybersecurity specialists. Management participates in periodic training and education on cybersecurity related topics. We engage specialized cybersecurity consultants and leverage third-party expertise to bolster our cybersecurity defenses. Our enterprise risk management program is designed to identify, prioritize and assess a broad range of risks, including risks from cybersecurity threats, that may affect our ability to execute our corporate strategy and fulfill our business objectives.

 

The following is a list of measures that were implemented as part of our increased focus on cybersecurity:

 

  Complete endpoint protection - All endpoints have been covered by an enhanced endpoint protection agent.
  Cloud infrastructure - Critical infrastructure started moving to the cloud and protected by enhanced anti-virus and recurring backup policies.
  Email services have been put through a rigorous intelligent phishing and spam filter to prevent attacks.

 

In addition, our third-party vendors and service providers play a role in our cybersecurity. These third parties are integral to our operations but pose cybersecurity challenges due to their access to our data and our reliance for various aspects of our operations, including our supply chain. We conduct due diligence before onboarding new vendors and maintain ongoing evaluations to ensure compliance with our security standards.

 

As of the date of this report, no cybersecurity incidents have had, either individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. However, despite the comprehensive measures outlined above, management has identified a material weakness in our cybersecurity setup, specifically regarding access controls and data encryption, This weakness increases the risk of a significant cybersecurity incident. We are actively developing and implementing a remediation plan to address this material weakness. We are committed to resolving this issue promptly and enhancing our overall cybersecurity posture. Notwithstanding our remediation efforts, we acknowledge that we may not be successful in preventing or mitigating all potential cybersecurity incidents that could have a material adverse effect on us.

 

Item 2. Properties.

 

The Company operates its business from numerous facilities in Florida, Virginia, New York, New Jersey, Kansas and Oklahoma. These leased facilities include our headquarters location, warehouse and retail stores.

 

As of December 31, 2024, we had 19 retail stores in Florida, New York, New Jersey, Virginia, Kansas and Oklahoma, which aggregate approximately 181,000 square feet, 19 stores are leased by our grocery stores. The Company considers these retail store locations strategically important to its operations, serving key markets in the Southeastern, Northeastern, and Midwestern United States. The Company believes the properties used by our grocery stores are in good operating condition and are suitable for the conduct of its business.

 

Our headquarters and warehouse are located in Hollywood, Florida which aggregates approximately 10,000 square feet.

 

Item 3. Legal Proceedings.

 

No response is required under Item 103 of Regulation S-K.

 

Item 4. Mine Safety Disclosures.

 

None.

 

9

 

 

PART II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Our common stock is currently listed on the NYSE American under the symbol “HCWC”.

 

As of March 27, 2025, there were approximately 171 stockholders of record for our common stock. A substantially greater number of stockholders may be “street name” or beneficial holders, whose shares are held of record by banks, brokers and other financial institutions.

 

As of March 27, 2025, the last reported sale price of our common stock on the NYSE American was $0.52 per share.

 

We have never declared or paid, and do not anticipate declaring or paying, any cash dividends on any of our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any dividends in the foreseeable future. Future determination as to the declaration and payment of dividends, if any, will be at the discretion of our Board and will depend on the existing conditions, including our operating results, financial conditions, contractual restrictions, capital requirements, business prospects and other factors our Board may deem relevant.

 

Item 6. Selected Financial Data.

 

Not required for smaller reporting companies.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

You should read the following discussion in conjunction with our audited historical consolidated financial statements, which are included elsewhere in this report. “Management’s Discussion and Analysis of Financial Condition” and “Results of Operations” contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.

 

Cautionary Note Regarding Forward Looking Statements

 

This report includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, liquidity, business strategy, plans and objectives of management for future operations, are forward-looking statements.

 

Forward-looking statements contained in this report include:

 

  Our liquidity;

 

  Opportunities for our business; and

 

  Growth of our business.

 

10

 

 

The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “expect,” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

 

The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that may cause actual results to differ materially from these forward-looking statements are contained in the Risk Factors contained herein. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. For more information regarding some of the ongoing risks and uncertainties of our business, see the Risk Factors below.

 

Factors Affecting Our Performance

 

We believe the following factors affect our performance:

 

Retail: We believe the operating performance of our retail stores will affect our revenue and financial performance. The Company has four natural and organic groceries and dietary supplement stores located in Florida, nine located in New York and New Jersey, one store in Virgina, as well as five stores in Kansas and Oklahoma.

 

Increased Competition: Food retail is a large and competitive industry. Our competition varies and includes national, regional, and local conventional supermarkets, national superstores, alternative food retailers, natural foods stores, smaller specialty stores, and farmers’ markets. In addition, we compete with restaurants and other dining options in the food-at-home and food-away-from-home markets. The opening and closing of competitive stores, as well as restaurants and other dining options, in regions where we operate will affect our results. In addition, changing consumer preferences with respect to food choices and to dining out or at home can impact us. We also expect increased product supply and the downward pressure on prices to continue and impact our operating results in the future.

 

Results of Operations

 

The following table sets forth our Consolidated Statements of Operations for the years ended December 31, 2024 and 2023 which is used in the following discussions of our results of operations:

 

   For the Years Ended December 31,   2024 to 2023 
   2024   2023   Change $ 
SALES  $69,370,803   $55,689,793   $13,681,010 
COST OF SALES   42,305,494    35,341,569    6,963,925 
GROSS PROFIT   27,065,309    20,348,224    6,717,085 
                
OPERATING EXPENSES, NET               
Selling, general and administrative   29,047,933    24,768,293    4,279,640 
Impairment of goodwill   -    6,104,000    (6,104,000)
Gain on sale of asset   (205,146)   -    (205,146)
TOTAL OPERATING EXPENSES, NET   28,842,787    30,872,293    (2,029,506)
                
LOSS FROM OPERATIONS   (1,777,478)   (10,524,069)   8,746,591 
                
OTHER INCOME (EXPENSE)               
Loss on debt extinguishment   (1,888,889)   -    (1,888,889)
Change in contingent consideration   -    774,900    (774,900)
Other income, net   8,552    16,230    (7,678)
Interest (expense) income, net   (848,651)   (199,681)   (648,970)
TOTAL INCOME (EXPENSE), NET   (2,728,988)   591,449    (3,320,437)
                
NET LOSS  $(4,506,466)  $(9,932,620)  $5,426,154 

 

11

 

 

Sales increased $13.7 million to $69.4 million for the year ended December 31, 2024 as compared to $55.7 million for the same period in 2023. The $8.7 million increase in sales was primarily a result of a full year operations for the year ended December 31, 2024 of Ellwood Thompson’s acquired in October 2023, $6.8 million increase in sales was a result of GreenAcres Market acquisition acquired in July 2024, offset by a decrease in same-store sales of $1.7 million.

 

Cost of goods sold for the years ended December 31, 2024 and 2023 were $42.3 million and $35.3 million, respectively, an increase of $5.4 million was primarily a result of full year operations in 2024 of Ellwood Thompson’s acquired in October 2023, an increase of $3.8 million was a result of GreenAcres Market acquisition acquired in July 2024, offset by a decrease in same-store cost of goods sold of $2.3 million.

 

Total operating expenses decreased $2.0 million from $30.9 million for the year ended December 31, 2023 to $28.8 million for the year ended December 31, 2024. The increase of $2.6 million was a result of full year operations for the year ended December 31, 2024 of Ellwood Thompson’s acquired in October 2023, the increase of $2.4 million was a result of GreenAcres Market acquisition acquired in July 2024, and the increase of $0.2 million was due to gain on sale on Saugerties building, The increases were offset by $6.1 million decrease in goodwill impairment charge, $0.4 million decrease in HCMC corporate overhead allocation, and $0.2 million in same-store expense reduction.

 

The Company had an impairment of $6.1 million for the year ended December 31, 2023. The Company experienced recurring losses coupled with the reduction in the same store revenue, a highly competitive industry and certain operational costs that have impacted our expectations such that future growth and profitability is lower than previous estimates. Furthermore, during the fourth quarter of 2023, the Company operated with negative working capital which, although not a determinant on its own, when combined with the other factors indicated that the Company’s goodwill of $6.1 million was determined to be impaired for the year ended December 31, 2023.

 

Total other (expenses) income, net of $2.7 million for the year ended December 31, 2024 consists of $1.9 million loss on debt extinguishment, and net interest expense of $0.8 million. Total other income (expense), net of $0.6 million for the year ended December 31, 2023 primarily consists of change in contingent consideration of $0.8 million and other miscellaneous income of $16,000, offset by interest expense of $0.2 million.

 

Liquidity and Capital Resources

 

   For the Years Ended December 31, 
   2024   2023 
Net cash provided by (used in):          
Operating activities  $(3,064,842)  $(2,525,354)
Investing activities   (4,977,793)   (929,623)
Financing activities   8,676,527    2,856,986 
 Net increase (decrease) in cash  $633,892   $(597,991)

 

12

 

 

Our net cash used in operating activities of $3.1 million for the year ended December 31, 2024 resulted from our net loss of $4.5 million and a net cash usage of $7.6 million from changes in operating assets and liabilities, offset by a non-cash adjustments of $9.1 million. Our net cash used in continuing operating activities of $2.5 million for the year ended December 31, 2023 resulted from our net loss of $9.9 million and a net cash usage of $4.5 million from changes in operating assets and liabilities, offset by a non-cash adjustments of $11.9 million.

 

The net cash used in investing activities of $5.0 million for the year ended December 31, 2024 consists of $5.5 million payment for GreenAcres Market acquisition, $0.2 million purchases of property and equipment, offset by $0.7 million proceeds from sale of Saugerties building. The net cash used in investing activities of $0.9 million for the year ended December 31, 2023 resulted from $0.7 million payment for Ellwood Thompson’s acquisition and $0.2 million payment for purchase of property and equipment.

 

The net cash provided by financing activities of $8.7 million for the year ended December 31, 2024 consists of cash proceeds of $1.7 million from Security Purchase Agreement (“SPA”) signed on January 18, 2024, $7.5 million cash proceeds from Loan and Security Agreement signed on July 18, 2024, $2.6 million cash proceed from initial public offering, $1.7 million net parent investment from HCMC, $2,000 cash proceed from warrant exercise, offset by principal payment on loan payable of $2.5 million and $2.3 million payment to related party.

 

At December 31, 2024 and December 31, 2023, we did not have any material financial guarantees or other contractual commitments with trade vendors that are reasonably likely to have an adverse effect on liquidity.

 

Our cash balances are kept liquid to support our growing acquisition and infrastructure needs for operational expansion. The majority of our cash are concentrated in one large financial institution and are generally in excess of the Federal Deposit Insurance Corporation (FDIC) insurance limit. The Company has not experienced any losses on its cash and cash equivalents. The following table presents the Company’s cash position as of December 31, 2024 and December 31, 2023.

 

  

December 31,

2024

   December 31,
2023
 
         
Cash  $2,056,472   $1,422,580 
Total assets  $34,112,517   $28,432,560 
Percentage of total assets   6.0%   5.0%

 

As of December 31, 2024, the Company had cash of $2.1 million and negative working capital of $2.2 million. The Company expects to continue incurring losses for the foreseeable future. The Company’s liquidity needs through December 31, 2024 have been satisfied through initial public offering and financing agreement with private lenders. Also, the Company is formulating plans to raise capital from outside investors and from equity offerings, as it has done in the past, to fund operating losses and also provide capital for further business acquisitions. The Company believes its cash on hand and the plan to raise capital through its security offering will enable the Company to meet its obligations and capital requirements for at least the twelve months from the date these consolidated financial statements are issued.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements other than operating leases for retail locations, equipment, and vehicles.

 

Seasonality

 

We do not consider our business to be seasonal.

 

Climate-Related Considerations

 

We have evaluated the potential impact of climate change on our business, including regulatory, physical, and market-related risks. Based on our assessment, we do not believe that climate change currently poses a material risk to our operations or financial performance. Our retail sales operations are not significantly affected by climate-related factors, such as extreme weather or emissions regulations. Nevertheless, we will continue to monitor any developments that could indirectly impact on our business, such as changes in consumer behavior or supply chain disruptions related to climate change.

 

13

 

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The consolidated financial statements include estimates based on currently available information and our judgment as to the outcome of future conditions and circumstances. These estimates and assumptions include useful lives and impairment of long-lived assets, goodwill, deferred taxes and related valuation allowances, and the valuation of the assets and liabilities acquired in business combinations. Changes in the status of certain facts or circumstances could result in material changes to the estimates used in the preparation of the consolidated financial statements and actual results could differ from the estimates and assumptions.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. To achieve this core principle, five basic criteria must be met before revenue can be recognized:

 

  Identification of the contract, or contracts, with a customer;

 

  Identification of the performance obligations in the contract;

 

  Determination of the transaction price;

 

  Allocation of the transaction price to the performance obligations in the contract; and

 

  Recognition of revenue when, or as, the Company satisfies a performance obligation.

 

Impairment of Long-Lived Assets

 

We review long-lived assets for impairment including intangible assets with determinable useful lives whenever events or changes in circumstances indicate that the carrying value of the corresponding asset group may not be realizable. The Company estimated future undiscounted cash flows associated with the asset group are compared to the asset group’s carrying amount to determine if an impairment of such asset is necessary. This requires us to make long-term forecasts of the future revenues and costs related to the assets groups subject to review. Forecasts require assumptions about demand for our products and future market conditions. Estimating future cash flows requires significant judgment, and our projections may vary from cash flows eventually realized. Future events and unanticipated changes to assumptions could require a provision for impairment in a future period. The effect of any impairment would be reflected in operating income in the Consolidated Statements of Operations. In addition, we estimate the useful lives of our long-lived assets and other intangibles and periodically review these estimates to determine whether these lives are appropriate.

 

14

 

 

Goodwill

 

Goodwill is the excess of consideration paid for an acquired entity over the fair value of the amounts assigned to assets acquired, including other identifiable intangible assets, and liabilities assumed in a business combination. To determine the amount of goodwill resulting from a business combination, the company hires a third-party valuation firm to perform valuation and assessment to determine the acquisition date fair value of the acquired company’s tangible and identifiable intangible assets and liabilities.

 

Goodwill is required to be evaluated for impairment on an annual basis or whenever events or changes in circumstances indicate the asset may be impaired. An entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. These qualitative factors include macroeconomic and industry conditions, cost factors, overall financial performance and other relevant entity-specific events. If the entity determines that this threshold is met, then the company may apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit’s carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The company determines fair value through multiple valuation techniques and weighs the results accordingly. The company is required to make certain subjective and complex judgments in assessing whether an event of impairment of goodwill has occurred, including assumptions and estimates used to determine the fair value of its reporting units. The company has elected to perform its annual goodwill impairment review on September 30 of each year or more often if deemed necessary.

 

Business Combinations

 

The Company applies the provisions of ASC Topic 805, Business Combinations (“ASC 805”) in the accounting for acquisitions of businesses. ASC 805 requires the Company to use the acquisition method of accounting by recognizing the identifiable tangible and intangible assets acquired and liabilities assumed, measured at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the aforementioned amounts. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations.

 

Deferred Taxes and Valuation Allowance

 

We account for income taxes pursuant to the asset and liability method of accounting for income taxes pursuant to FASB ASC740, “Income Taxes.” Deferred tax assets and liabilities are recognized for taxable temporary differences and operating loss carry forwards. Temporary differences are the differences between the reported amount of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Non-GAAP Financial Measures

 

The following discussion and analysis contain a non-GAAP financial measure. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternative to, net income, operating income, and cash flow from operating activities, liquidity or any other financial measures. Non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive of potential future financial results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.

 

Management believes stockholders benefit from referring to the Adjusted EBITDA (a non-GAAP metric) in planning, forecasting, and analyzing future periods. Management uses this non-GAAP financial measure in evaluating its financial and operational decision making and as a means of evaluating period-to-period comparison.

 

15

 

 

EBITDA, or earnings before interest, taxes, depreciation, and amortization, is an alternative measure of profitability to net income. Management believes Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of significant non-cash and non-recurring charges that affect comparability between reporting periods. We define Adjusted EBITDA as net loss adjusted for non-cash charges for depreciation and amortization, impairment of goodwill, stock compensation, change in contingent consideration, also adjusted for non-recurring other expenses (income), net, loss on investment, and interest income. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items.

 

We have included a reconciliation of our non-GAAP financial measure to net loss as calculated in accordance with GAAP. We believe that providing the non-GAAP financial measure, together with reconciliation to GAAP, helps investors make comparisons between the Company and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to specific definitions being used and to the reconciliation between such measures and the corresponding GAAP measures provided by each company under applicable rules of the Securities and Exchange Commission.

 

   2024   2023 
Reconciliation from net loss to adjusted EBITDA:          
Net loss  $(4,506,466)  $(9,932,620)
Interest expense   848,651    199,681 
Depreciation and amortization   1,576,457    1,431,815 
EBITDA   (2,081,358)   (8,301,124)
Impairment of goodwill   -    6,104,000 
Change in contingent consideration   -    (774,900)
Loss on debt extinguishment   1,888,889    - 
Other expenses (income), net   (8,552)   (16,230)
Adjusted EBITDA  $(201,021)  $(2,988,254)

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

Not applicable to smaller reporting companies.

 

Item 8. Financial Statements and Supplementary Data.

 

See pages F-1 through F-25.

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

 

None.

 

Item 9A. Controls and Procedures.

 

We are required to report under Section 404(a) of Sarbanes-Oxley regarding the effectiveness of our internal control over financial reporting.

 

Evaluation of Disclosure Controls and Procedures. Our management, including our Principal Executive Officer and Principal Financial Officer, carried out an evaluation on internal controls during the year ended December 31, 2024 in regard to the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act. Based on the evaluation, our Principal Executive Officer and Principal Financial Officer concluded that the Company’s disclosure controls and procedures were ineffective.

 

16

 

 

Inherent Limitations of Internal Controls over Financial Reporting. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the Company’s financial statements.

 

Changes in Internal Control Over Financial Reporting. There were no changes in the Company’s internal control over financial reporting that occurred during the quarter ending December 31, 2024 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

 

Management’s Annual Report on Internal Control over Financial Reporting. The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting. Under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, the Company evaluated the effectiveness of the design and operation of its internal control over financial reporting based on the framework established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s internal control over financial reporting was ineffective as of December 31, 2024 and noted the material weaknesses as follows:

 

  Failure to have properly documented and designed disclosure controls and procedures and testing of the operating effectiveness of our internal control over financial reporting.
  Failure to perform periodic cycle inventory counts and as such, does not monitor the inventory activity, between its semi-annual counts. In addition, the Company did not implement controls related to the review of inventory rollback and roll-forward procedures related to the year-end inventory counts. The Company did not implement segregation of duties surrounding the inventory purchase order process.
  Segregation of duties due to lack of personnel.
  Inadequacy in documenting accounts payable procedures and controls surrounding vendor master file changes.
  Segregation of duties due to lack of personnel.
  Failure to follow accounts payable policies and procedures for vendor information updates.
  Ineffective design and implementation over Information Technology General Controls (“ITGCs”):

 

(a)Multiple individuals in the accounting software system have virtually unlimited access to the accounting application and to the inventory point of sale applications. As such, such individuals can post journal entries and change pricing, which poses a risk that duties amongst employees with incompatible roles are not adequately segregated.
(b)Management does not evidence independent preparer and reviewer of journal entries, to demonstrate adequate segregation of duties, and the precision of the review of journal entries.
(c)Ineffective design, implementation and operation of controls over logical user access, physical security, change management, cyber security, and vendor management. The Company should have had controls for:

 

(i)Periodic review of access rights for networks and applications on a defined periodic basis, at least once per year;
(ii)Ensuring adequate physical safeguards and environmental controls over the Company’s servers at all Company locations, including stores;
(iii)Performing a cybersecurity assessment, training all personnel, performing phishing exercises, obtaining cybersecurity insurance; and performing third party audits when appropriate;
(iv)IT program and data changes affecting the Company’s financial IT applications and underlying accounting records, should be identified, tested, authorized and implemented appropriately to validate that data produced by its relevant IT system(s) were complete and accurate.
(v)Obtaining and reviewing third party service provider SOC reports, and;
(vi)Review of Service-Level Agreements (SLAs) for all IT service relationships across the Company to ensure active SLAs are in place and enforced.

 

Our management concluded that considering internal control deficiencies, in the aggregate, rise to the level of material weaknesses, we did not maintain effective internal control over financial reporting as of December 31, 2024 based on the criteria set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

Remediation Efforts

 

Following this assessment and during the twelve months ended December 31, 2024, we have undertaken an action plan to strengthen internal controls and procedures:

 

  Establishing policies and procedures in the IT area to mitigate data breach, unauthorized access and address segregation of duties, as well as review key third party service provider SOC reports.

 

We are currently working to improve and simplify our internal processes and implement enhanced controls, as discussed above, to address the material weaknesses in our internal control over financial reporting and to remedy the ineffectiveness of our disclosure controls and procedures. These material weaknesses will not be considered to be remediated until the applicable remediated controls are operating for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

 

Item 9B. Other Information.

 

None.

 

17

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

Directors and Executive Officers

 

The following table sets forth information regarding our executive officers and directors as of December 31, 2024:

 

Name   Age   Position
Executive Officers:        
Jeffrey Holman   57   Chief Executive Officer, Chairman and Director
John A. Ollet   62   Chief Financial Officer and Director
Christopher Santi   54   President and Chief Operating Officer
         
Non-Employee Directors:        
Gary Bodzin   68   Director
Behnam Myers   50   Director
Michael Lerman   60   Director

 

Executive Officers

 

Jeffrey Holman is our Chairman of the Board and Chief Executive Officer. He is a Founding member of our original operating subsidiary since its inception December 2008. Mr. Holman helped to acquire and grow all the assets currently owned by HCWC. He has been the President of Jeffrey E. Holman & Associates, P.A., a South Florida Based law firm, since 1998. Mr. Holman graduated from the State University of New York at Binghamton in 1989 with a Bachelor’s Degree, Benjamin N. Cardozo School of Law in 1995 with a degree in Juris Doctor.

 

Christopher Santi is our President and Chief Operating Officer, served as Director of Operations of the Company beginning in October 2011. Mr. Santi served as the National Sales Manager of Collages.net from November 2007 to October 2011. Mr. Santi holds a Bachelor of Arts from Lehigh University in Psychology, as well as a Master of Arts from the Miami Institute of Psychology

 

John A. Ollet is our Chief Financial Officer. Mr. Ollet previously served as Executive Vice President of Finance for Systemax, Inc. (NYSE: SYX) from 2006 to 2016. His prior experience as a Chief Financial Officer (CFO) includes roles as Vice President (VP) and CFO of Arrow Cargo Holdings, Inc., an airline logistics company, and as VP of Finance and CFO of The Americas Cargo Division at KLM Royal Dutch Airlines. He also served as Vice President (VP) of Finance and Administration at Sterling-Starr Maritime Group, Inc., and was a member of the audit staff at Arthur Andersen & Co.

 

Mr. Ollet holds a bachelor’s degree in Finance and Economics and a Master of Business Administration (MBA) from Florida International University. He is a Certified Public Accountant (CPA).

 

Non-Employee Directors

 

Gary A. Bodzin. Gary Bodzin has served as a director of SpinCo since May 2023. Since 1987, Mr. Bodzin has been serving as President of Trans-State Title Insurance Agency, LLC, a company located in Aventura, FL, offering escrow, title and closing services for commercial and residential real estate transactions, where he oversees all title and closing operations. Mr. Bodzin has also worked as an attorney at law representing clients almost exclusively in real estate transactions since 1982. Mr. Bodzin received his Bachelor of Science in Business Administration from the University of Florida and his Juris Doctor from the University of Miami Law School. We believe Mr. Bodzin is qualified to serve as a director of SpinCo because of his real estate, finance and legal expertise and related ability to advise our growth and expansion strategy.

 

Michael Lerman. Michael Lerman has served as a director of SpinCo since May 2023. Since November 2005, Mr. Lerman has served as Vice President of Development and Marketing for Markbuilt Homes, a boutique private residential development and construction company in Union, NJ. From March 1998 to August 2005, he worked as Director of Retail Property Administration then as Director of Land/Property Acquisition and Development at Garden Commercial Properties, a property management company in Short Hills, NJ. During his tenure at Garden Commercial Properties, Mr. Lerman oversaw all phases of retail commercial development and management, negotiated commercial leases, and was responsible for marketing. Earlier in his career, Mr. Lerman was associate counsel at Rinaldo and Rinaldo, a law firm. Mr. Lerman received his Bachelor of Arts from Rutgers College and his Master of Business Administration from Rutgers College, Graduate School of Management. He also received his Juris Doctor from Benjamin N. Cardozo School of Law. We believe Mr. Lerman is qualified to serve as director of SpinCo because of his extensive experience in business development and management as well as his retail and acquisition experience and related ability to provide valuable guidance.

 

Behnam J. Myers, DO, MPH. Behnam Myers, DO, MPH, has served as a director of SpinCo since May 2023. Dr. Myers is a board-certified orthopedic surgeon who has been practicing since 2006, and has been managing his own private practice, Spine Solutions, since 2012 in Hollywood, FL. In 2006, Dr. Myers completed his orthopedic surgery residency at Parkway Regional Medical Center as part of Nova Southeastern University’s Orthopedic Surgery Residency Program. He then completed a Spine Surgery Fellowship in 2007 at the Cleveland Clinic Spine Institute in Weston, FL. Dr. Myers received his Bachelor of Science from the University of California at Riverside, his Masters of Public Health from Loma Linda University and his medical degree from University of New England College of Medicine. We believe Dr. Myers is qualified to serve as a director of SpinCo because of his medical expertise and medical practice-related business experience.

 

18

 

 

Corporate Governance

 

Board Responsibilities

 

The Board oversees, counsels, and directs management in the long-term interest of the Company and its stockholders. The Board’s responsibilities include establishing broad corporate policies and reviewing the overall performance of the Company. The Board is not, however, involved in the operating details on a day-to-day basis.

 

Board Committees and Charters

 

The Board and its Committees meet throughout the year and act by written consent from time-to-time as appropriate. The Board delegates various responsibilities and authority to different Board Committees. Committees regularly report on their activities and actions to the Board.

 

The Board currently has and appoints the members of: The Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee. Each of these committees have a written charter which can be found on our corporate website at https://hcwc.com/committee-charters.

 

The following table identifies the independent and non-independent current Board and committee members:

 

Name   Independent   Audit   Compensation   Nominating And Corporate Governance
Jeffrey Holman                
John Ollet                
Gary Bodzin   X   X   X   X
Behnam Myers   X   X   X   X
Michael Lerman   X   X   X   X

 

Director Independence

 

Our Board has determined that Gary Bodzin (Director), Behnam Myers (Director), and Michael Lerman (Director) meet the criteria for independence as defined by the NYSE American listing standards. In accordance with these standards, the Board concluded that Jeffrey Holman and John Ollet, due to their roles as executive officers of the Company, are not independent under the NYSE American. Furthermore, the Board affirmed that Messrs. Bodzin, Myers, and Lerman satisfy the NYSE American’s heightened independence requirements for service on both the Audit Committee and Compensation Committee.

 

Committees of the Board

 

Audit Committee

 

The Audit Committee, which currently consists of Gary Bodzin (chair), Behnam Myers and Michael Lerman, reviews the Company’s financial reporting process on behalf of the Board and administers our engagement of the independent registered public accounting firm. The Audit Committee approves all audit and non-audit services and reviews the independence of our independent registered public accounting firm.

 

Audit Committee Financial Expert

 

Our Board has determined that Gary Bodzin is qualified as an Audit Committee Financial Expert, as that term is defined by the rules of the SEC and in compliance with the Sarbanes-Oxley Act of 2002.

 

Compensation Committee

 

The function of the Compensation Committee is to determine the compensation of our executive officers. The Compensation Committee has the power to set performance targets for determining periodic bonuses payable to executive officers and may review and make recommendations with respect to stockholder proposals related to compensation matters. Additionally, the Compensation Committee is responsible for administering the Company’s equity compensation plans.

 

The members of the Compensation Committee are all independent directors within the meaning set forth in the NYSE American Company Guide.

 

19

 

 

Nominating and Corporate Governance Committee

 

The responsibilities of the Nominating and Corporate Governance Committee include the identification of individuals qualified to become Board members, the selection of nominees to stand for election as directors, the oversight of the selection and composition of committees of the Board, establish procedures for the nomination process including procedures and the oversight of the evaluations of the Board and management. The Nominating and Corporate Governance Committee has not established a policy with regard to the consideration of any candidates recommended by stockholders since no stockholders have made any recommendations. If we receive any stockholder recommended nominations, the Nominating Committee will carefully review the recommendation(s) and consider such recommendation(s) in good faith.

 

Compensation Committee Interlocks and Insider Participation

 

None of the members of our compensation committee has ever been an officer or employee of the Company. None of our executive officers serve, or have served during the last fiscal year, as a member of our compensation committee or other Board committee performing equivalent functions of any entity that has one or more executive officers serving on our Board or on our compensation committee.

 

Clawback Policy

 

In accordance with SEC Rule 10D-1 and NYSE American listing standards, the Company has adopted a clawback policy to recover erroneously awarded incentive-based compensation in the event of a financial restatement resulting from material noncompliance with financial reporting requirements. This policy applies to current and former executive officers, and recovery is required regardless of fault. The Compensation Committee is responsible for administering the policy, which is filed as Exhibit 97.1 to this Annual Report on Form 10-K.

 

Board Assessment of Risk

 

The Board is actively involved in the oversight of risks that could affect the Company. This oversight is conducted primarily through the Audit Committee, but the full Board has retained responsibility for general oversight of risks. The Audit Committee considers and reviews with our independent public accounting firm and management the adequacy of our internal controls, including the processes for identifying significant risks and exposures, and elicits recommendations for the improvements of such procedures where desirable. In addition to the Audit Committee’s role, the full Board is involved in oversight and administration of risk and risk management practices. Members of our senior management have day-to-day responsibility for risk management and establishing risk management practices, and members of management are expected to report matters relating specifically to the Audit Committee directly thereto, and to report all other matters directly to the Board as a whole. Members of our senior management have an open line of communication to the Board and have the discretion to raise issues from time-to-time in any manner they deem appropriate, and management’s reporting on issues relating to risk management typically occurs through direct communication with directors or committee members as matters requiring attention arise. Members of our senior management regularly attend portions of the Board’s meetings, and often discuss the risks related to our business.

 

Code of Ethics

 

The Company has a code of ethics, “Business Conduct: “Code of Conduct and Policy,” that applies to all of the Company’s employees, including its principal executive officer, principal financial officer and principal accounting officer, and the Board. A copy of this code is available on the Company’s website at https://hcwc.com/code-of-conduct. The Company intends to disclose any changes in or waivers from its code of ethics by posting such information on its website or by filing a Current Report on Form 8-K.

 

Stockholder Communications

 

Although we do not have a formal policy regarding communications with our Board, stockholders may communicate with the Board by writing to us at Healthy Choice Wellness Corp., 3800 N 28th Way, Unit# 1, Hollywood, FL 33020, Attention: Corporate Secretary, or by facsimile at (954) 251-3057. Stockholders who wish to direct their correspondence to a specific Board member may indicate this in their submission, and the communication will be forwarded accordingly.

 

20

 

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Exchange Act requires our officers and directors, and persons who own more than 10% of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and the other equity securities. Officers, directors and greater than ten percent stockholders are required by SEC rules to furnish us with copies of all Section 16(a) reports they file.

 

Based solely on a review of the reports furnished to us, or written representations from reporting persons that all reportable transactions were reported and that no Form 5s were required, we believe that during 2024 our officers, directors and greater than 10% owners timely filed all reports they were required to file under Section 16(a).

 

ITEM 11. Executive Compensation

 

Following the spin-off from HCMC in September 2024, HCWC became an independent, publicly traded company. However, during the fiscal year 2024, the executive compensation structure remained intertwined with HCMC due to transitional arrangements and shared leadership responsibilities. For the entirety of 2024, the three executives who serve in leadership roles at both HCMC and HCWC continued to receive their full compensation directly from HCMC. For the year ended December 31, 2024, the total executive compensation paid by HCMC for these executives was approximately $1.4 million. In accordance with an internal allocation arrangement, approximately $0.7 million was allocated to HCWC to reflect the portion of the executives’ time and services dedicated to HCWC’s business. These allocations were made in accordance with the terms of the Transition Services Agreement (“TSA”), which was established to facilitate an orderly transition following the spin-off.

 

The Compensation Committee of HCWC’s Board of Directors is in the process of developing and approving an independent compensation structure that aligns with HCWC’s business objectives and shareholder interests. HCWC’s Board of Directors has formed a Compensation Committee responsible for overseeing future executive compensation policies. The Committee will evaluate and establish appropriate compensation structures to attract and retain key executive talent while ensuring alignment with HCWC’s strategic goals.

 

Because HCWC did not directly pay executive compensation in 2024, the executive compensation tables required under Item 11 of Form 10-K are not presented in this filing. Instead, executive compensation details, including salary, bonus, equity awards, and other benefits, are fully reported in HCMC’s 2024 Form 10-K.

 

Named Executive Officer Employment Agreements

 

We currently do not have any employment or other agreements in effect with our named executive officers.

 

Outstanding Awards at Fiscal Year End

 

No named executive officer had any option, restricted stock or other incentive equity awards of the Company outstanding at the 2024 fiscal year end.

 

21

 

 

Risk Assessment Regarding Compensation Policies and Practices as they Relate to Risk Management

 

Our compensation program for employees does not create incentives for excessive risk taking by our employees or involve risks that are reasonably likely to have a material adverse effect on us. Our compensation has the following risk-limiting characteristics:

 

  Our base pay programs consist of competitive salary rates that represent a reasonable portion of total compensation and provide a reliable level of income on a regular basis, which decreases incentive on the part of our executives to take unnecessary or imprudent risks; and

 

  Cash bonus awards are not tied to formulas that could focus executives on specific short-term outcomes.

 

 

Director Compensation

 

Non-employee directors are paid a monthly fee of $1,000 and $1,500 for each meeting attended. The Audit Committee chairman receives $15,000 annually and the Compensation Committee chairman receives $10,000 annually. Because we do not pay any compensation to employee directors, Mr. Holman is omitted from the following table. Non-employee members of our Board of Directors were compensated as follows:

 

Fiscal 2024 Director Compensation

 

Name 

Fees Earned or

Paid in Cash ($)

 
Gary Bodzin  $12,375 
Behnam Myers  $8,000 
Michael Lerman  $10,917 

 

22

 

 

Equity Compensation Plan Information

 

Our Stock Incentive Plan

 

The Healthy Choice Wellness Corp 2024 Equity Incentive Plan (the “Stock Incentive Plan”) became effective on September 16, 2024 as part of the SEC approval of HCWC. A form of the Stock Incentive Plan is filed as an exhibit to the registration statement, of which this prospectus forms a part. The following description of the Stock Incentive Plan is qualified in its entirety by reference to the Stock Incentive Plan.

 

Overview

 

The Stock Incentive Plan provides the Company with the ability to grant equity-based and cash incentive awards to its employees, non-employee directors, consultants and independent contractors. Such incentive awards are granted to attract, retain and motivate the Company’s service providers and help align them with the Company’s financial success over the long term and the interests of the Company and our stockholders. The Stock Incentive Plan will terminate ten years from inception unless terminated sooner.

 

Stock Incentive Plan Share Reserve; Limits; Adjustments

 

The available share reserve under the Stock Incentive Plan is 1,400,000 shares, which were granted into the plan on February, 2025; plus an annual increase on the first day of each year beginning in 2024 and ending in 2032, equal to the lesser of (A) 12.5% percent of the Shares outstanding on the last day of the immediately preceding fiscal year and (B) such smaller number of Shares as determined by the Board or the Compensation and Compensation Committee of the Board. The Company may satisfy its obligations under any equity-based award granted under the Stock Incentive Plan by issuing new shares or Treasury shares.

 

Shares subject to an equity award are counted only to the extent they are actually issued. Thus, awards that terminate by expiration, forfeiture, cancellation, or otherwise are settled in cash in lieu of shares, or exchanged for awards not involving shares, shall again be available for grant under the Stock Incentive Plan.

 

Any shares withheld to satisfy tax withholding obligations on awards issued under the Stock Incentive Plan, tendered to pay the exercise price of an award under the Stock Incentive Plan and shares repurchased on the open market with the proceeds of an option exercise will not be eligible to be again available for grant under the Stock Incentive Plan. Any substitute awards shall not be counted against the shares available for granting awards under the Stock Incentive Plan.

 

The number of shares that may be issued or subject to outstanding awards, the option price or grant price applicable to outstanding awards and other value determinations are subject to adjustment by the committee to reflect stock dividends, stock splits, reverse stock splits, spin-offs, and other corporate events or transactions, including without limitation distributions of stock or property other than normal cash dividends.

 

Non-employee directors can be granted any of the awards available under the Stock Incentive Plan except incentive stock options (“ISOs”), which are only available for employees. The Board shall from time to time determine the nature and number of awards to be granted to non-employee directors. The aggregate value of all compensation granted or paid, as applicable, to a non-employee director with respect to any calendar year, including awards granted and cash fees paid by the Company to such non-employee director, will not exceed $500,000, calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting purposes.

 

Administration

 

The Stock Incentive Plan will be administered by the committee appointed by the Board from among its members, provided that the full Board may act at any time as the committee. In the case of awards intended to qualify for the exemption from Section 16(b) of the Securities Exchange Act of 1934 that is available under Rule 16b-3, a subcommittee of the Board composed of at least two directors who are “outside directors” is responsible for administering the Stock Incentive Plan and has the final discretion, responsibility and authority to interpret the terms and intent of the Stock Incentive Plan and any related documentation, to determine eligibility for awards and the terms and conditions of awards, and to adopt rules, regulations, forms, instruments, and guidelines. The committee may delegate administrative duties and powers to one or more of its members or to one or more officers, agents, or advisers. The committee may also delegate to one or more officers the power to designate other employees (other than officers subject to Section 157(c) of the Delaware General Corporate Law) to be recipients of awards.

 

23

 

 

Eligibility

 

Employees, non-employee directors, consultants and independent contractors of the Company who are selected by the compensation committee are eligible to participate in the Stock Incentive Plan.

 

Types of Awards

 

The Stock Incentive Plan provides that the compensation committee may grant awards of various types. A description of each of the types of awards follows.

 

Stock Options

 

The committee may grant both ISOs and nonqualified stock options (“NQSOs”) under the Stock Incentive Plan. Eligibility for ISOs is limited to employees of the Company and its subsidiaries. The exercise price for options cannot be less than the fair market value of the Company’s Class A common stock as of the date of grant. The latest expiration date cannot be later than the tenth anniversary of the date of grant. Fair market value under the Stock Incentive Plan may be determined by reference to market prices on a particular trading day or on an average of trading days. The exercise price may be paid by means approved by the committee, which may include cash or check, the tendering of previously acquired Class A common stock, a reduction in shares issuable upon exercise which have a value at the time of exercise that is equal to the option price (a “net exercise”), to the extent permitted by applicable law, the proceeds of sale from a broker-assisted cashless exercise or any other legal consideration that the committee may deem appropriate on such basis as the committee may determine in accordance with the Stock Inventive Plan.

 

Stock Appreciation Rights

 

The committee may grant stock appreciation rights (“SARs”) under the Stock Incentive Plan either alone or in tandem with stock options. The grant price of an SAR cannot be less than the fair market value of the Company’s Class A common stock as of the date of grant.

 

Restricted Stock

 

The committee may award restricted Class A common stock and restricted stock units. Restricted stock awards consist of shares of stock that are transferred to the participant subject to restrictions that may result in forfeiture if specified conditions are not satisfied. A holder of restricted stock is treated as a current stockholder and is entitled to dividend and voting rights. The committee will determine the restrictions and conditions applicable to each award of restricted stock.

 

Performance-Based Restricted Shares and Performance-Based Restricted Share Units

 

Performance-based restricted shares and performance-based restricted share units may be granted under the Stock Incentive Plan. The performance cycle for each award will be determined by the committee and specify the performance goals that are to be achieved by the participant and a formula for determining the amount of any payment to be made.

 

In the case of performance-based restricted shares, during the period for which a substantial risk of forfeiture is to continue, the participant will not have any right to transfer any rights under the award, but the participant will have voting and other ownership rights (except for any rights to a liquidating distribution). Prior to payment of the award of performance-based restricted share units, the participant will not have any right to transfer any rights under the award or have any rights of ownership, including the right to vote.

 

For both performance-based restricted shares and performance-based restricted share units, the committee may on or after the grant date authorize the payment of dividend equivalents on the performance-based restricted shares or performance-based restricted share units in cash or securities with respect to any dividends or other distributions paid by the Company. Any dividend equivalents paid, or adjustments made with respect to the dividends paid in Common Stock will be subject to the same restrictions as the underlying award.

 

Following the completion of a performance cycle, the committee will determine whether the performance goals that have been chosen for a particular performance period have been met and calculate and determine the amount of the award earned for such performance cycle. Awards may be adjusted upwards or downwards in the sole discretion of the committee.

 

Cash-Based Awards

 

The committee may grant cash-based awards under the Stock Incentive Plan that specify the amount of cash to which the award pertains, the conditions under which the award will be vested and payable, and such other conditions as the committee may determine that are consistent with the terms of the Stock Incentive Plan.

 

Other Stock-Based Awards

 

The committee may grant equity-based or equity-related awards, referred to as “other stock-based awards,” other than options, SARs, restricted stock, restricted stock units, performance shares, or performance units. The terms and conditions of such other stock-based awards shall be determined by the committee. Payment under any other stock-based awards will be made in shares of Class A common stock or cash, as determined by the committee.

 

Termination of Employment

 

Except as otherwise provided in the award agreement or other written agreement between the participant and the Company, vesting of awards will cease upon termination of the participant’s continued service. Notwithstanding any other provision of the Stock Incentive Plan to the contrary, the committee may in its sole discretion determine the rights of participants with respect to awards upon termination of employment or service as a director.

 

Treatment of Awards Upon a Change in Control

 

In the event of a “change in control” of the Company, as defined in the Stock Incentive Plan, then unless otherwise provided in an award agreement, the committee may, in its sole discretion: (a) cancel awards for a cash payment equal to their fair value (as determined in the sole discretion of the committee), (b) provide for the issuance of replacement awards, (c) terminate options without providing accelerated vesting, (d) immediately vest the unvested portion of any award or (e) take any other action with respect to the awards the committee deems appropriate. The treatment of awards upon a change in control may vary among participants and types of awards in the committee’s sole discretion. Awards subject to performance goals shall be settled upon a “change in control” of the Company based upon the extent to which the performance goals underlying such awards have been achieved as determined in the sole discretion of the committee.

 

Amendment of Awards or Stock Incentive Plan

 

The committee may at any time alter, amend, modify, suspend, or terminate the Stock Incentive Plan or any outstanding award in whole or in part. No amendment of the Stock Incentive Plan will be made without stockholder approval if stockholder approval is required by law or stock exchange rule. No amendment may adversely affect the rights of any participant without his or her consent under an outstanding award, unless specifically provided for in the Stock Incentive Plan.

 

24

 

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.

 

The following table sets forth the number of shares of our common stock beneficially owned as of March 27, 2025, by (i) those persons known by us to be owners of more than 5% of our common stock, (ii) each director, (iii) our Named Executive Officers and (iv) all of our executive officers and directors of as a group. Unless otherwise specified in the notes to this table, the address for each person is: c/o Healthy Choice Wellness Corp., 3800 North 28th Way, Unit# 1, Hollywood, Florida 33020.

 

Title of Class  Beneficial Owner  Amount and Nature of Beneficial Owner (1)   Percent of Class (1) 
Directors and Executive Officers:             
Common Stock  Jeffrey E. Holman (2)   1,079,412    10.2%
Common Stock  Christopher Santi (3)   579,488    5.5%
Common Stock  John Ollet (4)   378,177    3.6%
Common Stock  Gary Bodzin (5)   -    -%
Common Stock  Behnam Myers (6)   -    -%
Common Stock  Michael Lerman (7)   -    -%
All directors and officers as a group (6 persons) (8)      2,037,077    19.3%
              
5% Stockholders:             
Common Stock  Jeffrey E. Holman   

1,079,412

    10.2%
Common Stock  Christopher Santi   

579,488

    

5.5

%
Total:      1,658,900    15.7%

 

25

 

 

(1) Beneficial Ownership. Applicable percentages are based on 10,565,749 shares of common stock outstanding as of March 27, 2025. Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options, warrants, convertible notes and preferred stock currently exercisable or convertible or exercisable or convertible within 60 days are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding for computing the percentage of any other person. The table includes shares of common stock, options, warrants, and preferred stock exercisable or convertible into common stock and vested or vesting within 60 days. Unless otherwise indicated in the footnotes to this table, we believe that each of the stockholders named in the table has sole voting and investment power with respect to the shares of common stock indicated as beneficially owned by them. The table does not include: (i) restricted stock units that do not have the right to vote until they vest and the shares are delivered or (ii) unvested options that do not vest within 60 days of the date listed above in this footnote.

 

(2) Holman. Chairman and Chief Executive Officer. Includes 1,079,412 shares of Common Stock.

 

(3) Santi. President and Chief Operation Officer. Includes 579,488 shares of Common.

 

(4) Ollet. Chief Financial Officer. Includes 378,177 shares Common Stock.

 

(5) Bodzin. A director. Includes 0 shares of Common Stock.

 

(6) Myers. A director. Includes 0 shares of Common Stock.

 

(7) Lerman. A director. Includes 0 shares of Common Stock.

 

(8) Directors and Executive Officers. Includes executive officers who are not Named Executive Officers under the SEC’s rules and regulations.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

Relationship with HCMC and Transition Services Agreement

 

HCMC provided human resources, accounting, payroll processing, legal, and other managerial services to HCWC prior to the Spin-Off. On September 13, 2024, HCWC was spun off from HCMC, becoming an independent, publicly traded company. Following the Spin-Off, HCWC and HCMC entered into a TSA, under which both companies agreed to provide certain transitional services to one another to ensure smooth separation. These services are provided on a transitional basis and will continue for a period of up to one year following the Spin-Off. Following the Spin-Off, HCWC recognized shared overhead costs of $0.4 million for services provided under the TSA and settled these billings with HCMC on a monthly basis.

 

Policies and Procedures for Related Party Transactions

 

We have adopted a policy that our executive officers, directors, nominees for election as a director, beneficial owners of more than 5% of any class of our common stock and any members of the immediate family of any of the foregoing persons are not permitted to enter into a related party transaction with us without the prior consent of our audit committee. Our audit committee will review and oversee all transactions with an executive officer, director, nominee for election as a director, beneficial owner of more than 5% of any class of our common stock or any member of the immediate family of any of the foregoing persons and such person would have a direct or indirect interest. In approving or rejecting any such transactions, our audit committee is to consider the material facts of the transaction, including, but not limited to, whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related party’s interest in the transaction.

 

26

 

 

Item 14. Principal Accounting Fees and Services.

 

Our Audit Committee pre-approves audit and permissible non-audit services performed by its independent registered public accounting firm, as well as the fees charged for such services. All services related to audit fees and audit-related fees charged were pre-approved by the Audit Committee. The following table shows the fees for the years ended December 31, 2024 and 2023.

 

   2024   2023 
Audit (1)  $456,488   $372,345 
Audit - Related   352,306    288,058 
Tax   14,208    - 
Other   54,075    - 
Total  $877,077   $660,403 

 

Audit fees — these fees relate to the audit of our consolidated annual financial statements and the review of our interim quarterly condensed consolidated financial statements and our registration statements.

 

Audit-related fees - the aggregate fees billed for assurance and related services by the principal accountant that are related to the performance of the audit or review of the registrant’s financial statements and are not reported under paragraph (1) above.

 

Tax fees - the aggregate fees billed for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning.

 

Other fees - the aggregate fees billed other than the services reported in audit, audit-related and tax fees.

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules.

 

(a) Documents filed as part of the report.

 

  (1) Financial Statements. See Index to Consolidated Financial Statements, which appears on page F-1 hereof. The financial statements listed in the accompanying Index to Consolidated Financial Statements are filed herewith in response to this Item.

 

  (2) Financial Statements Schedules. All schedules are omitted because they are not applicable or because the required information is contained in the consolidated financial statements or notes included in this report.

 

  (3) Exhibits. The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this report.

 

27

 

 

FINANCIAL STATEMENT INDEX

 

Report of Independent Registered Public Accounting Firm (PCAOB ID # 1195) F-2
   
Report of Independent Registered Public Accounting Firm (PCAOB ID # 688) F-3
   
Consolidated Financial Statements  
   
Consolidated Balance Sheets as of December 31, 2024 and 2023 F-4
   
Consolidated Statements of Operations for the Years Ended December 31, 2024 and 2023 F-5
   
Consolidated Statements of Changes in Stockholders’ Equity for the Years Ended December 31, 2024 and 2023 F-6
   
Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023 F-7
   
Notes to Consolidated Financial Statements F-8

 

F-1
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of Healthy Choice Wellness Corp.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Healthy Choice Wellness Corp. (the “Company”) as of December 31, 2024, and the related consolidated statements of operations, changes in stockholders’ equity, and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Emphasis of Matter

 

As discussed in Note 2 to the consolidated financial statements, the Company has experienced recurring losses from operations and has a net working capital deficit. Management’s evaluation of the events and conditions and management’s plans to mitigate those matters are also described in Note 2. Our opinion is not modified with respect to that matter.

 

/s/ UHY llp

 

UHY llp

 

We have served as the Company’s auditor since 2024.

 

Hudson, New York

March 27, 2025

 

F-2
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of

Healthy Choice Wellness Corp.

 

Opinion on the Financial Statements

 

We have audited, before the effects of the retrospective adjustments to the disclosures for the adoption of ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) discussed in Notes 3 and 5 and the reporting of basic and diluted weighted average shares and net loss per share discussed in Note 3 to the accompanying consolidated carve-out balance sheet of Healthy Choice Wellness Corp. (the “Company”) as of December 31, 2023, the related consolidated carve-out statements of operations, changes in net parent’s investment and cash flows for the year ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”) (the 2023 financial statements before the effects of the adjustments discussed in Notes 3 and 5 to the financial statements are not presented herein). In our opinion, the financial statements, before the effects of the retrospective adjustments to the disclosures for the adoption of ASU 2023-07 discussed in Notes 3 and 5 and the reporting of basic and diluted weighted average shares and net loss per share discussed in Note 3 to the financial statements, present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

We were not engaged to audit, review, or apply any procedures to the retrospective adjustments to the disclosures for the adoption of ASU 2023-07 discussed in Notes 3 and 5 and the reporting of basic and diluted weighted average shares and net loss per share discussed in Note 3 to the financial statements, and accordingly, we do not express an opinion or any other form of assurance about whether such retrospective adjustments are appropriate and have been properly applied. Those retrospective adjustments were audited by UHY, LLP.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Emphasis of Matter

 

As discussed in Note 3, the financial statements have been prepared on a “carve-out” basis from the financial statements of Healthier Choices Management Corp. to reflect the assets, liabilities, revenues and expenses of Healthy Choice Wellness Corp. as well as allocations deemed reasonable by management to present the results of operations, financial position and cash flows of Healthy Choice Wellness Corp. on a standalone basis and may not reflect Healthy Choice Wellness Corp. results of operations, financial position and cash flows had the Company operated as a standalone company during the period presented. Our opinion is not modified with respect to this matter.

 

/s/ Marcum llp

 

Marcum llp

 

We served as the Company’s auditor from 2022 to 2024

 

Saddle Brook, NJ

May 24, 2024

 

F-3
 

 

HEALTHY CHOICE WELLNESS CORP.

CONSOLIDATED BALANCE SHEETS

 

  

December 31,

2024

  

December 31,

 2023

 
         
ASSETS          
CURRENT ASSETS          
Cash  $2,056,472   $1,422,580 
Accounts receivable, net   509,763    128,171 
Inventories   6,445,560    4,162,218 
Prepaid expenses and vendor deposits   475,088    174,970 
Other current assets   29,806    56,842 
Due from related party   190,268    - 
TOTAL CURRENT ASSETS   9,706,957    5,944,781 
           
Property, plant, and equipment, net   1,976,469    2,676,639 
Intangible assets, net   5,441,478    4,178,519 
Goodwill   2,212,000    - 
Right of use assets   14,232,240    11,412,562 
Due from related party   -    3,753,003 
Other assets   543,373    467,056 
TOTAL ASSETS  $34,112,517   $28,432,560 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts payable and accrued expenses  $6,131,534   $4,920,411 
Contract liabilities   80,456    207,513 
Current portion of loan payable   2,131,336    702,701 
Operating lease liability, current   3,596,987    2,748,824 
TOTAL CURRENT LIABILITIES   11,940,313    8,579,449 
           
Loan payable, net of current portion   9,207,772    2,403,807 
Operating lease liability, net of current   10,584,431    8,461,182 
TOTAL LIABILITIES   31,732,516    19,444,438 
           
COMMITMENTS AND CONTINGENCIES (SEE NOTE 15)   -    - 
           
STOCKHOLDERS’ EQUITY          
Common Stock, $0.001 par value per share, 560,000,000 shares authorized; 9,815,749 and 10 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.   9,816    - 
Series A convertible preferred stock, $0.001 par value per share, 40,000,000 shares authorized, 0 share issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.   -    - 
Additional paid-in capital   3,101,092    - 
Net investment by former parent   -    8,988,122 
Accumulated deficit   (730,907)   - 
TOTAL STOCKHOLDERS’ EQUITY   2,380,001    8,988,122 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $34,112,517    28,432,560 

 

See notes to consolidated financial statements.

 

F-4
 

 

HEALTHY CHOICE WELLNESS CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   2024   2023 
   For The Years Ended December 31, 
   2024   2023 
SALES, NET  $69,370,803   $55,689,793 
COST OF SALES   42,305,494    35,341,569 
GROSS PROFIT   27,065,309    20,348,224 
           
OPERATING EXPENSES, NET          
Selling, general and administrative   29,047,933    24,768,293 
Gain on sale of asset   (205,146)   - 
Impairment of goodwill   -    6,104,000 
TOTAL OPERATING EXPENSES, NET   28,842,787     30,872,293 
           
LOSS FROM OPERATIONS   (1,777,478)   (10,524,069)
           
OTHER INCOME (EXPENSE)          
Loss on debt extinguishment   (1,888,889)   - 
Change in contingent consideration   -    774,900 
Other income, net   8,552    16,230 
Interest expense, net   (848,651)   (199,681)
TOTAL OTHER INCOME (EXPENSE)   (2,728,988)   591,449 
           
LOSS BEFORE TAXES   (4,506,466)   (9,932,620)
           
INCOME TAX BENEFIT   -    - 
           
NET LOSS  $(4,506,466)  $(9,932,620)
           
BASIC AND DILUTED NET LOSS PER SHARE  $(0.48)  $(1.08)
           
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES   9,395,500    9,226,860 

 

See notes to consolidated financial statements.

 

F-5
 

 

HEALTHY CHOICE WELLNESS CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

 

   Shares   Amount   Capital   Parent   Deficit   Total 
   Common Stock  

Additional

Paid-In

  

Net

Investment

From

   Accumulated     
   Shares   Amount   Capital   Parent   Deficit   Total 
Balance – January 1, 2023   -    -    -   $15,505,661    -   $15,505,661 
Net transfer from parent   -    -    -    3,415,081    -    3,415,081 
Net loss   -    -    -    (9,932,620)   -    (9,932,620)
Balance – December 31, 2023   -    -    -    8,988,122    -    8,988,122 
Issuance of common stock for Spin-Off and transfer of former parent investment to additional paid in capital   9,226,860    9,227    (1,369,097)   1,359,870    -    - 
Issuance of common stock for IPO   400,000    400    2,579,600    -    -    2,580,000 
Exercise of warrants   188,889    189    1,890,589    -    -    1,890,778 
Net transfers to former parent   -    -         (6,572,433)   -    (6,572,433)
Net loss   -    -    -    (3,775,559)   (730,907)   (4,506,466 )
Balance – December 31, 2024   9,815,749   $9,816   $3,101,092   $-   $(730,907)  $2,380,001 

 

See notes to consolidated financial statements.

 

F-6
 

 

HEALTHY CHOICE WELLNESS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   2024   2023 
   For the Years Ended December 31, 
   2024   2023 
OPERATING ACTIVITIES          
Net loss  $(4,506,466)  $(9,932,620)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   1,576,457    1,431,816 
Loss on debt extinguishment   1,888,889    - 
Gain on sale of building   (205,146)   - 
Amortization of right-of-use assets   3,273,597    2,570,202 
Write-down of obsolete and slow-moving inventory   2,491,934    2,471,653 
Non-cash interest expense   32,500    32,000 
Change in contingent consideration   -    (774,900)
Loss on vendor settlement   -    91,291 
Change in allowance for credit losses   12,925    15,425 
Impairment of goodwill   -    6,104,000 
Changes in operating assets and liabilities:          
Accounts receivable   (394,517)   (88,366)
Inventories   (2,375,226)   (2,032,996)
Prepaid expenses and vendor deposits   (300,118)   (92,016)
Other current assets   27,036    140,801 
Due to related party   (2,440,094)   (1,416,638)
Other assets   (76,317)   (16,090)
Accounts payable and accrued expenses   1,178,624    1,430,867 
Contract liabilities   (127,057)   (21,604)
Lease liabilities   (3,121,863)   (2,438,179)
NET CASH USED IN OPERATING ACTIVITIES   (3,064,842)   (2,525,354)
           
INVESTING ACTIVITIES          
Payment for acquisition   (5,475,000)   (750,000)
Proceeds from sale of Saugerties, NY building   749,000    - 
Purchases of property and equipment   (251,793)   (179,623)
NET CASH USED IN INVESTING ACTIVITIES   (4,977,793)   (929,623)
           
FINANCING ACTIVITIES          
Proceeds from security purchase agreement   1,700,000    - 
Principal payments on loan payable   (2,535,758)   (558,095)
Proceeds from acquisition loan   7,500,000    - 
Proceeds from initial public offering (IPO)   4,000,000    - 
Payment for IPO-related cost   (1,420,000)     
Investment from parent company   1,736,412    3,415,081 
Due to related party   (2,306,016)   - 
Proceeds from warrant exercised   1,889    - 
NET CASH PROVIDED BY FINANCING ACTIVITIES   8,676,527    2,856,986 
           
NET INCREASE (DECREASE) IN CASH   633,892    (597,991)
CASH — BEGINNING OF PERIOD   1,422,580    2,020,571 
CASH — END OF PERIOD  $2,056,472   $1,422,580 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for interest  $816,151   $199,705 
Cash paid for income tax  $-   $- 
NON-CASH INVESTING AND FINANCING ACTIVITIES          
Promissory note related to acquisition  $1,825,000   $718,000 
Right-of-use assets obtained in exchange for operating lease liabilities  $4,609,608   $1,325,409 

 

See notes to consolidated financial statements

 

F-7
 

 

HEALTHY CHOICE WELLNESS CORP.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1. ORGANIZATION

 

Organization

 

Healthy Choice Wellness Corp. (the “Company” or “HCWC” or “we” or “our” or “us”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives.

 

Through its wholly owned subsidiaries, the Company operates:

 

Ada’s Natural Market, a natural and organic grocery store offering fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
   
Paradise Health & Nutrition’s three stores that likewise offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
   
Mother Earth’s Storehouse, a two-store organic and health food and vitamin chain in New York’s Hudson Valley, which has been in existence for over 40 years.
   
Greens Natural Foods’ eight stores in New York and New Jersey, offering a selection of 100% organic produce and all-natural, non-GMO groceries & bulk foods; a wide selection of local products; an organic juice and smoothie bar; a fresh foods department, which offers fresh and healthy “grab & go” foods; a full selection of vitamins & supplements; as well as health and beauty products.
   
Ellwood Thompson’s, an organic and natural health food and vitamin store located in Richmond, Virginia.
   
GreenAcres Market, an organic and natural health food and vitamin chain with five store locations in Kansas and Oklahoma. GreenAcres Market offers organic and all natural products and vitamins from both top national brands as well as locally sourced specialty brands.

 

Through its wholly owned subsidiary, Healthy Choice Wellness, LLC, the Company operates a Healthy Choice Wellness Center in Kingston, NY and has a licensing agreement for a Healthy Choice Wellness Center located at the Casbah Spa and Salon in Fort Lauderdale, FL.

 

These centers offer multiple vitamin drip mixes and intramuscular shots for clients to choose from that are designed to help boost immunity, fight fatigue and stress, reduce inflammation, enhance weight loss, and efficiently deliver antioxidants and anti-aging mixes. Additionally, there are IV vitamin mixes and shots for health, beauty, and re-hydration.

 

Through its wholly owned subsidiary, Healthy U Wholesale, the Company sells vitamins and supplements, as well as health, beauty, and personal care products on its website www.TheVitaminStore.com.

 

F-8
 

 

Sourcing and Vendors

 

We source from multiple suppliers. These suppliers range from small independent businesses to multinational conglomerates. For the years ended December 31, 2024 and 2023, approximately 25% and 41% of our total purchases were from one vendor, respectively.

 

Spin-Off

 

Healthier Choices Management Corp. (“HCMC” or the “Parent”) announced on August 22, 2022 that its Board of Directors approved the separation of the grocery business, including wellness business, into an independent, publicly traded company (the “Spin-Off” or “Separation”). Prior to the Spin-Off, HCWC was a subsidiary under HCMC, which operated the Ada’s Natural Market, Paradise Health & Nutrition, Mother Earth’s Storehouse, Greens Natural Foods, Ellwood Thompson’s, and GreenAcres Market retail brands, as well as licensed wellness centers and Healthy U Wholesale.

 

On September 13, 2024 (the “Spin-Off Date”), after the New York Stock Exchange American (“NYSEAM”) market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock commenced trading on the NYSEAM under the stock symbol “HCWC.”

 

HCMC distributed all the outstanding shares of common stock held by it on a pro rata basis to holders of HCMC’s common stock. For each 208,632 shares of HCMC common stock held as of 5:00 p.m., New York City time, on September 9, 2024, the record date for the Spin-Off (the “Record Date”), a HCMC stockholder was entitled to receive one (1) share of Class A common stock and three (3) shares of Class B common stock. The Distribution was made in book-entry form by a distribution agent as soon as practicable after the date of the Distribution.

 

HCMC has secured binding commitments of $13.25 million in equity financing for HCWC from the same group of investors that invested $13.25 million in HCMC Series E Preferred Stock. Pursuant to the Securities Purchase Agreement for the HCMC Series E Stock (“HCMC Series E SPA”), the purchasers of HCMC Series E Stock will also be required to purchase Series A Preferred Stock of HCWC in the same subscription amounts that the Purchasers paid for the HCMC Series E Stock (regardless of whether or not such HCMC Series E Stock has been converted into HCMC common stock).

 

NOTE 2. GOING CONCERN

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.

 

The Company currently and historically has reported net losses and cash outflows from operations. Cash and cash equivalents increased to approximately $2.1 million as of December 31, 2024, compared to $1.4 million as of December 31, 2023, driven by increased sales and improved sales margin. Working capital deficit decreased from negative $2.6 million as of December 31, 2023, to negative $2.2 million as of December 31, 2024, primarily due to improvement in cash reserves and inventory management. Net losses improved to $4.5 million for the year ending December 31, 2024 from $9.9 million for the year ended December 31, 2023. Cash used in operating activities increased to $3.1 million in 2024 from $2.5 million in 2023, respectively.

 

On July 18, 2024, HCWC entered into a $7.5 million loan and security agreement with a private lender to support its expansion plans and funding of any working capital needs, of which $4.2 million was used for the July 18, 2024 purchase of GreenAcres Market. The face amount of the loan is $7,500,000 with 12% annual interest and has a maturity date of July 17, 2027. On July 24, 2024, the Company finalized the closing of Saugerties building sale with all parties involved and received net proceeds of $695,000.

 

On August 18, 2022, HCMC entered into a Securities Purchase Agreement (“HCMC Preferred Stock”) pursuant to which the HCMC sold and issued 14,722 shares of its Series E Convertible Preferred Stock to institutional investors for $1,000 per share or an aggregate subscription of $13.25 million. This same group of investors committed to invest $13.25 million in HCWC after the Spin-Off and IPO transactions were completed. As such, HCWC entered into an agreement to sell shares of its Series A Convertible Preferred Stock (the “Series A Preferred Stock”), with the gross proceeds from such offering expected to be $13.25 million. The institutional investors that acquired HCMC Series E Preferred Stock are contractually required to purchase the Series A Preferred Stock in the same dollar amounts as they invested in the HCMC Series E Preferred Stock (regardless of whether or not such HCMC Series E Preferred Stock has been converted into HCMC common stock).

 

The Company believes its cash on hand and the commitment of $13.25 million raised through its security offering noted above will enable the Company to meet its obligations and capital requirements for at least the twelve months from the date these financial statements are issued. Accordingly, no adjustment has been made to the financial statements to account for this uncertainty.

 

F-9
 

 

NOTE 3. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in accordance with U.S. GAAP.

 

The Company has historically operated as part of HCMC and not as a standalone company. Financial statements representing the historical operations of HCMC’s grocery segment have been derived from HCMC’s historical accounting records and are presented on a carve-out basis through the Spin-Off date. The Company’s financial statements for the period September 14, 2024 through December 31, 2024 are consolidated financial statements based on the reported results of HCWC as a stand-alone company. HCMC completed steps to spin off its grocery segment and wellness business into HCWC. The entities under the grocery segment and wellness business were contributed (100%) to HCWC, as such the accompanying consolidated financial statements through the Spin-Off date have been contributed to HCWC using their carryover basis in accordance with Accounting Standard Codification (“ASC”) Topic 805, Business Combinations (“ASC 805”) for entities under common control. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the consolidated financial statements. The consolidated financial statements also include allocations of certain general, administrative, sales and marketing expenses from HCMC though the Spin-Off date. However, the amounts recognized by the Company are not necessarily representative of the amounts that would have been reflected in the consolidated financial statements had the Company operated independently of HCMC. Related-party allocations are discussed further in Note 18.

 

Segment Reporting

 

Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision makers, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company operates as a single reportable segment, as the CODM reviews financial performance and makes decisions on a consolidated basis.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc. (“Ada’s Natural Market”), Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), Healthy Choice Markets 3, LLC (“Mother Earth’s Storehouse”), Healthy Choices Markets 3 Real Estate LLC, Healthy Choice Markets IV, LLC (Green’s Natural Foods), Healthy Choice Markets V, LLC (Ellwood Thompson’s), Healthy Choice Markets VI, LLC (GreenAcres Market), Healthy Choice Wellness, LLC, and Healthy U Wholesale, Inc (“The Vitamin Store, LLC”). All intercompany accounts and transactions have been eliminated in consolidation.

 

Net Parent Investment

 

The accompanying consolidated financial statements were derived from the consolidated financial statements of HCMC on a carve-out basis though the Spin-Off date, and the consolidated financial statements also include allocations of certain general, administrative, legal, and marketing expenses from HCMC. The primary components of the Net Parent Investment are intercompany balances other than related party payables, the allocation of shared costs, and funding received to cover any shortfall in operating cash requirements. Balances between HCMC and the Company that were not historically cash settled are included in Net Parent Investment. Net Parent Investment represents the cumulative investment by HCMC in the Company through the Spin-Off date. Upon Spin-Off, the Company reclassed the balance in net parent investment to additional paid-in capital.

 

Use of Estimates in the Preparation of the Financial Statements

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include promotional discounts, manufacturer coupons and rebates, return allowances that are netted against revenue, useful lives and impairment of long-lived assets, allowance for credit losses, inventory provisions, deferred taxes and related valuation allowances, allocation of corporate general expenses, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.

 

Revenue Recognition

 

Revenues from product sales and services rendered, net of promotional discounts, manufacturer coupons and rebates, return allowances, and sales and consumption taxes, are recorded when products are delivered, title passes to customers and collection is likely to occur. Title passes to customers at the point of sale for retail and upon delivery of products for wholesale. Return allowances, which reduce revenue, are estimated using historical experience.

 

The Company promotes its products with trade incentives and promotions. These programs include sales discounts, rebates, coupons, volume-based incentives, refunds, and returns, which represent variable considerations. The estimation of variable consideration involves judgment and is constrained to avoid overstatement of revenue. The Company applies the expected value method or the most likely amount method, depending on which better predicts the consideration to which it will be entitled. Management evaluates these estimates on a quarterly basis. The trade incentives and promotions are recorded as a reduction to the transaction price based on amounts estimated as being due to customers at the end of the period. The Company derives these estimates based on historical experience. The Company does not receive a distinct service in relation to the trade incentives and promotions.

 

The Company recognizes revenue in accordance with the following five-step model:

 

  identify arrangements with customers.
  identify performance obligations.
  determine transaction price.
  allocate transaction price to the separate performance obligations in the arrangement, if more than one exists; and
  recognize revenue as performance obligations are satisfied.

 

The Company does not have significant revenue recognized over time due to the nature of retail store operation. The Company recognizes revenue at a point in time when control of goods or services transfers to the customer.

 

F-10
 

 

Shipping and Handling

 

Shipping charges billed to customers are included in net sales and the related shipping and handling costs are included in cost of sales. For the years ended December 31, 2024 and 2023, shipping and handling costs of approximately $132,000 and $117,000, were included in cost of sales, respectively.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash is concentrated in one financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage. The Company has not experienced any losses in such accounts. The Company did not have any cash equivalents as of December 31, 2024 and December 31, 2023.

 

A summary of the financial institution that had cash in excess of FDIC limits of $250,000 as of December 31, 2024 and December 31, 2023 is presented below:

 

 

  

December 31,

2024

  

December 31,

2023

 
Total cash and restricted cash in excess of FDIC limits  $715,852   $161,644 

 

The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.

 

Accounts Receivable, Contract Assets and Contract Liabilities

 

Accounts receivables are claims to consideration which are unconditional; meaning no performance obligations remain for the Company and only the passage of time is necessary before collection. Contract assets are distinguished from accounts receivable as performance obligations remain before claims to consideration become unconditional. By nature of the Company’s operations, contract assets are typically not recognized. Contract liabilities are recorded when customers transfer consideration in advance of delivery of products or services, which the Company records for gift cards and loyalty reward programs. When one party to an arrangement performs before the other(s), the Company records an account receivable, contract asset or contract liability.

 

The majority of arrangements with customers contain one performance obligation: to provide a distinct set of products or services. Most performance obligations are satisfied simultaneously as the Company exchanges products or services for customer payment. Exceptions include gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products or services at a future date. As gift cards are purchased and loyalty points earned, contract liabilities are recorded until the performance obligations are satisfied through delivery of products or services or breakage based on gift card and loyalty reward program term limits. For the years ended December 31, 2024 and 2023, the contract liability balance were approximately $80,000 and $208,000, respectively.

 

The Company’s breakage policy is twenty-four months for gift cards and twelve months for loyalty rewards. Loyalty rewards are earned at five percent on qualifying purchases and the reward functions as an allocation of transaction price from the period earned by the customer to the period the performance obligation is satisfied by the Company. As such, all contract liabilities are expected to be recognized within a twenty-four-month period.

 

In August 2024, the Company transitioned its customer loyalty program from a points-based system to a VIP membership structure. Under the original loyalty program, customers earned redeemable loyalty points based on qualifying purchases, which have been discontinued. Existing unredeemed loyalty points remain valid for redemption until January 31, 2025. The new VIP program provides members with immediate discounts on qualifying purchases, replacing the accrual of future points. The elimination of future loyalty point accruals reduces the Company’s ongoing contract liability obligations, as discounts under the VIP program are recognized as reductions to revenue at the time of sale.

 

F-11
 

 

Other Current Assets

 

Other current assets are the non-trade related assets that the Company owns, benefits from, or uses to generate income that can be converted into cash within one business cycle. Included in “Other current assets” on our consolidated balance sheets are amounts primarily related to other receivables or non-trade receivable from other companies.

 

Inventories

 

Inventories are measured at the lower of cost and net realizable value using the average cost method. If the cost of the inventories exceeds their net realizable value, adjustments are recorded to write down excess carrying value to their net realizable value. The Company’s inventories consist primarily of merchandise available for resale, such as fresh produce, perishable grocery items and non-perishable consumable goods. Slow-moving inventory is rotated out and obsolete inventory is removed (expensed) on a monthly basis.

 

Property, Plant, and Equipment

 

Property, plant, and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the expected useful life of the respective asset, after the asset is placed in service. Revenue earning property, plant, and equipment includes signage, furniture and fixtures, building, computer hardware, appliance, cooler, displays with useful lives range from two to ten years. Leasehold improvements are amortized over the shorter of the life of the asset or the term of the lease.

 

Identifiable Intangible Assets

 

Identifiable intangible assets are recorded at cost, or when acquired as part of a business acquisition, at estimated fair value. Certain identifiable intangible assets are amortized over 4 to 13 years. Similar to tangible personal property and equipment, the Company periodically evaluates identifiable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Impairment of Long-Lived Assets

 

The Company reviews all long-lived assets such as property and equipment and amortized intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated future cash flows expected to be generated by the asset or asset group. Impairment is measured by the amount by which the carrying value of the asset(s) exceeds their fair value. There were no triggering events that would indicate impairment of long-lived assets in the twelve months period ended on December 31, 2024.

 

F-12
 

 

Goodwill

 

The Company assesses the carrying amounts of goodwill for recoverability on at least an annual basis or when events or changes in circumstances indicate evidence of potential impairment exists, using a fair value-based test. In performing the Company’s analysis of goodwill, the Company first evaluates qualitative factors, including relevant events and circumstances, to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value should be recognized; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Application of the goodwill impairment test requires significant judgments including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for the businesses, and the useful life over which cash flows will occur. Changes in these estimates and assumptions could materially affect the determination of fair value and/or conclusions on goodwill impairment for the Company. Our annual impairment test is conducted on September 30 of each year or more often if deemed necessary.

 

The Company incurred a non-cash impairment charge of $6,104,000 for the year ended December 31, 2023.

 

In July 2024, the Company acquired GreenAcres Market and recorded goodwill of $2,212,000 from the acquisition.

 

During the years ended December 31, 2024, there was no goodwill impairment charges recognized by the Company in the audited consolidated statements of operations.

 

Advertising

 

Advertising expense is classified as selling, general and administrative expense on the consolidated statements of operations. The Company expenses advertising costs as incurred. For the years ended December 31, 2024 and 2023, the company incurred advertising expenses of $581,000 and $564,000, respectively.

 

401(k) retirement savings plan

 

The Company’s employees are offered a 401(k)-retirement savings plan that is currently administered under HCMC with discretionary contribution matching opportunities. HCMC will continue provide this service to HCWC’s employees pursuant to the Transition Service Agreement (“TSA”) executed upon the separation. The Company is in the process of establishing this service with its payroll provider, and expects to provide 401(k) to its own employees at the beginning of next year. 401K employer expense amounted to $94,000 and $82,000 for the years ended December 31, 2024 and 2023, respectively.

 

Earnings per share

 

Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards. There is no dilution for the years ended December 31, 2024 and 2023.

 

On September 16, 2024, the Company separated from HCMC. As referenced in Note 1. Organization, the Separation resulted in the initial issuance of approximately 9.2 million shares of HCWC common stock. For purposes of computing basic and diluted earnings per common share for the year ended December 31, 2023, the number of HCWC common shares issued upon separation and distribution was used to reflect the outstanding shares.

 

The following table sets forth the computation of basic and diluted earnings per share attributable to the Company’s stockholders.

 

   2024   2023 
   For the Years Ended December 31, 
   2024   2023 
         
NET LOSS  $(4,506,466)  $(9,932,620)
           
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES   9,395,500    9,226,860 
           
BASIC AND DILUTED NET LOSS PER SHARE  $(0.48)  $(1.08)

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740”). Under this method, income tax expense is recognized as the amount of: (i) taxes payable or refundable for the current year and (ii) future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of available evidence it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 or 2023. The Company had no uncertain tax positions as of December 31, 2024 and 2023.

 

Leases

 

Operating lease liabilities are recognized at the lease commencement date based on the present value of the fixed lease payments using the Company’s incremental borrowing rates. Related lease right-of-use (“ROU”) are recognized based on the initial present value of the fixed lease payments, reduced by contributions from landlords, plus any prepaid rent and direct costs from executing the leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payments are recognized as lease expense as they are incurred.

 

The Company did not have finance leases in year 2024 and 2023. If the Company enters into a finance lease in the future, it will be accounted for in accordance with ASC Topic 842.

 

F-13
 

 

Fair Value Measurements

 

The fair value framework under FASB’s guidance requires the categorization of assets and liabilities into three levels based upon the assumptions used to measure the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, would generally require significant management judgment. The three levels for categorizing assets and liabilities under the fair value measurement requirements are as follows:

 

  Level 1: Fair value measurement of the asset or liability using observable inputs such as quoted prices in active markets for identical assets or liabilities;
     
  Level 2: Fair value measurement of the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and
     
  Level 3: Fair value measurement of the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.

 

Recurring Fair Value Measurements

 

The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, operating, derivatives and borrowings. Management believes that the carrying value of cash and cash equivalents, accounts receivable, accounts payable, and borrowings are representative of their respective fair values. All derivatives are recognized as either assets or liabilities on the balance sheet at fair value at the end of each quarter.

 

Nonrecurring Fair Value Measurements

 

The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets, indefinite-lived intangible assets and goodwill. The Company reviews the carrying amounts of such assets at least annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Any resulting asset impairment would require that the asset be recorded at its fair value. The resulting fair value measurement of the assets are considered to be Level 3 measurements.

 

Business Combination

 

The Company applies the provisions of ASC 805 in the accounting for acquisitions of businesses. ASC 805 requires the Company to use the acquisition method of accounting by recognizing identifiable assets and liabilities, including intangible assets of acquired businesses at their fair value at the date of acquisition. When the Company acquires control of a business, any previously held equity interest also is remeasured to fair value. The excess of the purchase consideration and any previously held equity interest over the fair value of identifiable net assets acquired is goodwill. If the fair value of identifiable net assets acquired exceeds the purchase consideration and any previously held equity interest, the difference is recognized in the consolidated statements of operations immediately as a gain or loss on acquisition. Acquisition-related expenses are expensed as incurred and the expenses are recorded in operating expenses in the consolidated statements of operations.

 

Recent Accounting Pronouncements

 

Public companies in the United States are subject to the accounting and reporting requirements of various authorities, including FASB and the SEC.

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (ASC 326)” This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL”) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to certain financial assets. The Company adopted ASC 326 on January 1, 2023, and estimated expected credit losses based on aging schedule, and provisioned approximately $28,000 and $15,000 credit loss for the year ended December 31, 2024 and 2023, respectively.

 

On December 14, 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s consolidated financial statements.

 

On November 27, 2023, FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which requires public entities to consider relevant qualitative and quantitative factors when determining whether segment expense categories and amounts are significant, and identify segment expenses on the basis of amounts that are regularly provided to the CODM, and included in reported segment profit or loss. The ASU is effective for fiscal years beginning after Dec. 15, 2023, and interim periods within fiscal years beginning after Dec. 15, 2024. The Company adopted this standard effective January 1, 2024, applying it retrospectively to all periods presented. As the Company has one reportable segment, the adoption had no material impact on the Company’s financial statements, but resulted in additional expense disclosures and reconciliations in the financial statement footnotes. See Note 5 for details.

 

F-14
 

 

NOTE 4. CONCENTRATIONS

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash is concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage.

 

The Company has not experienced any losses in such accounts. The Company did not have any cash equivalents as of December 31, 2024 and December 31, 2023.

 

A summary of the financial institution that had cash in excess of FDIC limits of $250,000 on December 31, 2024 and December 31, 2023 is presented below:

 

 

  

December 31,

2024

  

December 31,

2023

 
Total cash in excess of FDIC limits of $250,000  $715,852   $161,644 

 

The Company continually monitors its positions with, and the credit quality of the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.

 

The following table provides a reconciliation of cash and cash equivalents to amounts shown in audited consolidated statements of cash flow:

 

 

  

December 31,

2024

  

December 31,

2023

 
Cash  $2,056,472   $1,422,580 

 

Sourcing and Vendors

 

We source from approximately 1,000 suppliers and offer well-over 4,000 brands. These suppliers range from small independent businesses to multi-national conglomerates. We purchased approximately 70% and 75% of the goods we sell from our top 20 suppliers for the years ended December 31, 2024 and 2023, respectively, approximately 25% and 41% of our total purchases were from UNFI for the years ended December 31, 2024 and 2023, respectively. We maintain good relations with all our suppliers and believe we have adequate alternative supply methods, including self-distribution.

 

As mentioned, UNFI is our primary supplier of dry grocery and frozen food products. Our customer distribution agreement with UNFI commenced September 1, 2022, and has an initial term through September 1, 2027. Either party may terminate the agreement for defaults by the other party of certain provisions of the agreement. We are obligated to purchase a minimum annual volume of products from UNFI, except in certain defined circumstances when such purchasing obligation is excused. Pricing under our agreement with UNFI is on a “cost plus” basis. We believe UNFI has sufficient warehouse capacity and distribution technology to service our existing stores’ distribution needs for natural foods and products.

 

We have longstanding relationships with our suppliers, and we require disclosure from them regarding quality, freshness, potency and safety data information. Our bulk food private label products are packaged by us in pre-packed sealed bags to help prevent contamination while in transit and in our stores. Unlike most of our competitors, most of our private label nuts, trail mix, and flours are refrigerated in our warehouse and stores to maintain freshness.

 

F-15
 

 

NOTE 5. SEGMENT REPORTING AND DISAGGREGATION OF REVENUES

 

The Company operates in two operating segments: Grocery and Wellness. In accordance with ASC 280, these segments have been aggregated into a single reportable segment because they share similar economic characteristics and meet all aggregation criteria, including similar nature of products sold, product acquisition process, customer base, distribution methods, and regulatory environment.

 

The Company’s CODM reviews financial results and allocates resources at the consolidated level, as the aggregated segments operate as one integrated business unit. No segment-specific financial metrics are used by the CODM to assess performance.

 

The Company adopted ASU 2023-07 effective January 1, 2024, on a retrospective basis. As the Company operates as a single reportable segment, the adoption did not have an impact on the Company’s consolidated financial statements. However, it did result in enhanced disclosures related to segment expenses and reconciliations to consolidated totals. Specifically, the Company has begun disclosing segment-specific expenses that are regularly reviewed by the CODM, Jeffrey Holman, the Company’s Chief Executive Officer, in accordance with the new standard. This adoption did not have an impact on the Company’s consolidated financial statements.

 

The following table summarizes the significant segment expenses:

 

 SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES

         
   For the Years Ended December 31, 
   2024   2023 
Advertising  $581,357   $564,405 
Payroll and Benefits   13,963,361    12,645,985 
Occupancy   6,573,925    5,280,405 
Depreciation and Amortization   1,576,457    1,431,816 
Bank Service Charges and Merchant Account Fees   1,331,637    927,863 
Other selling, general and administrative expenses   1,680,001    1,368,736 
Goodwill impairment   -    6,104,000 
Total significant reporting segment expenses  $25,706,738   $28,323,210 

 

The following table summarizes the reconciliations of reportable segment profit or loss and assets to the Company’s consolidated totals:

 

 SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT

         
   For the Years Ended December 31, 
   2024   2023 
Segment net operating income (loss)  $1,358,571   $(7,974,985)
Unallocated amount   (3,136,049)   (2,549,084)
Consolidated loss from operation  $(1,777,478)  $(10,524,069)

 

         
   For the Years Ended December 31, 
   2024   2023 
Total reporting segment assets  $30,698,054   $28,432,560 
Unallocated amount   3,414,463    - 
Consolidated total assets  $34,112,517   $28,432,560 

 

When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors, including the nature of products sold, product acquisition processes, customer types, distribution methods, and regulatory environments.

 

  

December 31,

2024

  

December 31,

2023

 
Retail Grocery  $60,690,718   $47,243,163 
Food service/restaurant   8,679,160    8,440,245 
Online/eCommerce   925    6,385 
Total revenue  $69,370,803   $55,689,793 

 

The Company does not have significant revenue recognized over time due to the nature of retail store operation. The Company recognizes revenue at a point in time when control of goods or services transfers to the customer. Revenue is recognized as follows:

 

 Retail Sales: At the point of sale when payment is received, products are physically transferred, and title passes.
 Advertising Services (COOP Revenue): When promotional materials are distributed to end-user customers.

 

F-16
 

 

NOTE 6. ACCOUNTS RECEIVABLE, NET

 

Accounts receivable is mainly related to cooperative advertising (CO-OP) billing from each of the HCWC entities. HCWC bills its vendors for advertising vendors’ products in our sales channels. Advertising revenue is included in sales revenue in the consolidated statement of operations. The Company recorded advertising revenue of approximately $970,000 and $249,000 for the years ended December 31, 2024 and 2023, respectively. The Company’s accounts receivable totaled approximately $510,000 and $128,000 at December 31, 2024 and December 31, 2023, respectively. The accounts receivable balance at January 1, 2023 was approximately $55,000.

 

The Company’s credit loss is attributable to accounts receivable, and the Company determines the required allowance for expected credit losses using information such as customer credit history, current conditions, and reasonable and supportable forecasts about the future. Amounts are recorded to the allowance when it is determined that expected credit losses may occur. The Company reserved approximately $28,000 and $15,000 credit loss for the years ended December 31, 2024 and 2023, respectively.

 

NOTE 7. INVENTORIES

 

Inventories are measured at the lower of cost and net realizable value using the average cost method. If the cost of the inventories exceeds their market value, adjustments are recorded to write down excess inventory to its net realizable value. The Company, as a result of its physical inventory observations recorded the write down of inventories amounting to approximately $2.5 million in 2024 and 2023, respectively. The Company’s inventories consist primarily of merchandise available for resale.

 

NOTE 8. ACQUISITIONS

 

The purchase method of accounting in accordance with ASC 805 was applied for the Ellwood Thompson’s acquisition and GreenAcres Market acquisition. This requires the total cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill. Goodwill arising from the acquisition is attributable to expected operational synergies from combining the operations of the acquired business with those of the Company. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations.

 

Ellwood Thompson’s

 

On October 1, 2023, the Company through its wholly owned subsidiary, Healthy Choice Markets V, LLC, entered into an Asset Purchase Agreement with (i) ET Holding, Inc., d/b/a Ellwood Thompson’s Local Market, a Virginia corporation, (ii) Ellwood Thompson’s Natural Market, L.C., a Virginia limited liability company, and (iii) Richard T. Hood, an individual resident of the Commonwealth of Virginia. Pursuant to the Purchase Agreement, the Company acquired certain assets and assumed certain liabilities related to Ellwood Thompson’s grocery stores in Richmond, Virginia. The Company intends to continue to operate the grocery stores under their existing name.

 

The cash purchase price under the Asset Purchase Agreement was $750,000, and a promissory note provided to the seller of $750,000, with a fair value of $718,000. For twelve months ended on December 31, 2024, the Company recognized approximately $40,000 interest expense. In addition, the Company entered into a new lease agreement with the landlord and entered into an employment agreement with the store manager.

 

The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

  

October 1,

2023

 
Purchase Consideration     
Cash consideration paid  $750,000 
Promissory note   718,000 
Total Purchase Consideration  $1,468,000 
      
Purchase price allocation     
Inventory  $851,000 
Intangible assets   291,000 
Right of use asset - Operating lease   1,325,000 
Other liabilities   (31,000)
Operating lease liability   (1,325,000)
Goodwill   357,000 
Net assets acquired  $1,468,000 
      
Finite-lived intangible assets     
Trade Names (8 years)  $291,000 
Total intangible assets  $291,000 

 

F-17
 

 

The acquisition is structured as asset purchase in a business combination, and goodwill is tax-deductible, and amortizable over 15 years for tax purposes.

 

GreenAcres Market

 

On July 18, 2024, the Company through its wholly owned subsidiary, Healthy Choice Markets VI, LLC, entered into an Asset Purchase Agreement with (i) GreenAcres Markets of Oklahoma, LLC, an Oklahoma limited liability company, (ii) GACorp, Inc., a Kansas corporation; and (iii) the group of equity holders owning the majority interests of the Sellers. Pursuant to the Purchase Agreement, the Company acquired certain assets and assumed certain liabilities related to five GreenAcres Market’s grocery stores in Kansas and Oklahoma. The Company continued to operate the grocery stores under their existing name.

 

The cash purchase price under the Asset Purchase Agreement was $5,475,000, and a promissory note provided to the seller of $1,825,000. In addition, the Company entered into five new lease agreements with the landlords of the grocery stores.

 

The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

 

  

July 18,

2024

 
Purchase Consideration     
Cash consideration paid  $5,475,000 
Promissory note   1,568,000 
Total Purchase Consideration  $7,043,000 
      
Purchase price allocation     
Inventory  $2,400,000 
Property, plant, and equipment   127,000 
Intangible assets   2,304,000 
Goodwill   2,212,000 
Net assets acquired  $7,043,000 
      
Finite-lived intangible assets     
Trade Names (13 years)  $1,584,000 
Non-Compete Agreement (5 years)   720,000 
Total intangible assets  $2,304,000 

 

Revenue and Earnings

 

The following unaudited pro forma summary presents consolidated information of the Company, including Ellwood Thompson’s and GreenAcres Market, as if the business combinations had occurred on January 1, 2023, the earliest period presented herein:

SCHEDULE OF UNAUDITED PROFORMA INFORMATION 

         
   December 31, 
   2024   2023 
Sales  $77,762,430   $80,173,326 
Net loss   (4,791,021)   (11,401,315)

 

The pro forma financial information includes adjustments that are directly attributable to the business combinations and are factually supportable. The pro forma adjustments include incremental amortization of intangible, fixed assets depreciation and lease amortization. The proforma data gives effects to actual operating results prior to the acquisition. These proforma amounts do not purport to be indicative of the results that would have actually been obtained if the acquisitions occurred as of the beginning of each period presented or that may be obtained in future periods.

 

F-18
 

 

NOTE 9. ASSETS HELD FOR SALE

 

On February 7, 2024, the Company closed the operation of the Saugerties, NY store. The decision was based on management’s plan to maximize the profitability of the grocery segment. The Company transferred all operating assets and liabilities to other neighboring stores. The building, which is owned by the Company, has a net carrying value of approximately $544,000 and was put up for sale in February at its fair market value. The Company has classified the building as held for sale in accordance with ASC 360, “Property, Plant, and Equipment.” The building was previously classified as property, plant, and equipment (PP&E) and included in long-term assets.

 

On July 24, 2024, the Company finalized the closing of Saugerties, NY building sale with all parties involved and received net proceeds of $695,000. The building was sold at fair market value of $749,000 and the Company paid approximately $54,000 in legal fees, commission and other miscellaneous expenses. The title and deed were transferred on the closing date.

 

NOTE 10. PROPERTY, PLANT, AND EQUIPMENT

 

Property, plant, and equipment consist of the following as of December 31, 2024 and 2023:

 

         
   Year Ended December 31, 
   2024   2023 
         
Displays  $312,146   $312,146 
Building   -    575,000 
Furniture and fixtures   720,657    505,436 
Leasehold improvements   1,991,953    1,925,385 
Computer hardware & equipment   209,029    141,682 
Other   710,682    680,718 
Property, plant and equipment gross    3,944,467    4,140,367 
Less: accumulated depreciation and amortization   (1,967,998)   (1,463,728)
Total property, plant, and equipment  $1,976,469   $2,676,639 

 

The Company incurred approximately $0.5 million of depreciation expense for the years ended December 31, 2024 and 2023, respectively.

 

F-19
 

 

NOTE 11. INTANGIBLE ASSETS

 

Intangible assets, net consist of the following as of December 31, 2024 and 2023:

 

December 31, 2024 

Useful Lives

(Years)

 

Gross

Carrying
Amount

  

Accumulated

Amortization

  

Net

Carrying
Amount

 
Trade names  8-13 years  $4,444,000   $(1,427,798)  $3,016,202 
Customer relationships  4-6 years   2,669,000    (1,628,639)   1,040,361 
Non-compete  4-5 years   2,322,000    (937,085)   1,384,915 
Intangible assets, net     $9,435,000   $(3,993,522)  $5,441,478 

 

December 31, 2023 

Useful Lives

(Years)

 

Gross

Carrying
Amount

  

Accumulated

Amortization

  

Net

Carrying
Amount

 
Trade names  8-10 years  $2,860,000   $(1,035,443)  $1,824,557 
Customer relationships  4-6 years   2,669,000    (1,330,972)   1,338,028 
Non-compete  4-5 years   1,602,000    (586,066)   1,015,934 
Intangible assets, net     $7,131,000   $(2,952,481)  $4,178,519 

 

Intangible assets are amortized on a straight-line basis. Amortization expense was approximately $1.0 million and $0.9 million for the years ended December 31, 2024 and 2023, respectively.

 

The weighted-average remaining amortization period of the Company’s amortizable intangible assets is approximately 5 years as of December 31, 2024. The estimated future amortization of the intangible assets is as follows:

 

For the years ending December 31,    
2025  $1,180,613 
2026   1,103,576 
2027   964,771 
2028   655,332 
2029   302,221 
Thereafter   1,234,965 
Total  $5,441,478 

 

NOTE 12. GOODWILL

 

The Company tests goodwill for impairment annually on September 30 or more frequently if there are indicators that the carrying amount of the goodwill exceeds its estimated fair value.

 

As a result of the impairment test in 2023, the entire $6.1 million carrying value of goodwill was recognized as a non-cash impairment charge in 2023. There was no impairment of goodwill during the year ended December 31, 2024 based on the annual impairment assessment for 2024.

 

The changes in the carrying amount of goodwill as of December 31, 2024 and December 31, 2023 are as follows:

 

  

December 31,

2024

  

December 31,

2023

 
         
Beginning balance  $-   $5,747,000 
Acquisitions   2,212,000    357,000 
Impairment   -    (6,104,000)
Ending balance  $2,212,000   $- 

 

NOTE 13. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

At December 31, 2024 and December 31, 2023, accounts payable and accrued expenses consisted of:

 

  

December 31,

2024

  

December 31,

2023

 
Trade creditors  $5,133,782   $4,406,299 
Accrued expenses   997,752    514,112 
Total  $6,131,534   $4,920,411 

 

 

NOTE 14. DEBT

 

The following table provides a breakdown of the Company’s debt as of December 31, 2024 and 2023 is presented below:

 

   2024   2023 
   December 31, 
   2024   2023 
Promissory note  $11,623,392   $3,106,508 
Debt discount and issuance cost   (284,283)   - 
Total debt, net of debt discount and issuance costs   11,339,109    3,106,508 
Current portion of long-term debt   (2,200,210)   (702,701)
Current portion of debt discount and issuance cost   68,873    - 
Long-term debt  $9,207,772   $2,403,807 

 

F-20
 

 

Promissory Note

 

In connection with the Green’s Natural Foods acquisition, on October 14, 2022, the Company issued a secured promissory note (the “Greens Note”) in the principal amount of $3,000,000 as a portion of the purchase price. The Greens Note has a five-year term, an interest rate of 6.0% per annum and is secured by the assets of the Green’s Natural Foods. The outstanding balance was approximately $1,809,000 and $2,378,000 as of December 31, 2024 and December 31, 2023, respectively. The Company incurred approximately $127,000 and $160,000 interest expense for the year ended December 31, 2024 and 2023, respectively.

 

In connection with the Ellwood Thompson’s acquisition, on October 1, 2023, the Company issued a secured promissory note (the “Ellwood Note”) in the principal amount of $750,000, and discounted present value of $718,000 as a portion of the purchase price. The Ellwood Note has a five-year term, an interest rate of 6.0% per annum. The outstanding balance of the Ellwood Note was approximately $595,000 and $728,000 in principal amount as of December 31, 2024 and December 31, 2023, respectively. The Company recognized interest expense of approximately $40,000 and $39,000 for the years ended December 31, 2024, and 2023, respectively.

 

On January 18, 2024, HCWC entered into a Securities Purchase Agreement (the “Bridge Financing”) with institutional investors whereby (a) HCWC issued a total of approximately $1,889,000 in unsecured promissory notes (the “Notes”) and (b) on the date of the pricing of HCWC’s initial public offering (“IPO”), HCWC would deliver shares of its common stock equal to approximately $1,889,000 divided by the IPO price (“Bridge Shares”). The aggregate gross proceeds received from the investors in connection with the Security Purchase Agreement (“SPA”) was $1,700,000. The Notes were issued at a 10% original issue discount (“OID”) and accrue interest at a rate of 10% per annum beginning 60 days after issuance of the Notes. All accrued and unpaid principal and interest shall be due and payable upon the earlier of (1) the closing of the IPO, (2) January 18, 2025 or (3) upon an event of default as defined in the Notes.

 

On April 8, 2024, HCWC and the institutional investors entered into an amendment to the January 18, 2024 agreement whereby HCWC agreed to issue warrants (the “Bridge Warrants”) exercisable at $0.01 per share to purchase 188,889 shares of Class A common stock (the “Bridge Warrant Shares”) in lieu of Bridge Shares. The parties agreed to terminate any existing obligations of the institutional investors to acquire HCWC Bridge Shares as part of the IPO transaction.

 

On the Spin-Off Date, after the NYSEAM market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock was traded on the NYSEAM under the stock symbol “HCWC.”

 

Upon the completion of the IPO, HCWC paid in full the principal amount of Notes and OID. At December 31, 2024, the outstanding principal balance of the Notes and debt discount related with the Notes were at $0. HCWC incurred approximately $23,500 of debt issuance costs in connection with the issuance of the Notes, which, together with the OID of approximately $189,000, was recorded as a debt discount and was amortized over the life of the Notes using the straight-line method since such method was not materially different from the interest method. For the year ended December 31, 2024, approximately $298,000 of interest expense was recognized in the accompanying consolidated statements of operations.

 

The Company used the intrinsic value model to determine the fair value of the Bridge Warrants on April 18, 2024 and remeasured the fair value on September 16, 2024, and concluded that the fair value of the Bridge Warrants at September 16, 2024 was $1,887,001. Due to the fact that Bridge Warrants exercise was contingent upon the IPO, the Company did not recognize the warrant liability until the Spin-off date. The Bridge Warrants were exercised on September 17, 2024 by institutional investors. Upon warrant exercise, 188,889 shares of Class A common stock were issued and the warrant liability was eliminated against the loss on debt extinguishment in the amount of $1,888,889.

 

On July 18, 2024 (the “Loan Effective Date”), the Company entered into a loan and security agreement with a private lender for a $7,500,000 loan (the “Acquisition Loan”). A portion of the Acquisition Loan proceeds were used to acquire GreenAcres Markets. The loan is guaranteed by all of the subsidiaries of the Company (the “Guarantors”) and secured by all of the assets of the Company and the Guarantors. The Acquisition Loan has a term of three years and interest accrues at a rate of 12% on amounts borrowed. The Acquisition Loan may be prepaid at any time at a premium in the amount of ten percent (10%) of the principal amount of the Acquisition Loan outstanding prior to such prepayment. Payments on the Acquisition Loan are required to be made as follows: $1,125,000 on first anniversary of the Loan Effective Date, $1,875,000 on the second anniversary of the Loan Effective Date, and the remaining outstanding principal balance of principal and accrued interest on the third anniversary of the Loan Effective Date.

 

In connection with the GreenAcres Market acquisition, on August 23, 2024, the Company issued a secured promissory note (the “GreenAcres Note”) in the principal amount of $1,825,000 as a portion of the purchase price. The GreenAcres Note has a five-year term, an interest rate of 6.0% per annum and is secured by the assets of the GreenAcres Market. The outstanding balance was approximately $1,720,000 and $0 as of December 31, 2024 and 2023, respectively. The Company incurred approximately $36,000 and $0 interest expense for the years ended December 31, 2024 and 2023, respectively.

 

The Company may, at its option, at any time or from time to time prepay the outstanding principal amount or any accrued but unpaid interest, in each case in whole or in part, without penalty or premium, provided that any such prepayment of any outstanding amount of principal shall be accompanied by the payment of all accrued but unpaid interest on the amount of principal being prepaid, plus any costs and fees incurred.

 

The following table summarizes the 5-year repayment schedule:

 

For the years ending December 31,    
2025  $2,200,210 
2026   3,016,526 
2027   5,595,359 
2028   534,923 
2029   276,374 
Total  $11,623,392 

 

F-21
 

 

NOTE 15. COMMITMENTS AND CONTINGENCIES

 

Legal Proceedings

 

On July 31, 2024, one of the Company’s subsidiaries, Healthy Choice Markets IV, LLC, was served with a lawsuit filed by a former employee alleging violations of state and federal wage and hour laws. The Company believes the claims are without merit and intends to vigorously defend against the lawsuit. While the outcome of this litigation cannot be predicted with certainty, the Company does not believe that the lawsuit, if adversely resolved, would have a material adverse effect on its financial condition, results of operations, or cash flows.

 

From time to time the Company is involved in legal proceedings arising in the ordinary course of our business. We believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of December 31, 2024. With respect to legal costs, we record such costs as incurred.

 

NOTE 16. STOCKHOLDERS’ EQUITY

 

Spin-Off

 

HCMC announced on August 22, 2022 that its Board of Directors approved separation of the Grocery business, including wellness business, into an independent, publicly traded company (the “Spin-Off”). Prior to the Spin-Off, HCWC was a subsidiary under HCMC, which operated the Ada’s Natural Market, Paradise Health & Nutrition, Mother Earth’s Storehouse, Greens Natural Foods, Ellwood Thompson’s, and GreenAcres Market retail brands, as well as licensed wellness centers and Healthy U Wholesale.

 

On the Spin-Off Date, after the NYSEAM market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock was traded on the NYSEAM under the stock symbol “HCWC.”

 

HCMC distributed all the outstanding shares of Common Stock held by it on a pro rata basis to holders of HCMC’s common stock. For each 208,632 shares of HCMC common stock held as of 5:00 p.m., New York City time, on September 9, 2024, the record date for the Spin-Off (the “Record Date”), a HCMC stockholder was entitled to receive one (1) share of Class A common stock and three (3) shares of Class B common stock. The Distribution was made in book-entry form by a distribution agent as soon as practicable after the date of the Distribution.

 

As of December 31, 2024, 9,815,749 shares of common stock are outstanding.

 

The Company is authorized to issue 40,000,000 shares of Series A convertible preferred stock with par value of $0.001, none of which have been previously issued.

 

HCMC has secured binding commitments of $13.25 million in equity financing for HCWC from the same group of investors that invested $13.25 million in HCMC Series E Preferred Stock. Pursuant to the Securities Purchase Agreement for the HCMC Series E Stock (“HCMC Series E SPA”), the purchasers of HCMC Series E Stock will also be required to purchase Series A Preferred Stock of HCWC in the same subscription amounts that the Purchasers paid for the HCMC Series E Stock (regardless of whether or not such HCMC Series E Stock has been converted into HCMC common stock).

 

F-22
 

 

NOTE 17. LEASES

 

The Company has various lease agreements with terms of up to 20 years, including leases of retail stores, headquarters and equipment. All the leases are classified as operating leases.

 

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of December 31, 2024.

 

Maturity of Lease Liabilities by Fiscal Year    
2025  $4,221,590 
2026   3,923,741 
2027   2,956,171 
2028   2,280,186 
2029   1,617,808 
Thereafter   824,585 
Total undiscounted operating lease payments  $15,824,081 
Less: interest   (1,642,663)
Present value of operating lease liabilities  $14,181,418 

 

The following summarizes the Company’s operating leases:

 

Balance Sheet Classification 

December 31,

2024

  

December 31,

2023

 
Right of use assets  $14,232,240   $11,412,562 
           
Operating lease liability, current  $3,596,987   $2,748,824 
Operating lease liability, net of current   10,584,431    8,461,182 
Total operating lease liabilities  $14,181,418   $11,210,006 

 

The amortization of the right-of-use asset of approximately $3,274,000 and $2,570,000 for the years ended December 31, 2024 and 2023, respectively, were included in operating cash flows.

 

The following table provides a summary of other information related to the leases at December 31, 2024 and 2023:

 

Other Information  December 31, 2024   December 31, 2023 
Weighted-average remaining lease term for operating leases   4 years    5 years 
Weighted-average discount rate for operating leases   5.19%   3.98%

 

Rent expense for the years ended December 31, 2024 and 2023 was approximately $4,196,000 and $3,435,000, respectively, and is included in selling, general and administrative expenses in the accompanying consolidated statement of operations.

 

The following table represents the components of lease expense are as follows for twelve months ended December 31, 2024:

 

  

December 31,

2024

 
Operating lease cost  $3,273,563 
Variable lease cost   922,282 
Short-term lease cost   - 
Total rent expense  $4,195,845 

 

The aggregate cash payments under the leasing arrangement was approximately $3,122,000 for the year ended December 31, 2024 and was included in operating cash flows.

 

F-23
 

 

NOTE 18. RELATED PARTY TRANSACTIONS

 

Prior to the Spin-Off, the Company has not historically operated as a separate, stand-alone company and, accordingly has had various relationships with HCMC whereby HCMC provided services to the Company as noted below. Related party transactions prior to Spin-Off include allocation of general corporate expenses and advances from parent.

 

Allocation of General Corporate Expenses

 

HCMC provided human resources, accounting, payroll processing, legal and other managerial services to the Company prior to the Spin-Off. The accompanying consolidated financial statements include allocations of these expenses. Following the Spin-Off, HCWC and HCMC entered into a TSA, under which both companies agreed to provide certain transitional services to one another to ensure smooth separation. These services are provided on a transitional basis and will continue for a period of up to one year following the Spin-Off.

 

Management adopted a proportional cost allocation method to allocate HCMC expenses to the Company. The allocation method calculates the appropriate share of overhead costs to the Company based on management’s estimate that the sum of management time and resources spent managing the Company is approximately equal to the amount of time and resources spent managing HCMC and its subsidiaries. As a result, 50% of HCMC overhead on a weighted average basis was allocated to the Company based on the fact that management spent equal amount of time managing HCMC and the Company. The Company believes the allocation methodology used is reasonable and has been consistently applied, and results in an appropriate allocation of costs incurred. However, these allocations may not be indicative of the cost had the Company been a stand-alone entity or of future services. HCMC allocated approximately $2.1 million and $2.5 million for the years ended December 31, 2024 and 2023, respectively. The pre-Spin-Off allocated amounts will not be cash settled and are included in the Net Parent’s Investment.

 

Investment by Parent

 

For the thirty-six weeks ended September 13, 2024, the net operating expenses of $1.7 million incurred by HCMC on behalf of the Company was included in the Net Parent’s Investment. For the year ended December 31, 2023, the net operating expenses of $2.5 million incurred by HCMC on behalf of the Company, $0.8 million cash advance attributable to the Ellwood Thompson’ acquisition and $0.1 million HCMC loan payment on behalf of Green’s Natural Foods were included in the Net Parent’s Investment. Upon Spin-Off, the Company wrote off the net parent investment balance to additional paid-in capital.

 

Intercompany Receivable and Payable

 

Prior to Spin-Off, there was no intercompany agreement between the Company and HCMC. Management has determined those intercompany receivables and payables will be settled within twelve months after the balance sheet date. As a result, the Company’s intercompany balances are reflected as “due to” or “due from” accounts in the consolidated balance sheets. At the time of Spin-Off, the Company had a net payable balance to HCMC in the amount of $1.2 million, and the Company paid the balance in full to settle on the Spin-Off date of September 13, 2024. The Company had a net intercompany balance of $0.2 million and $3.8 million from HCMC as of December 31, 2024 and December 31, 2023, respectively.

 

Agreements with HCMC

 

The Company entered into several agreements with the former parent that, among other things, effect the separation and govern the relationship of the parties following the Spin-Off. These agreements include:

 

  a Separation Agreement that will set forth HCMC’s and the Company’s agreements regarding the principal actions that both parties will take in connection with the Spin-Off and aspects of our relationship following the Spin-Off;
  a Transition Services Agreement (“TSA”) pursuant to which HCMC and the Company will provide each other specified services on a transitional basis to help ensure an orderly transition following the Spin-Off.
  a Tax Matters Agreement (“TMA”) that will govern the respective rights, responsibilities and obligations of HCMC and the Company after the Spin-Off with respect to all tax matters and will include restrictions to preserve the tax-free status of the Spin-Off; and
  an Employee Matters Agreement (“EMA”) that will address employment, compensation and benefits matters, including the allocation and treatment of assets and liabilities arising out of employee compensation and benefits programs in which our employees participated prior to the Spin-Off.

 

Under the terms of the transition services agreement, the HCMC will provide to the Company, on a transitional basis, certain services or functions, including information technology, accounting, human resources, and payroll functions. Generally, these services will be provided for a period of up to one year following the Spin-Off. Consideration and costs for the transition services will be determined using several billing methodologies as described in the agreements, including customary billing and pass-through billing. Costs for transition services provided by the former parent are recorded within the Consolidated Statements of Operations based on the nature of the services. Following the Spin-Off, the Company recognized costs of $0.4 million for services provided by the former parent in 2024 pursuant to the transition services agreement.

 

NOTE 19. INCOME TAXES

 

Prior to September 13, 2024, the date of the Spin-Off of HCWC as a stand-alone entity, separate tax returns were not filed as they were included in the consolidated tax reporting of the former parent entity HCMC, within the respective entity’s tax jurisdiction. On September 13, 2024, HCWC completed its separation from HCMC through a tax-free distribution of HCWC common stock to HCMC shareholders. The Spin-Off was structured to qualify as tax-free under Sections 355(a) and 368(a)(1)(D) of the Internal Revenue Code (IRC). Pursuant to the Tax Matters Agreement (TMA) executed with HCMC in December 2023:

 

Pre-Spin Liabilities: HCMC retains responsibility for all taxes related to HCWC’s operations prior to September 13, 2024, including audits of HCMC’s consolidated returns.
Post-Spin Liabilities: HCWC is solely responsible for taxes attributable to its operations after the Spin-Off.
Indemnification: HCWC indemnifies HCMC for taxes arising from post-Spin actions that jeopardize the transaction’s tax-free status (e.g., violations of IRC Section 355(e)).

 

For periods prior to the Spin-Off, HCWC’s tax provision was calculated using the separate return method, as if HCWC had operated as a standalone taxpayer. Deferred tax assets and liabilities, including net operating losses (NOLs), were allocated to HCWC based on the carryover tax basis of assets and liabilities transferred in the Spin-Off. This method preserves the tax-free nature of the transaction.

 

As of December 31, 2024, all amounts related to the Company’s tax positions are recognized on the Consolidated Balance Sheet. Income taxes are accounted for under the asset and liability method.

 

The Company did not have expected tax expense (benefit) at the U.S. statutory rate 21% to the actual tax expense (benefit) reflected in the accompanying statement of operations:

 

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
         
U.S. federal statutory rate  $

(946,354

)  (2,085,850)
State tax benefit net of federal benefit   

(243,330

)   (557,568)
Change in valuation allowance   

1,358,776

    2,496,515 
True-Up & Deferred Adjustment   

(32,683

)   (73,814)
Other permanent items   

(119,803

)   209,444 
Change in tax rate   

(16,606

)   11,273 

Income tax provision/(benefit)

  $-   $- 

 

F-24
 

 

As of December 31, 2024 and 2023, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following:

 

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
Deferred tax assets:          
NOL carryforward  $3,129,808   $2,449,401 
Intangible assets   1,958,875    1,995,960 
Warrant liability   498,740    - 
Interest expense   227,272    - 
ASC 842 - Lease Accounting   89,309    65,172 
Charitable contributions   30,336    3,586 
UNICAP 263a Adjustment   (3,823)   53,284 
Allowances   7,485    - 
Total deferred tax assets   5,938,002    4,567,403 
           
Deferred tax liabilities:          
Net book value of fixed assets   (32,905)   (21,083)
Total deferred tax liabilities   (32,905)   (21,083)
           
Net deferred tax assets   5,905,097    4,546,320 
Valuation allowance   (5,905,097)   (4,546,320)
Net deferred tax assets  $-   $- 

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the positive and negative evidence available, management has determined that a valuation allowance is required at December 31, 2024 and 2023 to reduce the deferred tax assets to amounts that are more likely than not to be realized. The Company’s valuation increased by approximately $1,358,700 and $2,496,500 for the tax years ended 2024 and 2023, respectively. Should the factors underlying management’s analysis change, future valuation adjustments to the Company’s net deferred tax assets may be necessary. 

 

At December 31, 2024 the Company had U.S. federal and state post-2017 net operating loss carryforwards (“NOLs”) of $12 million and $12.2 million, respectively. Tax Cuts and Jobs Act (TCJA) allows NOLs incurred in tax years beginning in 2018 to be carried forward indefinitely subject to 80% of taxable income under Internal Revenue Code Section 172. Florida, Kansas, and Oklahoma net operating losses generated in taxable years beginning after December 31, 2017, are carried forward indefinitely until used and never expire; however, Oklahoma NOLs are subject to an 80% taxable income limitation per year. New York, New Jersey, and Virginia net operating losses expire after twenty years.

 

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. Among other provisions, the IRA includes a 15% corporate alternative minimum tax on applicable corporations and 1% excise tax on stock repurchases made after December 31, 2022. The IRA is not expected to have an impact on the consolidated financial statements.

 

The Company had no uncertain tax positions as of December 31, 2024, and 2023.

 

The Company files a federal income tax return and income tax returns in various state tax jurisdictions and the Company is generally no longer subject to examinations by federal and state tax authorities for years before 2021.

 

NOTE 20. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required disclosure in the consolidated financial statements.

 

On March 2, 2025, subsequent to the fiscal year ended December 31, 2024, the Company entered into an agreement with certain note holders to exchange $450,000 of outstanding principal under its existing Loan and Security Agreement dated July 18, 2024 for 750,000 shares of the Company’s Class A common stock. The exchange price of $0.60 per share equated to the closing bid price of the Company’s Class A common stock on February 28, 2025. Following this transaction, $7,050,000 in principal remains outstanding under the Loan and Security Agreement. The conversion strengthened the Company’s balance sheet by reducing its debt obligations.

 

F-25
 

 

EXHIBIT INDEX

 

Exhibit       Incorporated by Reference   Filed or Furnished
No.   Exhibit Description   Form   Date   Number   Herewith
                     
2.1(c)   Asset Purchase Agreement, dated November 19, 2018, by and among the Company and Paradise Health Foods, Inc.   8-K   11/21/18   2.1    
2.1(d)   Membership Interest Purchase Agreement, dated December 14, 2018, by and among Healthy U Wholesale, Inc. and the Sellers named therein   8-K   12/26/18   2.2    
2.1(e)   Asset Purchase Agreement, dated February 8, 2022, by and among the Healthy Choice Markets 3, LLC, Mother Earth’s Storehouse Inc., Christopher Schneider and Kevin Schneider   8-K   2/8/22   2.1    
3.1   Second Amended and Restated Certificate of Incorporation   S-1/A   2/13/24   3.1    
3.2   Bylaws   S-1   9/8/2023   3.2    
3.3   Certificate of Designation of Preferences, Rights And Limitations of Series A Convertible Preferred Stock   S-1/A   12/21/2023   3.3    
10.1+   Healthy Choice Wellness Corp. Equity Incentive Plan   S-1/A   8/30/24   10.1    
10.2   Form of Tax Matters Agreement between Healthier Choices Management Corp. and Healthy Choice Wellness Corp.   S-1/A   12/21/2023   10.2    
10.3   Form of Employee Matters Agreement between Healthier Choices Management Corp. and Healthy Choice Wellness Corp.   S-1/A   12/21/2023   10.3    
10.4+   Healthy Choice Wellness Corp. Form of Restricted Stock Award Agreement   S-1/A   8/30/24   10.4    
10.6+   Form of Director Indemnification Agreement   S-1/A   6/26/2024   10.6    
10.8   Form of Transition Services Agreement between Healthier Choices Management Corp. and Healthy Choice Wellness Corp.   S-1/A   12/21/2023   10.8    
10.9   Form of Separation and Distribution Agreement between Healthier Choices Management Corp. and Healthy Choice Wellness Corp.   S-1/A   2/13/24   10.9    
10.10   Securities Purchase Agreement, dated as of January 18, 2024, by and between Healthy Choice Wellness Corp. and the purchasers named therein   S-1/A   2/13/24   10.10    
10.11   Form of Promissory Note, dated January 18, 2024   S-1/A   2/13/24   10.11    
10.15   Form of Common Stock Purchase Warrant, dated April 8, 2024   S-1/A   5/24/24   10.15    
10.16   First Amendment to Securities Purchase Agreement, dated as of April 8, 2024, by and between Healthy Choice Wellness Corp. and the purchasers named therein   S-1/A   5/24/24   10.16    

 

28

 

 

Exhibit       Incorporated by Reference   Filed or Furnished
No.   Exhibit Description   Form   Date   Number   Herewith
10.20   Securities Purchase Agreement, dated as of August 18, 2022, by and between Healthier Choices Management Corp. and the purchasers named therein   8-K   8/18/2022   10.1    
10.21   First Amendment to Securities Purchase Agreement, dated as of March 1, 2023, by and between Healthier Choices Management Corp. and the purchasers named therein   8-K/A   3/6/23   10.1    
10.22   Second Amendment to Securities Purchase Agreement, dated as of May 15, 2023, by and between Healthier Choices Management Corp. and the purchasers named therein   8-K/A   5/19/23   10.1    
10.23   Third Amendment to Securities Purchase Agreement, dated as of October 30, 2023, by and between Healthier Choices Management Corp. and the purchasers named therein   8-K/A   11/3/23   10.1    
10.24   Fourth Amendment to Securities Purchase Agreement, dated as of February 20, 2024, by and between Healthier Choices Management Corp. and the purchasers named therein   8-K/A   2/23/24   10.1    
21.1   List of Subsidiaries               X
23.1   Consent of Marcum LLP               Filed
31.1   Certification of Principal Executive Officer (302)               Filed
31.2   Certification of Principal Financial Officer (302)               Filed
32.1   Certification of Principal Executive Officer and Principal Financial Officer (906)               Furnished**
101.INS   XBRL Instance Document               Filed
101.SCH   XBRL Taxonomy Extension Schema Document               Filed
101.CAL   XBRL Taxonomy Extension Calculation Link base Document               Filed
101.DEF   XBRL Taxonomy Extension Definition Link base Document               Filed
101.LAB   XBRL Taxonomy Extension Label Link base Document               Filed
101.PRE   XBRL Taxonomy Extension Presentation Link base Document               Filed

 

* Management contract or compensatory plan or arrangement.

 

** This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

 

Copies of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our stockholders who make a written request to our Corporate Secretary at 3800 North 28th Way, Unit# 1, Hollywood, Florida 33020.

 

29

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 27, 2025.

 

  Healthy Choice Wellness Corp.
     
  By: /s/ Jeffrey Holman
    Jeffrey Holman
    Chief Executive Officer
    (Principal Executive Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Jeffrey Holman   Principal Executive Officer and Director   March 27, 2025
Jeffrey Holman        
         
/s/ John A. Ollet   Chief Financial Officer   March 27, 2025
John A. Ollet   (Principal Financial and Accounting Officer)    
         
/s/ Gary Bodzin   Director   March 27, 2025
Gary Bodzin        
         
/s/ Behnam Myers   Director   March 27, 2025
Behnam Myers        
         
/s/ Michael Lerman   Director   March 27, 2025
Michael Lerman        

 

30

 

EX-21.1 2 ex21-1.htm

 

Exhibit 21.1

 

List of Subsidiaries

 

Subsidiaries   Jurisdiction
     
Healthy Choice Markets, Inc.   Florida
     
Healthy Choice Markets 2, LLC   Florida
     
The Vitamin Store, LLC   Florida
     
Healthy Choice Wellness, LLC   Florida
     
Healthy Choice Markets 3, LLC   Florida
     
Healthy Choices Markets 3 Real Estate LLC   New York
     
Heathy Choice Markets IV, LLC   Florida
     
Healthy Choice Markets V, LLC  

Virgina

     
Healthy Choice Markets VI, LLC   Florida
     
Healthy Choice Wellness II, LLC   Florida
     
Healthy U Wholesale, Inc.  

Florida

 

 

 

EX-23.1 3 ex23-1.htm

 

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in the Registration Statements on Amendment No. 9 to Form S-1 (No. 333-274435) and Post-Effective Amendment No. 1 to Form S-1 (No. 333-275209) of our report dated May 24, 2024 relating to the financial statements of Healthy Choice Wellness Corp. appearing in this Annual Report on Form 10-K for the year ended December 31, 2024.

 

/s/ Marcum llp

 

Saddle Brook, NJ

March 27, 2025

 

 

 

EX-31.1 4 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

 

I, Jeffrey Holman, certify that:

 

1. I have reviewed this annual report on Form 10-K of Healthy Choice Wellness Corp.;
   
2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 27, 2025

 

  /s/ Jeffrey Holman
  Jeffrey Holman
  Chief Executive Officer
  (Principal Executive Officer)

 

 

 

EX-31.2 5 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

 

I, John Ollet, certify that:

 

1. I have reviewed this annual report on Form 10-K of Healthy Choice Wellness Corp.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting

 

Date: March 27, 2025

 

  /s/ John Ollet
  John Ollet
  Chief Financial Officer
  (Principal Financial Officer)

 

 

 

EX-32.1 6 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of Healthy Choice Wellness Corp. (the “Company”) on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Jeffrey Holman, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

  1. The annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and
     
  2. The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 27, 2025

 

  /s/ Jeffrey Holman
  Jeffrey Holman
  Chief Executive Officer
  (Principal Executive Officer)

 

In connection with the annual report of Healthy Choice Wellness Corp. (the “Company”) on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, John Ollet, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

  1. The annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and
     
  2. The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 27, 2025

 

  /s/ John Ollet
  John Ollet
  Chief Financial Officer
  (Principal Financial Officer)

 

 

 

EX-101.SCH 7 hcwc-20241231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 999014 - Disclosure - ORGANIZATION link:presentationLink link:calculationLink link:definitionLink 999015 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 999016 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 999017 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 999018 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES link:presentationLink link:calculationLink link:definitionLink 999019 - Disclosure - ACCOUNTS RECEIVABLE, NET link:presentationLink link:calculationLink link:definitionLink 999020 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 999021 - Disclosure - ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 999022 - Disclosure - ASSETS HELD FOR SALE link:presentationLink link:calculationLink link:definitionLink 999023 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 999024 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 999025 - Disclosure - GOODWILL link:presentationLink link:calculationLink link:definitionLink 999026 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 999027 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 999028 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 999029 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 999030 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 999031 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 999032 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 999033 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 999034 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 999035 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 999036 - Disclosure - CONCENTRATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 999037 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Tables) link:presentationLink link:calculationLink link:definitionLink 999038 - Disclosure - ACQUISITIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 999039 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 999040 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 999041 - Disclosure - GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 999042 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 999043 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 999044 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 999045 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 999046 - Disclosure - ORGANIZATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999047 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999048 - Disclosure - SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS (Details) link:presentationLink link:calculationLink link:definitionLink 999049 - Disclosure - SCHEDULE OF EARNINGS PER SHARES (Details) link:presentationLink link:calculationLink link:definitionLink 999050 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999051 - Disclosure - SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS (Details) link:presentationLink link:calculationLink link:definitionLink 999052 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 999053 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS (Details) link:presentationLink link:calculationLink link:definitionLink 999054 - Disclosure - CONCENTRATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999055 - Disclosure - SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 999056 - Disclosure - SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT (Details) link:presentationLink link:calculationLink link:definitionLink 999057 - Disclosure - SCHEDULE DISAGGREGATED REVENUES (Details) link:presentationLink link:calculationLink link:definitionLink 999058 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999059 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999060 - Disclosure - INVENTORIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999061 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Details) link:presentationLink link:calculationLink link:definitionLink 999062 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 999063 - Disclosure - SCHEDULE OF UNAUDITED PROFORMA INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 999064 - Disclosure - ACQUISITIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999065 - Disclosure - ASSETS HELD FOR SALE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999066 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 999067 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999068 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details) link:presentationLink link:calculationLink link:definitionLink 999069 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 999070 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999071 - Disclosure - SCHEDULE OF GOODWILL (Details) link:presentationLink link:calculationLink link:definitionLink 999072 - Disclosure - GOODWILL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999073 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 999074 - Disclosure - SCHEDULE OF DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 999075 - Disclosure - SCHEDULE OF DEBT REPAYMENT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999076 - Disclosure - SCHEDULE OF DEBT REPAYMENT (Details) link:presentationLink link:calculationLink link:definitionLink 999077 - Disclosure - DEBT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999078 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999079 - Disclosure - SCHEDULE OF MATURITY OF LEASE LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 999080 - Disclosure - SCHEDULE OF COMPANY’S OPERATING LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 999081 - Disclosure - SCHEDULE OF OPERATING LEASE TERM (Details) link:presentationLink link:calculationLink link:definitionLink 999082 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 999083 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999084 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999085 - Disclosure - SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999086 - Disclosure - SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) link:presentationLink link:calculationLink link:definitionLink 999087 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 999088 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999089 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 hcwc-20241231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 hcwc-20241231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 hcwc-20241231_lab.xml XBRL LABEL FILE Related and Nonrelated Parties [Axis] Related Party [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Net Investment From Parent [Member] Retained Earnings [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] One Vendor [Member] Healthier Choices Management Corp [Member] Common Class A [Member] Common Class B [Member] Legal Entity [Axis] Series E Preferred Stock [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] Long-Lived Tangible Asset [Axis] Building [Member] Series E Convertible Preferred Stock [Member] Series A Preferred Stock [Member] Product and Service [Axis] Shipping and Handling [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Business Acquisition [Axis] GreenAcres Market [Member] Suppliers [Member] Purchase [Member] Consolidation Items [Axis] Operating Segments [Member] Segments [Axis] Segment Net Operating Income (Loss) [Member] Unallocated Amount [Member] Total Reporting Segment Assets [Member] Retail Grocery [Member] Food Service/Restaurant [Member] Online/ECommerce [Member] Asset Purchase Agreement [Member] Ellwood Thompson [Member] Finite-Lived Intangible Assets by Major Class [Axis] Trade Names [Member] Non-Compete Agreement [Member] Displays [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Computer Equipment [Member] Other Machinery and Equipment [Member] Asset Class [Axis] Property, Plant and Equipment [Member] Indefinite-Lived Intangible Assets [Axis] Customer Relationship [Member] Non-Compete [Member] Debt Instrument [Axis] Promissory Notes [Member] Secured Promissory Notes [Member] Unsecured Promissory Note [Member] Sale of Stock [Axis] IPO [Member] Class of Warrant or Right [Axis] Bridge Warrant Shares [Member] Loan And Security Agreement [Member] Award Type [Axis] First Anniversary [Member] Second Anniversary [Member] Acquisition Loan And Security Agreement [Member] Transition Services Agreement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Opinion [Text Block] Auditor Name Auditor Location Statement [Table] Statement [Line Items] ASSETS CURRENT ASSETS Cash Accounts receivable, net Inventories Prepaid expenses and vendor deposits Other current assets Due from related party current TOTAL CURRENT ASSETS Property, plant, and equipment, net Intangible assets, net Goodwill Right of use assets Due from related party noncurrent Other assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable and accrued expenses Contract liabilities Current portion of loan payable Operating lease liability, current TOTAL CURRENT LIABILITIES Loan payable, net of current portion Operating lease liability, net of current TOTAL LIABILITIES COMMITMENTS AND CONTINGENCIES (SEE NOTE 15) STOCKHOLDERS’ EQUITY Common Stock, $0.001 par value per share, 560,000,000 shares authorized; 9,815,749 and 10 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively. Series A convertible preferred stock, $0.001 par value per share, 40,000,000 shares authorized, 0 share issued and outstanding as of December 31, 2024 and December 31, 2023, respectively. Additional paid-in capital Net investment by former parent Accumulated deficit TOTAL STOCKHOLDERS’ EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Income Statement [Abstract] SALES, NET COST OF SALES GROSS PROFIT OPERATING EXPENSES, NET Selling, general and administrative Gain on sale of asset Impairment of goodwill TOTAL OPERATING EXPENSES, NET LOSS FROM OPERATIONS OTHER INCOME (EXPENSE) Loss on debt extinguishment Change in contingent consideration Other income, net Interest expense, net TOTAL OTHER INCOME (EXPENSE) LOSS BEFORE TAXES INCOME TAX BENEFIT NET LOSS BASIC NET LOSS PER SHARE DILUTED NET LOSS PER SHARE BASIC WEIGHTED AVERAGE COMMON SHARES DILUTED WEIGHTED AVERAGE COMMON SHARES Balance Balance, shares Net transfers to former parent Net loss Issuance of common stock for Spin-Off and transfer of former parent investment to additional paid in capital Issuance of common stock for Spin-Off and transfer of former parent investment to additional paid in capital, shares Issuance of common stock for IPO Issuance of common stock for IPO, shares Exercise of warrants Exercise of warrants, shares Balance Balance, shares Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Loss on debt extinguishment Gain on sale of building Amortization of right-of-use assets Write-down of obsolete and slow-moving inventory Non-cash interest expense Change in contingent consideration Loss on vendor settlement Change in allowance for credit losses Changes in operating assets and liabilities: Accounts receivable Inventories Prepaid expenses and vendor deposits Other current assets Due to related party Other assets Accounts payable and accrued expenses Contract liabilities Lease liabilities NET CASH USED IN OPERATING ACTIVITIES INVESTING ACTIVITIES Payment for acquisition Proceeds from sale of Saugerties, NY building Purchases of property and equipment NET CASH USED IN INVESTING ACTIVITIES FINANCING ACTIVITIES Proceeds from security purchase agreement Principal payments on loan payable Proceeds from acquisition loan Proceeds from initial public offering (IPO) Payment for IPO-related cost Investment from parent company Due to related party Proceeds from warrant exercised NET CASH PROVIDED BY FINANCING ACTIVITIES NET INCREASE (DECREASE) IN CASH CASH — BEGINNING OF PERIOD CASH — END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid for interest Cash paid for income tax NON-CASH INVESTING AND FINANCING ACTIVITIES Promissory note related to acquisition Right-of-use assets obtained in exchange for operating lease liabilities Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Flag Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION GOING CONCERN Accounting Policies [Abstract] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Risks and Uncertainties [Abstract] CONCENTRATIONS Segment Reporting [Abstract] SEGMENT REPORTING AND DISAGGREGATION OF REVENUES Credit Loss [Abstract] ACCOUNTS RECEIVABLE, NET Inventory Disclosure [Abstract] INVENTORIES Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] ACQUISITIONS Assets Held For Sale ASSETS HELD FOR SALE Property, Plant and Equipment [Abstract] PROPERTY, PLANT, AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS GOODWILL Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED EXPENSES Debt Disclosure [Abstract] DEBT Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] STOCKHOLDERS’ EQUITY Leases LEASES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Income Tax Disclosure [Abstract] INCOME TAXES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Segment Reporting Principles of Consolidation Net Parent Investment Use of Estimates in the Preparation of the Financial Statements Revenue Recognition Shipping and Handling Cash and Cash Equivalents Accounts Receivable, Contract Assets and Contract Liabilities Other Current Assets Inventories Property, Plant, and Equipment Identifiable Intangible Assets Impairment of Long-Lived Assets Goodwill Advertising 401(k) retirement savings plan Earnings per share Income Taxes Leases Fair Value Measurements Business Combination Recent Accounting Pronouncements SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS SCHEDULE OF EARNINGS PER SHARES SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT SCHEDULE DISAGGREGATED REVENUES SCHEDULE OF PURCHASE PRICE ALLOCATION SCHEDULE OF UNAUDITED PROFORMA INFORMATION SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF INTANGIBLE ASSETS, NET SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS SCHEDULE OF GOODWILL SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES SCHEDULE OF DEBT SCHEDULE OF DEBT REPAYMENT SCHEDULE OF MATURITY OF LEASE LIABILITIES SCHEDULE OF COMPANY’S OPERATING LEASE SCHEDULE OF OPERATING LEASE TERM SCHEDULE OF COMPONENTS OF LEASE EXPENSE SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Concentration risk percentage Number of shares issued Equity financing Investments Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Cash and cash equivalent Working capital Net loss Cash used in operating activities Private lender Purchase of greenacres market Face amount Interest rate Maturity date Proceeds from sale of building Shares issued Share price Preferrd stock subscriptions Gross proceeds Total cash and restricted cash in excess of FDIC limits NET LOSS Costs of sales Cash, FDIC amount Contract liability Property plant and equipment useful life Intangible asset useful life Goodwill, Impairment Loss Advertising expenses Employer expense amount Initial issuance shares Unrecognized tax benefits Estimated expected credit losses Total cash in excess of FDIC limits of $250,000 Concentration Risk [Table] Concentration Risk [Line Items] Cash equivalents Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Advertising Payroll and Benefits Occupancy Depreciation and Amortization Bank Service Charges and Merchant Account Fees Other selling, general and administrative expenses Goodwill impairment Total significant reporting segment expenses Consolidated loss from operation Consolidated total assets Segment Reporting, Revenue from External Customer, Product and Service [Table] Revenue from External Customer [Line Items] Total revenue Operating segments Advertising revenue Accounts receivable Credit losses Inventory write down Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Cash consideration paid Promissory note Total purchase consideration Inventory Property, plant, and equipment Total intangible assets Right of use asset - Operating lease Other liabilities Operating lease liability Net assets acquired Useful lives (years) Sales Net loss Fair value Interest expense Amortization period for goodwill for tax purposes (years) Property, Plant and Equipment, Other, Gross Fair market value Legal fee Property, plant and equipment gross  Less: accumulated depreciation and amortization Total property, plant, and equipment Impairment Effects on Earnings Per Share [Table] Impairment Effects on Earnings Per Share [Line Items] Depreciation Intangible Asset, Indefinite-Lived [Table] Indefinite-Lived Intangible Assets [Line Items] Gross Carrying Amount Accumulated Amortization Net Carrying Amount 2025 2026 2027 2028 2029 Thereafter Total Amortization of intangible assets Weighted-average remaining amortization period Beginning balance Acquisitions Ending balance Trade creditors Accrued expenses Total Promissory note Debt discount and issuance cost Total debt, net of debt discount and issuance costs Current portion of long-term debt Current portion of debt discount and issuance cost Long-term debt Debt instrument repayment term 2025 2026 2027 2028 2029 Total Short-Term Debt [Table] Short-Term Debt [Line Items] Outstanding Debt Interest expense Debt fair value Aggregate subscription price Debt instrument description Warrant exercise price Warrant purchase Debt discount Debt issuance cost Amortization of debt discount Warrant purchase Gains losses on extinguishment of debt Debt term Acquisition percentage Payment of long term debt Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Common stock shares outstanding Schedule Of Maturity Of Lease Liabilities 2025 2026 2027 2028 2029 Thereafter Total undiscounted operating lease payments Less: interest Present value of operating lease liabilities Schedule Of Companys Operating Lease Weighted-average remaining lease term for operating leases Weighted-average discount rate for operating leases Operating lease cost Variable lease cost Short-term lease cost Total rent expense Lease term Rent expense Cash payments Related Party Transaction [Table] Related Party Transaction [Line Items] Allocation amount Net operating expense Cah advance Due from affiliates Net payable Receivables, net, current Other expenses Federal statutory income tax rate U.S. federal statutory rate State tax benefit net of federal benefit Change in valuation allowance True-Up & Deferred Adjustment Other permanent items Change in tax rate Income tax provision/(benefit) NOL carryforward Intangible assets Warrant liability Interest expense ASC 842 - Lease Accounting Charitable contributions UNICAP 263a Adjustment Allowances Total deferred tax assets Net book value of fixed assets Total deferred tax liabilities Net deferred tax assets Valuation allowance Net deferred tax assets Increase in deferred tax valuation allowance Federal net operating loss State net operating loss Corporate alternative tax Subsequent Event [Table] Subsequent Event [Line Items] Price per share Prepaid expenses and vendor deposits. Net investment by former parent. Series A Convertible Preferred Stock [Member] Change in contingent consideration. Net Investment From Parent [Member] Issuance of common stock value for spin-off and transfer of former parent investment to additional paid in capital. Stock issued during period value warrants exercised. Issuance of common stock shares for spin-off and transfer of former parent investment to additional paid in capital. Stock issued during period shares warrants exercised. Loss on vendor settlement. Increase decrease in prepaid expenses and vendor deposits Proceeds from acquisition loan. Promissory note related to acquisition Rightofuse assets obtained in exchange for operating lease liabilities. One Vendor [Member] Healthier Choices Management Corp [Member] Equity financing Securities Purchase Agreement [Member] Working capital Purchase of green acres market Shipping And Handling [Policy Text Block] Schedule of Cash in FDIC Limits [Table Text Block] Accounts Receivable Contract Assets and Contract Liabilities [Policy Text Block] Other Current Assets [Policy Text Block] GreenAcres Market [Member] Schedule Of Cash In Excess FDIC Limits [Table Text Block] Suppliers [Member] Purchase [Member] No Insider Trading Flag Advertising revenue Asset Purchase Agreement [Member] Ellwood Thompson [Member] Right of use asset - operating lease. Business combination, recognized identifiable assets acquired and liabilities assumed, cash and equivalents. Amortization period for goodwill for tax purposes (years). Promissory Notes [Member] Secured Promissory Notes [Member] Non-Compete Agreement [Member] Long Lived Assets Held For Sale [Disclosure Text Block] Unsecured Promissory Note [Member] Bridge Warrant Shares [Member] Loan And Security Agreement [Member] First Anniversary [Member] Second Anniversary [Member] Acquisition Loan And Security Agreement [Member] ScheduleOfCompanyOperatingLeasesTableTextBlock LesseeOperatingLeaseLiabilityLeaseTerm [Table Text Block] Transition Services Agreement [Member] Customer Relationship [Member] Non-Compete [Member] Income tax reconciliation other permanent items Income tax reconciliation change in tax rate Segment Net Operating Income (Loss) [Member] Unallocated Amount [Member] Total Reporting Segment Assets [Member] Significant Segment Expenses [Table Text Block] Retail Grocery [Member] Food Service/Restaurant [Member] Online/ECommerce [Member] Displays [Member] Series E Convertible Preferred Stock [Member] Assets, Current Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Gain (Loss) on Disposition of Property Plant Equipment Interest Expense, Nonoperating Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Gain (Loss) on Disposition of Assets Other Noncash Income (Expense) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories IncreaseDecreaseInPrepaidExpensesAndVendorDeposits Increase (Decrease) in Other Current Assets Increase (Decrease) in Due from Related Parties Increase (Decrease) in Other Noncurrent Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments of Loan Costs Payments for Repurchase of Initial Public Offering Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Equity [Text Block] Inventory, Policy [Policy Text Block] Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Lessee, Leases [Policy Text Block] Operating Costs and Expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Business Acquisition, Pro Forma Net Income (Loss) Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Net Accounts Payable and Accrued Liabilities Long-Term Debt, Current Maturities Long-Term Debt, Maturity, Year One Long-Term Debt, Maturity, Year Two Long-Term Debt, Maturity, Year Three Long-Term Debt, Maturity, Year Four Long-Term Debt, Maturity, Year Five Interest Expense, Debt Warrants and Rights Outstanding Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Five Lessee, Operating Lease, Liability, to be Paid, after Year Five Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Operating Lease, Liability Lease, Cost DeferredTaxAssetsTaxDeferredExpenseReservesInterestExpense Deferred Tax Assets, Gross Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Gross Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance EX-101.PRE 11 hcwc-20241231_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Mar. 27, 2025
Sep. 30, 2024
Cover [Abstract]        
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Dec. 31, 2024      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2024      
Current Fiscal Year End Date --12-31      
Entity File Number 001-42274      
Entity Registrant Name HEALTHY CHOICE WELLNESS CORP.      
Entity Central Index Key 0001948864      
Entity Tax Identification Number 88-4128927      
Entity Incorporation, State or Country Code DE      
Entity Address, Address Line One 3800 North 28th Way      
Entity Address, Address Line Two Unit#1      
Entity Address, City or Town Hollywood      
Entity Address, State or Province FL      
Entity Address, Postal Zip Code 33020      
City Area Code (305)      
Local Phone Number 330-3839      
Title of 12(b) Security Common Stock, par value $0.001 per share      
Trading Symbol HCWC      
Security Exchange Name NYSEAMER      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company true      
Elected Not To Use the Extended Transition Period false      
Entity Shell Company false      
Entity Public Float       $ 24.4
Entity Common Stock, Shares Outstanding     10,565,749  
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction [Flag] false      
Auditor Firm ID 1195 688    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheet of Healthy Choice Wellness Corp. (the “Company”) as of December 31, 2024, and the related consolidated statements of operations, changes in stockholders’ equity, and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.      
Auditor Name UHY llp Marcum llp    
Auditor Location Hudson, New York Saddle Brook, NJ    
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
CURRENT ASSETS    
Cash $ 2,056,472 $ 1,422,580
Accounts receivable, net 509,763 128,171
Inventories 6,445,560 4,162,218
Prepaid expenses and vendor deposits 475,088 174,970
Other current assets 29,806 56,842
TOTAL CURRENT ASSETS 9,706,957 5,944,781
Property, plant, and equipment, net 1,976,469 2,676,639
Intangible assets, net 5,441,478 4,178,519
Goodwill 2,212,000
Right of use assets 14,232,240 11,412,562
Other assets 543,373 467,056
TOTAL ASSETS 34,112,517 28,432,560
CURRENT LIABILITIES    
Accounts payable and accrued expenses 6,131,534 4,920,411
Contract liabilities 80,456 207,513
Current portion of loan payable 2,131,336 702,701
Operating lease liability, current 3,596,987 2,748,824
TOTAL CURRENT LIABILITIES 11,940,313 8,579,449
Loan payable, net of current portion 9,207,772 2,403,807
Operating lease liability, net of current 10,584,431 8,461,182
TOTAL LIABILITIES 31,732,516 19,444,438
COMMITMENTS AND CONTINGENCIES (SEE NOTE 15)
STOCKHOLDERS’ EQUITY    
Common Stock, $0.001 par value per share, 560,000,000 shares authorized; 9,815,749 and 10 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively. 9,816
Additional paid-in capital 3,101,092
Net investment by former parent 8,988,122
Accumulated deficit (730,907)
TOTAL STOCKHOLDERS’ EQUITY 2,380,001 8,988,122
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 34,112,517 28,432,560
Series A Convertible Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Series A convertible preferred stock, $0.001 par value per share, 40,000,000 shares authorized, 0 share issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.
Related Party [Member]    
CURRENT ASSETS    
Due from related party current 190,268
Due from related party noncurrent $ 3,753,003
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2024
Dec. 31, 2023
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 560,000,000 560,000,000
Common stock, shares issued 9,815,749 10
Common stock, shares outstanding 9,815,749 10
Series A Convertible Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 40,000,000 40,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
SALES, NET $ 69,370,803 $ 55,689,793
COST OF SALES 42,305,494 35,341,569
GROSS PROFIT 27,065,309 20,348,224
OPERATING EXPENSES, NET    
Selling, general and administrative 29,047,933 24,768,293
Gain on sale of asset (205,146)
Impairment of goodwill 6,104,000
TOTAL OPERATING EXPENSES, NET 28,842,787 30,872,293
LOSS FROM OPERATIONS (1,777,478) (10,524,069)
OTHER INCOME (EXPENSE)    
Loss on debt extinguishment (1,888,889)
Change in contingent consideration 774,900
Other income, net 8,552 16,230
Interest expense, net (848,651) (199,681)
TOTAL OTHER INCOME (EXPENSE) (2,728,988) 591,449
LOSS BEFORE TAXES (4,506,466) (9,932,620)
INCOME TAX BENEFIT
NET LOSS $ (4,506,466) $ (9,932,620)
BASIC NET LOSS PER SHARE $ (0.48) $ (1.08)
DILUTED NET LOSS PER SHARE $ (0.48) $ (1.08)
BASIC WEIGHTED AVERAGE COMMON SHARES 9,395,500 9,226,860
DILUTED WEIGHTED AVERAGE COMMON SHARES 9,395,500 9,226,860
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Net Investment From Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 15,505,661 $ 15,505,661
Balance, shares at Dec. 31, 2022        
Net transfers to former parent 3,415,081 3,415,081
Net loss (9,932,620) (9,932,620)
Balance at Dec. 31, 2023 8,988,122 8,988,122
Balance, shares at Dec. 31, 2023        
Net transfers to former parent   (6,572,433) (6,572,433)
Net loss (3,775,559) (730,907) (4,506,466)
Issuance of common stock for Spin-Off and transfer of former parent investment to additional paid in capital $ 9,227 (1,369,097) 1,359,870
Issuance of common stock for Spin-Off and transfer of former parent investment to additional paid in capital, shares 9,226,860        
Issuance of common stock for IPO $ 400 2,579,600 2,580,000
Issuance of common stock for IPO, shares 400,000        
Exercise of warrants $ 189 1,890,589 1,890,778
Exercise of warrants, shares 188,889        
Balance at Dec. 31, 2024 $ 9,816 $ 3,101,092 $ (730,907) $ 2,380,001
Balance, shares at Dec. 31, 2024 9,815,749        
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
OPERATING ACTIVITIES    
Net loss $ (4,506,466) $ (9,932,620)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,576,457 1,431,816
Loss on debt extinguishment 1,888,889
Gain on sale of building (205,146)
Amortization of right-of-use assets 3,273,597 2,570,202
Write-down of obsolete and slow-moving inventory 2,491,934 2,471,653
Non-cash interest expense 32,500 32,000
Change in contingent consideration (774,900)
Loss on vendor settlement 91,291
Change in allowance for credit losses 12,925 15,425
Impairment of goodwill 6,104,000
Changes in operating assets and liabilities:    
Accounts receivable (394,517) (88,366)
Inventories (2,375,226) (2,032,996)
Prepaid expenses and vendor deposits (300,118) (92,016)
Other current assets 27,036 140,801
Due to related party (2,440,094) (1,416,638)
Other assets (76,317) (16,090)
Accounts payable and accrued expenses 1,178,624 1,430,867
Contract liabilities (127,057) (21,604)
Lease liabilities (3,121,863) (2,438,179)
NET CASH USED IN OPERATING ACTIVITIES (3,064,842) (2,525,354)
INVESTING ACTIVITIES    
Payment for acquisition (5,475,000) (750,000)
Proceeds from sale of Saugerties, NY building 749,000
Purchases of property and equipment (251,793) (179,623)
NET CASH USED IN INVESTING ACTIVITIES (4,977,793) (929,623)
FINANCING ACTIVITIES    
Proceeds from security purchase agreement 1,700,000
Principal payments on loan payable (2,535,758) (558,095)
Proceeds from acquisition loan 7,500,000
Proceeds from initial public offering (IPO) 4,000,000
Payment for IPO-related cost (1,420,000)  
Investment from parent company 1,736,412 3,415,081
Due to related party (2,306,016)
Proceeds from warrant exercised 1,889
NET CASH PROVIDED BY FINANCING ACTIVITIES 8,676,527 2,856,986
NET INCREASE (DECREASE) IN CASH 633,892 (597,991)
CASH — BEGINNING OF PERIOD 1,422,580 2,020,571
CASH — END OF PERIOD 2,056,472 1,422,580
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest 816,151 199,705
Cash paid for income tax
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Promissory note related to acquisition 1,825,000 718,000
Right-of-use assets obtained in exchange for operating lease liabilities $ 4,609,608 $ 1,325,409
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure [Table]    
Net Income (Loss) $ (4,506,466) $ (9,932,620)
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
12 Months Ended
Dec. 31, 2024
Insider Trading Arrangements [Line Items]  
Insider Trading Flag true
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.25.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Abstract]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] We recognize that cybersecurity is of critical importance to our success. We are susceptible to a number of significant and persistent cybersecurity threats, including those common to most industries as well as those we face as a retailer, operating in an industry characterized by a high volume of customer transactions and collection of sensitive data. These threats, which are constantly evolving, include data breaches, ransomware, and phishing attacks. We, and our vendors and suppliers, regularly face attempts by malicious actors to breach our security and compromise our information technology systems. A cybersecurity incident impacting us or any vendor or supplier could significantly disrupt our operations and result in damage to our reputation, costly litigation and/or government enforcement action. Accordingly, we are committed to maintaining robust cybersecurity and data protection and continuously evaluating the impact of cybersecurity threats, considering both immediate and potential long-term effects of these threats on our business strategy, operations, and financial condition.

Our Chief Operating Officer is primarily responsible for managing material risks from cybersecurity threats, and is supported by third party cybersecurity specialists. Management participates in periodic training and education on cybersecurity related topics. We engage specialized cybersecurity consultants and leverage third-party expertise to bolster our cybersecurity defenses. Our enterprise risk management program is designed to identify, prioritize and assess a broad range of risks, including risks from cybersecurity threats, that may affect our ability to execute our corporate strategy and fulfill our business objectives.

 

The following is a list of measures that were implemented as part of our increased focus on cybersecurity:

 

  Complete endpoint protection - All endpoints have been covered by an enhanced endpoint protection agent.
  Cloud infrastructure - Critical infrastructure started moving to the cloud and protected by enhanced anti-virus and recurring backup policies.
  Email services have been put through a rigorous intelligent phishing and spam filter to prevent attacks.

 

In addition, our third-party vendors and service providers play a role in our cybersecurity. These third parties are integral to our operations but pose cybersecurity challenges due to their access to our data and our reliance for various aspects of our operations, including our supply chain. We conduct due diligence before onboarding new vendors and maintain ongoing evaluations to ensure compliance with our security standards.

 

As of the date of this report, no cybersecurity incidents have had, either individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. However, despite the comprehensive measures outlined above, management has identified a material weakness in our cybersecurity setup, specifically regarding access controls and data encryption, This weakness increases the risk of a significant cybersecurity incident. We are actively developing and implementing a remediation plan to address this material weakness. We are committed to resolving this issue promptly and enhancing our overall cybersecurity posture. Notwithstanding our remediation efforts, we acknowledge that we may not be successful in preventing or mitigating all potential cybersecurity incidents that could have a material adverse effect on us.

 
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION
12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION

NOTE 1. ORGANIZATION

 

Organization

 

Healthy Choice Wellness Corp. (the “Company” or “HCWC” or “we” or “our” or “us”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives.

 

Through its wholly owned subsidiaries, the Company operates:

 

Ada’s Natural Market, a natural and organic grocery store offering fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
   
Paradise Health & Nutrition’s three stores that likewise offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
   
Mother Earth’s Storehouse, a two-store organic and health food and vitamin chain in New York’s Hudson Valley, which has been in existence for over 40 years.
   
Greens Natural Foods’ eight stores in New York and New Jersey, offering a selection of 100% organic produce and all-natural, non-GMO groceries & bulk foods; a wide selection of local products; an organic juice and smoothie bar; a fresh foods department, which offers fresh and healthy “grab & go” foods; a full selection of vitamins & supplements; as well as health and beauty products.
   
Ellwood Thompson’s, an organic and natural health food and vitamin store located in Richmond, Virginia.
   
GreenAcres Market, an organic and natural health food and vitamin chain with five store locations in Kansas and Oklahoma. GreenAcres Market offers organic and all natural products and vitamins from both top national brands as well as locally sourced specialty brands.

 

Through its wholly owned subsidiary, Healthy Choice Wellness, LLC, the Company operates a Healthy Choice Wellness Center in Kingston, NY and has a licensing agreement for a Healthy Choice Wellness Center located at the Casbah Spa and Salon in Fort Lauderdale, FL.

 

These centers offer multiple vitamin drip mixes and intramuscular shots for clients to choose from that are designed to help boost immunity, fight fatigue and stress, reduce inflammation, enhance weight loss, and efficiently deliver antioxidants and anti-aging mixes. Additionally, there are IV vitamin mixes and shots for health, beauty, and re-hydration.

 

Through its wholly owned subsidiary, Healthy U Wholesale, the Company sells vitamins and supplements, as well as health, beauty, and personal care products on its website www.TheVitaminStore.com.

 

 

Sourcing and Vendors

 

We source from multiple suppliers. These suppliers range from small independent businesses to multinational conglomerates. For the years ended December 31, 2024 and 2023, approximately 25% and 41% of our total purchases were from one vendor, respectively.

 

Spin-Off

 

Healthier Choices Management Corp. (“HCMC” or the “Parent”) announced on August 22, 2022 that its Board of Directors approved the separation of the grocery business, including wellness business, into an independent, publicly traded company (the “Spin-Off” or “Separation”). Prior to the Spin-Off, HCWC was a subsidiary under HCMC, which operated the Ada’s Natural Market, Paradise Health & Nutrition, Mother Earth’s Storehouse, Greens Natural Foods, Ellwood Thompson’s, and GreenAcres Market retail brands, as well as licensed wellness centers and Healthy U Wholesale.

 

On September 13, 2024 (the “Spin-Off Date”), after the New York Stock Exchange American (“NYSEAM”) market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock commenced trading on the NYSEAM under the stock symbol “HCWC.”

 

HCMC distributed all the outstanding shares of common stock held by it on a pro rata basis to holders of HCMC’s common stock. For each 208,632 shares of HCMC common stock held as of 5:00 p.m., New York City time, on September 9, 2024, the record date for the Spin-Off (the “Record Date”), a HCMC stockholder was entitled to receive one (1) share of Class A common stock and three (3) shares of Class B common stock. The Distribution was made in book-entry form by a distribution agent as soon as practicable after the date of the Distribution.

 

HCMC has secured binding commitments of $13.25 million in equity financing for HCWC from the same group of investors that invested $13.25 million in HCMC Series E Preferred Stock. Pursuant to the Securities Purchase Agreement for the HCMC Series E Stock (“HCMC Series E SPA”), the purchasers of HCMC Series E Stock will also be required to purchase Series A Preferred Stock of HCWC in the same subscription amounts that the Purchasers paid for the HCMC Series E Stock (regardless of whether or not such HCMC Series E Stock has been converted into HCMC common stock).

 

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.25.1
GOING CONCERN
12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 2. GOING CONCERN

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.

 

The Company currently and historically has reported net losses and cash outflows from operations. Cash and cash equivalents increased to approximately $2.1 million as of December 31, 2024, compared to $1.4 million as of December 31, 2023, driven by increased sales and improved sales margin. Working capital deficit decreased from negative $2.6 million as of December 31, 2023, to negative $2.2 million as of December 31, 2024, primarily due to improvement in cash reserves and inventory management. Net losses improved to $4.5 million for the year ending December 31, 2024 from $9.9 million for the year ended December 31, 2023. Cash used in operating activities increased to $3.1 million in 2024 from $2.5 million in 2023, respectively.

 

On July 18, 2024, HCWC entered into a $7.5 million loan and security agreement with a private lender to support its expansion plans and funding of any working capital needs, of which $4.2 million was used for the July 18, 2024 purchase of GreenAcres Market. The face amount of the loan is $7,500,000 with 12% annual interest and has a maturity date of July 17, 2027. On July 24, 2024, the Company finalized the closing of Saugerties building sale with all parties involved and received net proceeds of $695,000.

 

On August 18, 2022, HCMC entered into a Securities Purchase Agreement (“HCMC Preferred Stock”) pursuant to which the HCMC sold and issued 14,722 shares of its Series E Convertible Preferred Stock to institutional investors for $1,000 per share or an aggregate subscription of $13.25 million. This same group of investors committed to invest $13.25 million in HCWC after the Spin-Off and IPO transactions were completed. As such, HCWC entered into an agreement to sell shares of its Series A Convertible Preferred Stock (the “Series A Preferred Stock”), with the gross proceeds from such offering expected to be $13.25 million. The institutional investors that acquired HCMC Series E Preferred Stock are contractually required to purchase the Series A Preferred Stock in the same dollar amounts as they invested in the HCMC Series E Preferred Stock (regardless of whether or not such HCMC Series E Preferred Stock has been converted into HCMC common stock).

 

The Company believes its cash on hand and the commitment of $13.25 million raised through its security offering noted above will enable the Company to meet its obligations and capital requirements for at least the twelve months from the date these financial statements are issued. Accordingly, no adjustment has been made to the financial statements to account for this uncertainty.

 

 

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.25.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in accordance with U.S. GAAP.

 

The Company has historically operated as part of HCMC and not as a standalone company. Financial statements representing the historical operations of HCMC’s grocery segment have been derived from HCMC’s historical accounting records and are presented on a carve-out basis through the Spin-Off date. The Company’s financial statements for the period September 14, 2024 through December 31, 2024 are consolidated financial statements based on the reported results of HCWC as a stand-alone company. HCMC completed steps to spin off its grocery segment and wellness business into HCWC. The entities under the grocery segment and wellness business were contributed (100%) to HCWC, as such the accompanying consolidated financial statements through the Spin-Off date have been contributed to HCWC using their carryover basis in accordance with Accounting Standard Codification (“ASC”) Topic 805, Business Combinations (“ASC 805”) for entities under common control. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the consolidated financial statements. The consolidated financial statements also include allocations of certain general, administrative, sales and marketing expenses from HCMC though the Spin-Off date. However, the amounts recognized by the Company are not necessarily representative of the amounts that would have been reflected in the consolidated financial statements had the Company operated independently of HCMC. Related-party allocations are discussed further in Note 18.

 

Segment Reporting

 

Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision makers, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company operates as a single reportable segment, as the CODM reviews financial performance and makes decisions on a consolidated basis.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc. (“Ada’s Natural Market”), Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), Healthy Choice Markets 3, LLC (“Mother Earth’s Storehouse”), Healthy Choices Markets 3 Real Estate LLC, Healthy Choice Markets IV, LLC (Green’s Natural Foods), Healthy Choice Markets V, LLC (Ellwood Thompson’s), Healthy Choice Markets VI, LLC (GreenAcres Market), Healthy Choice Wellness, LLC, and Healthy U Wholesale, Inc (“The Vitamin Store, LLC”). All intercompany accounts and transactions have been eliminated in consolidation.

 

Net Parent Investment

 

The accompanying consolidated financial statements were derived from the consolidated financial statements of HCMC on a carve-out basis though the Spin-Off date, and the consolidated financial statements also include allocations of certain general, administrative, legal, and marketing expenses from HCMC. The primary components of the Net Parent Investment are intercompany balances other than related party payables, the allocation of shared costs, and funding received to cover any shortfall in operating cash requirements. Balances between HCMC and the Company that were not historically cash settled are included in Net Parent Investment. Net Parent Investment represents the cumulative investment by HCMC in the Company through the Spin-Off date. Upon Spin-Off, the Company reclassed the balance in net parent investment to additional paid-in capital.

 

Use of Estimates in the Preparation of the Financial Statements

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include promotional discounts, manufacturer coupons and rebates, return allowances that are netted against revenue, useful lives and impairment of long-lived assets, allowance for credit losses, inventory provisions, deferred taxes and related valuation allowances, allocation of corporate general expenses, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.

 

Revenue Recognition

 

Revenues from product sales and services rendered, net of promotional discounts, manufacturer coupons and rebates, return allowances, and sales and consumption taxes, are recorded when products are delivered, title passes to customers and collection is likely to occur. Title passes to customers at the point of sale for retail and upon delivery of products for wholesale. Return allowances, which reduce revenue, are estimated using historical experience.

 

The Company promotes its products with trade incentives and promotions. These programs include sales discounts, rebates, coupons, volume-based incentives, refunds, and returns, which represent variable considerations. The estimation of variable consideration involves judgment and is constrained to avoid overstatement of revenue. The Company applies the expected value method or the most likely amount method, depending on which better predicts the consideration to which it will be entitled. Management evaluates these estimates on a quarterly basis. The trade incentives and promotions are recorded as a reduction to the transaction price based on amounts estimated as being due to customers at the end of the period. The Company derives these estimates based on historical experience. The Company does not receive a distinct service in relation to the trade incentives and promotions.

 

The Company recognizes revenue in accordance with the following five-step model:

 

  identify arrangements with customers.
  identify performance obligations.
  determine transaction price.
  allocate transaction price to the separate performance obligations in the arrangement, if more than one exists; and
  recognize revenue as performance obligations are satisfied.

 

The Company does not have significant revenue recognized over time due to the nature of retail store operation. The Company recognizes revenue at a point in time when control of goods or services transfers to the customer.

 

 

Shipping and Handling

 

Shipping charges billed to customers are included in net sales and the related shipping and handling costs are included in cost of sales. For the years ended December 31, 2024 and 2023, shipping and handling costs of approximately $132,000 and $117,000, were included in cost of sales, respectively.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash is concentrated in one financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage. The Company has not experienced any losses in such accounts. The Company did not have any cash equivalents as of December 31, 2024 and December 31, 2023.

 

A summary of the financial institution that had cash in excess of FDIC limits of $250,000 as of December 31, 2024 and December 31, 2023 is presented below:

 

 

  

December 31,

2024

  

December 31,

2023

 
Total cash and restricted cash in excess of FDIC limits  $715,852   $161,644 

 

The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.

 

Accounts Receivable, Contract Assets and Contract Liabilities

 

Accounts receivables are claims to consideration which are unconditional; meaning no performance obligations remain for the Company and only the passage of time is necessary before collection. Contract assets are distinguished from accounts receivable as performance obligations remain before claims to consideration become unconditional. By nature of the Company’s operations, contract assets are typically not recognized. Contract liabilities are recorded when customers transfer consideration in advance of delivery of products or services, which the Company records for gift cards and loyalty reward programs. When one party to an arrangement performs before the other(s), the Company records an account receivable, contract asset or contract liability.

 

The majority of arrangements with customers contain one performance obligation: to provide a distinct set of products or services. Most performance obligations are satisfied simultaneously as the Company exchanges products or services for customer payment. Exceptions include gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products or services at a future date. As gift cards are purchased and loyalty points earned, contract liabilities are recorded until the performance obligations are satisfied through delivery of products or services or breakage based on gift card and loyalty reward program term limits. For the years ended December 31, 2024 and 2023, the contract liability balance were approximately $80,000 and $208,000, respectively.

 

The Company’s breakage policy is twenty-four months for gift cards and twelve months for loyalty rewards. Loyalty rewards are earned at five percent on qualifying purchases and the reward functions as an allocation of transaction price from the period earned by the customer to the period the performance obligation is satisfied by the Company. As such, all contract liabilities are expected to be recognized within a twenty-four-month period.

 

In August 2024, the Company transitioned its customer loyalty program from a points-based system to a VIP membership structure. Under the original loyalty program, customers earned redeemable loyalty points based on qualifying purchases, which have been discontinued. Existing unredeemed loyalty points remain valid for redemption until January 31, 2025. The new VIP program provides members with immediate discounts on qualifying purchases, replacing the accrual of future points. The elimination of future loyalty point accruals reduces the Company’s ongoing contract liability obligations, as discounts under the VIP program are recognized as reductions to revenue at the time of sale.

 

 

Other Current Assets

 

Other current assets are the non-trade related assets that the Company owns, benefits from, or uses to generate income that can be converted into cash within one business cycle. Included in “Other current assets” on our consolidated balance sheets are amounts primarily related to other receivables or non-trade receivable from other companies.

 

Inventories

 

Inventories are measured at the lower of cost and net realizable value using the average cost method. If the cost of the inventories exceeds their net realizable value, adjustments are recorded to write down excess carrying value to their net realizable value. The Company’s inventories consist primarily of merchandise available for resale, such as fresh produce, perishable grocery items and non-perishable consumable goods. Slow-moving inventory is rotated out and obsolete inventory is removed (expensed) on a monthly basis.

 

Property, Plant, and Equipment

 

Property, plant, and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the expected useful life of the respective asset, after the asset is placed in service. Revenue earning property, plant, and equipment includes signage, furniture and fixtures, building, computer hardware, appliance, cooler, displays with useful lives range from two to ten years. Leasehold improvements are amortized over the shorter of the life of the asset or the term of the lease.

 

Identifiable Intangible Assets

 

Identifiable intangible assets are recorded at cost, or when acquired as part of a business acquisition, at estimated fair value. Certain identifiable intangible assets are amortized over 4 to 13 years. Similar to tangible personal property and equipment, the Company periodically evaluates identifiable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Impairment of Long-Lived Assets

 

The Company reviews all long-lived assets such as property and equipment and amortized intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated future cash flows expected to be generated by the asset or asset group. Impairment is measured by the amount by which the carrying value of the asset(s) exceeds their fair value. There were no triggering events that would indicate impairment of long-lived assets in the twelve months period ended on December 31, 2024.

 

 

Goodwill

 

The Company assesses the carrying amounts of goodwill for recoverability on at least an annual basis or when events or changes in circumstances indicate evidence of potential impairment exists, using a fair value-based test. In performing the Company’s analysis of goodwill, the Company first evaluates qualitative factors, including relevant events and circumstances, to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value should be recognized; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Application of the goodwill impairment test requires significant judgments including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for the businesses, and the useful life over which cash flows will occur. Changes in these estimates and assumptions could materially affect the determination of fair value and/or conclusions on goodwill impairment for the Company. Our annual impairment test is conducted on September 30 of each year or more often if deemed necessary.

 

The Company incurred a non-cash impairment charge of $6,104,000 for the year ended December 31, 2023.

 

In July 2024, the Company acquired GreenAcres Market and recorded goodwill of $2,212,000 from the acquisition.

 

During the years ended December 31, 2024, there was no goodwill impairment charges recognized by the Company in the audited consolidated statements of operations.

 

Advertising

 

Advertising expense is classified as selling, general and administrative expense on the consolidated statements of operations. The Company expenses advertising costs as incurred. For the years ended December 31, 2024 and 2023, the company incurred advertising expenses of $581,000 and $564,000, respectively.

 

401(k) retirement savings plan

 

The Company’s employees are offered a 401(k)-retirement savings plan that is currently administered under HCMC with discretionary contribution matching opportunities. HCMC will continue provide this service to HCWC’s employees pursuant to the Transition Service Agreement (“TSA”) executed upon the separation. The Company is in the process of establishing this service with its payroll provider, and expects to provide 401(k) to its own employees at the beginning of next year. 401K employer expense amounted to $94,000 and $82,000 for the years ended December 31, 2024 and 2023, respectively.

 

Earnings per share

 

Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards. There is no dilution for the years ended December 31, 2024 and 2023.

 

On September 16, 2024, the Company separated from HCMC. As referenced in Note 1. Organization, the Separation resulted in the initial issuance of approximately 9.2 million shares of HCWC common stock. For purposes of computing basic and diluted earnings per common share for the year ended December 31, 2023, the number of HCWC common shares issued upon separation and distribution was used to reflect the outstanding shares.

 

The following table sets forth the computation of basic and diluted earnings per share attributable to the Company’s stockholders.

 

   2024   2023 
   For the Years Ended December 31, 
   2024   2023 
         
NET LOSS  $(4,506,466)  $(9,932,620)
           
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES   9,395,500    9,226,860 
           
BASIC AND DILUTED NET LOSS PER SHARE  $(0.48)  $(1.08)

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740”). Under this method, income tax expense is recognized as the amount of: (i) taxes payable or refundable for the current year and (ii) future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of available evidence it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 or 2023. The Company had no uncertain tax positions as of December 31, 2024 and 2023.

 

Leases

 

Operating lease liabilities are recognized at the lease commencement date based on the present value of the fixed lease payments using the Company’s incremental borrowing rates. Related lease right-of-use (“ROU”) are recognized based on the initial present value of the fixed lease payments, reduced by contributions from landlords, plus any prepaid rent and direct costs from executing the leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payments are recognized as lease expense as they are incurred.

 

The Company did not have finance leases in year 2024 and 2023. If the Company enters into a finance lease in the future, it will be accounted for in accordance with ASC Topic 842.

 

 

Fair Value Measurements

 

The fair value framework under FASB’s guidance requires the categorization of assets and liabilities into three levels based upon the assumptions used to measure the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, would generally require significant management judgment. The three levels for categorizing assets and liabilities under the fair value measurement requirements are as follows:

 

  Level 1: Fair value measurement of the asset or liability using observable inputs such as quoted prices in active markets for identical assets or liabilities;
     
  Level 2: Fair value measurement of the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and
     
  Level 3: Fair value measurement of the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.

 

Recurring Fair Value Measurements

 

The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, operating, derivatives and borrowings. Management believes that the carrying value of cash and cash equivalents, accounts receivable, accounts payable, and borrowings are representative of their respective fair values. All derivatives are recognized as either assets or liabilities on the balance sheet at fair value at the end of each quarter.

 

Nonrecurring Fair Value Measurements

 

The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets, indefinite-lived intangible assets and goodwill. The Company reviews the carrying amounts of such assets at least annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Any resulting asset impairment would require that the asset be recorded at its fair value. The resulting fair value measurement of the assets are considered to be Level 3 measurements.

 

Business Combination

 

The Company applies the provisions of ASC 805 in the accounting for acquisitions of businesses. ASC 805 requires the Company to use the acquisition method of accounting by recognizing identifiable assets and liabilities, including intangible assets of acquired businesses at their fair value at the date of acquisition. When the Company acquires control of a business, any previously held equity interest also is remeasured to fair value. The excess of the purchase consideration and any previously held equity interest over the fair value of identifiable net assets acquired is goodwill. If the fair value of identifiable net assets acquired exceeds the purchase consideration and any previously held equity interest, the difference is recognized in the consolidated statements of operations immediately as a gain or loss on acquisition. Acquisition-related expenses are expensed as incurred and the expenses are recorded in operating expenses in the consolidated statements of operations.

 

Recent Accounting Pronouncements

 

Public companies in the United States are subject to the accounting and reporting requirements of various authorities, including FASB and the SEC.

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (ASC 326)” This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL”) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to certain financial assets. The Company adopted ASC 326 on January 1, 2023, and estimated expected credit losses based on aging schedule, and provisioned approximately $28,000 and $15,000 credit loss for the year ended December 31, 2024 and 2023, respectively.

 

On December 14, 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s consolidated financial statements.

 

On November 27, 2023, FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which requires public entities to consider relevant qualitative and quantitative factors when determining whether segment expense categories and amounts are significant, and identify segment expenses on the basis of amounts that are regularly provided to the CODM, and included in reported segment profit or loss. The ASU is effective for fiscal years beginning after Dec. 15, 2023, and interim periods within fiscal years beginning after Dec. 15, 2024. The Company adopted this standard effective January 1, 2024, applying it retrospectively to all periods presented. As the Company has one reportable segment, the adoption had no material impact on the Company’s financial statements, but resulted in additional expense disclosures and reconciliations in the financial statement footnotes. See Note 5 for details.

 

 

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.25.1
CONCENTRATIONS
12 Months Ended
Dec. 31, 2024
Risks and Uncertainties [Abstract]  
CONCENTRATIONS

NOTE 4. CONCENTRATIONS

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash is concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage.

 

The Company has not experienced any losses in such accounts. The Company did not have any cash equivalents as of December 31, 2024 and December 31, 2023.

 

A summary of the financial institution that had cash in excess of FDIC limits of $250,000 on December 31, 2024 and December 31, 2023 is presented below:

 

 

  

December 31,

2024

  

December 31,

2023

 
Total cash in excess of FDIC limits of $250,000  $715,852   $161,644 

 

The Company continually monitors its positions with, and the credit quality of the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.

 

The following table provides a reconciliation of cash and cash equivalents to amounts shown in audited consolidated statements of cash flow:

 

 

  

December 31,

2024

  

December 31,

2023

 
Cash  $2,056,472   $1,422,580 

 

Sourcing and Vendors

 

We source from approximately 1,000 suppliers and offer well-over 4,000 brands. These suppliers range from small independent businesses to multi-national conglomerates. We purchased approximately 70% and 75% of the goods we sell from our top 20 suppliers for the years ended December 31, 2024 and 2023, respectively, approximately 25% and 41% of our total purchases were from UNFI for the years ended December 31, 2024 and 2023, respectively. We maintain good relations with all our suppliers and believe we have adequate alternative supply methods, including self-distribution.

 

As mentioned, UNFI is our primary supplier of dry grocery and frozen food products. Our customer distribution agreement with UNFI commenced September 1, 2022, and has an initial term through September 1, 2027. Either party may terminate the agreement for defaults by the other party of certain provisions of the agreement. We are obligated to purchase a minimum annual volume of products from UNFI, except in certain defined circumstances when such purchasing obligation is excused. Pricing under our agreement with UNFI is on a “cost plus” basis. We believe UNFI has sufficient warehouse capacity and distribution technology to service our existing stores’ distribution needs for natural foods and products.

 

We have longstanding relationships with our suppliers, and we require disclosure from them regarding quality, freshness, potency and safety data information. Our bulk food private label products are packaged by us in pre-packed sealed bags to help prevent contamination while in transit and in our stores. Unlike most of our competitors, most of our private label nuts, trail mix, and flours are refrigerated in our warehouse and stores to maintain freshness.

 

 

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING AND DISAGGREGATION OF REVENUES
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
SEGMENT REPORTING AND DISAGGREGATION OF REVENUES

NOTE 5. SEGMENT REPORTING AND DISAGGREGATION OF REVENUES

 

The Company operates in two operating segments: Grocery and Wellness. In accordance with ASC 280, these segments have been aggregated into a single reportable segment because they share similar economic characteristics and meet all aggregation criteria, including similar nature of products sold, product acquisition process, customer base, distribution methods, and regulatory environment.

 

The Company’s CODM reviews financial results and allocates resources at the consolidated level, as the aggregated segments operate as one integrated business unit. No segment-specific financial metrics are used by the CODM to assess performance.

 

The Company adopted ASU 2023-07 effective January 1, 2024, on a retrospective basis. As the Company operates as a single reportable segment, the adoption did not have an impact on the Company’s consolidated financial statements. However, it did result in enhanced disclosures related to segment expenses and reconciliations to consolidated totals. Specifically, the Company has begun disclosing segment-specific expenses that are regularly reviewed by the CODM, Jeffrey Holman, the Company’s Chief Executive Officer, in accordance with the new standard. This adoption did not have an impact on the Company’s consolidated financial statements.

 

The following table summarizes the significant segment expenses:

 

 SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES

         
   For the Years Ended December 31, 
   2024   2023 
Advertising  $581,357   $564,405 
Payroll and Benefits   13,963,361    12,645,985 
Occupancy   6,573,925    5,280,405 
Depreciation and Amortization   1,576,457    1,431,816 
Bank Service Charges and Merchant Account Fees   1,331,637    927,863 
Other selling, general and administrative expenses   1,680,001    1,368,736 
Goodwill impairment   -    6,104,000 
Total significant reporting segment expenses  $25,706,738   $28,323,210 

 

The following table summarizes the reconciliations of reportable segment profit or loss and assets to the Company’s consolidated totals:

 

 SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT

         
   For the Years Ended December 31, 
   2024   2023 
Segment net operating income (loss)  $1,358,571   $(7,974,985)
Unallocated amount   (3,136,049)   (2,549,084)
Consolidated loss from operation  $(1,777,478)  $(10,524,069)

 

         
   For the Years Ended December 31, 
   2024   2023 
Total reporting segment assets  $30,698,054   $28,432,560 
Unallocated amount   3,414,463    - 
Consolidated total assets  $34,112,517   $28,432,560 

 

When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors, including the nature of products sold, product acquisition processes, customer types, distribution methods, and regulatory environments.

 

  

December 31,

2024

  

December 31,

2023

 
Retail Grocery  $60,690,718   $47,243,163 
Food service/restaurant   8,679,160    8,440,245 
Online/eCommerce   925    6,385 
Total revenue  $69,370,803   $55,689,793 

 

The Company does not have significant revenue recognized over time due to the nature of retail store operation. The Company recognizes revenue at a point in time when control of goods or services transfers to the customer. Revenue is recognized as follows:

 

 Retail Sales: At the point of sale when payment is received, products are physically transferred, and title passes.
 Advertising Services (COOP Revenue): When promotional materials are distributed to end-user customers.

 

 

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.25.1
ACCOUNTS RECEIVABLE, NET
12 Months Ended
Dec. 31, 2024
Credit Loss [Abstract]  
ACCOUNTS RECEIVABLE, NET

NOTE 6. ACCOUNTS RECEIVABLE, NET

 

Accounts receivable is mainly related to cooperative advertising (CO-OP) billing from each of the HCWC entities. HCWC bills its vendors for advertising vendors’ products in our sales channels. Advertising revenue is included in sales revenue in the consolidated statement of operations. The Company recorded advertising revenue of approximately $970,000 and $249,000 for the years ended December 31, 2024 and 2023, respectively. The Company’s accounts receivable totaled approximately $510,000 and $128,000 at December 31, 2024 and December 31, 2023, respectively. The accounts receivable balance at January 1, 2023 was approximately $55,000.

 

The Company’s credit loss is attributable to accounts receivable, and the Company determines the required allowance for expected credit losses using information such as customer credit history, current conditions, and reasonable and supportable forecasts about the future. Amounts are recorded to the allowance when it is determined that expected credit losses may occur. The Company reserved approximately $28,000 and $15,000 credit loss for the years ended December 31, 2024 and 2023, respectively.

 

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.25.1
INVENTORIES
12 Months Ended
Dec. 31, 2024
Inventory Disclosure [Abstract]  
INVENTORIES

NOTE 7. INVENTORIES

 

Inventories are measured at the lower of cost and net realizable value using the average cost method. If the cost of the inventories exceeds their market value, adjustments are recorded to write down excess inventory to its net realizable value. The Company, as a result of its physical inventory observations recorded the write down of inventories amounting to approximately $2.5 million in 2024 and 2023, respectively. The Company’s inventories consist primarily of merchandise available for resale.

 

XML 29 R17.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITIONS
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
ACQUISITIONS

NOTE 8. ACQUISITIONS

 

The purchase method of accounting in accordance with ASC 805 was applied for the Ellwood Thompson’s acquisition and GreenAcres Market acquisition. This requires the total cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill. Goodwill arising from the acquisition is attributable to expected operational synergies from combining the operations of the acquired business with those of the Company. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations.

 

Ellwood Thompson’s

 

On October 1, 2023, the Company through its wholly owned subsidiary, Healthy Choice Markets V, LLC, entered into an Asset Purchase Agreement with (i) ET Holding, Inc., d/b/a Ellwood Thompson’s Local Market, a Virginia corporation, (ii) Ellwood Thompson’s Natural Market, L.C., a Virginia limited liability company, and (iii) Richard T. Hood, an individual resident of the Commonwealth of Virginia. Pursuant to the Purchase Agreement, the Company acquired certain assets and assumed certain liabilities related to Ellwood Thompson’s grocery stores in Richmond, Virginia. The Company intends to continue to operate the grocery stores under their existing name.

 

The cash purchase price under the Asset Purchase Agreement was $750,000, and a promissory note provided to the seller of $750,000, with a fair value of $718,000. For twelve months ended on December 31, 2024, the Company recognized approximately $40,000 interest expense. In addition, the Company entered into a new lease agreement with the landlord and entered into an employment agreement with the store manager.

 

The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

  

October 1,

2023

 
Purchase Consideration     
Cash consideration paid  $750,000 
Promissory note   718,000 
Total Purchase Consideration  $1,468,000 
      
Purchase price allocation     
Inventory  $851,000 
Intangible assets   291,000 
Right of use asset - Operating lease   1,325,000 
Other liabilities   (31,000)
Operating lease liability   (1,325,000)
Goodwill   357,000 
Net assets acquired  $1,468,000 
      
Finite-lived intangible assets     
Trade Names (8 years)  $291,000 
Total intangible assets  $291,000 

 

 

The acquisition is structured as asset purchase in a business combination, and goodwill is tax-deductible, and amortizable over 15 years for tax purposes.

 

GreenAcres Market

 

On July 18, 2024, the Company through its wholly owned subsidiary, Healthy Choice Markets VI, LLC, entered into an Asset Purchase Agreement with (i) GreenAcres Markets of Oklahoma, LLC, an Oklahoma limited liability company, (ii) GACorp, Inc., a Kansas corporation; and (iii) the group of equity holders owning the majority interests of the Sellers. Pursuant to the Purchase Agreement, the Company acquired certain assets and assumed certain liabilities related to five GreenAcres Market’s grocery stores in Kansas and Oklahoma. The Company continued to operate the grocery stores under their existing name.

 

The cash purchase price under the Asset Purchase Agreement was $5,475,000, and a promissory note provided to the seller of $1,825,000. In addition, the Company entered into five new lease agreements with the landlords of the grocery stores.

 

The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

 

  

July 18,

2024

 
Purchase Consideration     
Cash consideration paid  $5,475,000 
Promissory note   1,568,000 
Total Purchase Consideration  $7,043,000 
      
Purchase price allocation     
Inventory  $2,400,000 
Property, plant, and equipment   127,000 
Intangible assets   2,304,000 
Goodwill   2,212,000 
Net assets acquired  $7,043,000 
      
Finite-lived intangible assets     
Trade Names (13 years)  $1,584,000 
Non-Compete Agreement (5 years)   720,000 
Total intangible assets  $2,304,000 

 

Revenue and Earnings

 

The following unaudited pro forma summary presents consolidated information of the Company, including Ellwood Thompson’s and GreenAcres Market, as if the business combinations had occurred on January 1, 2023, the earliest period presented herein:

SCHEDULE OF UNAUDITED PROFORMA INFORMATION 

         
   December 31, 
   2024   2023 
Sales  $77,762,430   $80,173,326 
Net loss   (4,791,021)   (11,401,315)

 

The pro forma financial information includes adjustments that are directly attributable to the business combinations and are factually supportable. The pro forma adjustments include incremental amortization of intangible, fixed assets depreciation and lease amortization. The proforma data gives effects to actual operating results prior to the acquisition. These proforma amounts do not purport to be indicative of the results that would have actually been obtained if the acquisitions occurred as of the beginning of each period presented or that may be obtained in future periods.

 

 

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.25.1
ASSETS HELD FOR SALE
12 Months Ended
Dec. 31, 2024
Assets Held For Sale  
ASSETS HELD FOR SALE

NOTE 9. ASSETS HELD FOR SALE

 

On February 7, 2024, the Company closed the operation of the Saugerties, NY store. The decision was based on management’s plan to maximize the profitability of the grocery segment. The Company transferred all operating assets and liabilities to other neighboring stores. The building, which is owned by the Company, has a net carrying value of approximately $544,000 and was put up for sale in February at its fair market value. The Company has classified the building as held for sale in accordance with ASC 360, “Property, Plant, and Equipment.” The building was previously classified as property, plant, and equipment (PP&E) and included in long-term assets.

 

On July 24, 2024, the Company finalized the closing of Saugerties, NY building sale with all parties involved and received net proceeds of $695,000. The building was sold at fair market value of $749,000 and the Company paid approximately $54,000 in legal fees, commission and other miscellaneous expenses. The title and deed were transferred on the closing date.

 

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.25.1
PROPERTY, PLANT, AND EQUIPMENT
12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT, AND EQUIPMENT

NOTE 10. PROPERTY, PLANT, AND EQUIPMENT

 

Property, plant, and equipment consist of the following as of December 31, 2024 and 2023:

 

         
   Year Ended December 31, 
   2024   2023 
         
Displays  $312,146   $312,146 
Building   -    575,000 
Furniture and fixtures   720,657    505,436 
Leasehold improvements   1,991,953    1,925,385 
Computer hardware & equipment   209,029    141,682 
Other   710,682    680,718 
Property, plant and equipment gross    3,944,467    4,140,367 
Less: accumulated depreciation and amortization   (1,967,998)   (1,463,728)
Total property, plant, and equipment  $1,976,469   $2,676,639 

 

The Company incurred approximately $0.5 million of depreciation expense for the years ended December 31, 2024 and 2023, respectively.

 

 

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.25.1
INTANGIBLE ASSETS
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 11. INTANGIBLE ASSETS

 

Intangible assets, net consist of the following as of December 31, 2024 and 2023:

 

December 31, 2024 

Useful Lives

(Years)

 

Gross

Carrying
Amount

  

Accumulated

Amortization

  

Net

Carrying
Amount

 
Trade names  8-13 years  $4,444,000   $(1,427,798)  $3,016,202 
Customer relationships  4-6 years   2,669,000    (1,628,639)   1,040,361 
Non-compete  4-5 years   2,322,000    (937,085)   1,384,915 
Intangible assets, net     $9,435,000   $(3,993,522)  $5,441,478 

 

December 31, 2023 

Useful Lives

(Years)

 

Gross

Carrying
Amount

  

Accumulated

Amortization

  

Net

Carrying
Amount

 
Trade names  8-10 years  $2,860,000   $(1,035,443)  $1,824,557 
Customer relationships  4-6 years   2,669,000    (1,330,972)   1,338,028 
Non-compete  4-5 years   1,602,000    (586,066)   1,015,934 
Intangible assets, net     $7,131,000   $(2,952,481)  $4,178,519 

 

Intangible assets are amortized on a straight-line basis. Amortization expense was approximately $1.0 million and $0.9 million for the years ended December 31, 2024 and 2023, respectively.

 

The weighted-average remaining amortization period of the Company’s amortizable intangible assets is approximately 5 years as of December 31, 2024. The estimated future amortization of the intangible assets is as follows:

 

For the years ending December 31,    
2025  $1,180,613 
2026   1,103,576 
2027   964,771 
2028   655,332 
2029   302,221 
Thereafter   1,234,965 
Total  $5,441,478 

 

XML 33 R21.htm IDEA: XBRL DOCUMENT v3.25.1
GOODWILL
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL

NOTE 12. GOODWILL

 

The Company tests goodwill for impairment annually on September 30 or more frequently if there are indicators that the carrying amount of the goodwill exceeds its estimated fair value.

 

As a result of the impairment test in 2023, the entire $6.1 million carrying value of goodwill was recognized as a non-cash impairment charge in 2023. There was no impairment of goodwill during the year ended December 31, 2024 based on the annual impairment assessment for 2024.

 

The changes in the carrying amount of goodwill as of December 31, 2024 and December 31, 2023 are as follows:

 

  

December 31,

2024

  

December 31,

2023

 
         
Beginning balance  $-   $5,747,000 
Acquisitions   2,212,000    357,000 
Impairment   -    (6,104,000)
Ending balance  $2,212,000   $- 

 

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.25.1
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 13. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

At December 31, 2024 and December 31, 2023, accounts payable and accrued expenses consisted of:

 

  

December 31,

2024

  

December 31,

2023

 
Trade creditors  $5,133,782   $4,406,299 
Accrued expenses   997,752    514,112 
Total  $6,131,534   $4,920,411 

 

 

XML 35 R23.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
DEBT

NOTE 14. DEBT

 

The following table provides a breakdown of the Company’s debt as of December 31, 2024 and 2023 is presented below:

 

   2024   2023 
   December 31, 
   2024   2023 
Promissory note  $11,623,392   $3,106,508 
Debt discount and issuance cost   (284,283)   - 
Total debt, net of debt discount and issuance costs   11,339,109    3,106,508 
Current portion of long-term debt   (2,200,210)   (702,701)
Current portion of debt discount and issuance cost   68,873    - 
Long-term debt  $9,207,772   $2,403,807 

 

 

Promissory Note

 

In connection with the Green’s Natural Foods acquisition, on October 14, 2022, the Company issued a secured promissory note (the “Greens Note”) in the principal amount of $3,000,000 as a portion of the purchase price. The Greens Note has a five-year term, an interest rate of 6.0% per annum and is secured by the assets of the Green’s Natural Foods. The outstanding balance was approximately $1,809,000 and $2,378,000 as of December 31, 2024 and December 31, 2023, respectively. The Company incurred approximately $127,000 and $160,000 interest expense for the year ended December 31, 2024 and 2023, respectively.

 

In connection with the Ellwood Thompson’s acquisition, on October 1, 2023, the Company issued a secured promissory note (the “Ellwood Note”) in the principal amount of $750,000, and discounted present value of $718,000 as a portion of the purchase price. The Ellwood Note has a five-year term, an interest rate of 6.0% per annum. The outstanding balance of the Ellwood Note was approximately $595,000 and $728,000 in principal amount as of December 31, 2024 and December 31, 2023, respectively. The Company recognized interest expense of approximately $40,000 and $39,000 for the years ended December 31, 2024, and 2023, respectively.

 

On January 18, 2024, HCWC entered into a Securities Purchase Agreement (the “Bridge Financing”) with institutional investors whereby (a) HCWC issued a total of approximately $1,889,000 in unsecured promissory notes (the “Notes”) and (b) on the date of the pricing of HCWC’s initial public offering (“IPO”), HCWC would deliver shares of its common stock equal to approximately $1,889,000 divided by the IPO price (“Bridge Shares”). The aggregate gross proceeds received from the investors in connection with the Security Purchase Agreement (“SPA”) was $1,700,000. The Notes were issued at a 10% original issue discount (“OID”) and accrue interest at a rate of 10% per annum beginning 60 days after issuance of the Notes. All accrued and unpaid principal and interest shall be due and payable upon the earlier of (1) the closing of the IPO, (2) January 18, 2025 or (3) upon an event of default as defined in the Notes.

 

On April 8, 2024, HCWC and the institutional investors entered into an amendment to the January 18, 2024 agreement whereby HCWC agreed to issue warrants (the “Bridge Warrants”) exercisable at $0.01 per share to purchase 188,889 shares of Class A common stock (the “Bridge Warrant Shares”) in lieu of Bridge Shares. The parties agreed to terminate any existing obligations of the institutional investors to acquire HCWC Bridge Shares as part of the IPO transaction.

 

On the Spin-Off Date, after the NYSEAM market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock was traded on the NYSEAM under the stock symbol “HCWC.”

 

Upon the completion of the IPO, HCWC paid in full the principal amount of Notes and OID. At December 31, 2024, the outstanding principal balance of the Notes and debt discount related with the Notes were at $0. HCWC incurred approximately $23,500 of debt issuance costs in connection with the issuance of the Notes, which, together with the OID of approximately $189,000, was recorded as a debt discount and was amortized over the life of the Notes using the straight-line method since such method was not materially different from the interest method. For the year ended December 31, 2024, approximately $298,000 of interest expense was recognized in the accompanying consolidated statements of operations.

 

The Company used the intrinsic value model to determine the fair value of the Bridge Warrants on April 18, 2024 and remeasured the fair value on September 16, 2024, and concluded that the fair value of the Bridge Warrants at September 16, 2024 was $1,887,001. Due to the fact that Bridge Warrants exercise was contingent upon the IPO, the Company did not recognize the warrant liability until the Spin-off date. The Bridge Warrants were exercised on September 17, 2024 by institutional investors. Upon warrant exercise, 188,889 shares of Class A common stock were issued and the warrant liability was eliminated against the loss on debt extinguishment in the amount of $1,888,889.

 

On July 18, 2024 (the “Loan Effective Date”), the Company entered into a loan and security agreement with a private lender for a $7,500,000 loan (the “Acquisition Loan”). A portion of the Acquisition Loan proceeds were used to acquire GreenAcres Markets. The loan is guaranteed by all of the subsidiaries of the Company (the “Guarantors”) and secured by all of the assets of the Company and the Guarantors. The Acquisition Loan has a term of three years and interest accrues at a rate of 12% on amounts borrowed. The Acquisition Loan may be prepaid at any time at a premium in the amount of ten percent (10%) of the principal amount of the Acquisition Loan outstanding prior to such prepayment. Payments on the Acquisition Loan are required to be made as follows: $1,125,000 on first anniversary of the Loan Effective Date, $1,875,000 on the second anniversary of the Loan Effective Date, and the remaining outstanding principal balance of principal and accrued interest on the third anniversary of the Loan Effective Date.

 

In connection with the GreenAcres Market acquisition, on August 23, 2024, the Company issued a secured promissory note (the “GreenAcres Note”) in the principal amount of $1,825,000 as a portion of the purchase price. The GreenAcres Note has a five-year term, an interest rate of 6.0% per annum and is secured by the assets of the GreenAcres Market. The outstanding balance was approximately $1,720,000 and $0 as of December 31, 2024 and 2023, respectively. The Company incurred approximately $36,000 and $0 interest expense for the years ended December 31, 2024 and 2023, respectively.

 

The Company may, at its option, at any time or from time to time prepay the outstanding principal amount or any accrued but unpaid interest, in each case in whole or in part, without penalty or premium, provided that any such prepayment of any outstanding amount of principal shall be accompanied by the payment of all accrued but unpaid interest on the amount of principal being prepaid, plus any costs and fees incurred.

 

The following table summarizes the 5-year repayment schedule:

 

For the years ending December 31,    
2025  $2,200,210 
2026   3,016,526 
2027   5,595,359 
2028   534,923 
2029   276,374 
Total  $11,623,392 

 

 

XML 36 R24.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 15. COMMITMENTS AND CONTINGENCIES

 

Legal Proceedings

 

On July 31, 2024, one of the Company’s subsidiaries, Healthy Choice Markets IV, LLC, was served with a lawsuit filed by a former employee alleging violations of state and federal wage and hour laws. The Company believes the claims are without merit and intends to vigorously defend against the lawsuit. While the outcome of this litigation cannot be predicted with certainty, the Company does not believe that the lawsuit, if adversely resolved, would have a material adverse effect on its financial condition, results of operations, or cash flows.

 

From time to time the Company is involved in legal proceedings arising in the ordinary course of our business. We believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of December 31, 2024. With respect to legal costs, we record such costs as incurred.

 

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 16. STOCKHOLDERS’ EQUITY

 

Spin-Off

 

HCMC announced on August 22, 2022 that its Board of Directors approved separation of the Grocery business, including wellness business, into an independent, publicly traded company (the “Spin-Off”). Prior to the Spin-Off, HCWC was a subsidiary under HCMC, which operated the Ada’s Natural Market, Paradise Health & Nutrition, Mother Earth’s Storehouse, Greens Natural Foods, Ellwood Thompson’s, and GreenAcres Market retail brands, as well as licensed wellness centers and Healthy U Wholesale.

 

On the Spin-Off Date, after the NYSEAM market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock was traded on the NYSEAM under the stock symbol “HCWC.”

 

HCMC distributed all the outstanding shares of Common Stock held by it on a pro rata basis to holders of HCMC’s common stock. For each 208,632 shares of HCMC common stock held as of 5:00 p.m., New York City time, on September 9, 2024, the record date for the Spin-Off (the “Record Date”), a HCMC stockholder was entitled to receive one (1) share of Class A common stock and three (3) shares of Class B common stock. The Distribution was made in book-entry form by a distribution agent as soon as practicable after the date of the Distribution.

 

As of December 31, 2024, 9,815,749 shares of common stock are outstanding.

 

The Company is authorized to issue 40,000,000 shares of Series A convertible preferred stock with par value of $0.001, none of which have been previously issued.

 

HCMC has secured binding commitments of $13.25 million in equity financing for HCWC from the same group of investors that invested $13.25 million in HCMC Series E Preferred Stock. Pursuant to the Securities Purchase Agreement for the HCMC Series E Stock (“HCMC Series E SPA”), the purchasers of HCMC Series E Stock will also be required to purchase Series A Preferred Stock of HCWC in the same subscription amounts that the Purchasers paid for the HCMC Series E Stock (regardless of whether or not such HCMC Series E Stock has been converted into HCMC common stock).

 

 

XML 38 R26.htm IDEA: XBRL DOCUMENT v3.25.1
LEASES
12 Months Ended
Dec. 31, 2024
Leases  
LEASES

NOTE 17. LEASES

 

The Company has various lease agreements with terms of up to 20 years, including leases of retail stores, headquarters and equipment. All the leases are classified as operating leases.

 

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of December 31, 2024.

 

Maturity of Lease Liabilities by Fiscal Year    
2025  $4,221,590 
2026   3,923,741 
2027   2,956,171 
2028   2,280,186 
2029   1,617,808 
Thereafter   824,585 
Total undiscounted operating lease payments  $15,824,081 
Less: interest   (1,642,663)
Present value of operating lease liabilities  $14,181,418 

 

The following summarizes the Company’s operating leases:

 

Balance Sheet Classification 

December 31,

2024

  

December 31,

2023

 
Right of use assets  $14,232,240   $11,412,562 
           
Operating lease liability, current  $3,596,987   $2,748,824 
Operating lease liability, net of current   10,584,431    8,461,182 
Total operating lease liabilities  $14,181,418   $11,210,006 

 

The amortization of the right-of-use asset of approximately $3,274,000 and $2,570,000 for the years ended December 31, 2024 and 2023, respectively, were included in operating cash flows.

 

The following table provides a summary of other information related to the leases at December 31, 2024 and 2023:

 

Other Information  December 31, 2024   December 31, 2023 
Weighted-average remaining lease term for operating leases   4 years    5 years 
Weighted-average discount rate for operating leases   5.19%   3.98%

 

Rent expense for the years ended December 31, 2024 and 2023 was approximately $4,196,000 and $3,435,000, respectively, and is included in selling, general and administrative expenses in the accompanying consolidated statement of operations.

 

The following table represents the components of lease expense are as follows for twelve months ended December 31, 2024:

 

  

December 31,

2024

 
Operating lease cost  $3,273,563 
Variable lease cost   922,282 
Short-term lease cost   - 
Total rent expense  $4,195,845 

 

The aggregate cash payments under the leasing arrangement was approximately $3,122,000 for the year ended December 31, 2024 and was included in operating cash flows.

 

 

XML 39 R27.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 18. RELATED PARTY TRANSACTIONS

 

Prior to the Spin-Off, the Company has not historically operated as a separate, stand-alone company and, accordingly has had various relationships with HCMC whereby HCMC provided services to the Company as noted below. Related party transactions prior to Spin-Off include allocation of general corporate expenses and advances from parent.

 

Allocation of General Corporate Expenses

 

HCMC provided human resources, accounting, payroll processing, legal and other managerial services to the Company prior to the Spin-Off. The accompanying consolidated financial statements include allocations of these expenses. Following the Spin-Off, HCWC and HCMC entered into a TSA, under which both companies agreed to provide certain transitional services to one another to ensure smooth separation. These services are provided on a transitional basis and will continue for a period of up to one year following the Spin-Off.

 

Management adopted a proportional cost allocation method to allocate HCMC expenses to the Company. The allocation method calculates the appropriate share of overhead costs to the Company based on management’s estimate that the sum of management time and resources spent managing the Company is approximately equal to the amount of time and resources spent managing HCMC and its subsidiaries. As a result, 50% of HCMC overhead on a weighted average basis was allocated to the Company based on the fact that management spent equal amount of time managing HCMC and the Company. The Company believes the allocation methodology used is reasonable and has been consistently applied, and results in an appropriate allocation of costs incurred. However, these allocations may not be indicative of the cost had the Company been a stand-alone entity or of future services. HCMC allocated approximately $2.1 million and $2.5 million for the years ended December 31, 2024 and 2023, respectively. The pre-Spin-Off allocated amounts will not be cash settled and are included in the Net Parent’s Investment.

 

Investment by Parent

 

For the thirty-six weeks ended September 13, 2024, the net operating expenses of $1.7 million incurred by HCMC on behalf of the Company was included in the Net Parent’s Investment. For the year ended December 31, 2023, the net operating expenses of $2.5 million incurred by HCMC on behalf of the Company, $0.8 million cash advance attributable to the Ellwood Thompson’ acquisition and $0.1 million HCMC loan payment on behalf of Green’s Natural Foods were included in the Net Parent’s Investment. Upon Spin-Off, the Company wrote off the net parent investment balance to additional paid-in capital.

 

Intercompany Receivable and Payable

 

Prior to Spin-Off, there was no intercompany agreement between the Company and HCMC. Management has determined those intercompany receivables and payables will be settled within twelve months after the balance sheet date. As a result, the Company’s intercompany balances are reflected as “due to” or “due from” accounts in the consolidated balance sheets. At the time of Spin-Off, the Company had a net payable balance to HCMC in the amount of $1.2 million, and the Company paid the balance in full to settle on the Spin-Off date of September 13, 2024. The Company had a net intercompany balance of $0.2 million and $3.8 million from HCMC as of December 31, 2024 and December 31, 2023, respectively.

 

Agreements with HCMC

 

The Company entered into several agreements with the former parent that, among other things, effect the separation and govern the relationship of the parties following the Spin-Off. These agreements include:

 

  a Separation Agreement that will set forth HCMC’s and the Company’s agreements regarding the principal actions that both parties will take in connection with the Spin-Off and aspects of our relationship following the Spin-Off;
  a Transition Services Agreement (“TSA”) pursuant to which HCMC and the Company will provide each other specified services on a transitional basis to help ensure an orderly transition following the Spin-Off.
  a Tax Matters Agreement (“TMA”) that will govern the respective rights, responsibilities and obligations of HCMC and the Company after the Spin-Off with respect to all tax matters and will include restrictions to preserve the tax-free status of the Spin-Off; and
  an Employee Matters Agreement (“EMA”) that will address employment, compensation and benefits matters, including the allocation and treatment of assets and liabilities arising out of employee compensation and benefits programs in which our employees participated prior to the Spin-Off.

 

Under the terms of the transition services agreement, the HCMC will provide to the Company, on a transitional basis, certain services or functions, including information technology, accounting, human resources, and payroll functions. Generally, these services will be provided for a period of up to one year following the Spin-Off. Consideration and costs for the transition services will be determined using several billing methodologies as described in the agreements, including customary billing and pass-through billing. Costs for transition services provided by the former parent are recorded within the Consolidated Statements of Operations based on the nature of the services. Following the Spin-Off, the Company recognized costs of $0.4 million for services provided by the former parent in 2024 pursuant to the transition services agreement.

 

XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 19. INCOME TAXES

 

Prior to September 13, 2024, the date of the Spin-Off of HCWC as a stand-alone entity, separate tax returns were not filed as they were included in the consolidated tax reporting of the former parent entity HCMC, within the respective entity’s tax jurisdiction. On September 13, 2024, HCWC completed its separation from HCMC through a tax-free distribution of HCWC common stock to HCMC shareholders. The Spin-Off was structured to qualify as tax-free under Sections 355(a) and 368(a)(1)(D) of the Internal Revenue Code (IRC). Pursuant to the Tax Matters Agreement (TMA) executed with HCMC in December 2023:

 

Pre-Spin Liabilities: HCMC retains responsibility for all taxes related to HCWC’s operations prior to September 13, 2024, including audits of HCMC’s consolidated returns.
Post-Spin Liabilities: HCWC is solely responsible for taxes attributable to its operations after the Spin-Off.
Indemnification: HCWC indemnifies HCMC for taxes arising from post-Spin actions that jeopardize the transaction’s tax-free status (e.g., violations of IRC Section 355(e)).

 

For periods prior to the Spin-Off, HCWC’s tax provision was calculated using the separate return method, as if HCWC had operated as a standalone taxpayer. Deferred tax assets and liabilities, including net operating losses (NOLs), were allocated to HCWC based on the carryover tax basis of assets and liabilities transferred in the Spin-Off. This method preserves the tax-free nature of the transaction.

 

As of December 31, 2024, all amounts related to the Company’s tax positions are recognized on the Consolidated Balance Sheet. Income taxes are accounted for under the asset and liability method.

 

The Company did not have expected tax expense (benefit) at the U.S. statutory rate 21% to the actual tax expense (benefit) reflected in the accompanying statement of operations:

 

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
         
U.S. federal statutory rate  $

(946,354

)  (2,085,850)
State tax benefit net of federal benefit   

(243,330

)   (557,568)
Change in valuation allowance   

1,358,776

    2,496,515 
True-Up & Deferred Adjustment   

(32,683

)   (73,814)
Other permanent items   

(119,803

)   209,444 
Change in tax rate   

(16,606

)   11,273 

Income tax provision/(benefit)

  $-   $- 

 

 

As of December 31, 2024 and 2023, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following:

 

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
Deferred tax assets:          
NOL carryforward  $3,129,808   $2,449,401 
Intangible assets   1,958,875    1,995,960 
Warrant liability   498,740    - 
Interest expense   227,272    - 
ASC 842 - Lease Accounting   89,309    65,172 
Charitable contributions   30,336    3,586 
UNICAP 263a Adjustment   (3,823)   53,284 
Allowances   7,485    - 
Total deferred tax assets   5,938,002    4,567,403 
           
Deferred tax liabilities:          
Net book value of fixed assets   (32,905)   (21,083)
Total deferred tax liabilities   (32,905)   (21,083)
           
Net deferred tax assets   5,905,097    4,546,320 
Valuation allowance   (5,905,097)   (4,546,320)
Net deferred tax assets  $-   $- 

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the positive and negative evidence available, management has determined that a valuation allowance is required at December 31, 2024 and 2023 to reduce the deferred tax assets to amounts that are more likely than not to be realized. The Company’s valuation increased by approximately $1,358,700 and $2,496,500 for the tax years ended 2024 and 2023, respectively. Should the factors underlying management’s analysis change, future valuation adjustments to the Company’s net deferred tax assets may be necessary. 

 

At December 31, 2024 the Company had U.S. federal and state post-2017 net operating loss carryforwards (“NOLs”) of $12 million and $12.2 million, respectively. Tax Cuts and Jobs Act (TCJA) allows NOLs incurred in tax years beginning in 2018 to be carried forward indefinitely subject to 80% of taxable income under Internal Revenue Code Section 172. Florida, Kansas, and Oklahoma net operating losses generated in taxable years beginning after December 31, 2017, are carried forward indefinitely until used and never expire; however, Oklahoma NOLs are subject to an 80% taxable income limitation per year. New York, New Jersey, and Virginia net operating losses expire after twenty years.

 

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. Among other provisions, the IRA includes a 15% corporate alternative minimum tax on applicable corporations and 1% excise tax on stock repurchases made after December 31, 2022. The IRA is not expected to have an impact on the consolidated financial statements.

 

The Company had no uncertain tax positions as of December 31, 2024, and 2023.

 

The Company files a federal income tax return and income tax returns in various state tax jurisdictions and the Company is generally no longer subject to examinations by federal and state tax authorities for years before 2021.

 

XML 41 R29.htm IDEA: XBRL DOCUMENT v3.25.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 20. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required disclosure in the consolidated financial statements.

 

On March 2, 2025, subsequent to the fiscal year ended December 31, 2024, the Company entered into an agreement with certain note holders to exchange $450,000 of outstanding principal under its existing Loan and Security Agreement dated July 18, 2024 for 750,000 shares of the Company’s Class A common stock. The exchange price of $0.60 per share equated to the closing bid price of the Company’s Class A common stock on February 28, 2025. Following this transaction, $7,050,000 in principal remains outstanding under the Loan and Security Agreement. The conversion strengthened the Company’s balance sheet by reducing its debt obligations.

XML 42 R30.htm IDEA: XBRL DOCUMENT v3.25.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in accordance with U.S. GAAP.

 

The Company has historically operated as part of HCMC and not as a standalone company. Financial statements representing the historical operations of HCMC’s grocery segment have been derived from HCMC’s historical accounting records and are presented on a carve-out basis through the Spin-Off date. The Company’s financial statements for the period September 14, 2024 through December 31, 2024 are consolidated financial statements based on the reported results of HCWC as a stand-alone company. HCMC completed steps to spin off its grocery segment and wellness business into HCWC. The entities under the grocery segment and wellness business were contributed (100%) to HCWC, as such the accompanying consolidated financial statements through the Spin-Off date have been contributed to HCWC using their carryover basis in accordance with Accounting Standard Codification (“ASC”) Topic 805, Business Combinations (“ASC 805”) for entities under common control. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the consolidated financial statements. The consolidated financial statements also include allocations of certain general, administrative, sales and marketing expenses from HCMC though the Spin-Off date. However, the amounts recognized by the Company are not necessarily representative of the amounts that would have been reflected in the consolidated financial statements had the Company operated independently of HCMC. Related-party allocations are discussed further in Note 18.

 

Segment Reporting

Segment Reporting

 

Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision makers, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company operates as a single reportable segment, as the CODM reviews financial performance and makes decisions on a consolidated basis.

 

Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc. (“Ada’s Natural Market”), Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), Healthy Choice Markets 3, LLC (“Mother Earth’s Storehouse”), Healthy Choices Markets 3 Real Estate LLC, Healthy Choice Markets IV, LLC (Green’s Natural Foods), Healthy Choice Markets V, LLC (Ellwood Thompson’s), Healthy Choice Markets VI, LLC (GreenAcres Market), Healthy Choice Wellness, LLC, and Healthy U Wholesale, Inc (“The Vitamin Store, LLC”). All intercompany accounts and transactions have been eliminated in consolidation.

 

Net Parent Investment

Net Parent Investment

 

The accompanying consolidated financial statements were derived from the consolidated financial statements of HCMC on a carve-out basis though the Spin-Off date, and the consolidated financial statements also include allocations of certain general, administrative, legal, and marketing expenses from HCMC. The primary components of the Net Parent Investment are intercompany balances other than related party payables, the allocation of shared costs, and funding received to cover any shortfall in operating cash requirements. Balances between HCMC and the Company that were not historically cash settled are included in Net Parent Investment. Net Parent Investment represents the cumulative investment by HCMC in the Company through the Spin-Off date. Upon Spin-Off, the Company reclassed the balance in net parent investment to additional paid-in capital.

 

Use of Estimates in the Preparation of the Financial Statements

Use of Estimates in the Preparation of the Financial Statements

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include promotional discounts, manufacturer coupons and rebates, return allowances that are netted against revenue, useful lives and impairment of long-lived assets, allowance for credit losses, inventory provisions, deferred taxes and related valuation allowances, allocation of corporate general expenses, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.

 

Revenue Recognition

Revenue Recognition

 

Revenues from product sales and services rendered, net of promotional discounts, manufacturer coupons and rebates, return allowances, and sales and consumption taxes, are recorded when products are delivered, title passes to customers and collection is likely to occur. Title passes to customers at the point of sale for retail and upon delivery of products for wholesale. Return allowances, which reduce revenue, are estimated using historical experience.

 

The Company promotes its products with trade incentives and promotions. These programs include sales discounts, rebates, coupons, volume-based incentives, refunds, and returns, which represent variable considerations. The estimation of variable consideration involves judgment and is constrained to avoid overstatement of revenue. The Company applies the expected value method or the most likely amount method, depending on which better predicts the consideration to which it will be entitled. Management evaluates these estimates on a quarterly basis. The trade incentives and promotions are recorded as a reduction to the transaction price based on amounts estimated as being due to customers at the end of the period. The Company derives these estimates based on historical experience. The Company does not receive a distinct service in relation to the trade incentives and promotions.

 

The Company recognizes revenue in accordance with the following five-step model:

 

  identify arrangements with customers.
  identify performance obligations.
  determine transaction price.
  allocate transaction price to the separate performance obligations in the arrangement, if more than one exists; and
  recognize revenue as performance obligations are satisfied.

 

The Company does not have significant revenue recognized over time due to the nature of retail store operation. The Company recognizes revenue at a point in time when control of goods or services transfers to the customer.

 

 

Shipping and Handling

Shipping and Handling

 

Shipping charges billed to customers are included in net sales and the related shipping and handling costs are included in cost of sales. For the years ended December 31, 2024 and 2023, shipping and handling costs of approximately $132,000 and $117,000, were included in cost of sales, respectively.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash is concentrated in one financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage. The Company has not experienced any losses in such accounts. The Company did not have any cash equivalents as of December 31, 2024 and December 31, 2023.

 

A summary of the financial institution that had cash in excess of FDIC limits of $250,000 as of December 31, 2024 and December 31, 2023 is presented below:

 

 

  

December 31,

2024

  

December 31,

2023

 
Total cash and restricted cash in excess of FDIC limits  $715,852   $161,644 

 

The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.

 

Accounts Receivable, Contract Assets and Contract Liabilities

Accounts Receivable, Contract Assets and Contract Liabilities

 

Accounts receivables are claims to consideration which are unconditional; meaning no performance obligations remain for the Company and only the passage of time is necessary before collection. Contract assets are distinguished from accounts receivable as performance obligations remain before claims to consideration become unconditional. By nature of the Company’s operations, contract assets are typically not recognized. Contract liabilities are recorded when customers transfer consideration in advance of delivery of products or services, which the Company records for gift cards and loyalty reward programs. When one party to an arrangement performs before the other(s), the Company records an account receivable, contract asset or contract liability.

 

The majority of arrangements with customers contain one performance obligation: to provide a distinct set of products or services. Most performance obligations are satisfied simultaneously as the Company exchanges products or services for customer payment. Exceptions include gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products or services at a future date. As gift cards are purchased and loyalty points earned, contract liabilities are recorded until the performance obligations are satisfied through delivery of products or services or breakage based on gift card and loyalty reward program term limits. For the years ended December 31, 2024 and 2023, the contract liability balance were approximately $80,000 and $208,000, respectively.

 

The Company’s breakage policy is twenty-four months for gift cards and twelve months for loyalty rewards. Loyalty rewards are earned at five percent on qualifying purchases and the reward functions as an allocation of transaction price from the period earned by the customer to the period the performance obligation is satisfied by the Company. As such, all contract liabilities are expected to be recognized within a twenty-four-month period.

 

In August 2024, the Company transitioned its customer loyalty program from a points-based system to a VIP membership structure. Under the original loyalty program, customers earned redeemable loyalty points based on qualifying purchases, which have been discontinued. Existing unredeemed loyalty points remain valid for redemption until January 31, 2025. The new VIP program provides members with immediate discounts on qualifying purchases, replacing the accrual of future points. The elimination of future loyalty point accruals reduces the Company’s ongoing contract liability obligations, as discounts under the VIP program are recognized as reductions to revenue at the time of sale.

 

 

Other Current Assets

Other Current Assets

 

Other current assets are the non-trade related assets that the Company owns, benefits from, or uses to generate income that can be converted into cash within one business cycle. Included in “Other current assets” on our consolidated balance sheets are amounts primarily related to other receivables or non-trade receivable from other companies.

 

Inventories

Inventories

 

Inventories are measured at the lower of cost and net realizable value using the average cost method. If the cost of the inventories exceeds their net realizable value, adjustments are recorded to write down excess carrying value to their net realizable value. The Company’s inventories consist primarily of merchandise available for resale, such as fresh produce, perishable grocery items and non-perishable consumable goods. Slow-moving inventory is rotated out and obsolete inventory is removed (expensed) on a monthly basis.

 

Property, Plant, and Equipment

Property, Plant, and Equipment

 

Property, plant, and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the expected useful life of the respective asset, after the asset is placed in service. Revenue earning property, plant, and equipment includes signage, furniture and fixtures, building, computer hardware, appliance, cooler, displays with useful lives range from two to ten years. Leasehold improvements are amortized over the shorter of the life of the asset or the term of the lease.

 

Identifiable Intangible Assets

Identifiable Intangible Assets

 

Identifiable intangible assets are recorded at cost, or when acquired as part of a business acquisition, at estimated fair value. Certain identifiable intangible assets are amortized over 4 to 13 years. Similar to tangible personal property and equipment, the Company periodically evaluates identifiable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

The Company reviews all long-lived assets such as property and equipment and amortized intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated future cash flows expected to be generated by the asset or asset group. Impairment is measured by the amount by which the carrying value of the asset(s) exceeds their fair value. There were no triggering events that would indicate impairment of long-lived assets in the twelve months period ended on December 31, 2024.

 

 

Goodwill

Goodwill

 

The Company assesses the carrying amounts of goodwill for recoverability on at least an annual basis or when events or changes in circumstances indicate evidence of potential impairment exists, using a fair value-based test. In performing the Company’s analysis of goodwill, the Company first evaluates qualitative factors, including relevant events and circumstances, to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value should be recognized; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Application of the goodwill impairment test requires significant judgments including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for the businesses, and the useful life over which cash flows will occur. Changes in these estimates and assumptions could materially affect the determination of fair value and/or conclusions on goodwill impairment for the Company. Our annual impairment test is conducted on September 30 of each year or more often if deemed necessary.

 

The Company incurred a non-cash impairment charge of $6,104,000 for the year ended December 31, 2023.

 

In July 2024, the Company acquired GreenAcres Market and recorded goodwill of $2,212,000 from the acquisition.

 

During the years ended December 31, 2024, there was no goodwill impairment charges recognized by the Company in the audited consolidated statements of operations.

 

Advertising

Advertising

 

Advertising expense is classified as selling, general and administrative expense on the consolidated statements of operations. The Company expenses advertising costs as incurred. For the years ended December 31, 2024 and 2023, the company incurred advertising expenses of $581,000 and $564,000, respectively.

 

401(k) retirement savings plan

401(k) retirement savings plan

 

The Company’s employees are offered a 401(k)-retirement savings plan that is currently administered under HCMC with discretionary contribution matching opportunities. HCMC will continue provide this service to HCWC’s employees pursuant to the Transition Service Agreement (“TSA”) executed upon the separation. The Company is in the process of establishing this service with its payroll provider, and expects to provide 401(k) to its own employees at the beginning of next year. 401K employer expense amounted to $94,000 and $82,000 for the years ended December 31, 2024 and 2023, respectively.

 

Earnings per share

Earnings per share

 

Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards. There is no dilution for the years ended December 31, 2024 and 2023.

 

On September 16, 2024, the Company separated from HCMC. As referenced in Note 1. Organization, the Separation resulted in the initial issuance of approximately 9.2 million shares of HCWC common stock. For purposes of computing basic and diluted earnings per common share for the year ended December 31, 2023, the number of HCWC common shares issued upon separation and distribution was used to reflect the outstanding shares.

 

The following table sets forth the computation of basic and diluted earnings per share attributable to the Company’s stockholders.

 

   2024   2023 
   For the Years Ended December 31, 
   2024   2023 
         
NET LOSS  $(4,506,466)  $(9,932,620)
           
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES   9,395,500    9,226,860 
           
BASIC AND DILUTED NET LOSS PER SHARE  $(0.48)  $(1.08)

 

Income Taxes

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740”). Under this method, income tax expense is recognized as the amount of: (i) taxes payable or refundable for the current year and (ii) future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of available evidence it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 or 2023. The Company had no uncertain tax positions as of December 31, 2024 and 2023.

 

Leases

Leases

 

Operating lease liabilities are recognized at the lease commencement date based on the present value of the fixed lease payments using the Company’s incremental borrowing rates. Related lease right-of-use (“ROU”) are recognized based on the initial present value of the fixed lease payments, reduced by contributions from landlords, plus any prepaid rent and direct costs from executing the leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payments are recognized as lease expense as they are incurred.

 

The Company did not have finance leases in year 2024 and 2023. If the Company enters into a finance lease in the future, it will be accounted for in accordance with ASC Topic 842.

 

 

Fair Value Measurements

Fair Value Measurements

 

The fair value framework under FASB’s guidance requires the categorization of assets and liabilities into three levels based upon the assumptions used to measure the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, would generally require significant management judgment. The three levels for categorizing assets and liabilities under the fair value measurement requirements are as follows:

 

  Level 1: Fair value measurement of the asset or liability using observable inputs such as quoted prices in active markets for identical assets or liabilities;
     
  Level 2: Fair value measurement of the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and
     
  Level 3: Fair value measurement of the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.

 

Recurring Fair Value Measurements

 

The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, operating, derivatives and borrowings. Management believes that the carrying value of cash and cash equivalents, accounts receivable, accounts payable, and borrowings are representative of their respective fair values. All derivatives are recognized as either assets or liabilities on the balance sheet at fair value at the end of each quarter.

 

Nonrecurring Fair Value Measurements

 

The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets, indefinite-lived intangible assets and goodwill. The Company reviews the carrying amounts of such assets at least annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Any resulting asset impairment would require that the asset be recorded at its fair value. The resulting fair value measurement of the assets are considered to be Level 3 measurements.

 

Business Combination

Business Combination

 

The Company applies the provisions of ASC 805 in the accounting for acquisitions of businesses. ASC 805 requires the Company to use the acquisition method of accounting by recognizing identifiable assets and liabilities, including intangible assets of acquired businesses at their fair value at the date of acquisition. When the Company acquires control of a business, any previously held equity interest also is remeasured to fair value. The excess of the purchase consideration and any previously held equity interest over the fair value of identifiable net assets acquired is goodwill. If the fair value of identifiable net assets acquired exceeds the purchase consideration and any previously held equity interest, the difference is recognized in the consolidated statements of operations immediately as a gain or loss on acquisition. Acquisition-related expenses are expensed as incurred and the expenses are recorded in operating expenses in the consolidated statements of operations.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Public companies in the United States are subject to the accounting and reporting requirements of various authorities, including FASB and the SEC.

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (ASC 326)” This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL”) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to certain financial assets. The Company adopted ASC 326 on January 1, 2023, and estimated expected credit losses based on aging schedule, and provisioned approximately $28,000 and $15,000 credit loss for the year ended December 31, 2024 and 2023, respectively.

 

On December 14, 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s consolidated financial statements.

 

On November 27, 2023, FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which requires public entities to consider relevant qualitative and quantitative factors when determining whether segment expense categories and amounts are significant, and identify segment expenses on the basis of amounts that are regularly provided to the CODM, and included in reported segment profit or loss. The ASU is effective for fiscal years beginning after Dec. 15, 2023, and interim periods within fiscal years beginning after Dec. 15, 2024. The Company adopted this standard effective January 1, 2024, applying it retrospectively to all periods presented. As the Company has one reportable segment, the adoption had no material impact on the Company’s financial statements, but resulted in additional expense disclosures and reconciliations in the financial statement footnotes. See Note 5 for details.

XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS

 

  

December 31,

2024

  

December 31,

2023

 
Total cash and restricted cash in excess of FDIC limits  $715,852   $161,644 
SCHEDULE OF EARNINGS PER SHARES

The following table sets forth the computation of basic and diluted earnings per share attributable to the Company’s stockholders.

 

   2024   2023 
   For the Years Ended December 31, 
   2024   2023 
         
NET LOSS  $(4,506,466)  $(9,932,620)
           
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES   9,395,500    9,226,860 
           
BASIC AND DILUTED NET LOSS PER SHARE  $(0.48)  $(1.08)
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.25.1
CONCENTRATIONS (Tables)
12 Months Ended
Dec. 31, 2024
Risks and Uncertainties [Abstract]  
SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS

A summary of the financial institution that had cash in excess of FDIC limits of $250,000 on December 31, 2024 and December 31, 2023 is presented below:

 

 

  

December 31,

2024

  

December 31,

2023

 
Total cash in excess of FDIC limits of $250,000  $715,852   $161,644 
SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS

 

  

December 31,

2024

  

December 31,

2023

 
Cash  $2,056,472   $1,422,580 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES

 SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES

         
   For the Years Ended December 31, 
   2024   2023 
Advertising  $581,357   $564,405 
Payroll and Benefits   13,963,361    12,645,985 
Occupancy   6,573,925    5,280,405 
Depreciation and Amortization   1,576,457    1,431,816 
Bank Service Charges and Merchant Account Fees   1,331,637    927,863 
Other selling, general and administrative expenses   1,680,001    1,368,736 
Goodwill impairment   -    6,104,000 
Total significant reporting segment expenses  $25,706,738   $28,323,210 
SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT

The following table summarizes the reconciliations of reportable segment profit or loss and assets to the Company’s consolidated totals:

 

 SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT

         
   For the Years Ended December 31, 
   2024   2023 
Segment net operating income (loss)  $1,358,571   $(7,974,985)
Unallocated amount   (3,136,049)   (2,549,084)
Consolidated loss from operation  $(1,777,478)  $(10,524,069)

 

         
   For the Years Ended December 31, 
   2024   2023 
Total reporting segment assets  $30,698,054   $28,432,560 
Unallocated amount   3,414,463    - 
Consolidated total assets  $34,112,517   $28,432,560 
SCHEDULE DISAGGREGATED REVENUES

  

December 31,

2024

  

December 31,

2023

 
Retail Grocery  $60,690,718   $47,243,163 
Food service/restaurant   8,679,160    8,440,245 
Online/eCommerce   925    6,385 
Total revenue  $69,370,803   $55,689,793 
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITIONS (Tables)
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
SCHEDULE OF PURCHASE PRICE ALLOCATION

The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

  

October 1,

2023

 
Purchase Consideration     
Cash consideration paid  $750,000 
Promissory note   718,000 
Total Purchase Consideration  $1,468,000 
      
Purchase price allocation     
Inventory  $851,000 
Intangible assets   291,000 
Right of use asset - Operating lease   1,325,000 
Other liabilities   (31,000)
Operating lease liability   (1,325,000)
Goodwill   357,000 
Net assets acquired  $1,468,000 
      
Finite-lived intangible assets     
Trade Names (8 years)  $291,000 
Total intangible assets  $291,000 
The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

 

  

July 18,

2024

 
Purchase Consideration     
Cash consideration paid  $5,475,000 
Promissory note   1,568,000 
Total Purchase Consideration  $7,043,000 
      
Purchase price allocation     
Inventory  $2,400,000 
Property, plant, and equipment   127,000 
Intangible assets   2,304,000 
Goodwill   2,212,000 
Net assets acquired  $7,043,000 
      
Finite-lived intangible assets     
Trade Names (13 years)  $1,584,000 
Non-Compete Agreement (5 years)   720,000 
Total intangible assets  $2,304,000 
 
SCHEDULE OF UNAUDITED PROFORMA INFORMATION

The following unaudited pro forma summary presents consolidated information of the Company, including Ellwood Thompson’s and GreenAcres Market, as if the business combinations had occurred on January 1, 2023, the earliest period presented herein:

SCHEDULE OF UNAUDITED PROFORMA INFORMATION 

         
   December 31, 
   2024   2023 
Sales  $77,762,430   $80,173,326 
Net loss   (4,791,021)   (11,401,315)
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.25.1
PROPERTY, PLANT, AND EQUIPMENT (Tables)
12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

Property, plant, and equipment consist of the following as of December 31, 2024 and 2023:

 

         
   Year Ended December 31, 
   2024   2023 
         
Displays  $312,146   $312,146 
Building   -    575,000 
Furniture and fixtures   720,657    505,436 
Leasehold improvements   1,991,953    1,925,385 
Computer hardware & equipment   209,029    141,682 
Other   710,682    680,718 
Property, plant and equipment gross    3,944,467    4,140,367 
Less: accumulated depreciation and amortization   (1,967,998)   (1,463,728)
Total property, plant, and equipment  $1,976,469   $2,676,639 
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.25.1
INTANGIBLE ASSETS (Tables)
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS, NET

Intangible assets, net consist of the following as of December 31, 2024 and 2023:

 

December 31, 2024 

Useful Lives

(Years)

 

Gross

Carrying
Amount

  

Accumulated

Amortization

  

Net

Carrying
Amount

 
Trade names  8-13 years  $4,444,000   $(1,427,798)  $3,016,202 
Customer relationships  4-6 years   2,669,000    (1,628,639)   1,040,361 
Non-compete  4-5 years   2,322,000    (937,085)   1,384,915 
Intangible assets, net     $9,435,000   $(3,993,522)  $5,441,478 

 

December 31, 2023 

Useful Lives

(Years)

 

Gross

Carrying
Amount

  

Accumulated

Amortization

  

Net

Carrying
Amount

 
Trade names  8-10 years  $2,860,000   $(1,035,443)  $1,824,557 
Customer relationships  4-6 years   2,669,000    (1,330,972)   1,338,028 
Non-compete  4-5 years   1,602,000    (586,066)   1,015,934 
Intangible assets, net     $7,131,000   $(2,952,481)  $4,178,519 
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS

 

For the years ending December 31,    
2025  $1,180,613 
2026   1,103,576 
2027   964,771 
2028   655,332 
2029   302,221 
Thereafter   1,234,965 
Total  $5,441,478 
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.25.1
GOODWILL (Tables)
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF GOODWILL

The changes in the carrying amount of goodwill as of December 31, 2024 and December 31, 2023 are as follows:

 

  

December 31,

2024

  

December 31,

2023

 
         
Beginning balance  $-   $5,747,000 
Acquisitions   2,212,000    357,000 
Impairment   -    (6,104,000)
Ending balance  $2,212,000   $- 
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.25.1
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)
12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES

At December 31, 2024 and December 31, 2023, accounts payable and accrued expenses consisted of:

 

  

December 31,

2024

  

December 31,

2023

 
Trade creditors  $5,133,782   $4,406,299 
Accrued expenses   997,752    514,112 
Total  $6,131,534   $4,920,411 
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT (Tables)
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
SCHEDULE OF DEBT

The following table provides a breakdown of the Company’s debt as of December 31, 2024 and 2023 is presented below:

 

   2024   2023 
   December 31, 
   2024   2023 
Promissory note  $11,623,392   $3,106,508 
Debt discount and issuance cost   (284,283)   - 
Total debt, net of debt discount and issuance costs   11,339,109    3,106,508 
Current portion of long-term debt   (2,200,210)   (702,701)
Current portion of debt discount and issuance cost   68,873    - 
Long-term debt  $9,207,772   $2,403,807 
SCHEDULE OF DEBT REPAYMENT

The following table summarizes the 5-year repayment schedule:

 

For the years ending December 31,    
2025  $2,200,210 
2026   3,016,526 
2027   5,595,359 
2028   534,923 
2029   276,374 
Total  $11,623,392 
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.25.1
LEASES (Tables)
12 Months Ended
Dec. 31, 2024
Leases  
SCHEDULE OF MATURITY OF LEASE LIABILITIES

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of December 31, 2024.

 

Maturity of Lease Liabilities by Fiscal Year    
2025  $4,221,590 
2026   3,923,741 
2027   2,956,171 
2028   2,280,186 
2029   1,617,808 
Thereafter   824,585 
Total undiscounted operating lease payments  $15,824,081 
Less: interest   (1,642,663)
Present value of operating lease liabilities  $14,181,418 
SCHEDULE OF COMPANY’S OPERATING LEASE

The following summarizes the Company’s operating leases:

 

Balance Sheet Classification 

December 31,

2024

  

December 31,

2023

 
Right of use assets  $14,232,240   $11,412,562 
           
Operating lease liability, current  $3,596,987   $2,748,824 
Operating lease liability, net of current   10,584,431    8,461,182 
Total operating lease liabilities  $14,181,418   $11,210,006 
SCHEDULE OF OPERATING LEASE TERM

The following table provides a summary of other information related to the leases at December 31, 2024 and 2023:

 

Other Information  December 31, 2024   December 31, 2023 
Weighted-average remaining lease term for operating leases   4 years    5 years 
Weighted-average discount rate for operating leases   5.19%   3.98%
SCHEDULE OF COMPONENTS OF LEASE EXPENSE

The following table represents the components of lease expense are as follows for twelve months ended December 31, 2024:

 

  

December 31,

2024

 
Operating lease cost  $3,273,563 
Variable lease cost   922,282 
Short-term lease cost   - 
Total rent expense  $4,195,845 
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
SCHEDULE OF INCOME TAX EXPENSE (BENEFIT)

The Company did not have expected tax expense (benefit) at the U.S. statutory rate 21% to the actual tax expense (benefit) reflected in the accompanying statement of operations:

 

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
         
U.S. federal statutory rate  $

(946,354

)  (2,085,850)
State tax benefit net of federal benefit   

(243,330

)   (557,568)
Change in valuation allowance   

1,358,776

    2,496,515 
True-Up & Deferred Adjustment   

(32,683

)   (73,814)
Other permanent items   

(119,803

)   209,444 
Change in tax rate   

(16,606

)   11,273 

Income tax provision/(benefit)

  $-   $- 
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

As of December 31, 2024 and 2023, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following:

 

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
Deferred tax assets:          
NOL carryforward  $3,129,808   $2,449,401 
Intangible assets   1,958,875    1,995,960 
Warrant liability   498,740    - 
Interest expense   227,272    - 
ASC 842 - Lease Accounting   89,309    65,172 
Charitable contributions   30,336    3,586 
UNICAP 263a Adjustment   (3,823)   53,284 
Allowances   7,485    - 
Total deferred tax assets   5,938,002    4,567,403 
           
Deferred tax liabilities:          
Net book value of fixed assets   (32,905)   (21,083)
Total deferred tax liabilities   (32,905)   (21,083)
           
Net deferred tax assets   5,905,097    4,546,320 
Valuation allowance   (5,905,097)   (4,546,320)
Net deferred tax assets  $-   $- 
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Sep. 16, 2024
Sep. 09, 2024
Dec. 31, 2024
Dec. 31, 2023
Sep. 13, 2024
Aug. 18, 2022
Product Information [Line Items]            
Number of shares issued 9,200,000          
Healthier Choices Management Corp [Member]            
Product Information [Line Items]            
Equity financing         $ 13,250  
Healthier Choices Management Corp [Member] | Securities Purchase Agreement [Member]            
Product Information [Line Items]            
Investments         13,250  
Series E Preferred Stock [Member] | Healthier Choices Management Corp [Member]            
Product Information [Line Items]            
Equity financing         13,250  
Series E Preferred Stock [Member] | Healthier Choices Management Corp [Member] | Securities Purchase Agreement [Member]            
Product Information [Line Items]            
Investments         $ 13,250  
Common Stock [Member]            
Product Information [Line Items]            
Number of shares issued     400,000      
Healthier Choices Management Corp [Member]            
Product Information [Line Items]            
Investments           $ 13,250
Healthier Choices Management Corp [Member] | Common Class A [Member]            
Product Information [Line Items]            
Number of shares issued   1        
Healthier Choices Management Corp [Member] | Common Class B [Member]            
Product Information [Line Items]            
Number of shares issued   3        
Healthier Choices Management Corp [Member] | Common Stock [Member]            
Product Information [Line Items]            
Number of shares issued   208,632        
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | One Vendor [Member]            
Product Information [Line Items]            
Concentration risk percentage     25.00% 41.00%    
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.25.1
GOING CONCERN (Details Narrative) - USD ($)
12 Months Ended
Jul. 24, 2024
Jul. 18, 2024
Aug. 18, 2022
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]          
Cash and cash equivalent       $ 2,100,000 $ 1,400,000
Working capital       (2,200,000) 2,600,000
Net loss       4,506,466 9,932,620
Cash used in operating activities       (3,064,842) (2,525,354)
Private lender   $ 7,500,000      
Purchase of greenacres market   4,200,000      
Face amount   $ 7,500,000      
Interest rate   12.00%      
Maturity date   Jul. 17, 2027      
Proceeds from sale of building       $ 749,000
Healthier Choices Management Corp [Member]          
Property, Plant and Equipment [Line Items]          
Investments     $ 13,250,000    
Gross proceeds     $ 13,250,000    
Healthier Choices Management Corp [Member] | Series E Convertible Preferred Stock [Member]          
Property, Plant and Equipment [Line Items]          
Shares issued     14,722    
Share price     $ 1,000    
Preferrd stock subscriptions     $ 13,250,000    
Healthier Choices Management Corp [Member] | Series A Preferred Stock [Member]          
Property, Plant and Equipment [Line Items]          
Gross proceeds     $ 13,250,000    
Building [Member]          
Property, Plant and Equipment [Line Items]          
Proceeds from sale of building $ 695,000        
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]    
Total cash and restricted cash in excess of FDIC limits $ 715,852 $ 161,644
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF EARNINGS PER SHARES (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]    
NET LOSS $ (4,506,466) $ (9,932,620)
BASIC WEIGHTED AVERAGE COMMON SHARES 9,395,500 9,226,860
DILUTED WEIGHTED AVERAGE COMMON SHARES 9,395,500 9,226,860
BASIC NET LOSS PER SHARE $ (0.48) $ (1.08)
DILUTED NET LOSS PER SHARE $ (0.48) $ (1.08)
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.25.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
shares in Millions
12 Months Ended
Sep. 16, 2024
Dec. 31, 2024
Dec. 31, 2023
Jul. 31, 2024
Jul. 18, 2024
Dec. 31, 2022
Product Information [Line Items]            
Costs of sales   $ 42,305,494 $ 35,341,569      
Cash, FDIC amount   250,000 250,000      
Contract liability   80,000 208,000      
Goodwill, Impairment Loss   6,104,000      
Goodwill   2,212,000     $ 5,747,000
Advertising expenses   581,000 564,000      
Employer expense amount   94,000 82,000      
Initial issuance shares 9.2          
Unrecognized tax benefits   0 0      
Estimated expected credit losses   $ 28,000 15,000      
GreenAcres Market [Member]            
Product Information [Line Items]            
Goodwill       $ 2,212,000 $ 2,212,000  
Minimum [Member]            
Product Information [Line Items]            
Property plant and equipment useful life   2 years        
Intangible asset useful life   4 years        
Maximum [Member]            
Product Information [Line Items]            
Property plant and equipment useful life   10 years        
Intangible asset useful life   13 years        
Shipping and Handling [Member]            
Product Information [Line Items]            
Costs of sales   $ 132,000 $ 117,000      
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Risks and Uncertainties [Abstract]    
Cash, FDIC amount $ 250,000 $ 250,000
Total cash in excess of FDIC limits of $250,000 $ 715,852 $ 161,644
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF CASH AND CASH EQUIVALENTS (Parenthetical) (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Risks and Uncertainties [Abstract]    
Cash, FDIC amount $ 250,000 $ 250,000
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Risks and Uncertainties [Abstract]    
Cash $ 2,056,472 $ 1,422,580
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.25.1
CONCENTRATIONS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Concentration Risk [Line Items]    
Cash equivalents $ 0 $ 0
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Suppliers [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage 70.00% 75.00%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Purchase [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage 25.00% 41.00%
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
Advertising $ 581,000 $ 564,000
Goodwill impairment 6,104,000
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Advertising 581,357 564,405
Payroll and Benefits 13,963,361 12,645,985
Occupancy 6,573,925 5,280,405
Depreciation and Amortization 1,576,457 1,431,816
Bank Service Charges and Merchant Account Fees 1,331,637 927,863
Other selling, general and administrative expenses 1,680,001 1,368,736
Goodwill impairment 6,104,000
Total significant reporting segment expenses $ 25,706,738 $ 28,323,210
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
Consolidated loss from operation $ (1,777,478) $ (10,524,069)
Consolidated total assets 34,112,517 28,432,560
Segment Net Operating Income (Loss) [Member]    
Segment Reporting Information [Line Items]    
Consolidated loss from operation 1,358,571 (7,974,985)
Unallocated Amount [Member]    
Segment Reporting Information [Line Items]    
Consolidated loss from operation (3,136,049) (2,549,084)
Consolidated total assets 3,414,463
Total Reporting Segment Assets [Member]    
Segment Reporting Information [Line Items]    
Consolidated total assets $ 30,698,054 $ 28,432,560
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE DISAGGREGATED REVENUES (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue from External Customer [Line Items]    
Total revenue $ 69,370,803 $ 55,689,793
Retail Grocery [Member]    
Revenue from External Customer [Line Items]    
Total revenue 60,690,718 47,243,163
Food Service/Restaurant [Member]    
Revenue from External Customer [Line Items]    
Total revenue 8,679,160 8,440,245
Online/ECommerce [Member]    
Revenue from External Customer [Line Items]    
Total revenue $ 925 $ 6,385
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Details Narrative)
12 Months Ended
Dec. 31, 2024
Segment
Segment Reporting [Abstract]  
Operating segments 2
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.25.1
ACCOUNTS RECEIVABLE, NET (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Jan. 01, 2023
Credit Loss [Abstract]      
Advertising revenue $ 970,000 $ 249,000  
Accounts receivable 510,000 128,000 $ 55,000
Credit losses $ 28,000 $ 15,000  
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.25.1
INVENTORIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Inventory write down $ 2,491,934 $ 2,471,653
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF PURCHASE PRICE ALLOCATION (Details) - USD ($)
12 Months Ended
Jul. 18, 2024
Oct. 01, 2023
Dec. 31, 2024
Dec. 31, 2023
Jul. 31, 2024
Dec. 31, 2022
Business Acquisition [Line Items]            
Cash consideration paid     $ 5,475,000 $ 750,000    
Goodwill     $ 2,212,000   $ 5,747,000
Ellwood Thompson [Member]            
Business Acquisition [Line Items]            
Cash consideration paid   $ 750,000        
Promissory note   718,000        
Total purchase consideration   1,468,000        
Inventory   851,000        
Total intangible assets   291,000        
Right of use asset - Operating lease   1,325,000        
Other liabilities   (31,000)        
Operating lease liability   (1,325,000)        
Goodwill   357,000        
Net assets acquired   1,468,000        
Ellwood Thompson [Member] | Trade Names [Member]            
Business Acquisition [Line Items]            
Total intangible assets   $ 291,000        
GreenAcres Market [Member]            
Business Acquisition [Line Items]            
Cash consideration paid $ 5,475,000          
Promissory note 1,568,000          
Total purchase consideration 7,043,000          
Inventory 2,400,000          
Property, plant, and equipment 127,000          
Total intangible assets 2,304,000          
Goodwill 2,212,000       $ 2,212,000  
Net assets acquired 7,043,000          
GreenAcres Market [Member] | Trade Names [Member]            
Business Acquisition [Line Items]            
Total intangible assets 1,584,000          
GreenAcres Market [Member] | Non-Compete Agreement [Member]            
Business Acquisition [Line Items]            
Total intangible assets $ 720,000          
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF PURCHASE PRICE ALLOCATION (Parenthetical) (Details)
Jul. 18, 2024
Oct. 01, 2023
Ellwood Thompson [Member] | Trade Names [Member]    
Business Acquisition [Line Items]    
Useful lives (years) 13 years 8 years
GreenAcres Market [Member] | Non-Compete Agreement [Member]    
Business Acquisition [Line Items]    
Useful lives (years) 5 years  
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF UNAUDITED PROFORMA INFORMATION (Details) - Ellwood Thompson [Member] - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Business Acquisition [Line Items]    
Sales $ 77,762,430 $ 80,173,326
Net loss $ (4,791,021) $ (11,401,315)
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITIONS (Details Narrative) - USD ($)
12 Months Ended
Jul. 18, 2024
Oct. 01, 2023
Dec. 31, 2024
Dec. 31, 2023
Business Acquisition [Line Items]        
Cash consideration paid     $ 5,475,000 $ 750,000
Ellwood Thompson [Member]        
Business Acquisition [Line Items]        
Cash consideration paid   $ 750,000    
Promissory note   $ 718,000    
Amortization period for goodwill for tax purposes (years)   15 years    
GreenAcres Market [Member]        
Business Acquisition [Line Items]        
Cash consideration paid $ 5,475,000      
Promissory note 1,568,000      
Asset Purchase Agreement [Member] | Ellwood Thompson [Member]        
Business Acquisition [Line Items]        
Cash consideration paid   $ 750,000    
Promissory note   750,000    
Fair value   $ 718,000    
Interest expense     $ 40,000  
Asset Purchase Agreement [Member] | GreenAcres Market [Member]        
Business Acquisition [Line Items]        
Cash consideration paid 5,475,000      
Promissory note $ 1,825,000      
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.25.1
ASSETS HELD FOR SALE (Details Narrative) - USD ($)
12 Months Ended
Jul. 24, 2024
Dec. 31, 2024
Dec. 31, 2023
Feb. 07, 2024
Property, Plant and Equipment [Line Items]        
Proceeds from sale of building   $ 749,000  
Building [Member]        
Property, Plant and Equipment [Line Items]        
Property, Plant and Equipment, Other, Gross       $ 544,000
Proceeds from sale of building $ 695,000      
Fair market value 749,000      
Legal fee $ 54,000      
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross  $ 3,944,467 $ 4,140,367
Less: accumulated depreciation and amortization (1,967,998) (1,463,728)
Total property, plant, and equipment 1,976,469 2,676,639
Displays [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross  312,146 312,146
Building [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross  575,000
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross  720,657 505,436
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross  1,991,953 1,925,385
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross  209,029 141,682
Other Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross  $ 710,682 $ 680,718
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.25.1
PROPERTY, PLANT, AND EQUIPMENT (Details Narrative) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Depreciation $ 0.5 $ 0.5
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF INTANGIBLE ASSETS, NET (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Indefinite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 9,435,000 $ 7,131,000
Accumulated Amortization (3,993,522) (2,952,481)
Net Carrying Amount $ 5,441,478 4,178,519
Minimum [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Useful lives (years) 4 years  
Maximum [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Useful lives (years) 13 years  
Trade Names [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 4,444,000 2,860,000
Accumulated Amortization (1,427,798) (1,035,443)
Net Carrying Amount $ 3,016,202 $ 1,824,557
Trade Names [Member] | Minimum [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Useful lives (years) 8 years 8 years
Trade Names [Member] | Maximum [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Useful lives (years) 13 years 10 years
Customer Relationship [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 2,669,000 $ 2,669,000
Accumulated Amortization (1,628,639) (1,330,972)
Net Carrying Amount $ 1,040,361 $ 1,338,028
Customer Relationship [Member] | Minimum [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Useful lives (years) 4 years 4 years
Customer Relationship [Member] | Maximum [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Useful lives (years) 6 years 6 years
Non-Compete [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 2,322,000 $ 1,602,000
Accumulated Amortization (937,085) (586,066)
Net Carrying Amount $ 1,384,915 $ 1,015,934
Non-Compete [Member] | Minimum [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Useful lives (years) 4 years 4 years
Non-Compete [Member] | Maximum [Member]    
Indefinite-Lived Intangible Assets [Line Items]    
Useful lives (years) 5 years 5 years
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS (Details)
Dec. 31, 2024
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2025 $ 1,180,613
2026 1,103,576
2027 964,771
2028 655,332
2029 302,221
Thereafter 1,234,965
Total $ 5,441,478
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.25.1
INTANGIBLE ASSETS (Details Narrative) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization of intangible assets $ 1.0 $ 0.9
Weighted-average remaining amortization period   5 years
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF GOODWILL (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Beginning balance $ 5,747,000
Acquisitions 2,212,000 357,000
Impairment of goodwill 6,104,000
Ending balance $ 2,212,000
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.25.1
GOODWILL (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Impairment of goodwill $ 6,104,000
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Trade creditors $ 5,133,782 $ 4,406,299
Accrued expenses 997,752 514,112
Total $ 6,131,534 $ 4,920,411
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEBT (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
Promissory note $ 11,623,392 $ 3,106,508
Debt discount and issuance cost (284,283)
Total debt, net of debt discount and issuance costs 11,339,109 3,106,508
Current portion of long-term debt (2,200,210) (702,701)
Current portion of debt discount and issuance cost 68,873
Long-term debt $ 9,207,772 $ 2,403,807
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEBT REPAYMENT (Details) (Parenthetical)
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Debt instrument repayment term 5 years
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEBT REPAYMENT (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
2025 $ 2,200,210  
2026 3,016,526  
2027 5,595,359  
2028 534,923  
2029 276,374  
Total $ 11,623,392 $ 3,106,508
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT (Details Narrative) - USD ($)
12 Months Ended
Sep. 17, 2024
Jul. 18, 2024
Jan. 18, 2024
Dec. 31, 2024
Dec. 31, 2023
Sep. 16, 2024
Aug. 23, 2024
Apr. 08, 2024
Oct. 01, 2023
Oct. 14, 2022
Short-Term Debt [Line Items]                    
Face amount   $ 7,500,000                
Interest rate   12.00%                
Aggregate subscription price       $ 2,580,000            
Debt discount       284,283          
Gains losses on extinguishment of debt       $ (1,888,889)          
Debt term       5 years            
First Anniversary [Member]                    
Short-Term Debt [Line Items]                    
Payment of long term debt   $ 1,125,000                
Second Anniversary [Member]                    
Short-Term Debt [Line Items]                    
Payment of long term debt   1,875,000                
Common Class A [Member] | Bridge Warrant Shares [Member]                    
Short-Term Debt [Line Items]                    
Warrant exercise price               $ 0.01    
Warrant purchase 188,889             188,889    
Warrant purchase           $ 1,887,001        
Gains losses on extinguishment of debt $ 1,888,889                  
IPO [Member] | Common Class A [Member]                    
Short-Term Debt [Line Items]                    
Aggregate subscription price     $ 1,700,000              
Securities Purchase Agreement [Member]                    
Short-Term Debt [Line Items]                    
Debt discount       $ 0            
Debt issuance cost       23,500            
Amortization of debt discount       189,000            
Interest expense       298,000            
Securities Purchase Agreement [Member] | IPO [Member]                    
Short-Term Debt [Line Items]                    
Debt instrument description     The aggregate gross proceeds received from the investors in connection with the Security Purchase Agreement (“SPA”) was $1,700,000. The Notes were issued at a 10% original issue discount (“OID”) and accrue interest at a rate of 10% per annum beginning 60 days after issuance of the Notes. All accrued and unpaid principal and interest shall be due and payable upon the earlier of (1) the closing of the IPO, (2) January 18, 2025 or (3) upon an event of default as defined in the Notes.              
Loan And Security Agreement [Member]                    
Short-Term Debt [Line Items]                    
Face amount   750,000                
Loan And Security Agreement [Member] | GreenAcres Market [Member]                    
Short-Term Debt [Line Items]                    
Face amount   $ 7,500,000                
Interest rate   12.00%                
Debt term   3 years                
Acquisition percentage   10.00%                
Promissory Notes [Member]                    
Short-Term Debt [Line Items]                    
Face amount                   $ 3,000,000
Interest rate                   6.00%
Outstanding Debt       1,809,000 2,378,000          
Interest expense       127,000 160,000          
Secured Promissory Notes [Member]                    
Short-Term Debt [Line Items]                    
Face amount       595,000 728,000       $ 750,000  
Interest rate                 6.00%  
Interest expense       40,000 39,000          
Debt fair value                 $ 718,000  
Secured Promissory Notes [Member] | Acquisition Loan And Security Agreement [Member]                    
Short-Term Debt [Line Items]                    
Face amount             $ 1,825,000      
Interest rate             6.00%      
Outstanding Debt       1,720,000 0          
Interest expense       $ 36,000 $ 0          
Unsecured Promissory Note [Member] | Securities Purchase Agreement [Member]                    
Short-Term Debt [Line Items]                    
Interest rate     10.00%              
Aggregate subscription price     $ 1,889,000              
Unsecured Promissory Note [Member] | Securities Purchase Agreement [Member] | IPO [Member]                    
Short-Term Debt [Line Items]                    
Aggregate subscription price     $ 1,889,000              
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Sep. 16, 2024
Sep. 09, 2024
Dec. 31, 2024
Sep. 13, 2024
Dec. 31, 2023
Aug. 18, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued 9,200,000          
Common stock shares outstanding     9,815,749   10  
Healthier Choices Management Corp [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Equity financing       $ 13,250    
Healthier Choices Management Corp [Member] | Securities Purchase Agreement [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Investments       $ 13,250    
Series A Convertible Preferred Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Preferred stock, shares authorized     40,000,000   40,000,000  
Preferred stock, par value     $ 0.001   $ 0.001  
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued     400,000      
Healthier Choices Management Corp [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Investments           $ 13,250
Healthier Choices Management Corp [Member] | Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued   208,632        
XML 87 R75.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF MATURITY OF LEASE LIABILITIES (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Leases    
2025 $ 4,221,590  
2026 3,923,741  
2027 2,956,171  
2028 2,280,186  
2029 1,617,808  
Thereafter 824,585  
Total undiscounted operating lease payments 15,824,081  
Less: interest (1,642,663)  
Present value of operating lease liabilities $ 14,181,418 $ 11,210,006
XML 88 R76.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF COMPANY’S OPERATING LEASE (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Leases    
Right of use assets $ 14,232,240 $ 11,412,562
Operating lease liability, current 3,596,987 2,748,824
Operating lease liability, net of current 10,584,431 8,461,182
Present value of operating lease liabilities $ 14,181,418 $ 11,210,006
XML 89 R77.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF OPERATING LEASE TERM (Details)
Dec. 31, 2024
Dec. 31, 2023
Leases    
Weighted-average remaining lease term for operating leases 4 years 5 years
Weighted-average discount rate for operating leases 5.19% 3.98%
XML 90 R78.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF COMPONENTS OF LEASE EXPENSE (Details)
12 Months Ended
Dec. 31, 2024
USD ($)
Leases  
Operating lease cost $ 3,273,563
Variable lease cost 922,282
Short-term lease cost
Total rent expense $ 4,195,845
XML 91 R79.htm IDEA: XBRL DOCUMENT v3.25.1
LEASES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Leases    
Lease term 20 years  
Amortization of right-of-use assets $ 3,273,597 $ 2,570,202
Rent expense 4,196,000 $ 3,435,000
Cash payments $ 3,122,000  
XML 92 R80.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
8 Months Ended 12 Months Ended
Sep. 13, 2024
Dec. 31, 2024
Dec. 31, 2023
Sep. 13, 2023
Related Party Transaction [Line Items]        
Net operating expense   $ 28,842,787 $ 30,872,293  
Cah advance   2,056,472 1,422,580  
Receivables, net, current   200,000 3,800,000  
Transition Services Agreement [Member]        
Related Party Transaction [Line Items]        
Other expenses   400,000    
Healthier Choices Management Corp [Member]        
Related Party Transaction [Line Items]        
Allocation amount   2,100,000 2,500,000  
Net operating expense $ 1,700,000   $ 2,500,000  
Cah advance   800,000    
Due from affiliates   $ 100,000    
Net payable       $ 1,200,000
XML 93 R81.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) (Parenthetical)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Federal statutory income tax rate 21.00%
XML 94 R82.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
U.S. federal statutory rate $ (946,354) $ (2,085,850)
State tax benefit net of federal benefit (243,330) (557,568)
Change in valuation allowance 1,358,776 2,496,515
True-Up & Deferred Adjustment (32,683) (73,814)
Other permanent items (119,803) 209,444
Change in tax rate (16,606) 11,273
Income tax provision/(benefit)
XML 95 R83.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
NOL carryforward $ 3,129,808 $ 2,449,401
Intangible assets 1,958,875 1,995,960
Warrant liability 498,740
Interest expense 227,272
ASC 842 - Lease Accounting 89,309 65,172
Charitable contributions 30,336 3,586
UNICAP 263a Adjustment (3,823) 53,284
Allowances 7,485
Total deferred tax assets 5,938,002 4,567,403
Net book value of fixed assets (32,905) (21,083)
Total deferred tax liabilities (32,905) (21,083)
Net deferred tax assets 5,905,097 4,546,320
Valuation allowance (5,905,097) (4,546,320)
Net deferred tax assets
XML 96 R84.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Jun. 12, 2022
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]        
Increase in deferred tax valuation allowance     $ 1,358,700 $ 2,496,500
Federal net operating loss     $ 12,000,000  
State net operating loss       $ 12,200,000
Corporate alternative tax 1.00% 15.00%    
XML 97 R85.htm IDEA: XBRL DOCUMENT v3.25.1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
Mar. 02, 2025
Feb. 28, 2025
Jul. 18, 2024
Subsequent Event [Line Items]      
Face amount     $ 7,500,000
Loan And Security Agreement [Member]      
Subsequent Event [Line Items]      
Face amount     $ 750,000
Subsequent Event [Member]      
Subsequent Event [Line Items]      
Face amount $ 450,000    
Subsequent Event [Member] | Loan And Security Agreement [Member]      
Subsequent Event [Line Items]      
Face amount   $ 7,050,000  
Subsequent Event [Member] | Loan And Security Agreement [Member] | Common Class A [Member]      
Subsequent Event [Line Items]      
Price per share   $ 0.60  
EXCEL 98 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 100 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 102 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.1 html 161 351 1 false 55 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://healthychoicewellness.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://healthychoicewellness.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://healthychoicewellness.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://healthychoicewellness.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://healthychoicewellness.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 9 false false R10.htm 999014 - Disclosure - ORGANIZATION Sheet http://healthychoicewellness.com/role/Organization ORGANIZATION Notes 10 false false R11.htm 999015 - Disclosure - GOING CONCERN Sheet http://healthychoicewellness.com/role/GoingConcern GOING CONCERN Notes 11 false false R12.htm 999016 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 12 false false R13.htm 999017 - Disclosure - CONCENTRATIONS Sheet http://healthychoicewellness.com/role/Concentrations CONCENTRATIONS Notes 13 false false R14.htm 999018 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES Sheet http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenues SEGMENT REPORTING AND DISAGGREGATION OF REVENUES Notes 14 false false R15.htm 999019 - Disclosure - ACCOUNTS RECEIVABLE, NET Sheet http://healthychoicewellness.com/role/AccountsReceivableNet ACCOUNTS RECEIVABLE, NET Notes 15 false false R16.htm 999020 - Disclosure - INVENTORIES Sheet http://healthychoicewellness.com/role/Inventories INVENTORIES Notes 16 false false R17.htm 999021 - Disclosure - ACQUISITIONS Sheet http://healthychoicewellness.com/role/Acquisitions ACQUISITIONS Notes 17 false false R18.htm 999022 - Disclosure - ASSETS HELD FOR SALE Sheet http://healthychoicewellness.com/role/AssetsHeldForSale ASSETS HELD FOR SALE Notes 18 false false R19.htm 999023 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT Sheet http://healthychoicewellness.com/role/PropertyPlantAndEquipment PROPERTY, PLANT, AND EQUIPMENT Notes 19 false false R20.htm 999024 - Disclosure - INTANGIBLE ASSETS Sheet http://healthychoicewellness.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 20 false false R21.htm 999025 - Disclosure - GOODWILL Sheet http://healthychoicewellness.com/role/Goodwill GOODWILL Notes 21 false false R22.htm 999026 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES Sheet http://healthychoicewellness.com/role/AccountsPayableAndAccruedExpenses ACCOUNTS PAYABLE AND ACCRUED EXPENSES Notes 22 false false R23.htm 999027 - Disclosure - DEBT Sheet http://healthychoicewellness.com/role/Debt DEBT Notes 23 false false R24.htm 999028 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://healthychoicewellness.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 24 false false R25.htm 999029 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://healthychoicewellness.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 25 false false R26.htm 999030 - Disclosure - LEASES Sheet http://healthychoicewellness.com/role/Leases LEASES Notes 26 false false R27.htm 999031 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://healthychoicewellness.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 27 false false R28.htm 999032 - Disclosure - INCOME TAXES Sheet http://healthychoicewellness.com/role/IncomeTaxes INCOME TAXES Notes 28 false false R29.htm 999033 - Disclosure - SUBSEQUENT EVENTS Sheet http://healthychoicewellness.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 29 false false R30.htm 999034 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 30 false false R31.htm 999035 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 31 false false R32.htm 999036 - Disclosure - CONCENTRATIONS (Tables) Sheet http://healthychoicewellness.com/role/ConcentrationsTables CONCENTRATIONS (Tables) Tables http://healthychoicewellness.com/role/Concentrations 32 false false R33.htm 999037 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Tables) Sheet http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesTables SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Tables) Tables http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenues 33 false false R34.htm 999038 - Disclosure - ACQUISITIONS (Tables) Sheet http://healthychoicewellness.com/role/AcquisitionsTables ACQUISITIONS (Tables) Tables http://healthychoicewellness.com/role/Acquisitions 34 false false R35.htm 999039 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT (Tables) Sheet http://healthychoicewellness.com/role/PropertyPlantAndEquipmentTables PROPERTY, PLANT, AND EQUIPMENT (Tables) Tables http://healthychoicewellness.com/role/PropertyPlantAndEquipment 35 false false R36.htm 999040 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://healthychoicewellness.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://healthychoicewellness.com/role/IntangibleAssets 36 false false R37.htm 999041 - Disclosure - GOODWILL (Tables) Sheet http://healthychoicewellness.com/role/GoodwillTables GOODWILL (Tables) Tables http://healthychoicewellness.com/role/Goodwill 37 false false R38.htm 999042 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Sheet http://healthychoicewellness.com/role/AccountsPayableAndAccruedExpensesTables ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Tables http://healthychoicewellness.com/role/AccountsPayableAndAccruedExpenses 38 false false R39.htm 999043 - Disclosure - DEBT (Tables) Sheet http://healthychoicewellness.com/role/DebtTables DEBT (Tables) Tables http://healthychoicewellness.com/role/Debt 39 false false R40.htm 999044 - Disclosure - LEASES (Tables) Sheet http://healthychoicewellness.com/role/LeasesTables LEASES (Tables) Tables http://healthychoicewellness.com/role/Leases 40 false false R41.htm 999045 - Disclosure - INCOME TAXES (Tables) Sheet http://healthychoicewellness.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://healthychoicewellness.com/role/IncomeTaxes 41 false false R42.htm 999046 - Disclosure - ORGANIZATION (Details Narrative) Sheet http://healthychoicewellness.com/role/OrganizationDetailsNarrative ORGANIZATION (Details Narrative) Details http://healthychoicewellness.com/role/Organization 42 false false R43.htm 999047 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://healthychoicewellness.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://healthychoicewellness.com/role/GoingConcern 43 false false R44.htm 999048 - Disclosure - SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfFinancialInstitutionThatHadCashInExcessOfFdicLimitsDetails SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS (Details) Details 44 false false R45.htm 999049 - Disclosure - SCHEDULE OF EARNINGS PER SHARES (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfEarningsPerSharesDetails SCHEDULE OF EARNINGS PER SHARES (Details) Details 45 false false R46.htm 999050 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 46 false false R47.htm 999051 - Disclosure - SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfCashInExcessOfFdicLimitsDetails SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS (Details) Details 47 false false R48.htm 999052 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Parenthetical) (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfCashAndCashEquivalentsParentheticalDetails SCHEDULE OF CASH AND CASH EQUIVALENTS (Parenthetical) (Details) Details 48 false false R49.htm 999053 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfReconciliationOfCashAndCashEquivalentsDetails SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS (Details) Details 49 false false R50.htm 999054 - Disclosure - CONCENTRATIONS (Details Narrative) Sheet http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative CONCENTRATIONS (Details Narrative) Details http://healthychoicewellness.com/role/ConcentrationsTables 50 false false R51.htm 999055 - Disclosure - SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES (Details) Details 51 false false R52.htm 999056 - Disclosure - SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT (Details) Details 52 false false R53.htm 999057 - Disclosure - SCHEDULE DISAGGREGATED REVENUES (Details) Sheet http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails SCHEDULE DISAGGREGATED REVENUES (Details) Details 53 false false R54.htm 999058 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Details Narrative) Sheet http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesDetailsNarrative SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Details Narrative) Details http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesTables 54 false false R55.htm 999059 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative) Sheet http://healthychoicewellness.com/role/AccountsReceivableNetDetailsNarrative ACCOUNTS RECEIVABLE, NET (Details Narrative) Details http://healthychoicewellness.com/role/AccountsReceivableNet 55 false false R56.htm 999060 - Disclosure - INVENTORIES (Details Narrative) Sheet http://healthychoicewellness.com/role/InventoriesDetailsNarrative INVENTORIES (Details Narrative) Details http://healthychoicewellness.com/role/Inventories 56 false false R57.htm 999061 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails SCHEDULE OF PURCHASE PRICE ALLOCATION (Details) Details 57 false false R58.htm 999062 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Parenthetical) (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails SCHEDULE OF PURCHASE PRICE ALLOCATION (Parenthetical) (Details) Details 58 false false R59.htm 999063 - Disclosure - SCHEDULE OF UNAUDITED PROFORMA INFORMATION (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails SCHEDULE OF UNAUDITED PROFORMA INFORMATION (Details) Details 59 false false R60.htm 999064 - Disclosure - ACQUISITIONS (Details Narrative) Sheet http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative ACQUISITIONS (Details Narrative) Details http://healthychoicewellness.com/role/AcquisitionsTables 60 false false R61.htm 999065 - Disclosure - ASSETS HELD FOR SALE (Details Narrative) Sheet http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative ASSETS HELD FOR SALE (Details Narrative) Details http://healthychoicewellness.com/role/AssetsHeldForSale 61 false false R62.htm 999066 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 62 false false R63.htm 999067 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT (Details Narrative) Sheet http://healthychoicewellness.com/role/PropertyPlantAndEquipmentDetailsNarrative PROPERTY, PLANT, AND EQUIPMENT (Details Narrative) Details http://healthychoicewellness.com/role/PropertyPlantAndEquipmentTables 63 false false R64.htm 999068 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails SCHEDULE OF INTANGIBLE ASSETS, NET (Details) Details 64 false false R65.htm 999069 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS (Details) Details 65 false false R66.htm 999070 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://healthychoicewellness.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://healthychoicewellness.com/role/IntangibleAssetsTables 66 false false R67.htm 999071 - Disclosure - SCHEDULE OF GOODWILL (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfGoodwillDetails SCHEDULE OF GOODWILL (Details) Details 67 false false R68.htm 999072 - Disclosure - GOODWILL (Details Narrative) Sheet http://healthychoicewellness.com/role/GoodwillDetailsNarrative GOODWILL (Details Narrative) Details http://healthychoicewellness.com/role/GoodwillTables 68 false false R69.htm 999073 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Details 69 false false R70.htm 999074 - Disclosure - SCHEDULE OF DEBT (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfDebtDetails SCHEDULE OF DEBT (Details) Details 70 false false R71.htm 999075 - Disclosure - SCHEDULE OF DEBT REPAYMENT (Details) (Parenthetical) Sheet http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetailsParenthetical SCHEDULE OF DEBT REPAYMENT (Details) (Parenthetical) Details 71 false false R72.htm 999076 - Disclosure - SCHEDULE OF DEBT REPAYMENT (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails SCHEDULE OF DEBT REPAYMENT (Details) Details 72 false false R73.htm 999077 - Disclosure - DEBT (Details Narrative) Sheet http://healthychoicewellness.com/role/DebtDetailsNarrative DEBT (Details Narrative) Details http://healthychoicewellness.com/role/DebtTables 73 false false R74.htm 999078 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://healthychoicewellness.com/role/StockholdersEquity 74 false false R75.htm 999079 - Disclosure - SCHEDULE OF MATURITY OF LEASE LIABILITIES (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails SCHEDULE OF MATURITY OF LEASE LIABILITIES (Details) Details 75 false false R76.htm 999080 - Disclosure - SCHEDULE OF COMPANY???S OPERATING LEASE (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails SCHEDULE OF COMPANY???S OPERATING LEASE (Details) Details 76 false false R77.htm 999081 - Disclosure - SCHEDULE OF OPERATING LEASE TERM (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfOperatingLeaseTermDetails SCHEDULE OF OPERATING LEASE TERM (Details) Details 77 false false R78.htm 999082 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE EXPENSE (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails SCHEDULE OF COMPONENTS OF LEASE EXPENSE (Details) Details 78 false false R79.htm 999083 - Disclosure - LEASES (Details Narrative) Sheet http://healthychoicewellness.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://healthychoicewellness.com/role/LeasesTables 79 false false R80.htm 999084 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://healthychoicewellness.com/role/RelatedPartyTransactions 80 false false R81.htm 999085 - Disclosure - SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) (Parenthetical) Sheet http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetailsParenthetical SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) (Parenthetical) Details 81 false false R82.htm 999086 - Disclosure - SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) Details 82 false false R83.htm 999087 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 83 false false R84.htm 999088 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://healthychoicewellness.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://healthychoicewellness.com/role/IncomeTaxesTables 84 false false R85.htm 999089 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://healthychoicewellness.com/role/SubsequentEvents 85 false false All Reports Book All Reports form10-k.htm hcwc-20241231.xsd hcwc-20241231_cal.xml hcwc-20241231_def.xml hcwc-20241231_lab.xml hcwc-20241231_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/cyd/2024 http://xbrl.sec.gov/dei/2024 true true JSON 105 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "HCWC", "nsuri": "http://healthychoicewellness.com/20241231", "dts": { "inline": { "local": [ "form10-k.htm" ] }, "schema": { "local": [ "hcwc-20241231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "hcwc-20241231_cal.xml" ] }, "definitionLink": { "local": [ "hcwc-20241231_def.xml" ] }, "labelLink": { "local": [ "hcwc-20241231_lab.xml" ] }, "presentationLink": { "local": [ "hcwc-20241231_pre.xml" ] } }, "keyStandard": 318, "keyCustom": 33, "axisStandard": 22, "axisCustom": 0, "memberStandard": 23, "memberCustom": 30, "hidden": { "total": 83, "http://fasb.org/us-gaap/2024": 69, "http://healthychoicewellness.com/20241231": 11, "http://xbrl.sec.gov/dei/2024": 3 }, "contextCount": 161, "entityCount": 1, "segmentCount": 55, "elementCount": 634, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 677, "http://xbrl.sec.gov/dei/2024": 43, "http://xbrl.sec.gov/cyd/2024": 4 }, "report": { "R1": { "role": "http://healthychoicewellness.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://healthychoicewellness.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R3": { "role": "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R4": { "role": "http://healthychoicewellness.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:GrossProfit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R5": { "role": "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_NetInvestmentFromParentMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_NetInvestmentFromParentMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R6": { "role": "http://healthychoicewellness.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:NoInsiderTradingFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:NoInsiderTradingFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R9": { "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure", "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure", "shortName": "Cybersecurity Risk Management and Strategy Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://healthychoicewellness.com/role/Organization", "longName": "999014 - Disclosure - ORGANIZATION", "shortName": "ORGANIZATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://healthychoicewellness.com/role/GoingConcern", "longName": "999015 - Disclosure - GOING CONCERN", "shortName": "GOING CONCERN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies", "longName": "999016 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://healthychoicewellness.com/role/Concentrations", "longName": "999017 - Disclosure - CONCENTRATIONS", "shortName": "CONCENTRATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenues", "longName": "999018 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES", "shortName": "SEGMENT REPORTING AND DISAGGREGATION OF REVENUES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://healthychoicewellness.com/role/AccountsReceivableNet", "longName": "999019 - Disclosure - ACCOUNTS RECEIVABLE, NET", "shortName": "ACCOUNTS RECEIVABLE, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://healthychoicewellness.com/role/Inventories", "longName": "999020 - Disclosure - INVENTORIES", "shortName": "INVENTORIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://healthychoicewellness.com/role/Acquisitions", "longName": "999021 - Disclosure - ACQUISITIONS", "shortName": "ACQUISITIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://healthychoicewellness.com/role/AssetsHeldForSale", "longName": "999022 - Disclosure - ASSETS HELD FOR SALE", "shortName": "ASSETS HELD FOR SALE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:LongLivedAssetsHeldForSaleDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:LongLivedAssetsHeldForSaleDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://healthychoicewellness.com/role/PropertyPlantAndEquipment", "longName": "999023 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT", "shortName": "PROPERTY, PLANT, AND EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://healthychoicewellness.com/role/IntangibleAssets", "longName": "999024 - Disclosure - INTANGIBLE ASSETS", "shortName": "INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://healthychoicewellness.com/role/Goodwill", "longName": "999025 - Disclosure - GOODWILL", "shortName": "GOODWILL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://healthychoicewellness.com/role/AccountsPayableAndAccruedExpenses", "longName": "999026 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES", "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R23": { "role": "http://healthychoicewellness.com/role/Debt", "longName": "999027 - Disclosure - DEBT", "shortName": "DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R24": { "role": "http://healthychoicewellness.com/role/CommitmentsAndContingencies", "longName": "999028 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R25": { "role": "http://healthychoicewellness.com/role/StockholdersEquity", "longName": "999029 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R26": { "role": "http://healthychoicewellness.com/role/Leases", "longName": "999030 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R27": { "role": "http://healthychoicewellness.com/role/RelatedPartyTransactions", "longName": "999031 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R28": { "role": "http://healthychoicewellness.com/role/IncomeTaxes", "longName": "999032 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R29": { "role": "http://healthychoicewellness.com/role/SubsequentEvents", "longName": "999033 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R30": { "role": "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "longName": "999034 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "30", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R31": { "role": "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "longName": "999035 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:ScheduleOfCashInFDICLimitsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:ScheduleOfCashInFDICLimitsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R32": { "role": "http://healthychoicewellness.com/role/ConcentrationsTables", "longName": "999036 - Disclosure - CONCENTRATIONS (Tables)", "shortName": "CONCENTRATIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:ScheduleOfCashInExcessFDICLimitsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:ScheduleOfCashInExcessFDICLimitsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R33": { "role": "http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesTables", "longName": "999037 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Tables)", "shortName": "SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:SignificantSegmentExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:SignificantSegmentExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R34": { "role": "http://healthychoicewellness.com/role/AcquisitionsTables", "longName": "999038 - Disclosure - ACQUISITIONS (Tables)", "shortName": "ACQUISITIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R35": { "role": "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentTables", "longName": "999039 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT (Tables)", "shortName": "PROPERTY, PLANT, AND EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R36": { "role": "http://healthychoicewellness.com/role/IntangibleAssetsTables", "longName": "999040 - Disclosure - INTANGIBLE ASSETS (Tables)", "shortName": "INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R37": { "role": "http://healthychoicewellness.com/role/GoodwillTables", "longName": "999041 - Disclosure - GOODWILL (Tables)", "shortName": "GOODWILL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R38": { "role": "http://healthychoicewellness.com/role/AccountsPayableAndAccruedExpensesTables", "longName": "999042 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)", "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R39": { "role": "http://healthychoicewellness.com/role/DebtTables", "longName": "999043 - Disclosure - DEBT (Tables)", "shortName": "DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R40": { "role": "http://healthychoicewellness.com/role/LeasesTables", "longName": "999044 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R41": { "role": "http://healthychoicewellness.com/role/IncomeTaxesTables", "longName": "999045 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R42": { "role": "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "longName": "999046 - Disclosure - ORGANIZATION (Details Narrative)", "shortName": "ORGANIZATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2024-09-162024-09-16", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-09-13_custom_HealthierChoicesManagementCorpMember_us-gaap_SeriesEPreferredStockMember", "name": "HCWC:EquityFinancing", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R43": { "role": "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "longName": "999047 - Disclosure - GOING CONCERN (Details Narrative)", "shortName": "GOING CONCERN (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R44": { "role": "http://healthychoicewellness.com/role/ScheduleOfFinancialInstitutionThatHadCashInExcessOfFdicLimitsDetails", "longName": "999048 - Disclosure - SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS (Details)", "shortName": "SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashUninsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "HCWC:ScheduleOfCashInFDICLimitsTableTextBlock", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://healthychoicewellness.com/role/ScheduleOfEarningsPerSharesDetails", "longName": "999049 - Disclosure - SCHEDULE OF EARNINGS PER SHARES (Details)", "shortName": "SCHEDULE OF EARNINGS PER SHARES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "999050 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CostOfRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "HCWC:AccountsReceivableContractAssetsAndContractLiabilitiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R47": { "role": "http://healthychoicewellness.com/role/ScheduleOfCashInExcessOfFdicLimitsDetails", "longName": "999051 - Disclosure - SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS (Details)", "shortName": "SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R48": { "role": "http://healthychoicewellness.com/role/ScheduleOfCashAndCashEquivalentsParentheticalDetails", "longName": "999052 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Parenthetical) (Details)", "shortName": "SCHEDULE OF CASH AND CASH EQUIVALENTS (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R49": { "role": "http://healthychoicewellness.com/role/ScheduleOfReconciliationOfCashAndCashEquivalentsDetails", "longName": "999053 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS (Details)", "shortName": "SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R50": { "role": "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "longName": "999054 - Disclosure - CONCENTRATIONS (Details Narrative)", "shortName": "CONCENTRATIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R51": { "role": "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails", "longName": "999055 - Disclosure - SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES (Details)", "shortName": "SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AdvertisingExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:AdvertisingCostsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember", "name": "us-gaap:AdvertisingExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "HCWC:SignificantSegmentExpensesTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R52": { "role": "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails", "longName": "999056 - Disclosure - SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT (Details)", "shortName": "SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_custom_SegmentNetOperatingIncomeLossMember", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R53": { "role": "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails", "longName": "999057 - Disclosure - SCHEDULE DISAGGREGATED REVENUES (Details)", "shortName": "SCHEDULE DISAGGREGATED REVENUES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_custom_RetailGroceryMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R54": { "role": "http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesDetailsNarrative", "longName": "999058 - Disclosure - SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Details Narrative)", "shortName": "SEGMENT REPORTING AND DISAGGREGATION OF REVENUES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R55": { "role": "http://healthychoicewellness.com/role/AccountsReceivableNetDetailsNarrative", "longName": "999059 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative)", "shortName": "ACCOUNTS RECEIVABLE, NET (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:AdvertisingRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "HCWC:AdvertisingRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R56": { "role": "http://healthychoicewellness.com/role/InventoriesDetailsNarrative", "longName": "999060 - Disclosure - INVENTORIES (Details Narrative)", "shortName": "INVENTORIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:InventoryWriteDown", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R57": { "role": "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "longName": "999061 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Details)", "shortName": "SCHEDULE OF PURCHASE PRICE ALLOCATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-10-012023-10-01_custom_EllwoodThompsonMember", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R58": { "role": "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails", "longName": "999062 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Parenthetical) (Details)", "shortName": "SCHEDULE OF PURCHASE PRICE ALLOCATION (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2024-07-18_us-gaap_TradeNamesMember_custom_EllwoodThompsonMember", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-07-18_us-gaap_TradeNamesMember_custom_EllwoodThompsonMember", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R59": { "role": "http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails", "longName": "999063 - Disclosure - SCHEDULE OF UNAUDITED PROFORMA INFORMATION (Details)", "shortName": "SCHEDULE OF UNAUDITED PROFORMA INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2024-01-012024-12-31_custom_EllwoodThompsonMember", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_custom_EllwoodThompsonMember", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R60": { "role": "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "longName": "999064 - Disclosure - ACQUISITIONS (Details Narrative)", "shortName": "ACQUISITIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-10-012023-10-01_custom_EllwoodThompsonMember", "name": "HCWC:BusinessAcquisitionGoodwillTaxDeductibleAmountAmortizationPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R61": { "role": "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative", "longName": "999065 - Disclosure - ASSETS HELD FOR SALE (Details Narrative)", "shortName": "ASSETS HELD FOR SALE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ProceedsFromSaleOfBuildings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-02-07_us-gaap_BuildingMember", "name": "us-gaap:PropertyPlantAndEquipmentOther", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "HCWC:LongLivedAssetsHeldForSaleDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R62": { "role": "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "longName": "999066 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R63": { "role": "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentDetailsNarrative", "longName": "999067 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT (Details Narrative)", "shortName": "PROPERTY, PLANT, AND EQUIPMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2024-01-012024-12-31_us-gaap_PropertyPlantAndEquipmentMember", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_us-gaap_PropertyPlantAndEquipmentMember", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R64": { "role": "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails", "longName": "999068 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)", "shortName": "SCHEDULE OF INTANGIBLE ASSETS, NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R65": { "role": "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails", "longName": "999069 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS (Details)", "shortName": "SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R66": { "role": "http://healthychoicewellness.com/role/IntangibleAssetsDetailsNarrative", "longName": "999070 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R67": { "role": "http://healthychoicewellness.com/role/ScheduleOfGoodwillDetails", "longName": "999071 - Disclosure - SCHEDULE OF GOODWILL (Details)", "shortName": "SCHEDULE OF GOODWILL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:Goodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R68": { "role": "http://healthychoicewellness.com/role/GoodwillDetailsNarrative", "longName": "999072 - Disclosure - GOODWILL (Details Narrative)", "shortName": "GOODWILL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2023-01-012023-12-31", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R69": { "role": "http://healthychoicewellness.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails", "longName": "999073 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)", "shortName": "SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R70": { "role": "http://healthychoicewellness.com/role/ScheduleOfDebtDetails", "longName": "999074 - Disclosure - SCHEDULE OF DEBT (Details)", "shortName": "SCHEDULE OF DEBT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R71": { "role": "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetailsParenthetical", "longName": "999075 - Disclosure - SCHEDULE OF DEBT REPAYMENT (Details) (Parenthetical)", "shortName": "SCHEDULE OF DEBT REPAYMENT (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DebtInstrumentTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:DebtInstrumentRedemptionTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R72": { "role": "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails", "longName": "999076 - Disclosure - SCHEDULE OF DEBT REPAYMENT (Details)", "shortName": "SCHEDULE OF DEBT REPAYMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DebtInstrumentRedemptionTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DebtInstrumentRedemptionTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R73": { "role": "http://healthychoicewellness.com/role/DebtDetailsNarrative", "longName": "999077 - Disclosure - DEBT (Details Narrative)", "shortName": "DEBT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "AsOf2024-07-18", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-07-182024-07-18_custom_FirstAnniversaryMember", "name": "us-gaap:RepaymentsOfLongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R74": { "role": "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative", "longName": "999078 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "From2024-09-162024-09-16", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R75": { "role": "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails", "longName": "999079 - Disclosure - SCHEDULE OF MATURITY OF LEASE LIABILITIES (Details)", "shortName": "SCHEDULE OF MATURITY OF LEASE LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R76": { "role": "http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails", "longName": "999080 - Disclosure - SCHEDULE OF COMPANY\u2019S OPERATING LEASE (Details)", "shortName": "SCHEDULE OF COMPANY\u2019S OPERATING LEASE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R77": { "role": "http://healthychoicewellness.com/role/ScheduleOfOperatingLeaseTermDetails", "longName": "999081 - Disclosure - SCHEDULE OF OPERATING LEASE TERM (Details)", "shortName": "SCHEDULE OF OPERATING LEASE TERM (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "HCWC:LesseeOperatingLeaseLiabilityLeaseTermTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "HCWC:LesseeOperatingLeaseLiabilityLeaseTermTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R78": { "role": "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails", "longName": "999082 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE EXPENSE (Details)", "shortName": "SCHEDULE OF COMPONENTS OF LEASE EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:OperatingLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:OperatingLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R79": { "role": "http://healthychoicewellness.com/role/LeasesDetailsNarrative", "longName": "999083 - Disclosure - LEASES (Details Narrative)", "shortName": "LEASES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R80": { "role": "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "999084 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:OperatingExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:ReceivablesNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R81": { "role": "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetailsParenthetical", "longName": "999085 - Disclosure - SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) (Parenthetical)", "shortName": "SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R82": { "role": "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails", "longName": "999086 - Disclosure - SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details)", "shortName": "SCHEDULE OF INCOME TAX EXPENSE (BENEFIT) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R83": { "role": "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "longName": "999087 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R84": { "role": "http://healthychoicewellness.com/role/IncomeTaxesDetailsNarrative", "longName": "999088 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R85": { "role": "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative", "longName": "999089 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "AsOf2024-07-18", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-02_us-gaap_SubsequentEventMember", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsAndNontradeReceivableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/AccountsReceivableNet" ], "lang": { "en-us": { "role": { "label": "ACCOUNTS RECEIVABLE, NET", "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable." } } }, "auth_ref": [ "r256", "r259" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r55", "r56" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Accounts Payable and Accrued Liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r108", "r110" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/AccountsPayableAndAccruedExpenses" ], "lang": { "en-us": { "role": { "label": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r54", "r56", "r60", "r944" ] }, "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableTradeCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Trade creditors", "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r110" ] }, "HCWC_AccountsReceivableContractAssetsAndContractLiabilitiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "AccountsReceivableContractAssetsAndContractLiabilitiesPolicy", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Contract Assets and Contract Liabilities", "documentation": "Accounts Receivable Contract Assets and Contract Liabilities [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNet", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/AccountsReceivableNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r623", "r681", "r751", "r977", "r978" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r902" ] }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities." } } }, "auth_ref": [ "r110" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: accumulated depreciation and amortization", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r34", "r148", "r541" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r167", "r168", "r478", "r479", "r480", "r481", "r482", "r483" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r167", "r168", "r478", "r479", "r480", "r481", "r482", "r483" ] }, "HCWC_AcquisitionLoanAndSecurityAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "AcquisitionLoanAndSecurityAgreementMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Acquisition Loan And Security Agreement [Member]", "documentation": "Acquisition Loan And Security Agreement [Member]" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r819" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r67", "r737", "r1010" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r590", "r890", "r891", "r892", "r893", "r950", "r1013" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r825" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r825" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r825" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r825" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r128" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Advertising expenses", "verboseLabel": "Advertising", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r409", "r723" ] }, "HCWC_AdvertisingRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "AdvertisingRevenue", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/AccountsReceivableNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advertising revenue", "documentation": "Advertising revenue" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r786", "r797", "r811", "r837" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r789", "r800", "r814", "r840" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r825" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r832" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r790", "r801", "r815", "r832", "r841", "r845", "r853" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization of debt discount", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r7", "r79", "r349", "r959" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r7", "r284", "r291", "r711" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r793" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative", "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r453" ] }, "HCWC_AssetPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "AssetPurchaseAgreementMember", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Asset Purchase Agreement [Member]", "documentation": "Asset Purchase Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Consolidated total assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r106", "r122", "r152", "r181", "r210", "r218", "r244", "r248", "r258", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r325", "r326", "r454", "r456", "r477", "r530", "r628", "r703", "r704", "r737", "r758", "r937", "r938", "r966" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL CURRENT ASSETS", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r143", "r163", "r181", "r258", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r325", "r326", "r454", "r456", "r477", "r737", "r937", "r938", "r966" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsHeldForSaleLongLivedFairValueDisclosure", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair market value", "documentation": "Fair value portion of assets classified as held for sale." } } }, "auth_ref": [ "r726", "r727", "r729", "r951" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r793" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorFirmId", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r770", "r772", "r793" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorLocation", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r770", "r772", "r793" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorName", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r770", "r772", "r793" ] }, "dei_AuditorOpinionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorOpinionTextBlock", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Opinion [Text Block]" } } }, "auth_ref": [ "r867" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [ "r848" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r849" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r844" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r844" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method" } } }, "auth_ref": [ "r844" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r844" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r844" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined" } } }, "auth_ref": [ "r844" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Securities" } } }, "auth_ref": [ "r847" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r846" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r845" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r845" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "HCWC_BridgeWarrantSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "BridgeWarrantSharesMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bridge Warrant Shares [Member]", "documentation": "Bridge Warrant Shares [Member]" } } }, "auth_ref": [] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BuildingMember", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r93" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails", "http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r285", "r286", "r287", "r288", "r289", "r448", "r720", "r721" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails", "http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r39", "r40", "r285", "r286", "r287", "r288", "r289", "r448", "r720", "r721" ] }, "HCWC_BusinessAcquisitionGoodwillTaxDeductibleAmountAmortizationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "BusinessAcquisitionGoodwillTaxDeductibleAmountAmortizationPeriod", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization period for goodwill for tax purposes (years)", "documentation": "Amortization period for goodwill for tax purposes (years)." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails", "http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r448" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF UNAUDITED PROFORMA INFORMATION", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r874", "r875" ] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r446", "r447" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sales", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r446", "r447" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Total purchase consideration", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r10" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/Acquisitions" ], "lang": { "en-us": { "role": { "label": "ACQUISITIONS", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r100", "r449" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Total intangible assets", "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date." } } }, "auth_ref": [ "r41", "r42" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r41", "r42" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Net assets acquired", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r41", "r42" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r42" ] }, "HCWC_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liability", "documentation": "Business combination, recognized identifiable assets acquired and liabilities assumed, cash and equivalents." } } }, "auth_ref": [] }, "HCWC_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Right of use asset - Operating lease", "documentation": "Right of use asset - operating lease." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant, and equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r41", "r42" ] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value", "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages." } } }, "auth_ref": [ "r12" ] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Business Combination", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r101", "r102", "r103", "r104" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Cash", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfReconciliationOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "verboseLabel": "Cah advance", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r125", "r534", "r601", "r621", "r737", "r758", "r878" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalent", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r17", "r146", "r690" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r18" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "CASH \u2014 BEGINNING OF PERIOD", "periodEndLabel": "CASH \u2014 END OF PERIOD", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r17", "r85", "r177" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET INCREASE (DECREASE) IN CASH", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r85" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash equivalents", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r878", "r976" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfCashAndCashEquivalentsParentheticalDetails", "http://healthychoicewellness.com/role/ScheduleOfCashInExcessOfFdicLimitsDetails" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "NON-CASH INVESTING AND FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_CashUninsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashUninsuredAmount", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfCashInExcessOfFdicLimitsDetails", "http://healthychoicewellness.com/role/ScheduleOfFinancialInstitutionThatHadCashInExcessOfFdicLimitsDetails" ], "lang": { "en-us": { "role": { "label": "Total cash and restricted cash in excess of FDIC limits", "verboseLabel": "Total cash in excess of FDIC limits of $250,000", "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "HCWC_ChangeInContingentConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "ChangeInContingentConsideration", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 }, "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Change in contingent consideration", "negatedLabel": "Change in contingent consideration", "documentation": "Change in contingent consideration." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r823" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative", "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r138", "r156", "r157", "r158", "r181", "r202", "r203", "r205", "r207", "r212", "r213", "r258", "r316", "r319", "r320", "r321", "r325", "r326", "r358", "r359", "r361", "r364", "r370", "r477", "r581", "r582", "r583", "r584", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r602", "r613", "r637", "r660", "r675", "r676", "r677", "r678", "r679", "r871", "r887", "r894" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant exercise price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r371" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant purchase", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r371" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r824" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r824" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES (SEE NOTE 15)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r61", "r113", "r533", "r612" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r95", "r308", "r309", "r683", "r929", "r934" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassAMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r1013" ] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassBMember", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Class B [Member]", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r1013" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r748", "r749", "r750", "r752", "r753", "r754", "r755", "r890", "r891", "r893", "r950", "r1008", "r1013" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r66" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r66", "r613" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r66" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "verboseLabel": "Common stock shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r11", "r66", "r613", "r634", "r1013", "r1014" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, $0.001 par value per share, 560,000,000 shares authorized; 9,815,749 and 10 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r66", "r536", "r737" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r829" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r828" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r830" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r827" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComputerEquipmentMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r23", "r24", "r45", "r46", "r255", "r682" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r23", "r24", "r45", "r46", "r255", "r575", "r682" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r23", "r24", "r45", "r46", "r255", "r682", "r873" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/Concentrations" ], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r89" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r682" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration risk percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r23", "r24", "r45", "r46", "r255" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTable", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk." } } }, "auth_ref": [ "r22", "r23", "r24", "r25", "r45", "r105", "r682" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r23", "r24", "r45", "r46", "r255", "r682" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsAxis", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r120", "r185", "r210", "r220", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r250", "r316", "r317", "r318", "r319", "r321", "r322", "r323", "r324", "r325", "r703", "r704", "r937", "r938" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsDomain", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "auth_ref": [ "r120", "r185", "r210", "r220", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r250", "r316", "r317", "r318", "r319", "r321", "r322", "r323", "r324", "r325", "r703", "r704", "r937", "r938" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r44", "r692" ] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contract liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r373", "r374", "r377" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Contract liabilities", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r373", "r374", "r377" ] }, "us-gaap_CostDirectLabor": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostDirectLabor", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Payroll and Benefits", "documentation": "Cost of labor directly related to good produced and service rendered. Includes, but is not limited to, payroll cost and equity-based compensation." } } }, "auth_ref": [ "r881" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "COST OF SALES", "verboseLabel": "Costs of sales", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r74", "r181", "r258", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r325", "r326", "r477", "r703", "r937" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditLossAbstract", "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r90", "r255" ] }, "HCWC_CustomerRelationshipMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "CustomerRelationshipMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Customer Relationship [Member]", "documentation": "Customer Relationship [Member]" } } }, "auth_ref": [] }, "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r780", "r863" ] }, "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]" } } }, "auth_ref": [ "r780", "r863" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]" } } }, "auth_ref": [ "r782", "r865" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r782", "r865" ] }, "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]" } } }, "auth_ref": [ "r775", "r858" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Flag]" } } }, "auth_ref": [ "r776", "r859" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Text Block]" } } }, "auth_ref": [ "r776", "r859" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract", "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]" } } }, "auth_ref": [ "r774", "r857" ] }, "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Third Party Engaged [Flag]" } } }, "auth_ref": [ "r777", "r860" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]" } } }, "auth_ref": [ "r779", "r862" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]" } } }, "auth_ref": [ "r779", "r862" ] }, "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r780", "r863" ] }, "cyd_CybersecurityRiskRoleOfManagementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskRoleOfManagementTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Role of Management [Text Block]" } } }, "auth_ref": [ "r781", "r864" ] }, "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]" } } }, "auth_ref": [ "r778", "r861" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/Debt" ], "lang": { "en-us": { "role": { "label": "DEBT", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r96", "r179", "r301", "r302", "r303", "r304", "r305", "r314", "r315", "r327", "r333", "r334", "r335", "r336", "r337", "r338", "r343", "r350", "r351", "r352", "r486" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r13", "r55", "r56", "r107", "r112", "r185", "r328", "r329", "r330", "r331", "r332", "r334", "r339", "r340", "r341", "r342", "r344", "r345", "r346", "r347", "r348", "r349", "r712", "r713", "r714", "r715", "r716", "r735", "r888", "r930", "r931", "r932", "r958", "r960" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtDetails", "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Promissory note", "label": "Total", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r13", "r112", "r353" ] }, "us-gaap_DebtInstrumentDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentDescription", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument description", "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total." } } }, "auth_ref": [ "r13", "r37", "r49", "r55", "r107", "r112", "r486" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Face amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r328", "r486", "r487", "r713", "r714", "r735" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt fair value", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r341", "r476", "r713", "r714", "r951", "r952", "r953", "r954", "r955" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Acquisition percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r58", "r355", "r486", "r487", "r735" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r58", "r329" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r154", "r712", "r953", "r954" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r13", "r185", "r328", "r329", "r330", "r331", "r332", "r334", "r339", "r340", "r341", "r342", "r344", "r345", "r346", "r347", "r348", "r349", "r712", "r713", "r714", "r715", "r716", "r735", "r888", "r930", "r931", "r932", "r958", "r960" ] }, "us-gaap_DebtInstrumentRedemptionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentRedemptionTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEBT REPAYMENT", "documentation": "Tabular disclosure of debt instruments or arrangements with redemption features. Includes, but is not limited to, description of debt redemption features, percentage price at which debt can be redeemed by the issuer, and period start and end for debt maturity or redemption." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTerm", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt instrument repayment term", "verboseLabel": "Debt term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Debt discount and issuance cost", "label": "Debt discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r940", "r957", "r958", "r960" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscountCurrent", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtDetails": { "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Current portion of debt discount and issuance cost", "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer." } } }, "auth_ref": [ "r957", "r958", "r960" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt issuance cost", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r940", "r957", "r958", "r960" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r62", "r63", "r109", "r425" ] }, "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsCharitableContributionCarryforwards", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Charitable contributions", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards." } } }, "auth_ref": [ "r948" ] }, "us-gaap_DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "ASC 842 - Lease Accounting", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from a gain reported for tax purposes on sale and leaseback transactions in accordance with enacted tax laws." } } }, "auth_ref": [ "r948" ] }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill." } } }, "auth_ref": [ "r948" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r426" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Net deferred tax assets", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r947" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r947" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "State net operating loss", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards." } } }, "auth_ref": [ "r948" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "UNICAP 263a Adjustment", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r948" ] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "NOL carryforward", "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards." } } }, "auth_ref": [ "r948" ] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Federal net operating loss", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards." } } }, "auth_ref": [ "r948" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Allowances", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances." } } }, "auth_ref": [ "r948" ] }, "HCWC_DeferredTaxAssetsTaxDeferredExpenseReservesInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesInterestExpense", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest expense", "label": "DeferredTaxAssetsTaxDeferredExpenseReservesInterestExpense" } } }, "auth_ref": [] }, "HCWC_DeferredTaxAssetsTaxDeferredExpenseReservesWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesWarrantLiability", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Warrant liability" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r427" ] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net book value of fixed assets", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r948" ] }, "us-gaap_DefinedContributionPlanCostRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedContributionPlanCostRecognized", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employer expense amount", "documentation": "Amount of cost for defined contribution plan." } } }, "auth_ref": [ "r380" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation and Amortization", "verboseLabel": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r7", "r33" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r7", "r33" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE DISAGGREGATED REVENUES", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r942" ] }, "HCWC_DisclosureAssetsHeldForSaleAbstract": { "xbrltype": "stringItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "DisclosureAssetsHeldForSaleAbstract", "lang": { "en-us": { "role": { "label": "Assets Held For Sale" } } }, "auth_ref": [] }, "HCWC_DisclosureLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "DisclosureLeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases", "verboseLabel": "Schedule Of Maturity Of Lease Liabilities", "terseLabel": "Schedule Of Companys Operating Lease" } } }, "auth_ref": [] }, "HCWC_DisplaysMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "DisplaysMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Displays [Member]", "documentation": "Displays [Member]" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r772" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r770", "r772", "r793" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r770", "r772", "r793", "r833" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r771" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r759" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r772" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r772" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r818" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r762" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEarningsPerSharesDetails", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "BASIC NET LOSS PER SHARE", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r170", "r191", "r192", "r193", "r194", "r195", "r196", "r200", "r202", "r205", "r206", "r207", "r209", "r444", "r452", "r466", "r467", "r525", "r546", "r695" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEarningsPerSharesDetails", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "DILUTED NET LOSS PER SHARE", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r170", "r191", "r192", "r193", "r194", "r195", "r196", "r202", "r205", "r206", "r207", "r209", "r444", "r452", "r466", "r467", "r525", "r546", "r695" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings per share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r20", "r21", "r208" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://healthychoicewellness.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Corporate alternative tax", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r415", "r725" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Federal statutory income tax rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r182", "r415", "r435", "r725" ] }, "HCWC_EllwoodThompsonMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "EllwoodThompsonMember", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails", "http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails" ], "lang": { "en-us": { "role": { "label": "Ellwood Thompson [Member]", "documentation": "Ellwood Thompson [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r765" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r761" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r761" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r870" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r761" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r866" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r793" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r761" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r761" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r761" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r761" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r868" ] }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "presentation": [ "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from External Customer [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r11", "r140", "r167", "r168", "r169", "r186", "r187", "r188", "r190", "r195", "r197", "r199", "r211", "r260", "r261", "r299", "r372", "r433", "r434", "r441", "r442", "r443", "r445", "r451", "r452", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r478", "r479", "r480", "r481", "r482", "r483", "r488", "r490", "r504", "r545", "r569", "r570", "r571", "r590", "r660" ] }, "HCWC_EquityFinancing": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "EquityFinancing", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity financing", "documentation": "Equity financing" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r826" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r786", "r797", "r811", "r837" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r783", "r794", "r808", "r834" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r832" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Class of asset." } } }, "auth_ref": [ "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r730" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r730" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Intangible asset useful life", "verboseLabel": "Useful lives (years)", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension", "presentation": [ "http://healthychoicewellness.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted-average remaining amortization period", "documentation": "Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r295", "r687" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r150", "r267", "r290", "r711" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r925", "r1015" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r292", "r687", "r711" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2029", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r292", "r687", "r711" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r292", "r687", "r711" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r292", "r687", "r711" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r292", "r687", "r711" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r283", "r285", "r286", "r287", "r289", "r290", "r294", "r295", "r522", "r523", "r687" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Gross Carrying Amount", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r267", "r290", "r523", "r711" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r283", "r285", "r286", "r287", "r289", "r290", "r294", "r295", "r687" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEstimatedFutureAmortizationOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r522", "r924" ] }, "HCWC_FirstAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "FirstAnniversaryMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "First Anniversary [Member]", "documentation": "First Anniversary [Member]" } } }, "auth_ref": [] }, "HCWC_FoodServiceRestaurantMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "FoodServiceRestaurantMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Food Service/Restaurant [Member]", "documentation": "Food Service/Restaurant [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r790", "r801", "r815", "r841" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r790", "r801", "r815", "r841" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r790", "r801", "r815", "r841" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r790", "r801", "r815", "r841" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r790", "r801", "r815", "r841" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on sale of building", "label": "Gain (Loss) on Disposition of Assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r886" ] }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnSaleOfPropertyPlantEquipment", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on sale of asset", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property." } } }, "auth_ref": [ "r7" ] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 }, "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfCashFlows", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss on debt extinguishment", "negatedLabel": "Loss on debt extinguishment", "verboseLabel": "Gains losses on extinguishment of debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r7", "r35", "r36" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfGoodwillDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r149", "r269", "r524", "r704", "r710", "r728", "r737", "r906", "r913" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Acquisitions", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r273", "r710" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r268", "r281", "r710" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Identifiable Intangible Assets", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r904", "r916" ] }, "us-gaap_GoodwillDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/Goodwill" ], "lang": { "en-us": { "role": { "label": "GOODWILL", "documentation": "The entire disclosure for goodwill." } } }, "auth_ref": [ "r268", "r271", "r280", "r710" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 }, "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/GoodwillDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfGoodwillDetails", "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails", "http://healthychoicewellness.com/role/StatementsOfCashFlows", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Impairment of goodwill", "verboseLabel": "Goodwill, Impairment Loss", "terseLabel": "Goodwill impairment", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r7", "r270", "r276", "r281", "r710", "r728" ] }, "HCWC_GreenAcresMarketMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "GreenAcresMarketMember", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "GreenAcres Market [Member]", "documentation": "GreenAcres Market [Member]" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "GROSS PROFIT", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r72", "r74", "r121", "r181", "r258", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r325", "r326", "r477", "r697", "r703", "r896", "r898", "r899", "r900", "r901", "r937" ] }, "HCWC_HealthierChoicesManagementCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "HealthierChoicesManagementCorpMember", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Healthier Choices Management Corp [Member]", "documentation": "Healthier Choices Management Corp [Member]" } } }, "auth_ref": [] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IPOMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r770", "r772", "r793" ] }, "us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentEffectsOnEarningsPerShareLineItems", "presentation": [ "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment Effects on Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ImpairmentEffectsOnEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentEffectsOnEarningsPerShareTable", "presentation": [ "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment Effects on Earnings Per Share [Table]", "documentation": "Disclosure of information about the effects of asset impairment charge on per share or per unit basis." } } }, "auth_ref": [] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r94" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "LOSS BEFORE TAXES", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r73", "r117", "r121", "r526", "r543", "r697", "r703", "r896", "r898", "r899", "r900", "r901" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r182", "r410", "r415", "r418", "r419", "r420", "r422", "r429", "r436", "r438", "r439", "r440", "r586", "r725" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "INCOME TAX BENEFIT", "totalLabel": "Income tax provision/(benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r124", "r136", "r198", "r199", "r210", "r226", "r248", "r414", "r415", "r437", "r548", "r725" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r166", "r412", "r413", "r422", "r423", "r428", "r432", "r580" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Change in valuation allowance", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r417", "r725", "r945" ] }, "HCWC_IncomeTaxReconciliationChangeInTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "IncomeTaxReconciliationChangeInTaxRate", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Change in tax rate", "documentation": "Income tax reconciliation change in tax rate" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "U.S. federal statutory rate", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r415", "r725" ] }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationOtherAdjustments", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "True-Up & Deferred Adjustment", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r725", "r945", "r946" ] }, "HCWC_IncomeTaxReconciliationOtherPermanentItems": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "IncomeTaxReconciliationOtherPermanentItems", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Other permanent items", "documentation": "Income tax reconciliation other permanent items" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "State tax benefit net of federal benefit", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r416", "r725", "r945" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for income tax", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r19", "r176", "r430", "r431" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Contract liabilities", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r519", "r885" ] }, "us-gaap_IncreaseDecreaseInDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDueFromRelatedParties", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Due to related party", "label": "Increase (Decrease) in Due from Related Parties", "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r876", "r885" ] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r885" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Noncurrent Assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r885" ] }, "HCWC_IncreaseDecreaseInPrepaidExpensesAndVendorDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "IncreaseDecreaseInPrepaidExpensesAndVendorDeposits", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and vendor deposits", "documentation": "Increase decrease in prepaid expenses and vendor deposits", "label": "IncreaseDecreaseInPrepaidExpensesAndVendorDeposits" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r283", "r288", "r293", "r711" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r283", "r293", "r297", "r711" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r283", "r288", "r293", "r711" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r790", "r801", "r815", "r832", "r841", "r845", "r853" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r851" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r773", "r856" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r773", "r856" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r773", "r856" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r282", "r296", "r298", "r686", "r687" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "verboseLabel": "Net Carrying Amount", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r283", "r924", "r926" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest expense", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r210", "r218", "r222", "r228", "r248", "r485", "r703", "r704" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest expense", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r79", "r347", "r356", "r715", "r716" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense, net", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r222", "r882" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r172", "r174", "r175" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "INVENTORIES", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r263" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventories", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r161", "r691", "r737" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventories", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r126", "r145", "r160", "r263", "r264", "r266", "r520", "r693" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWriteDown", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://healthychoicewellness.com/role/InventoriesDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Write-down of obsolete and slow-moving inventory", "verboseLabel": "Inventory write down", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r265" ] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net Parent Investment", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r547", "r576", "r577", "r578", "r579", "r669", "r670" ] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Investments", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investments", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r528", "r529", "r745", "r747" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total rent expense", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r495", "r736" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPONENTS OF LEASE EXPENSE", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r962" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r93", "r503" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LegalFees", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal fee", "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings." } } }, "auth_ref": [ "r877" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r494" ] }, "HCWC_LesseeOperatingLeaseLiabilityLeaseTermTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "LesseeOperatingLeaseLiabilityLeaseTermTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE TERM", "documentation": "LesseeOperatingLeaseLiabilityLeaseTerm [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF MATURITY OF LEASE LIABILITIES", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r963" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total undiscounted operating lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r502" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r502" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r502" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2029", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r502" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r502" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r502" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r502" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r502" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://healthychoicewellness.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease term", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r961" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://healthychoicewellness.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "LEASES", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r489" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r13", "r55", "r56", "r57", "r59", "r60", "r61", "r64", "r181", "r258", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r325", "r326", "r455", "r456", "r457", "r477", "r611", "r696", "r758", "r937", "r966", "r967" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r71", "r114", "r538", "r737", "r889", "r903", "r956" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL CURRENT LIABILITIES", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r57", "r144", "r181", "r258", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r325", "r326", "r455", "r456", "r457", "r477", "r737", "r937", "r966", "r967" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "auth_ref": [] }, "HCWC_LoanAndSecurityAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "LoanAndSecurityAgreementMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan And Security Agreement [Member]", "documentation": "Loan And Security Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_LoansPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoansPayableCurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current portion of loan payable", "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r56" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "HCWC_LongLivedAssetsHeldForSaleDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "LongLivedAssetsHeldForSaleDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSale" ], "lang": { "en-us": { "role": { "label": "ASSETS HELD FOR SALE", "documentation": "Long Lived Assets Held For Sale [Disclosure Text Block]" } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtDetails": { "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Total debt, net of debt discount and issuance costs", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r13", "r112", "r340", "r354", "r713", "r714", "r735", "r974" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtDetails": { "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Current portion of long-term debt", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r153" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r185", "r345" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2029", "label": "Long-Term Debt, Maturity, Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r185", "r345" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2028", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r185", "r345" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r185", "r345" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtRepaymentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r185", "r345" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r155" ] }, "us-gaap_LongTermLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermLoansPayable", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Loan payable, net of current portion", "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r13" ] }, "HCWC_LossOnVendorSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "LossOnVendorSettlement", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss on vendor settlement", "documentation": "Loss on vendor settlement." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r255", "r719", "r739", "r743", "r942", "r979", "r980", "r981", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007" ] }, "cyd_MaterialCybersecurityIncidentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentAbstract", "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Abstract]" } } }, "auth_ref": [ "r804", "r805" ] }, "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]" } } }, "auth_ref": [ "r804", "r806" ] }, "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]" } } }, "auth_ref": [ "r804", "r807" ] }, "cyd_MaterialCybersecurityIncidentNatureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentNatureTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Nature [Text Block]" } } }, "auth_ref": [ "r804", "r807" ] }, "cyd_MaterialCybersecurityIncidentScopeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentScopeTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Scope [Text Block]" } } }, "auth_ref": [ "r804", "r807" ] }, "cyd_MaterialCybersecurityIncidentTimingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentTimingTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Timing [Text Block]" } } }, "auth_ref": [ "r804", "r807" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r310", "r311", "r312", "r313", "r381", "r408", "r468", "r518", "r567", "r568", "r574", "r603", "r604", "r668", "r671", "r672", "r673", "r674", "r684", "r685", "r709", "r717", "r722", "r731", "r732", "r733", "r734", "r740", "r939", "r968", "r969", "r970", "r971", "r972", "r973" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r824" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r824" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r310", "r311", "r312", "r313", "r381", "r408", "r468", "r518", "r567", "r568", "r574", "r603", "r604", "r668", "r671", "r672", "r673", "r674", "r684", "r685", "r709", "r717", "r722", "r731", "r732", "r733", "r740", "r939", "r968", "r969", "r970", "r971", "r972", "r973" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r844" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r852" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "auth_ref": [ "r255", "r719", "r739", "r743", "r942", "r979", "r980", "r981", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r825" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NatureOfOperations", "presentation": [ "http://healthychoicewellness.com/role/Organization" ], "lang": { "en-us": { "role": { "label": "ORGANIZATION", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r127", "r137" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r173" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r173" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "INVESTING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES", "label": "Cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r85", "r86", "r87" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfEarningsPerSharesDetails", "http://healthychoicewellness.com/role/StatementsOfCashFlows", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity", "http://healthychoicewellness.com/role/StatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "NET LOSS", "label": "Net loss", "verboseLabel": "Net Income (Loss)", "negatedLabel": "Net loss", "terseLabel": "NET LOSS", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r75", "r87", "r118", "r142", "r164", "r165", "r169", "r181", "r189", "r191", "r192", "r193", "r194", "r195", "r198", "r199", "r204", "r258", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r325", "r326", "r444", "r452", "r467", "r477", "r544", "r636", "r658", "r659", "r756", "r937" ] }, "HCWC_NetInvestmentByFormerParent": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "NetInvestmentByFormerParent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Net investment by former parent", "documentation": "Net investment by former parent." } } }, "auth_ref": [] }, "HCWC_NetInvestmentFromParentMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "NetInvestmentFromParentMember", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Net Investment From Parent [Member]", "documentation": "Net Investment From Parent [Member]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "HCWC_NoInsiderTradingFlag": { "xbrltype": "booleanItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "NoInsiderTradingFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Insider Trading Flag", "documentation": "No Insider Trading Flag" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "HCWC_NonCompeteAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "NonCompeteAgreementMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Non-Compete Agreement [Member]", "documentation": "Non-Compete Agreement [Member]" } } }, "auth_ref": [] }, "HCWC_NonCompeteMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "NonCompeteMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Non-Compete [Member]", "documentation": "Non-Compete [Member]" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r824" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r822" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r821" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r852" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r852" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL OTHER INCOME (EXPENSE)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r78" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "OTHER INCOME (EXPENSE)" } } }, "auth_ref": [] }, "us-gaap_NotesPayableToBankNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesPayableToBankNoncurrent", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Promissory note", "documentation": "The total amount due within more than 12 month, or the operating cycle if longer, on all notes payable to banks paid on an installment. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances." } } }, "auth_ref": [ "r13", "r112" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfOperatingSegments", "presentation": [ "http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r704", "r897" ] }, "us-gaap_OccupancyNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OccupancyNet", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Occupancy", "documentation": "Amount of net occupancy expense that may include items, such as depreciation of facilities and equipment, lease expenses, property taxes and property and casualty insurance expense." } } }, "auth_ref": [ "r77", "r116", "r123" ] }, "HCWC_OneVendorMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "OneVendorMember", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "One Vendor [Member]", "documentation": "One Vendor [Member]" } } }, "auth_ref": [] }, "HCWC_OnlineECommerceMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "OnlineECommerceMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Online/ECommerce [Member]", "documentation": "Online/ECommerce [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total significant reporting segment expenses", "label": "Operating Costs and Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL OPERATING EXPENSES, NET", "label": "Net operating expense", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES, NET" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "LOSS FROM OPERATIONS", "label": "Consolidated loss from operation", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r121", "r697", "r896", "r898", "r899", "r900", "r901" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r496", "r736" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails", "http://healthychoicewellness.com/role/ScheduleOfMaturityOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Present value of operating lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r492" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liability, current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r492" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liability, net of current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r492" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r493", "r499" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/ScheduleOfCompanysOperatingLeaseDetails" ], "lang": { "en-us": { "role": { "label": "Right of use assets", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r491" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/LeasesDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of right-of-use assets", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r886" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfOperatingLeaseTermDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average discount rate for operating leases", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r501", "r736" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfOperatingLeaseTermDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average remaining lease term for operating leases", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r500", "r736" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingSegmentsMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r242", "r243", "r244", "r245", "r246", "r249", "r703", "r704" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other current assets", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r162", "r737" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r151" ] }, "HCWC_OtherCurrentAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "OtherCurrentAssetsPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Other Current Assets", "documentation": "Other Current Assets [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_OtherExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherExpenses", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other expenses", "documentation": "Amount of expense classified as other." } } }, "auth_ref": [ "r76", "r77" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net payable", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r111", "r531", "r607", "r608", "r758", "r975", "r1009" ] }, "us-gaap_OtherMachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherMachineryAndEquipmentMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Other Machinery and Equipment [Member]", "documentation": "Other tangible personal property, nonconsumable in nature, with finite lives used to produce goods and services." } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Non-cash interest expense", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r87" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income, net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r80" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r824" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivables", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Due from related party noncurrent", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r159", "r622", "r704", "r977" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Due from related party current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r772" ] }, "us-gaap_OtherSellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherSellingGeneralAndAdministrativeExpense", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Other selling, general and administrative expenses", "documentation": "Amount of selling, general and administrative expense classified as other." } } }, "auth_ref": [ "r76" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r788", "r799", "r813", "r839" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Amount" } } }, "auth_ref": [ "r791", "r802", "r816", "r842" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r791", "r802", "r816", "r842" ] }, "us-gaap_PartnersCapitalAccountPrivatePlacementOfUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PartnersCapitalAccountPrivatePlacementOfUnits", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Private lender", "documentation": "Monetary value of the issuance of new units of limited partnership interest in a private placement." } } }, "auth_ref": [ "r98", "r99" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r820" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Rent expense", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PaymentsForRepurchaseOfInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfInitialPublicOffering", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment for IPO-related cost", "label": "Payments for Repurchase of Initial Public Offering", "documentation": "The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r83" ] }, "us-gaap_PaymentsOfLoanCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfLoanCosts", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Principal payments on loan payable", "label": "Payments of Loan Costs", "documentation": "The cash outflow for loan origination associated cost which is usually collected through escrow." } } }, "auth_ref": [ "r16" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment for acquisition", "label": "Cash consideration paid", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r14", "r450" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r82" ] }, "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToFundLongtermLoansToRelatedParties", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Due from affiliates", "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates." } } }, "auth_ref": [ "r883", "r964" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r823" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r823" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r822" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r825" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r821" ] }, "us-gaap_PlantRetirementAndAbandonmentPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlantRetirementAndAbandonmentPolicy", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "401(k) retirement savings plan", "documentation": "Disclosure of accounting policy for plant retirement and for abandonment (under construction or in use) in regulated industries when abandonment becomes probable. Any difference between the new asset and the asset cost is recognized as a loss in the income statement. May also indicate the discount rate used in the calculation of present value of recoverable abandoned assets." } } }, "auth_ref": [ "r50", "r51", "r52" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r822" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r766" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r768" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r65", "r358" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r65", "r613" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r65", "r358" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r65", "r613", "r634", "r1013", "r1014" ] }, "us-gaap_PreferredStockSharesSubscribedButUnissuedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesSubscribedButUnissuedValue", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferrd stock subscriptions", "documentation": "Amount of subscription received from investors who have been allocated nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r65" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Series A convertible preferred stock, $0.001 par value per share, 40,000,000 shares authorized, 0 share issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r65", "r535", "r737" ] }, "HCWC_PrepaidExpensesAndVendorDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "PrepaidExpensesAndVendorDeposits", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and vendor deposits", "documentation": "Prepaid expenses and vendor deposits." } } }, "auth_ref": [] }, "HCWC_ProceedsFromAcquisitionLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "ProceedsFromAcquisitionLoan", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from acquisition loan", "documentation": "Proceeds from acquisition loan." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromContributionsFromParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromContributionsFromParent", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Investment from parent company", "documentation": "The cash inflow from parent as a source of financing that is recorded as additional paid in capital." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from initial public offering (IPO)", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds", "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRepaymentOfLoansToPurchaseCommonStock", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from security purchase agreement", "documentation": "Cash inflow from repayment of loans for purchasing common stock." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ProceedsFromSaleOfBuildings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleOfBuildings", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of Saugerties, NY building", "verboseLabel": "Proceeds from sale of building", "documentation": "The cash inflow from sale of buildings." } } }, "auth_ref": [ "r81" ] }, "us-gaap_ProceedsFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromWarrantExercises", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from warrant exercised", "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants." } } }, "auth_ref": [ "r884" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductInformationLineItems", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r252", "r521", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r689", "r718", "r738", "r740", "r741", "r744", "r746", "r935", "r936", "r942", "r979", "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails" ], "auth_ref": [ "r252", "r521", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r689", "r718", "r738", "r740", "r741", "r744", "r746", "r935", "r936", "r942", "r979", "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfessionalFees", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Bank Service Charges and Merchant Account Fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r703", "r756", "r1011", "r1012" ] }, "HCWC_PromissoryNoteRelatedToAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "PromissoryNoteRelatedToAcquisition", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Promissory note related to acquisition", "documentation": "Promissory note related to acquisition" } } }, "auth_ref": [] }, "HCWC_PromissoryNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "PromissoryNotesMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Promissory Notes [Member]", "documentation": "Promissory Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r8", "r503" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/PropertyPlantAndEquipment" ], "lang": { "en-us": { "role": { "label": "PROPERTY, PLANT, AND EQUIPMENT", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r92", "r131", "r134", "r135" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r93", "r147", "r542" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r503" ] }, "us-gaap_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Member]", "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant, and equipment, net", "totalLabel": "Total property, plant, and equipment", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r8", "r503", "r527", "r542", "r737" ] }, "us-gaap_PropertyPlantAndEquipmentOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentOther", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Other, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property, Plant, and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r8", "r131", "r134", "r540" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://healthychoicewellness.com/role/PropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r93", "r503" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property plant and equipment useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Change in allowance for credit losses", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r171", "r262" ] }, "us-gaap_ProvisionForOtherCreditLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForOtherCreditLosses", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/AccountsReceivableNetDetailsNarrative", "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Estimated expected credit losses", "verboseLabel": "Credit losses", "documentation": "Amount of expense related to credit loss from transactions other than loan and lease transactions." } } }, "auth_ref": [ "r6", "r115" ] }, "HCWC_PurchaseMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "PurchaseMember", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase [Member]", "documentation": "Purchase [Member]" } } }, "auth_ref": [] }, "HCWC_PurchaseOfGreenAcresMarket": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "PurchaseOfGreenAcresMarket", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase of greenacres market", "documentation": "Purchase of green acres market" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r820" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r820" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r310", "r311", "r312", "r313", "r378", "r381", "r404", "r405", "r406", "r408", "r468", "r516", "r517", "r518", "r567", "r568", "r574", "r603", "r604", "r668", "r671", "r672", "r673", "r674", "r684", "r685", "r709", "r717", "r722", "r731", "r732", "r733", "r734", "r740", "r750", "r933", "r939", "r953", "r969", "r970", "r971", "r972", "r973" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "auth_ref": [ "r310", "r311", "r312", "r313", "r378", "r381", "r404", "r405", "r406", "r408", "r468", "r516", "r517", "r518", "r567", "r568", "r574", "r603", "r604", "r668", "r671", "r672", "r673", "r674", "r684", "r685", "r709", "r717", "r722", "r731", "r732", "r733", "r734", "r740", "r750", "r933", "r939", "r953", "r969", "r970", "r971", "r972", "r973" ] }, "us-gaap_ReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReceivablesNetCurrent", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Receivables, net, current", "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value." } } }, "auth_ref": [ "r737" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r783", "r794", "r808", "r834" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r257", "r379", "r508", "r509", "r532", "r539", "r606", "r607", "r608", "r609", "r610", "r633", "r635", "r667" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r183", "r184", "r508", "r509", "r510", "r511", "r532", "r539", "r606", "r607", "r608", "r609", "r610", "r633", "r635", "r667" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Allocation amount", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r48", "r508" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r257", "r640", "r641", "r644" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r257", "r379", "r508", "r509", "r532", "r539", "r606", "r607", "r608", "r609", "r610", "r633", "r635", "r667", "r965" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r505", "r506", "r507", "r509", "r512", "r587", "r588", "r589", "r642", "r643", "r644", "r664", "r666" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payment of long term debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r84", "r584" ] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Due to related party", "label": "Repayments of Related Party Debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r84" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r784", "r795", "r809", "r835" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r785", "r796", "r810", "r836" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement does not require Recovery" } } }, "auth_ref": [ "r792", "r803", "r817", "r843" ] }, "HCWC_RetailGroceryMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "RetailGroceryMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Retail Grocery [Member]", "documentation": "Retail Grocery [Member]" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r68", "r98", "r537", "r572", "r573", "r585", "r614", "r737" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r140", "r186", "r187", "r188", "r190", "r195", "r197", "r199", "r260", "r261", "r299", "r433", "r434", "r441", "r442", "r443", "r445", "r451", "r452", "r458", "r460", "r461", "r463", "r465", "r488", "r490", "r569", "r571", "r590", "r1013" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "SALES, NET", "verboseLabel": "Total revenue", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r119", "r120", "r210", "r219", "r220", "r242", "r248", "r252", "r254", "r255", "r375", "r376", "r521" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r638", "r688", "r694" ] }, "HCWC_RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets obtained in exchange for operating lease liabilities", "documentation": "Rightofuse assets obtained in exchange for operating lease liabilities." } } }, "auth_ref": [] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r852" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r852" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r255", "r872" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/AccountsPayableAndAccruedExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails", "http://healthychoicewellness.com/role/ScheduleOfUnauditedProformaInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability." } } }, "auth_ref": [ "r39", "r40", "r448" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PURCHASE PRICE ALLOCATION", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r39", "r40" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "HCWC_ScheduleOfCashInExcessFDICLimitsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "ScheduleOfCashInExcessFDICLimitsTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS", "documentation": "Schedule Of Cash In Excess FDIC Limits [Table Text Block]" } } }, "auth_ref": [] }, "HCWC_ScheduleOfCashInFDICLimitsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "ScheduleOfCashInFDICLimitsTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS", "documentation": "Schedule of Cash in FDIC Limits [Table Text Block]" } } }, "auth_ref": [] }, "HCWC_ScheduleOfCompanyOperatingLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "ScheduleOfCompanyOperatingLeasesTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPANY\u2019S OPERATING LEASE", "documentation": "ScheduleOfCompanyOperatingLeasesTableTextBlock" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INCOME TAX EXPENSE (BENEFIT)", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r949" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEBT", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r947" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EARNINGS PER SHARES", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r895" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "presentation": [ "http://healthychoicewellness.com/role/ScheduleDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Revenue from External Customer, Product and Service [Table]", "documentation": "Disclosure of information about revenue from external customer by product and service when not provided as part of reportable operating segment information." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INTANGIBLE ASSETS, NET", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r711", "r923" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://healthychoicewellness.com/role/GoodwillTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GOODWILL", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r710", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914", "r915" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Indefinite-Lived [Table]", "documentation": "Disclosure of information about indefinite-lived intangible asset. Excludes finite-lived intangible asset." } } }, "auth_ref": [ "r283", "r293", "r297", "r711" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nature of Operation, Product Information, Concentration of Risk [Table]", "documentation": "Disclosure of information about concentration risk of product within nature of operation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://healthychoicewellness.com/role/AssetsHeldForSaleDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r8", "r503" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r47", "r48", "r640", "r641", "r644" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails", "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r29", "r30", "r31" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r29", "r30", "r31" ] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Table]", "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability." } } }, "auth_ref": [ "r55" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r711", "r925" ] }, "HCWC_SecondAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "SecondAnniversaryMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second Anniversary [Member]", "documentation": "Second Anniversary [Member]" } } }, "auth_ref": [] }, "HCWC_SecuredPromissoryNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "SecuredPromissoryNotesMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Secured Promissory Notes [Member]", "documentation": "Secured Promissory Notes [Member]" } } }, "auth_ref": [] }, "HCWC_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]", "documentation": "Securities Purchase Agreement [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r760" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r764" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r763" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r769" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDomain", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r119", "r120", "r121", "r122", "r210", "r215", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r232", "r233", "r234", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r250", "r255", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r297", "r306", "r307", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r700", "r703", "r704", "r710", "r742", "r979", "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007" ] }, "HCWC_SegmentNetOperatingIncomeLossMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "SegmentNetOperatingIncomeLossMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segment Net Operating Income (Loss) [Member]", "documentation": "Segment Net Operating Income (Loss) [Member]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenues" ], "lang": { "en-us": { "role": { "label": "SEGMENT REPORTING AND DISAGGREGATION OF REVENUES", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r122", "r210", "r214", "r215", "r216", "r217", "r218", "r231", "r233", "r234", "r246", "r247", "r248", "r249", "r250", "r252", "r253", "r255", "r698", "r701", "r702", "r703", "r705", "r707", "r708" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails", "http://healthychoicewellness.com/role/ScheduleOfSignificantSegmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segment Reporting", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r251", "r254", "r699", "r700", "r706" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r76" ] }, "HCWC_SeriesAConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "SeriesAConvertiblePreferredStockMember", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series A Convertible Preferred Stock [Member]", "documentation": "Series A Convertible Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r879", "r880", "r941" ] }, "HCWC_SeriesEConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "SeriesEConvertiblePreferredStockMember", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series E Convertible Preferred Stock [Member]", "documentation": "Series E Convertible Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_SeriesEPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeriesEPreferredStockMember", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series E Preferred Stock [Member]", "documentation": "Series E preferred stock." } } }, "auth_ref": [ "r879", "r880", "r941" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharePrice", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssued", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r11" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShippingAndHandlingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShippingAndHandlingMember", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shipping and Handling [Member]", "documentation": "Packing and transport of product." } } }, "auth_ref": [ "r943" ] }, "HCWC_ShippingAndHandlingPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "ShippingAndHandlingPolicyTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Shipping and Handling", "documentation": "Shipping And Handling [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtLineItems", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Short-term lease cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r497", "r736" ] }, "us-gaap_ShorttermDebtAverageOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShorttermDebtAverageOutstandingAmount", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Outstanding Debt", "documentation": "For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, average borrowings during the period." } } }, "auth_ref": [ "r138", "r139", "r645" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r88", "r178" ] }, "HCWC_SignificantSegmentExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "SignificantSegmentExpensesTableTextBlock", "presentation": [ "http://healthychoicewellness.com/role/SegmentReportingAndDisaggregationOfRevenuesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES", "documentation": "Significant Segment Expenses [Table Text Block]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r767" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r119", "r120", "r121", "r122", "r141", "r210", "r215", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r232", "r233", "r234", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r250", "r255", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r297", "r300", "r306", "r307", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r700", "r703", "r704", "r710", "r742", "r979", "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative", "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r138", "r156", "r157", "r158", "r181", "r202", "r203", "r205", "r207", "r212", "r213", "r258", "r316", "r319", "r320", "r321", "r325", "r326", "r358", "r359", "r361", "r364", "r370", "r477", "r581", "r582", "r583", "r584", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r602", "r613", "r637", "r660", "r675", "r676", "r677", "r678", "r679", "r871", "r887", "r894" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r11", "r66", "r69", "r70", "r140", "r167", "r168", "r169", "r186", "r187", "r188", "r190", "r195", "r197", "r199", "r211", "r260", "r261", "r299", "r372", "r433", "r434", "r441", "r442", "r443", "r445", "r451", "r452", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r478", "r479", "r480", "r481", "r482", "r483", "r488", "r490", "r504", "r545", "r569", "r570", "r571", "r590", "r660" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r186", "r187", "r188", "r211", "r490", "r521", "r576", "r602", "r605", "r606", "r607", "r608", "r609", "r610", "r613", "r616", "r617", "r618", "r619", "r620", "r624", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r635", "r638", "r639", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r660", "r751" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/BalanceSheetsParenthetical", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r186", "r187", "r188", "r211", "r257", "r490", "r521", "r576", "r602", "r605", "r606", "r607", "r608", "r609", "r610", "r613", "r616", "r617", "r618", "r619", "r620", "r624", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r635", "r638", "r639", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r660", "r751" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r787", "r798", "r812", "r838" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for IPO, shares", "verboseLabel": "Number of shares issued", "terseLabel": "Initial issuance shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r11", "r65", "r66", "r98", "r581", "r660", "r676" ] }, "HCWC_StockIssuedDuringPeriodSharesNewIssuesOne": { "xbrltype": "sharesItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "StockIssuedDuringPeriodSharesNewIssuesOne", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for Spin-Off and transfer of former parent investment to additional paid in capital, shares", "documentation": "Issuance of common stock shares for spin-off and transfer of former parent investment to additional paid in capital." } } }, "auth_ref": [] }, "HCWC_StockIssuedDuringPeriodSharesWarrantsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "StockIssuedDuringPeriodSharesWarrantsExercised", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants, shares", "documentation": "Stock issued during period shares warrants exercised." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for IPO", "verboseLabel": "Aggregate subscription price", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r11", "r65", "r66", "r98", "r590", "r660", "r676", "r757" ] }, "HCWC_StockIssuedDuringPeriodValueNewIssuesOne": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "StockIssuedDuringPeriodValueNewIssuesOne", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for Spin-Off and transfer of former parent investment to additional paid in capital", "documentation": "Issuance of common stock value for spin-off and transfer of former parent investment to additional paid in capital." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueOther", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Net transfers to former parent", "documentation": "Value of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "HCWC_StockIssuedDuringPeriodValueWarrantsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "StockIssuedDuringPeriodValueWarrantsExercised", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants", "documentation": "Stock issued during period value warrants exercised." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://healthychoicewellness.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets", "http://healthychoicewellness.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r66", "r69", "r70", "r91", "r615", "r634", "r661", "r662", "r737", "r758", "r889", "r903", "r956", "r1013" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://healthychoicewellness.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://healthychoicewellness.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "STOCKHOLDERS\u2019 EQUITY", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r97", "r180", "r357", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r372", "r464", "r663", "r665", "r680" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r484", "r514" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r484", "r514" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r484", "r514" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r484", "r514" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r484", "r514" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://healthychoicewellness.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r513", "r515" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://healthychoicewellness.com/role/GoingConcern" ], "lang": { "en-us": { "role": { "label": "GOING CONCERN", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r53" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://healthychoicewellness.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION" } } }, "auth_ref": [] }, "HCWC_SuppliersMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "SuppliersMember", "presentation": [ "http://healthychoicewellness.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Suppliers [Member]", "documentation": "Suppliers [Member]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List, Table" } } }, "auth_ref": [ "r831" ] }, "HCWC_TotalReportingSegmentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "TotalReportingSegmentAssetsMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Total Reporting Segment Assets [Member]", "documentation": "Total Reporting Segment Assets [Member]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r823" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r830" ] }, "us-gaap_TradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TradeNamesMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfIntangibleAssetsNetDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://healthychoicewellness.com/role/ScheduleOfPurchasePriceAllocationParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Trade Names [Member]", "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r43", "r917", "r918", "r919", "r920", "r921", "r922", "r924", "r926", "r927", "r928" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "HCWC_TransitionServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "TransitionServicesAgreementMember", "presentation": [ "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transition Services Agreement [Member]", "documentation": "Transition Services Agreement [Member]" } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r854" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r855" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Expiration Date" } } }, "auth_ref": [ "r855" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r853" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r853" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r854" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfArrangementAxis", "presentation": [ "http://healthychoicewellness.com/role/AcquisitionsDetailsNarrative", "http://healthychoicewellness.com/role/DebtDetailsNarrative", "http://healthychoicewellness.com/role/OrganizationDetailsNarrative", "http://healthychoicewellness.com/role/RelatedPartyTransactionsDetailsNarrative", "http://healthychoicewellness.com/role/StockholdersEquityDetailsNarrative", "http://healthychoicewellness.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r453" ] }, "HCWC_UnallocatedAmountMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "UnallocatedAmountMember", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfReconciliationsOfReportableSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Unallocated Amount [Member]", "documentation": "Unallocated Amount [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r850" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized tax benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r411", "r421", "r724" ] }, "HCWC_UnsecuredPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "UnsecuredPromissoryNoteMember", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unsecured Promissory Note [Member]", "documentation": "Unsecured Promissory Note [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://healthychoicewellness.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates in the Preparation of the Financial Statements", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r26", "r27", "r28", "r129", "r130", "r132", "r133" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase in deferred tax valuation allowance", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r424" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableLeaseCost", "crdr": "debit", "calculation": { "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfComponentsOfLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Variable lease cost", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r498", "r736" ] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrant purchase", "label": "Warrants and Rights Outstanding", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [ "r952", "r953", "r954" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEarningsPerSharesDetails", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "DILUTED WEIGHTED AVERAGE COMMON SHARES", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r201", "r207" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://healthychoicewellness.com/role/ScheduleOfEarningsPerSharesDetails", "http://healthychoicewellness.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "BASIC WEIGHTED AVERAGE COMMON SHARES", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r200", "r207" ] }, "HCWC_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://healthychoicewellness.com/20241231", "localname": "WorkingCapital", "crdr": "credit", "presentation": [ "http://healthychoicewellness.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working capital", "documentation": "Working capital" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://healthychoicewellness.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r869" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(1)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "980", "SubTopic": "360", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478654/980-360-35-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "980", "SubTopic": "360", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478654/980-360-35-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "980", "SubTopic": "360", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478654/980-360-35-3" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-40/tableOfContent" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805/tableOfContent" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(14)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481161/840-30-50-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/310/tableOfContent" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/326/tableOfContent" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/330/tableOfContent" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.1.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-20/tableOfContent" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/985-20/tableOfContent" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "2" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "1" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 6-K", "Section": "General Instruction", "Subsection": "B" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "Instruction", "Paragraph": "2" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "a" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "2" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "1" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-X", "Number": "210", "Section": "2", "Subsection": "2" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r871": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(6))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" } } } ZIP 106 0001641172-25-001000-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001641172-25-001000-xbrl.zip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ቌ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end XML 107 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001948864 2024-01-01 2024-12-31 0001948864 2024-09-30 0001948864 2025-03-27 0001948864 2023-01-01 2023-12-31 0001948864 2024-12-31 0001948864 2023-12-31 0001948864 us-gaap:RelatedPartyMember 2024-12-31 0001948864 us-gaap:RelatedPartyMember 2023-12-31 0001948864 HCWC:SeriesAConvertiblePreferredStockMember 2024-12-31 0001948864 HCWC:SeriesAConvertiblePreferredStockMember 2023-12-31 0001948864 us-gaap:CommonStockMember 2022-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2022-12-31 0001948864 us-gaap:RetainedEarningsMember 2022-12-31 0001948864 2022-12-31 0001948864 us-gaap:CommonStockMember 2023-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2023-12-31 0001948864 us-gaap:RetainedEarningsMember 2023-12-31 0001948864 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2023-01-01 2023-12-31 0001948864 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001948864 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2024-01-01 2024-12-31 0001948864 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001948864 us-gaap:CommonStockMember 2024-12-31 0001948864 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001948864 HCWC:NetInvestmentFromParentMember 2024-12-31 0001948864 us-gaap:RetainedEarningsMember 2024-12-31 0001948864 HCWC:OneVendorMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001948864 HCWC:OneVendorMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:CommonStockMember 2024-09-08 2024-09-09 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:CommonClassAMember 2024-09-08 2024-09-09 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:CommonClassBMember 2024-09-08 2024-09-09 0001948864 us-gaap:SeriesEPreferredStockMember HCWC:HealthierChoicesManagementCorpMember 2024-09-13 0001948864 us-gaap:SeriesEPreferredStockMember HCWC:SecuritiesPurchaseAgreementMember HCWC:HealthierChoicesManagementCorpMember 2024-09-13 0001948864 2024-07-18 2024-07-18 0001948864 2024-07-18 0001948864 us-gaap:BuildingMember 2024-07-24 2024-07-24 0001948864 HCWC:HealthierChoicesManagementCorpMember HCWC:SeriesEConvertiblePreferredStockMember 2022-08-18 0001948864 HCWC:HealthierChoicesManagementCorpMember 2022-08-18 0001948864 HCWC:HealthierChoicesManagementCorpMember us-gaap:SeriesAPreferredStockMember 2022-08-18 2022-08-18 0001948864 HCWC:HealthierChoicesManagementCorpMember 2022-08-18 2022-08-18 0001948864 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-12-31 0001948864 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-12-31 0001948864 srt:MinimumMember 2024-12-31 0001948864 srt:MaximumMember 2024-12-31 0001948864 HCWC:GreenAcresMarketMember 2024-07-31 0001948864 2024-09-16 2024-09-16 0001948864 HCWC:SuppliersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001948864 HCWC:SuppliersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001948864 HCWC:PurchaseMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001948864 HCWC:PurchaseMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001948864 us-gaap:OperatingSegmentsMember 2024-01-01 2024-12-31 0001948864 us-gaap:OperatingSegmentsMember 2023-01-01 2023-12-31 0001948864 HCWC:SegmentNetOperatingIncomeLossMember 2024-01-01 2024-12-31 0001948864 HCWC:SegmentNetOperatingIncomeLossMember 2023-01-01 2023-12-31 0001948864 HCWC:UnallocatedAmountMember 2024-01-01 2024-12-31 0001948864 HCWC:UnallocatedAmountMember 2023-01-01 2023-12-31 0001948864 HCWC:TotalReportingSegmentAssetsMember 2024-12-31 0001948864 HCWC:TotalReportingSegmentAssetsMember 2023-12-31 0001948864 HCWC:UnallocatedAmountMember 2024-12-31 0001948864 HCWC:UnallocatedAmountMember 2023-12-31 0001948864 HCWC:RetailGroceryMember 2024-01-01 2024-12-31 0001948864 HCWC:RetailGroceryMember 2023-01-01 2023-12-31 0001948864 HCWC:FoodServiceRestaurantMember 2024-01-01 2024-12-31 0001948864 HCWC:FoodServiceRestaurantMember 2023-01-01 2023-12-31 0001948864 HCWC:OnlineECommerceMember 2024-01-01 2024-12-31 0001948864 HCWC:OnlineECommerceMember 2023-01-01 2023-12-31 0001948864 2023-01-01 0001948864 HCWC:EllwoodThompsonMember HCWC:AssetPurchaseAgreementMember 2023-10-01 2023-10-01 0001948864 HCWC:EllwoodThompsonMember HCWC:AssetPurchaseAgreementMember 2023-10-01 0001948864 HCWC:EllwoodThompsonMember HCWC:AssetPurchaseAgreementMember 2024-01-01 2024-12-31 0001948864 HCWC:EllwoodThompsonMember 2023-10-01 2023-10-01 0001948864 HCWC:GreenAcresMarketMember HCWC:AssetPurchaseAgreementMember 2024-07-18 2024-07-18 0001948864 HCWC:GreenAcresMarketMember HCWC:AssetPurchaseAgreementMember 2024-07-18 0001948864 HCWC:EllwoodThompsonMember 2023-10-01 0001948864 HCWC:EllwoodThompsonMember us-gaap:TradeNamesMember 2023-10-01 0001948864 HCWC:GreenAcresMarketMember 2024-07-18 2024-07-18 0001948864 HCWC:GreenAcresMarketMember 2024-07-18 0001948864 HCWC:GreenAcresMarketMember us-gaap:TradeNamesMember 2024-07-18 0001948864 HCWC:GreenAcresMarketMember HCWC:NonCompeteAgreementMember 2024-07-18 0001948864 HCWC:EllwoodThompsonMember us-gaap:TradeNamesMember 2024-07-18 0001948864 HCWC:EllwoodThompsonMember 2024-01-01 2024-12-31 0001948864 HCWC:EllwoodThompsonMember 2023-01-01 2023-12-31 0001948864 us-gaap:BuildingMember 2024-02-07 0001948864 us-gaap:BuildingMember 2024-07-24 0001948864 HCWC:DisplaysMember 2024-12-31 0001948864 HCWC:DisplaysMember 2023-12-31 0001948864 us-gaap:BuildingMember 2024-12-31 0001948864 us-gaap:BuildingMember 2023-12-31 0001948864 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001948864 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001948864 us-gaap:LeaseholdImprovementsMember 2024-12-31 0001948864 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001948864 us-gaap:ComputerEquipmentMember 2024-12-31 0001948864 us-gaap:ComputerEquipmentMember 2023-12-31 0001948864 us-gaap:OtherMachineryAndEquipmentMember 2024-12-31 0001948864 us-gaap:OtherMachineryAndEquipmentMember 2023-12-31 0001948864 us-gaap:PropertyPlantAndEquipmentMember 2024-01-01 2024-12-31 0001948864 us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-12-31 0001948864 srt:MinimumMember us-gaap:TradeNamesMember 2024-12-31 0001948864 srt:MaximumMember us-gaap:TradeNamesMember 2024-12-31 0001948864 us-gaap:TradeNamesMember 2024-12-31 0001948864 srt:MinimumMember HCWC:CustomerRelationshipMember 2024-12-31 0001948864 srt:MaximumMember HCWC:CustomerRelationshipMember 2024-12-31 0001948864 HCWC:CustomerRelationshipMember 2024-12-31 0001948864 srt:MinimumMember HCWC:NonCompeteMember 2024-12-31 0001948864 srt:MaximumMember HCWC:NonCompeteMember 2024-12-31 0001948864 HCWC:NonCompeteMember 2024-12-31 0001948864 srt:MinimumMember us-gaap:TradeNamesMember 2023-12-31 0001948864 srt:MaximumMember us-gaap:TradeNamesMember 2023-12-31 0001948864 us-gaap:TradeNamesMember 2023-12-31 0001948864 srt:MinimumMember HCWC:CustomerRelationshipMember 2023-12-31 0001948864 srt:MaximumMember HCWC:CustomerRelationshipMember 2023-12-31 0001948864 HCWC:CustomerRelationshipMember 2023-12-31 0001948864 srt:MinimumMember HCWC:NonCompeteMember 2023-12-31 0001948864 srt:MaximumMember HCWC:NonCompeteMember 2023-12-31 0001948864 HCWC:NonCompeteMember 2023-12-31 0001948864 HCWC:PromissoryNotesMember 2022-10-14 0001948864 HCWC:PromissoryNotesMember 2024-01-01 2024-12-31 0001948864 HCWC:PromissoryNotesMember 2023-01-01 2023-12-31 0001948864 HCWC:SecuredPromissoryNotesMember 2023-10-01 0001948864 HCWC:SecuredPromissoryNotesMember 2024-12-31 0001948864 HCWC:SecuredPromissoryNotesMember 2023-12-31 0001948864 HCWC:SecuredPromissoryNotesMember 2024-01-01 2024-12-31 0001948864 HCWC:SecuredPromissoryNotesMember 2023-01-01 2023-12-31 0001948864 HCWC:UnsecuredPromissoryNoteMember us-gaap:IPOMember HCWC:SecuritiesPurchaseAgreementMember 2024-01-18 2024-01-18 0001948864 HCWC:UnsecuredPromissoryNoteMember HCWC:SecuritiesPurchaseAgreementMember 2024-01-18 2024-01-18 0001948864 us-gaap:IPOMember HCWC:SecuritiesPurchaseAgreementMember 2024-01-18 2024-01-18 0001948864 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-01-18 2024-01-18 0001948864 HCWC:UnsecuredPromissoryNoteMember HCWC:SecuritiesPurchaseAgreementMember 2024-01-18 0001948864 HCWC:BridgeWarrantSharesMember us-gaap:CommonClassAMember 2024-04-08 0001948864 HCWC:SecuritiesPurchaseAgreementMember 2024-12-31 0001948864 HCWC:SecuritiesPurchaseAgreementMember 2024-01-01 2024-12-31 0001948864 HCWC:BridgeWarrantSharesMember us-gaap:CommonClassAMember 2024-09-16 0001948864 HCWC:BridgeWarrantSharesMember us-gaap:CommonClassAMember 2024-09-17 0001948864 HCWC:BridgeWarrantSharesMember us-gaap:CommonClassAMember 2024-09-16 2024-09-17 0001948864 HCWC:GreenAcresMarketMember HCWC:LoanAndSecurityAgreementMember 2024-07-18 0001948864 HCWC:GreenAcresMarketMember HCWC:LoanAndSecurityAgreementMember 2024-07-18 2024-07-18 0001948864 HCWC:FirstAnniversaryMember 2024-07-18 2024-07-18 0001948864 HCWC:SecondAnniversaryMember 2024-07-18 2024-07-18 0001948864 HCWC:SecuredPromissoryNotesMember HCWC:AcquisitionLoanAndSecurityAgreementMember 2024-08-23 0001948864 HCWC:SecuredPromissoryNotesMember HCWC:AcquisitionLoanAndSecurityAgreementMember 2024-01-01 2024-12-31 0001948864 HCWC:SecuredPromissoryNotesMember HCWC:AcquisitionLoanAndSecurityAgreementMember 2023-01-01 2023-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember 2024-09-13 0001948864 HCWC:SecuritiesPurchaseAgreementMember HCWC:HealthierChoicesManagementCorpMember 2024-09-13 0001948864 HCWC:HealthierChoicesManagementCorpMember 2024-01-01 2024-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember 2023-01-01 2023-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember 2024-01-01 2024-09-13 0001948864 HCWC:HealthierChoicesManagementCorpMember 2024-12-31 0001948864 HCWC:HealthierChoicesManagementCorpMember 2023-09-13 0001948864 HCWC:TransitionServicesAgreementMember 2024-01-01 2024-12-31 0001948864 2022-06-12 2022-06-12 0001948864 2022-12-31 2022-12-31 0001948864 us-gaap:SubsequentEventMember 2025-03-02 0001948864 HCWC:LoanAndSecurityAgreementMember 2024-07-18 0001948864 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember HCWC:LoanAndSecurityAgreementMember 2025-02-28 0001948864 us-gaap:SubsequentEventMember HCWC:LoanAndSecurityAgreementMember 2025-02-28 iso4217:USD shares iso4217:USD shares pure HCWC:Segment false FY 0001948864 P2Y 10-K true 2024-12-31 --12-31 2024 false HEALTHY CHOICE WELLNESS CORP. DE 001-42274 88-4128927 3800 North 28th Way Unit#1 Hollywood FL 33020 (305) 330-3839 Common Stock, par value $0.001 per share HCWC NYSEAMER No No Yes Yes Non-accelerated Filer true true false false false false 24400000 10565749 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span>We recognize that cybersecurity is of critical importance to our success. We are susceptible to a number of significant and persistent cybersecurity threats, including those common to most industries as well as those we face as a retailer, operating in an industry characterized by a high volume of customer transactions and collection of sensitive data. These threats, which are constantly evolving, include data breaches, ransomware, and phishing attacks. We, and our vendors and suppliers, regularly face attempts by malicious actors to breach our security and compromise our information technology systems. A cybersecurity incident impacting us or any vendor or supplier could significantly disrupt our operations and result in damage to our reputation, costly litigation and/or government enforcement action. Accordingly, we are committed to maintaining robust cybersecurity and data protection and continuously evaluating the impact of cybersecurity threats, considering both immediate and potential long-term effects of these threats on our business strategy, operations, and financial condition.</span></span></span><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span>Our Chief Operating Officer is primarily responsible for managing material risks from cybersecurity threats, and is supported by third party cybersecurity specialists. Management participates in periodic training and education on cybersecurity related topics. We engage specialized cybersecurity consultants and leverage third-party expertise to bolster our cybersecurity defenses. Our enterprise risk management program is designed to identify, prioritize and assess a broad range of risks, including risks from cybersecurity threats, that may affect our ability to execute our corporate strategy and fulfill our business objectives.</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a list of measures that were implemented as part of our increased focus on cybersecurity:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete endpoint protection - All endpoints have been covered by an enhanced endpoint protection agent.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cloud infrastructure - Critical infrastructure started moving to the cloud and protected by enhanced anti-virus and recurring backup policies.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_900_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zuQIP9L30UI">Email services have been put through a rigorous intelligent phishing and spam filter to prevent attacks.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zONj2ZP2Jug6">third-party vendors and service providers play a role in our cybersecurity</span>. These third parties are integral to our operations but pose cybersecurity challenges due to their access to our data and our reliance for various aspects of our operations, including our supply chain. We conduct due diligence before onboarding new vendors and maintain ongoing evaluations to ensure compliance with our security standards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of this report, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zMwLJxM0yeQ5">no</span> cybersecurity incidents have had, either individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. However, despite the comprehensive measures outlined above, management has identified a material weakness in our cybersecurity setup, specifically regarding access controls and data encryption, This weakness increases the risk of a significant cybersecurity incident. We are actively developing and implementing a remediation plan to address this material weakness. We are committed to resolving this issue promptly and enhancing our overall cybersecurity posture. Notwithstanding our remediation efforts, we acknowledge that we may not be successful in preventing or mitigating all potential cybersecurity incidents that could have a material adverse effect on us.</span></p> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span> </span></span></span> true true false true 1195 688 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have audited the accompanying consolidated balance sheet of Healthy Choice Wellness Corp. (the “Company”) as of December 31, 2024, and the related consolidated statements of operations, changes in stockholders’ equity, and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.</span> UHY llp Hudson, New York Marcum llp Saddle Brook, NJ 2056472 1422580 509763 128171 6445560 4162218 475088 174970 29806 56842 190268 190268 9706957 5944781 1976469 2676639 5441478 4178519 2212000 14232240 11412562 3753003 3753003 543373 467056 34112517 28432560 6131534 4920411 80456 207513 2131336 702701 3596987 2748824 11940313 8579449 9207772 2403807 10584431 8461182 31732516 19444438 0.001 0.001 560000000 560000000 9815749 9815749 10 10 9816 0.001 0.001 40000000 40000000 0 0 0 0 3101092 8988122 -730907 2380001 8988122 34112517 28432560 69370803 55689793 42305494 35341569 27065309 20348224 29047933 24768293 205146 6104000 28842787 30872293 -1777478 -10524069 -1888889 774900 8552 16230 848651 199681 -2728988 591449 -4506466 -9932620 -4506466 -9932620 -0.48 -0.48 -1.08 -1.08 9395500 9395500 9226860 9226860 15505661 15505661 3415081 3415081 -9932620 -9932620 8988122 8988122 8988122 8988122 9226860 9227 -1369097 1359870 400000 400 2579600 2580000 188889 189 1890589 1890778 -6572433 -6572433 -3775559 -730907 -4506466 9815749 9816 3101092 -730907 2380001 9815749 9816 3101092 -730907 2380001 -4506466 -9932620 1576457 1431816 -1888889 205146 3273597 2570202 2491934 2471653 -32500 -32000 774900 91291 12925 15425 6104000 394517 88366 2375226 2032996 300118 92016 -27036 -140801 2440094 1416638 76317 16090 1178624 1430867 -127057 -21604 -3121863 -2438179 -3064842 -2525354 5475000 750000 749000 251793 179623 -4977793 -929623 1700000 2535758 558095 7500000 4000000 1420000 1736412 3415081 2306016 1889 8676527 2856986 633892 -597991 1422580 2020571 2056472 1422580 816151 199705 1825000 718000 4609608 1325409 <p id="xdx_807_eus-gaap--NatureOfOperations_zFHQhwxj7q99" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_82A_zSKKDXB4livb">ORGANIZATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organization</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthy Choice Wellness Corp. (the “Company” or “HCWC” or “we” or “our” or “us”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through its wholly owned subsidiaries, the Company operates:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ada’s Natural Market, a natural and organic grocery store offering fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health &amp; beauty products and natural household items.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paradise Health &amp; Nutrition’s three stores that likewise offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health &amp; beauty products and natural household items.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mother Earth’s Storehouse, a two-store organic and health food and vitamin chain in New York’s Hudson Valley, which has been in existence for over 40 years.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greens Natural Foods’ eight stores in New York and New Jersey, offering a selection of 100% organic produce and all-natural, non-GMO groceries &amp; bulk foods; a wide selection of local products; an organic juice and smoothie bar; a fresh foods department, which offers fresh and healthy “grab &amp; go” foods; a full selection of vitamins &amp; supplements; as well as health and beauty products.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ellwood Thompson’s, an organic and natural health food and vitamin store located in Richmond, Virginia.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GreenAcres Market, an organic and natural health food and vitamin chain with five store locations in Kansas and Oklahoma. GreenAcres Market offers organic and all natural products and vitamins from both top national brands as well as locally sourced specialty brands.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through its wholly owned subsidiary, Healthy Choice Wellness, LLC, the Company operates a Healthy Choice Wellness Center in Kingston, NY and has a licensing agreement for a Healthy Choice Wellness Center located at the Casbah Spa and Salon in Fort Lauderdale, FL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These centers offer multiple vitamin drip mixes and intramuscular shots for clients to choose from that are designed to help boost immunity, fight fatigue and stress, reduce inflammation, enhance weight loss, and efficiently deliver antioxidants and anti-aging mixes. Additionally, there are IV vitamin mixes and shots for health, beauty, and re-hydration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through its wholly owned subsidiary, Healthy U Wholesale, the Company sells vitamins and supplements, as well as health, beauty, and personal care products on its website <span style="text-decoration: underline">www.TheVitaminStore.com</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sourcing and Vendors</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We source from multiple suppliers. These suppliers range from small independent businesses to multinational conglomerates. For the years ended December 31, 2024 and 2023, approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneVendorMember_ztxPudWN2C6k" title="Concentration risk percentage">25</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneVendorMember_zpUVsPStSzT8" title="Concentration risk percentage">41</span>% of our total purchases were from one vendor, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Spin-Off</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthier Choices Management Corp. (“HCMC” or the “Parent”) announced on August 22, 2022 that its Board of Directors approved the separation of the grocery business, including wellness business, into an independent, publicly traded company (the “Spin-Off” or “Separation”). Prior to the Spin-Off, HCWC was a subsidiary under HCMC, which operated the Ada’s Natural Market, Paradise Health &amp; Nutrition, Mother Earth’s Storehouse, Greens Natural Foods, Ellwood Thompson’s, and GreenAcres Market retail brands, as well as licensed wellness centers and Healthy U Wholesale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 13, 2024 (the “Spin-Off Date”), after the New York Stock Exchange American (“NYSEAM”) market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock commenced trading on the NYSEAM under the stock symbol “HCWC.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HCMC distributed all the outstanding shares of common stock held by it on a pro rata basis to holders of HCMC’s common stock. For each <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240908__20240909__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ4MuhFjGGz8" title="Number of shares issued">208,632</span> shares of HCMC common stock held as of 5:00 p.m., New York City time, on September 9, 2024, the record date for the Spin-Off (the “Record Date”), a HCMC stockholder was entitled to receive one (<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240908__20240909__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zb0Gpnvz6vwf" title="Number of shares issued">1</span>) share of Class A common stock and three (<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240908__20240909__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zJFJ75QzEZZc" title="Number of shares issued">3</span>) shares of Class B common stock. The Distribution was made in book-entry form by a distribution agent as soon as practicable after the date of the Distribution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HCMC has secured binding commitments of $<span id="xdx_909_ecustom--EquityFinancing_iI_pn4n6_c20240913__dei--LegalEntityAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zT81pgMsCnyh" title="Equity financing">13.25</span> million in equity financing for HCWC from the same group of investors that invested $<span id="xdx_909_eus-gaap--Investments_iI_pn4n6_c20240913__dei--LegalEntityAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zFUvKuwbYa53" title="Investments">13.25</span> million in HCMC Series E Preferred Stock. Pursuant to the Securities Purchase Agreement for the HCMC Series E Stock (“HCMC Series E SPA”), the purchasers of HCMC Series E Stock will also be required to purchase Series A Preferred Stock of HCWC in the same subscription amounts that the Purchasers paid for the HCMC Series E Stock (regardless of whether or not such HCMC Series E Stock has been converted into HCMC common stock).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.25 0.41 208632 1 3 13250000 13250000 <p id="xdx_80B_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zyOpVwaaNBdi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2. <span id="xdx_821_zcNz0bWpzZaa">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently and historically has reported net losses and cash outflows from operations. Cash and cash equivalents increased to approximately $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20241231_zB2Iynjh1D53" title="Cash and cash equivalent">2.1</span> million as of December 31, 2024, compared to $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20231231_zU5syxRvpTd8" title="Cash and cash equivalent">1.4</span> million as of December 31, 2023, driven by increased sales and improved sales margin. Working capital deficit decreased from negative $<span id="xdx_90E_ecustom--WorkingCapital_iI_pn5n6_c20231231_zjNyLnnk7uH1" title="Working capital">2.6</span> million as of December 31, 2023, to negative $<span id="xdx_90D_ecustom--WorkingCapital_iI_pn5n6_di_c20241231_zFKfUaCqNOl2" title="Working capital">2.2</span> million as of December 31, 2024, primarily due to improvement in cash reserves and inventory management. Net losses improved to $<span id="xdx_903_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240101__20241231_z9YIFnZvhqt9" title="Net loss">4.5</span> million for the year ending December 31, 2024 from $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20231231_zFmbT9a1i8Se" title="Net loss">9.9</span> million for the year ended December 31, 2023. Cash used in operating activities increased to $<span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn5n6_di_c20240101__20241231_zOE6KlB54Qtb" title="Cash used in operating activities">3.1</span> million in 2024 from $<span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn5n6_di_c20230101__20231231_zNpWlkZjddm8" title="Cash used in operating activities">2.5</span> million in 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 18, 2024, HCWC entered into a $<span id="xdx_90A_eus-gaap--PartnersCapitalAccountPrivatePlacementOfUnits_pn5n6_c20240718__20240718_z8FQqelZCjMe" title="Private lender">7.5</span> million loan and security agreement with a private lender to support its expansion plans and funding of any working capital needs, of which $<span id="xdx_908_ecustom--PurchaseOfGreenAcresMarket_pn5n6_c20240718__20240718_zhVJOIOo1Ty8" title="Purchase of greenacres market">4.2</span> million was used for the July 18, 2024 purchase of GreenAcres Market. The face amount of the loan is $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20240718_zyyinGGIOxtf" title="Face amount">7,500,000</span> with <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240718_zGOLEli7x4b8" title="Interest rate">12</span>% annual interest and has a maturity date of <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20240718__20240718_zcPyC2sz2wLg" title="Maturity date">July 17, 2027</span>. On July 24, 2024, the Company finalized the closing of Saugerties building sale with all parties involved and received net proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromSaleOfBuildings_c20240724__20240724__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zPpfQgNBBiof" title="Proceeds from sale of building">695,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 18, 2022, HCMC entered into a Securities Purchase Agreement (“HCMC Preferred Stock”) pursuant to which the HCMC sold and issued <span id="xdx_909_eus-gaap--SharesIssued_iI_c20220818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zH7T1M73Yyqb" title="Shares issued">14,722</span> shares of its Series E Convertible Preferred Stock to institutional investors for $<span id="xdx_903_eus-gaap--SharePrice_iI_c20220818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zEQObTEoujRj" title="Share price">1,000</span> per share or an aggregate subscription of $<span id="xdx_90C_eus-gaap--PreferredStockSharesSubscribedButUnissuedValue_iI_pn4n6_c20220818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zaCSwsP4zoHa" title="Preferrd stock subscriptions">13.25</span> million. This same group of investors committed to invest $<span id="xdx_902_eus-gaap--Investments_iI_pn4n6_c20220818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_zvcaboHVPy5g" title="Investments">13.25</span> million in HCWC after the Spin-Off and IPO transactions were completed. As such, HCWC entered into an agreement to sell shares of its Series A Convertible Preferred Stock (the “Series A Preferred Stock”), with the gross proceeds from such offering expected to be $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn4n6_c20220818__20220818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zVT3xRIUgTE7" title="Gross proceeds">13.25</span> million. The institutional investors that acquired HCMC Series E Preferred Stock are contractually required to purchase the Series A Preferred Stock in the same dollar amounts as they invested in the HCMC Series E Preferred Stock (regardless of whether or not such HCMC Series E Preferred Stock has been converted into HCMC common stock).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes its cash on hand and the commitment of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn4n6_c20220818__20220818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_zgZKlGCacRk7" title="Gross proceeds">13.25</span> million raised through its security offering noted above will enable the Company to meet its obligations and capital requirements for at least the twelve months from the date these financial statements are issued. Accordingly, no adjustment has been made to the financial statements to account for this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2100000 1400000 2600000 -2200000 -4500000 -9900000 -3100000 -2500000 7500000 4200000 7500000 0.12 2027-07-17 695000 14722 1000 13250000 13250000 13250000 13250000 <p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zzxTfDnX3wp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3. <span id="xdx_82B_zpmZyMspEfI">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zZybFR8XYYRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z2LyY0uJG6ka">Basis of Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements are prepared in accordance with U.S. GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has historically operated as part of HCMC and not as a standalone company. Financial statements representing the historical operations of HCMC’s grocery segment have been derived from HCMC’s historical accounting records and are presented on a carve-out basis through the Spin-Off date. The Company’s financial statements for the period September 14, 2024 through December 31, 2024 are consolidated financial statements based on the reported results of HCWC as a stand-alone company. HCMC completed steps to spin off its grocery segment and wellness business into HCWC. The entities under the grocery segment and wellness business were contributed (100%) to HCWC, as such the accompanying consolidated financial statements through the Spin-Off date have been contributed to HCWC using their carryover basis in accordance with Accounting Standard Codification (“ASC”) Topic 805, Business Combinations (“ASC 805”) for entities under common control. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the consolidated financial statements. The consolidated financial statements also include allocations of certain general, administrative, sales and marketing expenses from HCMC though the Spin-Off date. However, the amounts recognized by the Company are not necessarily representative of the amounts that would have been reflected in the consolidated financial statements had the Company operated independently of HCMC. Related-party allocations are discussed further in Note 18.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zC9fqI3Z5uQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z7t5Ab4Zpqp">Segment Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision makers, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company operates as a single reportable segment, as the CODM reviews financial performance and makes decisions on a consolidated basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zzddZjAwa1b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zZe6V7zh6AXd">Principles of Consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc. (“Ada’s Natural Market”), Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), Healthy Choice Markets 3, LLC (“Mother Earth’s Storehouse”), Healthy Choices Markets 3 Real Estate LLC, Healthy Choice Markets IV, LLC (Green’s Natural Foods), Healthy Choice Markets V, LLC (Ellwood Thompson’s), Healthy Choice Markets VI, LLC (GreenAcres Market), Healthy Choice Wellness, LLC, and Healthy U Wholesale, Inc (“The Vitamin Store, LLC”). All intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--InvestmentPolicyTextBlock_zjL1mzBtn7w9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_z5RwCQQVAsm2">Net Parent Investment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements were derived from the consolidated financial statements of HCMC on a carve-out basis though the Spin-Off date, and the consolidated financial statements also include allocations of certain general, administrative, legal, and marketing expenses from HCMC. The primary components of the Net Parent Investment are intercompany balances other than related party payables, the allocation of shared costs, and funding received to cover any shortfall in operating cash requirements. Balances between HCMC and the Company that were not historically cash settled are included in Net Parent Investment. Net Parent Investment represents the cumulative investment by HCMC in the Company through the Spin-Off date. Upon Spin-Off, the Company reclassed the balance in net parent investment to additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zE3m63RRF7Dc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z569Rrlxqv97">Use of Estimates in the Preparation of the Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include promotional discounts, manufacturer coupons and rebates, return allowances that are netted against revenue, useful lives and impairment of long-lived assets, allowance for credit losses, inventory provisions, deferred taxes and related valuation allowances, allocation of corporate general expenses, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zD0KRN9Z4Ijc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zjEA7NjhrYA8">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from product sales and services rendered, net of promotional discounts, manufacturer coupons and rebates, return allowances, and sales and consumption taxes, are recorded when products are delivered, title passes to customers and collection is likely to occur. Title passes to customers at the point of sale for retail and upon delivery of products for wholesale. Return allowances, which reduce revenue, are estimated using historical experience.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company promotes its products with trade incentives and promotions. These programs include sales discounts, rebates, coupons, volume-based incentives, refunds, and returns, which represent variable considerations. The estimation of variable consideration involves judgment and is constrained to avoid overstatement of revenue. The Company applies the expected value method or the most likely amount method, depending on which better predicts the consideration to which it will be entitled. Management evaluates these estimates on a quarterly basis. The trade incentives and promotions are recorded as a reduction to the transaction price based on amounts estimated as being due to customers at the end of the period. The Company derives these estimates based on historical experience. The Company does not receive a distinct service in relation to the trade incentives and promotions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with the following five-step model:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify arrangements with customers.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify performance obligations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine transaction price.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate transaction price to the separate performance obligations in the arrangement, if more than one exists; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as performance obligations are satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have significant revenue recognized over time due to the nature of retail store operation. The Company recognizes revenue at a point in time when control of goods or services transfers to the customer. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--ShippingAndHandlingPolicyTextBlock_zZHsaHzYuVIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_znmFN9MOrzHd">Shipping and Handling</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping charges billed to customers are included in net sales and the related shipping and handling costs are included in cost of sales. For the years ended December 31, 2024 and 2023, shipping and handling costs of approximately $<span id="xdx_909_eus-gaap--CostOfRevenue_c20240101__20241231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zPCip19Zl5ue" title="Costs of sales">132,000</span> and $<span id="xdx_90C_eus-gaap--CostOfRevenue_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zv3VnuVDq69c" title="Costs of sales">117,000</span>, were included in cost of sales, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zG6dF5Re1CKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zsAtWo5KULfk">Cash and Cash Equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash is concentrated in one financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage. The Company has not experienced any losses in such accounts. The Company did not have any cash equivalents as of December 31, 2024 and December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the financial institution that had cash in excess of FDIC limits of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJBU0lTIE9GIFBSRVNFTlRBVElPTiBBTkQgU1VNTUFSWSBPRiBTSUdOSUZJQ0FOVCBBQ0NPVU5USU5HIFBPTElDSUVTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_c20241231_zvn5X8n887ze" title="Cash, FDIC amount"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJBU0lTIE9GIFBSRVNFTlRBVElPTiBBTkQgU1VNTUFSWSBPRiBTSUdOSUZJQ0FOVCBBQ0NPVU5USU5HIFBPTElDSUVTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zl6ZbvDZnqQj" title="Cash, FDIC amount">250,000</span></span> as of December 31, 2024 and December 31, 2023 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_ecustom--ScheduleOfCashInFDICLimitsTableTextBlock_zGYIPJ9jljvi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z6VZ7h6yneGi" style="display: none">SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20241231_zZ3F7XUE5Yqf" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20231231_zYrXcJXC0gf8" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--CashUninsuredAmount_iI_zQZbzHAlE3Mk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Total cash and restricted cash in excess of FDIC limits</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; font-weight: bold; text-align: right">715,852</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">161,644</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zFIjhWgOIGI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--AccountsReceivableContractAssetsAndContractLiabilitiesPolicy_zwIiQDfdVEkb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zX8u8UkQKR4d">Accounts Receivable, Contract Assets and Contract Liabilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are claims to consideration which are unconditional; meaning no performance obligations remain for the Company and only the passage of time is necessary before collection. Contract assets are distinguished from accounts receivable as performance obligations remain before claims to consideration become unconditional. By nature of the Company’s operations, contract assets are typically not recognized. Contract liabilities are recorded when customers transfer consideration in advance of delivery of products or services, which the Company records for gift cards and loyalty reward programs. When one party to an arrangement performs before the other(s), the Company records an account receivable, contract asset or contract liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of arrangements with customers contain one performance obligation: to provide a distinct set of products or services. Most performance obligations are satisfied simultaneously as the Company exchanges products or services for customer payment. Exceptions include gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products or services at a future date. As gift cards are purchased and loyalty points earned, contract liabilities are recorded until the performance obligations are satisfied through delivery of products or services or breakage based on gift card and loyalty reward program term limits. For the years ended December 31, 2024 and 2023, the contract liability balance were approximately $<span id="xdx_907_eus-gaap--ContractWithCustomerLiability_iI_c20241231_zDZ0YqzVgz31" title="Contract liability">80,000</span> and $<span id="xdx_905_eus-gaap--ContractWithCustomerLiability_iI_c20231231_z6sAiOQGcUJ8" title="Contract liability">208,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s breakage policy is twenty-four months for gift cards and twelve months for loyalty rewards. Loyalty rewards are earned at five percent on qualifying purchases and the reward functions as an allocation of transaction price from the period earned by the customer to the period the performance obligation is satisfied by the Company. As such, all contract liabilities are expected to be recognized within a twenty-four-month period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2024, the Company transitioned its customer loyalty program from a points-based system to a VIP membership structure. Under the original loyalty program, customers earned redeemable loyalty points based on qualifying purchases, which have been discontinued. Existing unredeemed loyalty points remain valid for redemption until January 31, 2025. The new VIP program provides members with immediate discounts on qualifying purchases, replacing the accrual of future points. The elimination of future loyalty point accruals reduces the Company’s ongoing contract liability obligations, as discounts under the VIP program are recognized as reductions to revenue at the time of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p> <p id="xdx_84A_ecustom--OtherCurrentAssetsPolicyTextBlock_zxLvqxwSAWzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zMtVvgTIwxfb">Other Current Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current assets are the non-trade related assets that the Company owns, benefits from, or uses to generate income that can be converted into cash within one business cycle. Included in “Other current assets” on our consolidated balance sheets are amounts primarily related to other receivables or non-trade receivable from other companies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_z2Z6KHQHLvC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zTMoc8Xfec93">Inventories</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are measured at the lower of cost and net realizable value using the average cost method. If the cost of the inventories exceeds their net realizable value, adjustments are recorded to write down excess carrying value to their net realizable value. The Company’s inventories consist primarily of merchandise available for resale, such as fresh produce, perishable grocery items and non-perishable consumable goods. Slow-moving inventory is rotated out and obsolete inventory is removed (expensed) on a monthly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zESyKcTl11mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z8hyJtnGHdej">Property, Plant, and Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant, and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the expected useful life of the respective asset, after the asset is placed in service. Revenue earning property, plant, and equipment includes signage, furniture and fixtures, building, computer hardware, appliance, cooler, displays with useful lives range from <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20241231__srt--RangeAxis__srt--MinimumMember_z8z9ApS7EtQ3" title="Property plant and equipment useful life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl0607">two</span></span> to <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20241231__srt--RangeAxis__srt--MaximumMember_zTs83iOnA7H4" title="Property plant and equipment useful life">ten years</span>. Leasehold improvements are amortized over the shorter of the life of the asset or the term of the lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zN9OAA4lsvjk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zohZsl6QJHD">Identifiable Intangible Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifiable intangible assets are recorded at cost, or when acquired as part of a business acquisition, at estimated fair value. Certain identifiable intangible assets are amortized over <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__srt--RangeAxis__srt--MinimumMember_zZkfvf6pG4rg" title="Intangible asset useful life">4</span> to <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__srt--RangeAxis__srt--MaximumMember_zlaZrt5uKLh7" title="Intangible asset useful life">13</span> years. Similar to tangible personal property and equipment, the Company periodically evaluates identifiable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z2MFDvy5lPxf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z5iKzsghXi3i">Impairment of Long-Lived Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews all long-lived assets such as property and equipment and amortized intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated future cash flows expected to be generated by the asset or asset group. Impairment is measured by the amount by which the carrying value of the asset(s) exceeds their fair value. There were no triggering events that would indicate impairment of long-lived assets in the twelve months period ended on December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_z2xS60l5mI3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z9maksTeVjlh">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the carrying amounts of goodwill for recoverability on at least an annual basis or when events or changes in circumstances indicate evidence of potential impairment exists, using a fair value-based test. In performing the Company’s analysis of goodwill, the Company first evaluates qualitative factors, including relevant events and circumstances, to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value should be recognized; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Application of the goodwill impairment test requires significant judgments including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for the businesses, and the useful life over which cash flows will occur. Changes in these estimates and assumptions could materially affect the determination of fair value and/or conclusions on goodwill impairment for the Company. Our annual impairment test is conducted on September 30 of each year or more often if deemed necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred a non-cash impairment charge of $<span id="xdx_90B_eus-gaap--GoodwillImpairmentLoss_c20230101__20231231_zbsGqCBRrgQb">6,104,000</span> for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2024, the Company acquired GreenAcres Market and recorded goodwill of $<span id="xdx_901_eus-gaap--Goodwill_iI_c20240731__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zG2AFUwCX5zh" title="Goodwill">2,212,000</span> from the acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2024, there was no goodwill impairment charges recognized by the Company in the audited consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zbQkRxL3K25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zpuul8SNb9rh">Advertising</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising expense is classified as selling, general and administrative expense on the consolidated statements of operations. The Company expenses advertising costs as incurred. For the years ended December 31, 2024 and 2023, the company incurred advertising expenses of $<span id="xdx_90C_eus-gaap--AdvertisingExpense_c20240101__20241231_zcQ74YgUB6Qe" title="Advertising expenses">581,000</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_c20230101__20231231_zpSq1SjZhsb5" title="Advertising expenses">564,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--PlantRetirementAndAbandonmentPolicy_z9Ic3Yf7JcNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zICRTfDDAfV6">401(k) retirement savings plan</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s employees are offered a 401(k)-retirement savings plan that is currently administered under HCMC with discretionary contribution matching opportunities. HCMC will continue provide this service to HCWC’s employees pursuant to the Transition Service Agreement (“TSA”) executed upon the separation. The Company is in the process of establishing this service with its payroll provider, and expects to provide 401(k) to its own employees at the beginning of next year. 401K employer expense amounted to $<span id="xdx_902_eus-gaap--DefinedContributionPlanCostRecognized_c20240101__20241231_zx6vj7OEsnNj" title="Employer expense amount">94,000</span> and $<span id="xdx_907_eus-gaap--DefinedContributionPlanCostRecognized_c20230101__20231231_zAGr37abHuQ1" title="Employer expense amount">82,000</span> for the years ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zyKruTfgy0m3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zCKXvYAqief5">Earnings per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards. There is no dilution for the years ended December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 16, 2024, the Company separated from HCMC. As referenced in Note 1. Organization, the Separation resulted in the initial issuance of approximately <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn5n6_c20240916__20240916_zatJeiJLKmAh" title="Initial issuance shares">9.2</span> million shares of HCWC common stock. For purposes of computing basic and diluted earnings per common share for the year ended December 31, 2023, the number of HCWC common shares issued upon separation and distribution was used to reflect the outstanding shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zpW9GR123A4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the computation of basic and diluted earnings per share attributable to the Company’s stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zK4sFVVRavGl" style="display: none">SCHEDULE OF EARNINGS PER SHARES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20240101__20241231_z4yDj7LIAa6e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_zjPkXhe0aIl7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zZUJYoC4xlx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">NET LOSS</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">(4,506,466</td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(9,932,620</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zO8iG1kM1zxk" title="BASIC WEIGHTED AVERAGE COMMON SHARES"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zSEYaFzxfMtb" title="DILUTED WEIGHTED AVERAGE COMMON SHARES">9,395,500</span></span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zxEZrvPF01di" title="BASIC WEIGHTED AVERAGE COMMON SHARES"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zqqAwe7z5m4i" title="DILUTED WEIGHTED AVERAGE COMMON SHARES">9,226,860</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">BASIC AND DILUTED NET LOSS PER SHARE</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zY6msbVIbEd" title="BASIC NET LOSS PER SHARE"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zDRhNwZG8l8k" title="DILUTED NET LOSS PER SHARE">(0.48</span></span></td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zer47a7dgysf" title="BASIC NET LOSS PER SHARE"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zPv4v5xwj1d1" title="DILUTED NET LOSS PER SHARE">(1.08</span></span></td><td style="text-align: left">)</td></tr> </table> <p id="xdx_8A1_zULGjvF2bEvb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zIplGFIq3ra7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zpBf8CyMuiC4">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740”). Under this method, income tax expense is recognized as the amount of: (i) taxes payable or refundable for the current year and (ii) future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of available evidence it is more likely than not that some portion or all of the deferred tax assets will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20241231_zdiEyST2feQf" title="Unrecognized tax benefits"><span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zA4rTZXYvpn6" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 or 2023. The Company had no uncertain tax positions as of December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_z51Ljyywfeai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zAWkTUiO98Jd">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities are recognized at the lease commencement date based on the present value of the fixed lease payments using the Company’s incremental borrowing rates. Related lease right-of-use (“ROU”) are recognized based on the initial present value of the fixed lease payments, reduced by contributions from landlords, plus any prepaid rent and direct costs from executing the leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payments are recognized as lease expense as they are incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not have finance leases in year 2024 and 2023. If the Company enters into a finance lease in the future, it will be accounted for in accordance with ASC Topic 842.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z5knVnqKktm1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z30eDTsj19S4">Fair Value Measurements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value framework under FASB’s guidance requires the categorization of assets and liabilities into three levels based upon the assumptions used to measure the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, would generally require significant management judgment. The three levels for categorizing assets and liabilities under the fair value measurement requirements are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Fair value measurement of the asset or liability using observable inputs such as quoted prices in active markets for identical assets or liabilities;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Fair value measurement of the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Fair value measurement of the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recurring Fair Value Measurements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, operating, derivatives and borrowings. Management believes that the carrying value of cash and cash equivalents, accounts receivable, accounts payable, and borrowings are representative of their respective fair values. All derivatives are recognized as either assets or liabilities on the balance sheet at fair value at the end of each quarter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nonrecurring Fair Value Measurements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets, indefinite-lived intangible assets and goodwill. The Company reviews the carrying amounts of such assets at least annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Any resulting asset impairment would require that the asset be recorded at its fair value. The resulting fair value measurement of the assets are considered to be Level 3 measurements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_zSi4TCaENrwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zZzHaFchKkwl">Business Combination</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company applies the provisions of ASC 805 in the accounting for acquisitions of businesses. ASC 805 requires the Company to use the acquisition method of accounting by recognizing identifiable assets and liabilities, including intangible assets of acquired businesses at their fair value at the date of acquisition. When the Company acquires control of a business, any previously held equity interest also is remeasured to fair value. The excess of the purchase consideration and any previously held equity interest over the fair value of identifiable net assets acquired is goodwill. If the fair value of identifiable net assets acquired exceeds the purchase consideration and any previously held equity interest, the difference is recognized in the consolidated statements of operations immediately as a gain or loss on acquisition. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition-related expenses are expensed as incurred and the expenses are recorded in operating expenses in the consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z59VHRF97Irf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zpyHgS46KQ2e">Recent Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public companies in the United States are subject to the accounting and reporting requirements of various authorities, including FASB and the SEC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (ASC 326)” This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL”) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to certain financial assets. The Company adopted ASC 326 on January 1, 2023, and estimated expected credit losses based on aging schedule, and provisioned approximately $<span id="xdx_909_eus-gaap--ProvisionForOtherCreditLosses_c20240101__20241231_zA1vf2YBl3Qi" title="Estimated expected credit losses">28,000</span> and $<span id="xdx_906_eus-gaap--ProvisionForOtherCreditLosses_c20230101__20231231_z9XiQlHvClL3" title="Estimated expected credit losses">15,000</span> credit loss for the year ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 14, 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 27, 2023, FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which requires public entities to consider relevant qualitative and quantitative factors when determining whether segment expense categories and amounts are significant, and identify segment expenses on the basis of amounts that are regularly provided to the CODM, and included in reported segment profit or loss. The ASU is effective for fiscal years beginning after Dec. 15, 2023, and interim periods within fiscal years beginning after Dec. 15, 2024. The Company adopted this standard effective January 1, 2024, applying it retrospectively to all periods presented. As the Company has one reportable segment, the adoption had no material impact on the Company’s financial statements, but resulted in additional expense disclosures and reconciliations in the financial statement footnotes. See Note 5 for details.</span></p> <p id="xdx_856_zrSL8caUyAW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zZybFR8XYYRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z2LyY0uJG6ka">Basis of Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements are prepared in accordance with U.S. GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has historically operated as part of HCMC and not as a standalone company. Financial statements representing the historical operations of HCMC’s grocery segment have been derived from HCMC’s historical accounting records and are presented on a carve-out basis through the Spin-Off date. The Company’s financial statements for the period September 14, 2024 through December 31, 2024 are consolidated financial statements based on the reported results of HCWC as a stand-alone company. HCMC completed steps to spin off its grocery segment and wellness business into HCWC. The entities under the grocery segment and wellness business were contributed (100%) to HCWC, as such the accompanying consolidated financial statements through the Spin-Off date have been contributed to HCWC using their carryover basis in accordance with Accounting Standard Codification (“ASC”) Topic 805, Business Combinations (“ASC 805”) for entities under common control. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the consolidated financial statements. The consolidated financial statements also include allocations of certain general, administrative, sales and marketing expenses from HCMC though the Spin-Off date. However, the amounts recognized by the Company are not necessarily representative of the amounts that would have been reflected in the consolidated financial statements had the Company operated independently of HCMC. Related-party allocations are discussed further in Note 18.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zC9fqI3Z5uQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z7t5Ab4Zpqp">Segment Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision makers, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company operates as a single reportable segment, as the CODM reviews financial performance and makes decisions on a consolidated basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zzddZjAwa1b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zZe6V7zh6AXd">Principles of Consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc. (“Ada’s Natural Market”), Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), Healthy Choice Markets 3, LLC (“Mother Earth’s Storehouse”), Healthy Choices Markets 3 Real Estate LLC, Healthy Choice Markets IV, LLC (Green’s Natural Foods), Healthy Choice Markets V, LLC (Ellwood Thompson’s), Healthy Choice Markets VI, LLC (GreenAcres Market), Healthy Choice Wellness, LLC, and Healthy U Wholesale, Inc (“The Vitamin Store, LLC”). All intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--InvestmentPolicyTextBlock_zjL1mzBtn7w9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_z5RwCQQVAsm2">Net Parent Investment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements were derived from the consolidated financial statements of HCMC on a carve-out basis though the Spin-Off date, and the consolidated financial statements also include allocations of certain general, administrative, legal, and marketing expenses from HCMC. The primary components of the Net Parent Investment are intercompany balances other than related party payables, the allocation of shared costs, and funding received to cover any shortfall in operating cash requirements. Balances between HCMC and the Company that were not historically cash settled are included in Net Parent Investment. Net Parent Investment represents the cumulative investment by HCMC in the Company through the Spin-Off date. Upon Spin-Off, the Company reclassed the balance in net parent investment to additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zE3m63RRF7Dc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z569Rrlxqv97">Use of Estimates in the Preparation of the Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include promotional discounts, manufacturer coupons and rebates, return allowances that are netted against revenue, useful lives and impairment of long-lived assets, allowance for credit losses, inventory provisions, deferred taxes and related valuation allowances, allocation of corporate general expenses, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zD0KRN9Z4Ijc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zjEA7NjhrYA8">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from product sales and services rendered, net of promotional discounts, manufacturer coupons and rebates, return allowances, and sales and consumption taxes, are recorded when products are delivered, title passes to customers and collection is likely to occur. Title passes to customers at the point of sale for retail and upon delivery of products for wholesale. Return allowances, which reduce revenue, are estimated using historical experience.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company promotes its products with trade incentives and promotions. These programs include sales discounts, rebates, coupons, volume-based incentives, refunds, and returns, which represent variable considerations. The estimation of variable consideration involves judgment and is constrained to avoid overstatement of revenue. The Company applies the expected value method or the most likely amount method, depending on which better predicts the consideration to which it will be entitled. Management evaluates these estimates on a quarterly basis. The trade incentives and promotions are recorded as a reduction to the transaction price based on amounts estimated as being due to customers at the end of the period. The Company derives these estimates based on historical experience. The Company does not receive a distinct service in relation to the trade incentives and promotions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with the following five-step model:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify arrangements with customers.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify performance obligations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine transaction price.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate transaction price to the separate performance obligations in the arrangement, if more than one exists; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as performance obligations are satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have significant revenue recognized over time due to the nature of retail store operation. The Company recognizes revenue at a point in time when control of goods or services transfers to the customer. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--ShippingAndHandlingPolicyTextBlock_zZHsaHzYuVIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_znmFN9MOrzHd">Shipping and Handling</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping charges billed to customers are included in net sales and the related shipping and handling costs are included in cost of sales. For the years ended December 31, 2024 and 2023, shipping and handling costs of approximately $<span id="xdx_909_eus-gaap--CostOfRevenue_c20240101__20241231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zPCip19Zl5ue" title="Costs of sales">132,000</span> and $<span id="xdx_90C_eus-gaap--CostOfRevenue_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zv3VnuVDq69c" title="Costs of sales">117,000</span>, were included in cost of sales, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 132000 117000 <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zG6dF5Re1CKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zsAtWo5KULfk">Cash and Cash Equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash is concentrated in one financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage. The Company has not experienced any losses in such accounts. The Company did not have any cash equivalents as of December 31, 2024 and December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the financial institution that had cash in excess of FDIC limits of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJBU0lTIE9GIFBSRVNFTlRBVElPTiBBTkQgU1VNTUFSWSBPRiBTSUdOSUZJQ0FOVCBBQ0NPVU5USU5HIFBPTElDSUVTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_c20241231_zvn5X8n887ze" title="Cash, FDIC amount"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJBU0lTIE9GIFBSRVNFTlRBVElPTiBBTkQgU1VNTUFSWSBPRiBTSUdOSUZJQ0FOVCBBQ0NPVU5USU5HIFBPTElDSUVTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zl6ZbvDZnqQj" title="Cash, FDIC amount">250,000</span></span> as of December 31, 2024 and December 31, 2023 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_ecustom--ScheduleOfCashInFDICLimitsTableTextBlock_zGYIPJ9jljvi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z6VZ7h6yneGi" style="display: none">SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20241231_zZ3F7XUE5Yqf" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20231231_zYrXcJXC0gf8" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--CashUninsuredAmount_iI_zQZbzHAlE3Mk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Total cash and restricted cash in excess of FDIC limits</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; font-weight: bold; text-align: right">715,852</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">161,644</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zFIjhWgOIGI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 250000 <p id="xdx_896_ecustom--ScheduleOfCashInFDICLimitsTableTextBlock_zGYIPJ9jljvi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z6VZ7h6yneGi" style="display: none">SCHEDULE OF FINANCIAL INSTITUTION THAT HAD CASH IN EXCESS OF FDIC LIMITS</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20241231_zZ3F7XUE5Yqf" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20231231_zYrXcJXC0gf8" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--CashUninsuredAmount_iI_zQZbzHAlE3Mk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Total cash and restricted cash in excess of FDIC limits</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; font-weight: bold; text-align: right">715,852</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">161,644</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 715852 161644 <p id="xdx_84D_ecustom--AccountsReceivableContractAssetsAndContractLiabilitiesPolicy_zwIiQDfdVEkb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zX8u8UkQKR4d">Accounts Receivable, Contract Assets and Contract Liabilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are claims to consideration which are unconditional; meaning no performance obligations remain for the Company and only the passage of time is necessary before collection. Contract assets are distinguished from accounts receivable as performance obligations remain before claims to consideration become unconditional. By nature of the Company’s operations, contract assets are typically not recognized. Contract liabilities are recorded when customers transfer consideration in advance of delivery of products or services, which the Company records for gift cards and loyalty reward programs. When one party to an arrangement performs before the other(s), the Company records an account receivable, contract asset or contract liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of arrangements with customers contain one performance obligation: to provide a distinct set of products or services. Most performance obligations are satisfied simultaneously as the Company exchanges products or services for customer payment. Exceptions include gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products or services at a future date. As gift cards are purchased and loyalty points earned, contract liabilities are recorded until the performance obligations are satisfied through delivery of products or services or breakage based on gift card and loyalty reward program term limits. For the years ended December 31, 2024 and 2023, the contract liability balance were approximately $<span id="xdx_907_eus-gaap--ContractWithCustomerLiability_iI_c20241231_zDZ0YqzVgz31" title="Contract liability">80,000</span> and $<span id="xdx_905_eus-gaap--ContractWithCustomerLiability_iI_c20231231_z6sAiOQGcUJ8" title="Contract liability">208,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s breakage policy is twenty-four months for gift cards and twelve months for loyalty rewards. Loyalty rewards are earned at five percent on qualifying purchases and the reward functions as an allocation of transaction price from the period earned by the customer to the period the performance obligation is satisfied by the Company. As such, all contract liabilities are expected to be recognized within a twenty-four-month period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2024, the Company transitioned its customer loyalty program from a points-based system to a VIP membership structure. Under the original loyalty program, customers earned redeemable loyalty points based on qualifying purchases, which have been discontinued. Existing unredeemed loyalty points remain valid for redemption until January 31, 2025. The new VIP program provides members with immediate discounts on qualifying purchases, replacing the accrual of future points. The elimination of future loyalty point accruals reduces the Company’s ongoing contract liability obligations, as discounts under the VIP program are recognized as reductions to revenue at the time of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p> 80000 208000 <p id="xdx_84A_ecustom--OtherCurrentAssetsPolicyTextBlock_zxLvqxwSAWzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zMtVvgTIwxfb">Other Current Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current assets are the non-trade related assets that the Company owns, benefits from, or uses to generate income that can be converted into cash within one business cycle. Included in “Other current assets” on our consolidated balance sheets are amounts primarily related to other receivables or non-trade receivable from other companies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_z2Z6KHQHLvC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zTMoc8Xfec93">Inventories</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are measured at the lower of cost and net realizable value using the average cost method. If the cost of the inventories exceeds their net realizable value, adjustments are recorded to write down excess carrying value to their net realizable value. The Company’s inventories consist primarily of merchandise available for resale, such as fresh produce, perishable grocery items and non-perishable consumable goods. Slow-moving inventory is rotated out and obsolete inventory is removed (expensed) on a monthly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zESyKcTl11mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z8hyJtnGHdej">Property, Plant, and Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant, and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the expected useful life of the respective asset, after the asset is placed in service. Revenue earning property, plant, and equipment includes signage, furniture and fixtures, building, computer hardware, appliance, cooler, displays with useful lives range from <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20241231__srt--RangeAxis__srt--MinimumMember_z8z9ApS7EtQ3" title="Property plant and equipment useful life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl0607">two</span></span> to <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20241231__srt--RangeAxis__srt--MaximumMember_zTs83iOnA7H4" title="Property plant and equipment useful life">ten years</span>. Leasehold improvements are amortized over the shorter of the life of the asset or the term of the lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P10Y <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zN9OAA4lsvjk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zohZsl6QJHD">Identifiable Intangible Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifiable intangible assets are recorded at cost, or when acquired as part of a business acquisition, at estimated fair value. Certain identifiable intangible assets are amortized over <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__srt--RangeAxis__srt--MinimumMember_zZkfvf6pG4rg" title="Intangible asset useful life">4</span> to <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__srt--RangeAxis__srt--MaximumMember_zlaZrt5uKLh7" title="Intangible asset useful life">13</span> years. Similar to tangible personal property and equipment, the Company periodically evaluates identifiable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P4Y P13Y <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z2MFDvy5lPxf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z5iKzsghXi3i">Impairment of Long-Lived Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews all long-lived assets such as property and equipment and amortized intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated future cash flows expected to be generated by the asset or asset group. Impairment is measured by the amount by which the carrying value of the asset(s) exceeds their fair value. There were no triggering events that would indicate impairment of long-lived assets in the twelve months period ended on December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_z2xS60l5mI3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z9maksTeVjlh">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the carrying amounts of goodwill for recoverability on at least an annual basis or when events or changes in circumstances indicate evidence of potential impairment exists, using a fair value-based test. In performing the Company’s analysis of goodwill, the Company first evaluates qualitative factors, including relevant events and circumstances, to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value should be recognized; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Application of the goodwill impairment test requires significant judgments including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for the businesses, and the useful life over which cash flows will occur. Changes in these estimates and assumptions could materially affect the determination of fair value and/or conclusions on goodwill impairment for the Company. Our annual impairment test is conducted on September 30 of each year or more often if deemed necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred a non-cash impairment charge of $<span id="xdx_90B_eus-gaap--GoodwillImpairmentLoss_c20230101__20231231_zbsGqCBRrgQb">6,104,000</span> for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2024, the Company acquired GreenAcres Market and recorded goodwill of $<span id="xdx_901_eus-gaap--Goodwill_iI_c20240731__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zG2AFUwCX5zh" title="Goodwill">2,212,000</span> from the acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2024, there was no goodwill impairment charges recognized by the Company in the audited consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6104000 2212000 <p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zbQkRxL3K25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zpuul8SNb9rh">Advertising</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising expense is classified as selling, general and administrative expense on the consolidated statements of operations. The Company expenses advertising costs as incurred. For the years ended December 31, 2024 and 2023, the company incurred advertising expenses of $<span id="xdx_90C_eus-gaap--AdvertisingExpense_c20240101__20241231_zcQ74YgUB6Qe" title="Advertising expenses">581,000</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_c20230101__20231231_zpSq1SjZhsb5" title="Advertising expenses">564,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 581000 564000 <p id="xdx_844_eus-gaap--PlantRetirementAndAbandonmentPolicy_z9Ic3Yf7JcNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zICRTfDDAfV6">401(k) retirement savings plan</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s employees are offered a 401(k)-retirement savings plan that is currently administered under HCMC with discretionary contribution matching opportunities. HCMC will continue provide this service to HCWC’s employees pursuant to the Transition Service Agreement (“TSA”) executed upon the separation. The Company is in the process of establishing this service with its payroll provider, and expects to provide 401(k) to its own employees at the beginning of next year. 401K employer expense amounted to $<span id="xdx_902_eus-gaap--DefinedContributionPlanCostRecognized_c20240101__20241231_zx6vj7OEsnNj" title="Employer expense amount">94,000</span> and $<span id="xdx_907_eus-gaap--DefinedContributionPlanCostRecognized_c20230101__20231231_zAGr37abHuQ1" title="Employer expense amount">82,000</span> for the years ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 94000 82000 <p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zyKruTfgy0m3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zCKXvYAqief5">Earnings per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards. There is no dilution for the years ended December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 16, 2024, the Company separated from HCMC. As referenced in Note 1. Organization, the Separation resulted in the initial issuance of approximately <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn5n6_c20240916__20240916_zatJeiJLKmAh" title="Initial issuance shares">9.2</span> million shares of HCWC common stock. For purposes of computing basic and diluted earnings per common share for the year ended December 31, 2023, the number of HCWC common shares issued upon separation and distribution was used to reflect the outstanding shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zpW9GR123A4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the computation of basic and diluted earnings per share attributable to the Company’s stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zK4sFVVRavGl" style="display: none">SCHEDULE OF EARNINGS PER SHARES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20240101__20241231_z4yDj7LIAa6e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_zjPkXhe0aIl7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zZUJYoC4xlx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">NET LOSS</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">(4,506,466</td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(9,932,620</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zO8iG1kM1zxk" title="BASIC WEIGHTED AVERAGE COMMON SHARES"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zSEYaFzxfMtb" title="DILUTED WEIGHTED AVERAGE COMMON SHARES">9,395,500</span></span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zxEZrvPF01di" title="BASIC WEIGHTED AVERAGE COMMON SHARES"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zqqAwe7z5m4i" title="DILUTED WEIGHTED AVERAGE COMMON SHARES">9,226,860</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">BASIC AND DILUTED NET LOSS PER SHARE</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zY6msbVIbEd" title="BASIC NET LOSS PER SHARE"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zDRhNwZG8l8k" title="DILUTED NET LOSS PER SHARE">(0.48</span></span></td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zer47a7dgysf" title="BASIC NET LOSS PER SHARE"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zPv4v5xwj1d1" title="DILUTED NET LOSS PER SHARE">(1.08</span></span></td><td style="text-align: left">)</td></tr> </table> <p id="xdx_8A1_zULGjvF2bEvb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 9200000 <p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zpW9GR123A4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the computation of basic and diluted earnings per share attributable to the Company’s stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zK4sFVVRavGl" style="display: none">SCHEDULE OF EARNINGS PER SHARES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20240101__20241231_z4yDj7LIAa6e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_zjPkXhe0aIl7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zZUJYoC4xlx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">NET LOSS</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">(4,506,466</td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(9,932,620</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zO8iG1kM1zxk" title="BASIC WEIGHTED AVERAGE COMMON SHARES"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zSEYaFzxfMtb" title="DILUTED WEIGHTED AVERAGE COMMON SHARES">9,395,500</span></span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zxEZrvPF01di" title="BASIC WEIGHTED AVERAGE COMMON SHARES"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zqqAwe7z5m4i" title="DILUTED WEIGHTED AVERAGE COMMON SHARES">9,226,860</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">BASIC AND DILUTED NET LOSS PER SHARE</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zY6msbVIbEd" title="BASIC NET LOSS PER SHARE"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zDRhNwZG8l8k" title="DILUTED NET LOSS PER SHARE">(0.48</span></span></td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zer47a7dgysf" title="BASIC NET LOSS PER SHARE"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVBUk5JTkdTIFBFUiBTSEFSRVMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zPv4v5xwj1d1" title="DILUTED NET LOSS PER SHARE">(1.08</span></span></td><td style="text-align: left">)</td></tr> </table> -4506466 -9932620 9395500 9395500 9226860 9226860 -0.48 -0.48 -1.08 -1.08 <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zIplGFIq3ra7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zpBf8CyMuiC4">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740”). Under this method, income tax expense is recognized as the amount of: (i) taxes payable or refundable for the current year and (ii) future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of available evidence it is more likely than not that some portion or all of the deferred tax assets will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20241231_zdiEyST2feQf" title="Unrecognized tax benefits"><span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zA4rTZXYvpn6" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 or 2023. The Company had no uncertain tax positions as of December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_z51Ljyywfeai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zAWkTUiO98Jd">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities are recognized at the lease commencement date based on the present value of the fixed lease payments using the Company’s incremental borrowing rates. Related lease right-of-use (“ROU”) are recognized based on the initial present value of the fixed lease payments, reduced by contributions from landlords, plus any prepaid rent and direct costs from executing the leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payments are recognized as lease expense as they are incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not have finance leases in year 2024 and 2023. If the Company enters into a finance lease in the future, it will be accounted for in accordance with ASC Topic 842.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z5knVnqKktm1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z30eDTsj19S4">Fair Value Measurements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value framework under FASB’s guidance requires the categorization of assets and liabilities into three levels based upon the assumptions used to measure the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, would generally require significant management judgment. The three levels for categorizing assets and liabilities under the fair value measurement requirements are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Fair value measurement of the asset or liability using observable inputs such as quoted prices in active markets for identical assets or liabilities;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Fair value measurement of the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Fair value measurement of the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recurring Fair Value Measurements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, operating, derivatives and borrowings. Management believes that the carrying value of cash and cash equivalents, accounts receivable, accounts payable, and borrowings are representative of their respective fair values. All derivatives are recognized as either assets or liabilities on the balance sheet at fair value at the end of each quarter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nonrecurring Fair Value Measurements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets, indefinite-lived intangible assets and goodwill. The Company reviews the carrying amounts of such assets at least annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Any resulting asset impairment would require that the asset be recorded at its fair value. The resulting fair value measurement of the assets are considered to be Level 3 measurements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_zSi4TCaENrwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zZzHaFchKkwl">Business Combination</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company applies the provisions of ASC 805 in the accounting for acquisitions of businesses. ASC 805 requires the Company to use the acquisition method of accounting by recognizing identifiable assets and liabilities, including intangible assets of acquired businesses at their fair value at the date of acquisition. When the Company acquires control of a business, any previously held equity interest also is remeasured to fair value. The excess of the purchase consideration and any previously held equity interest over the fair value of identifiable net assets acquired is goodwill. If the fair value of identifiable net assets acquired exceeds the purchase consideration and any previously held equity interest, the difference is recognized in the consolidated statements of operations immediately as a gain or loss on acquisition. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition-related expenses are expensed as incurred and the expenses are recorded in operating expenses in the consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z59VHRF97Irf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zpyHgS46KQ2e">Recent Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public companies in the United States are subject to the accounting and reporting requirements of various authorities, including FASB and the SEC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (ASC 326)” This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL”) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to certain financial assets. The Company adopted ASC 326 on January 1, 2023, and estimated expected credit losses based on aging schedule, and provisioned approximately $<span id="xdx_909_eus-gaap--ProvisionForOtherCreditLosses_c20240101__20241231_zA1vf2YBl3Qi" title="Estimated expected credit losses">28,000</span> and $<span id="xdx_906_eus-gaap--ProvisionForOtherCreditLosses_c20230101__20231231_z9XiQlHvClL3" title="Estimated expected credit losses">15,000</span> credit loss for the year ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 14, 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 27, 2023, FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which requires public entities to consider relevant qualitative and quantitative factors when determining whether segment expense categories and amounts are significant, and identify segment expenses on the basis of amounts that are regularly provided to the CODM, and included in reported segment profit or loss. The ASU is effective for fiscal years beginning after Dec. 15, 2023, and interim periods within fiscal years beginning after Dec. 15, 2024. The Company adopted this standard effective January 1, 2024, applying it retrospectively to all periods presented. As the Company has one reportable segment, the adoption had no material impact on the Company’s financial statements, but resulted in additional expense disclosures and reconciliations in the financial statement footnotes. See Note 5 for details.</span></p> 28000 15000 <p id="xdx_80C_eus-gaap--ConcentrationRiskDisclosureTextBlock_ziTl6fyYhn5d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4. <span id="xdx_825_znP4aDzCqSmk">CONCENTRATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash and Cash Equivalents</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash is concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not experienced any losses in such accounts. The Company did <span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20241231_zhfDvqVYEbm" title="Cash equivalents"><span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zrP7CLAQcxea" title="Cash equivalents">no</span></span>t have any cash equivalents as of December 31, 2024 and December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfCashInExcessFDICLimitsTableTextBlock_zYYgXxTnk0s8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the financial institution that had cash in excess of FDIC limits of $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_c20241231_zPnzidbJfNQh" title="Cash, FDIC amount"><span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zYaYh7WP6txl" title="Cash, FDIC amount">250,000</span></span> on December 31, 2024 and December 31, 2023 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zJWILowuz5Uk" style="display: none">SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20241231_zgdDNnlXYUlj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20231231_zvAD5OecTtBi" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_405_eus-gaap--CashUninsuredAmount_iI_zhAuT3tR4CW8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Total cash in excess of FDIC limits of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENBU0ggQU5EIENBU0ggRVFVSVZBTEVOVFMgKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20241231_zb53G0V0a2V8" title="Cash, FDIC amount"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENBU0ggQU5EIENBU0ggRVFVSVZBTEVOVFMgKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zy7Q6AIiVEpl" title="Cash, FDIC amount">250,000</span></span></td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; font-weight: bold; text-align: right">715,852</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">161,644</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_z07hTxkTPKtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continually monitors its positions with, and the credit quality of the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a reconciliation of cash and cash equivalents to amounts shown in audited consolidated statements of cash flow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zmdNL3AUhpc6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zfhb4A5qRkN" style="display: none">SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS</span> </span></span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20241231_zWVemeRj2q25" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20231231_z8C96jiLrORj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--Cash_iI_zYWkwC98Gr83" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Cash</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">2,056,472</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,422,580</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zthXw60JlbGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sourcing and Vendors</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We source from approximately 1,000 suppliers and offer well-over 4,000 brands. These suppliers range from small independent businesses to multi-national conglomerates. We purchased approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--SuppliersMember_zmQ2BvsjLsl3" title="Concentration risk percentage">70</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--SuppliersMember_zLJwZApgVYtk" title="Concentration risk percentage">75</span>% of the goods we sell from our top 20 suppliers for the years ended December 31, 2024 and 2023, respectively, approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--PurchaseMember_zXKMODr3gAtj" title="Concentration risk percentage">25</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--PurchaseMember_zxIIheowkk9e" title="Concentration risk percentage">41</span>% of our total purchases were from UNFI for the years ended December 31, 2024 and 2023, respectively. We maintain good relations with all our suppliers and believe we have adequate alternative supply methods, including self-distribution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As mentioned, UNFI is our primary supplier of dry grocery and frozen food products. Our customer distribution agreement with UNFI commenced September 1, 2022, and has an initial term through September 1, 2027. Either party may terminate the agreement for defaults by the other party of certain provisions of the agreement. We are obligated to purchase a minimum annual volume of products from UNFI, except in certain defined circumstances when such purchasing obligation is excused. Pricing under our agreement with UNFI is on a “cost plus” basis. We believe UNFI has sufficient warehouse capacity and distribution technology to service our existing stores’ distribution needs for natural foods and products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have longstanding relationships with our suppliers, and we require disclosure from them regarding quality, freshness, potency and safety data information. Our bulk food private label products are packaged by us in pre-packed sealed bags to help prevent contamination while in transit and in our stores. Unlike most of our competitors, most of our private label nuts, trail mix, and flours are refrigerated in our warehouse and stores to maintain freshness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_892_ecustom--ScheduleOfCashInExcessFDICLimitsTableTextBlock_zYYgXxTnk0s8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the financial institution that had cash in excess of FDIC limits of $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_c20241231_zPnzidbJfNQh" title="Cash, FDIC amount"><span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zYaYh7WP6txl" title="Cash, FDIC amount">250,000</span></span> on December 31, 2024 and December 31, 2023 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zJWILowuz5Uk" style="display: none">SCHEDULE OF CASH IN EXCESS OF FDIC LIMITS</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20241231_zgdDNnlXYUlj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20231231_zvAD5OecTtBi" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_405_eus-gaap--CashUninsuredAmount_iI_zhAuT3tR4CW8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Total cash in excess of FDIC limits of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENBU0ggQU5EIENBU0ggRVFVSVZBTEVOVFMgKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20241231_zb53G0V0a2V8" title="Cash, FDIC amount"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENBU0ggQU5EIENBU0ggRVFVSVZBTEVOVFMgKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zy7Q6AIiVEpl" title="Cash, FDIC amount">250,000</span></span></td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; font-weight: bold; text-align: right">715,852</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">161,644</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 250000 250000 250000 250000 715852 161644 <p id="xdx_89B_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zmdNL3AUhpc6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zfhb4A5qRkN" style="display: none">SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS</span> </span></span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20241231_zWVemeRj2q25" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20231231_z8C96jiLrORj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--Cash_iI_zYWkwC98Gr83" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Cash</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">2,056,472</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,422,580</td><td style="width: 1%; text-align: left"> </td></tr> </table> 2056472 1422580 0.70 0.75 0.25 0.41 <p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_zVNABsORVKV3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5. <span id="xdx_82F_zYEbhVRxh0P5">SEGMENT REPORTING AND DISAGGREGATION OF REVENUES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in <span id="xdx_904_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20240101__20241231_zndKhOGrReNl" title="Operating segments">two</span> operating segments: Grocery and Wellness. In accordance with ASC 280, these segments have been aggregated into a single reportable segment because they share similar economic characteristics and meet all aggregation criteria, including similar nature of products sold, product acquisition process, customer base, distribution methods, and regulatory environment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s CODM reviews financial results and allocates resources at the consolidated level, as the aggregated segments operate as one integrated business unit. No segment-specific financial metrics are used by the CODM to assess performance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASU 2023-07 effective January 1, 2024, on a retrospective basis. As the Company operates as a single reportable segment, the adoption did not have an impact on the Company’s consolidated financial statements. However, it did result in enhanced disclosures related to segment expenses and reconciliations to consolidated totals. Specifically, the Company has begun disclosing segment-specific expenses that are regularly reviewed by the CODM, Jeffrey Holman, the Company’s Chief Executive Officer, in accordance with the new standard. This adoption did not have an impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the significant segment expenses:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--SignificantSegmentExpensesTableTextBlock_zGOVi3Tolwak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zf4Gl7uzukf">SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z5omT2vKoQB5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230101__20231231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z14kQquibvD1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--AdvertisingExpense_zq4JlROvBStg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Advertising</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">581,357</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">564,405</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CostDirectLabor_zrlbhjBPAMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Payroll and Benefits</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">13,963,361</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,645,985</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OccupancyNet_zK1s0eTeCjab" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Occupancy</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">6,573,925</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,280,405</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--Depreciation_z9nFDXut67md" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and Amortization</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,576,457</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,431,816</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProfessionalFees_z4BMXeW07wK9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Bank Service Charges and Merchant Account Fees</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,331,637</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">927,863</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_zP5SBt8RjZe7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other selling, general and administrative expenses</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,680,001</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,368,736</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--GoodwillImpairmentLoss_zGhtyHiEjfrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Goodwill impairment</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,104,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingCostsAndExpenses_iT_z2B7JcAysm81" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total significant reporting segment expenses</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">25,706,738</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">28,323,210</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zg43WZoHRLs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zWGm5QZEuXqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the reconciliations of reportable segment profit or loss and assets to the Company’s consolidated totals:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_z8Q0QJwm4zMj">SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20240101__20241231_zexsUbh8Lkke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_zfJdS74VCAu5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_hus-gaap--StatementBusinessSegmentsAxis__custom--SegmentNetOperatingIncomeLossMember_zex3rporZOdl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Segment net operating income (loss)</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">1,358,571</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(7,974,985</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--OperatingIncomeLoss_hus-gaap--StatementBusinessSegmentsAxis__custom--UnallocatedAmountMember_zdjV9MXLsLth" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unallocated amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(3,136,049</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,549,084</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_zozMeewjsET3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Consolidated loss from operation</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,777,478</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,524,069</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20241231_zgjBoVeHVHPd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20231231_zGuWUX9va1g1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--Assets_iI_hus-gaap--StatementBusinessSegmentsAxis__custom--TotalReportingSegmentAssetsMember_zycCQYPgMH26" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Total reporting segment assets</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">30,698,054</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">28,432,560</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Assets_iI_hus-gaap--StatementBusinessSegmentsAxis__custom--UnallocatedAmountMember_z1yBg7z1jvm4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unallocated amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,414,463</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0756">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Assets_iI_z6mrpWx7VnTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Consolidated total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">34,112,517</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">28,432,560</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zBccoO7Y5gn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors, including the nature of products sold, product acquisition processes, customer types, distribution methods, and regulatory environments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zFs8uWV9Bf0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zsFptsS6n4q" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE DISAGGREGATED REVENUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20240101__20241231_z1NltnPeiYS5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">December 31,</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">2024</p></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_zWAGALJoVN5c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">December 31,</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">2023</p></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--RetailGroceryMember_z2wuXxbFsUs6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Retail Grocery</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><b>$</b></td><td style="width: 16%; text-align: right"><b>60,690,718</b></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47,243,163</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--FoodServiceRestaurantMember_zNKGH40yeeub" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Food service/restaurant</td><td> </td> <td style="text-align: left"><b> </b></td><td style="text-align: right"><b>8,679,160</b></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,440,245</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OnlineECommerceMember_zkRaQfqIjWgb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Online/eCommerce</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1pt solid; text-align: right"><b>925</b></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,385</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zcp6dXLrNvhg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><b>69,370,803</b></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55,689,793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_z6doyxU2oAW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have significant revenue recognized over time due to the nature of retail store operation. The Company recognizes revenue at a point in time when control of goods or services transfers to the customer. Revenue is recognized as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif"><tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retail Sales: At the point of sale when payment is received, products are physically transferred, and title passes.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising Services (COOP Revenue): When promotional materials are distributed to end-user customers.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2 <p id="xdx_89A_ecustom--SignificantSegmentExpensesTableTextBlock_zGOVi3Tolwak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zf4Gl7uzukf">SCHEDULE OF SIGNIFICANT SEGMENT EXPENSES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z5omT2vKoQB5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230101__20231231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z14kQquibvD1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--AdvertisingExpense_zq4JlROvBStg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Advertising</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">581,357</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">564,405</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CostDirectLabor_zrlbhjBPAMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Payroll and Benefits</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">13,963,361</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,645,985</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OccupancyNet_zK1s0eTeCjab" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Occupancy</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">6,573,925</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,280,405</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--Depreciation_z9nFDXut67md" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and Amortization</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,576,457</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,431,816</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProfessionalFees_z4BMXeW07wK9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Bank Service Charges and Merchant Account Fees</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,331,637</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">927,863</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_zP5SBt8RjZe7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other selling, general and administrative expenses</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,680,001</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,368,736</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--GoodwillImpairmentLoss_zGhtyHiEjfrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Goodwill impairment</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,104,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingCostsAndExpenses_iT_z2B7JcAysm81" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total significant reporting segment expenses</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">25,706,738</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">28,323,210</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 581357 564405 13963361 12645985 6573925 5280405 1576457 1431816 1331637 927863 1680001 1368736 6104000 25706738 28323210 <p id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zWGm5QZEuXqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the reconciliations of reportable segment profit or loss and assets to the Company’s consolidated totals:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_z8Q0QJwm4zMj">SCHEDULE OF RECONCILIATIONS OF REPORTABLE SEGMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20240101__20241231_zexsUbh8Lkke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_zfJdS74VCAu5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_hus-gaap--StatementBusinessSegmentsAxis__custom--SegmentNetOperatingIncomeLossMember_zex3rporZOdl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Segment net operating income (loss)</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">1,358,571</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(7,974,985</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--OperatingIncomeLoss_hus-gaap--StatementBusinessSegmentsAxis__custom--UnallocatedAmountMember_zdjV9MXLsLth" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unallocated amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(3,136,049</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,549,084</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_zozMeewjsET3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Consolidated loss from operation</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,777,478</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,524,069</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20241231_zgjBoVeHVHPd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20231231_zGuWUX9va1g1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--Assets_iI_hus-gaap--StatementBusinessSegmentsAxis__custom--TotalReportingSegmentAssetsMember_zycCQYPgMH26" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Total reporting segment assets</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">30,698,054</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">28,432,560</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Assets_iI_hus-gaap--StatementBusinessSegmentsAxis__custom--UnallocatedAmountMember_z1yBg7z1jvm4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unallocated amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,414,463</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0756">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Assets_iI_z6mrpWx7VnTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Consolidated total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">34,112,517</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">28,432,560</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1358571 -7974985 -3136049 -2549084 -1777478 -10524069 30698054 28432560 3414463 34112517 28432560 <p id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zFs8uWV9Bf0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zsFptsS6n4q" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE DISAGGREGATED REVENUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20240101__20241231_z1NltnPeiYS5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">December 31,</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">2024</p></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_zWAGALJoVN5c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">December 31,</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">2023</p></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--RetailGroceryMember_z2wuXxbFsUs6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Retail Grocery</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><b>$</b></td><td style="width: 16%; text-align: right"><b>60,690,718</b></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47,243,163</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--FoodServiceRestaurantMember_zNKGH40yeeub" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Food service/restaurant</td><td> </td> <td style="text-align: left"><b> </b></td><td style="text-align: right"><b>8,679,160</b></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,440,245</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OnlineECommerceMember_zkRaQfqIjWgb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Online/eCommerce</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1pt solid; text-align: right"><b>925</b></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,385</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zcp6dXLrNvhg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><b>69,370,803</b></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55,689,793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 60690718 47243163 8679160 8440245 925 6385 69370803 55689793 <p id="xdx_804_eus-gaap--AccountsAndNontradeReceivableTextBlock_zBFCornWfx3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6. <span id="xdx_82B_z7yjAePAwQn3">ACCOUNTS RECEIVABLE, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable is mainly related to cooperative advertising (CO-OP) billing from each of the HCWC entities. HCWC bills its vendors for advertising vendors’ products in our sales channels. Advertising revenue is included in sales revenue in the consolidated statement of operations. The Company recorded advertising revenue of approximately $<span id="xdx_901_ecustom--AdvertisingRevenue_c20240101__20241231_z0OFIXEb87v1" title="Advertising revenue">970,000</span> and $<span id="xdx_90D_ecustom--AdvertisingRevenue_c20230101__20231231_zvKOcmfmawu2" title="Advertising revenue">249,000</span> for the years ended December 31, 2024 and 2023, respectively. The Company’s accounts receivable totaled approximately $<span id="xdx_90D_eus-gaap--AccountsReceivableNet_iI_c20241231_zcHsK5DE3UKk" title="Accounts receivable">510,000</span> and $<span id="xdx_90D_eus-gaap--AccountsReceivableNet_iI_c20231231_z3HNAcMerH3g" title="Accounts receivable">128,000</span> at December 31, 2024 and December 31, 2023, respectively. The accounts receivable balance at January 1, 2023 was approximately $<span id="xdx_901_eus-gaap--AccountsReceivableNet_iI_c20230101_zjLA4wFDRvx" title="Accounts receivable">55,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit loss is attributable to accounts receivable, and the Company determines the required allowance for expected credit losses using information such as customer credit history, current conditions, and reasonable and supportable forecasts about the future. Amounts are recorded to the allowance when it is determined that expected credit losses may occur. The Company reserved approximately $<span id="xdx_906_eus-gaap--ProvisionForOtherCreditLosses_c20240101__20241231_z9lvRTlv5312" title="Credit losses">28,000</span> and $<span id="xdx_90B_eus-gaap--ProvisionForOtherCreditLosses_c20230101__20231231_z5EMCLspQRal" title="Credit losses">15,000</span> credit loss for the years ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 970000 249000 510000 128000 55000 28000 15000 <p id="xdx_80F_eus-gaap--InventoryDisclosureTextBlock_zpGNHX4Sru0a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7. <span id="xdx_827_z3YpULG4fuf">INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are measured at the lower of cost and net realizable value using the average cost method. If the cost of the inventories exceeds their market value, adjustments are recorded to write down excess inventory to its net realizable value. The Company, as a result of its physical inventory observations recorded the write down of inventories amounting to approximately $<span id="xdx_902_eus-gaap--InventoryWriteDown_pn5n6_c20240101__20241231_zVRvWjNs2KU9" title="Inventory write down"><span id="xdx_906_eus-gaap--InventoryWriteDown_pn5n6_c20230101__20231231_z0Pvu5ZqoaBc" title="Inventory write down">2.5</span></span> million in 2024 and 2023, respectively. The Company’s inventories consist primarily of merchandise available for resale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2500000 2500000 <p id="xdx_800_eus-gaap--BusinessCombinationDisclosureTextBlock_zTDhVIjdiaLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8. <span id="xdx_82C_zTuVP42CfMBc">ACQUISITIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase method of accounting in accordance with ASC 805 was applied for the Ellwood Thompson’s acquisition and GreenAcres Market acquisition. This requires the total cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill. Goodwill arising from the acquisition is attributable to expected operational synergies from combining the operations of the acquired business with those of the Company. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ellwood Thompson’s</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 1, 2023, the Company through its wholly owned subsidiary, Healthy Choice Markets V, LLC, entered into an Asset Purchase Agreement with (i) ET Holding, Inc., d/b/a Ellwood Thompson’s Local Market, a Virginia corporation, (ii) Ellwood Thompson’s Natural Market, L.C., a Virginia limited liability company, and (iii) Richard T. Hood, an individual resident of the Commonwealth of Virginia. Pursuant to the Purchase Agreement, the Company acquired certain assets and assumed certain liabilities related to Ellwood Thompson’s grocery stores in Richmond, Virginia. The Company intends to continue to operate the grocery stores under their existing name.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cash purchase price under the Asset Purchase Agreement was $<span id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_c20231001__20231001__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zIztKtkUqItb" title="Cash purchase">750,000</span>, and a promissory note provided to the seller of $<span id="xdx_903_eus-gaap--NotesPayableToBankNoncurrent_iI_c20231001__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zxJUVKPPAU18" title="Promissory note">750,000</span>, with a fair value of $<span id="xdx_901_eus-gaap--BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_c20231001__20231001__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zp9ztaX3HMuh" title="Fair value">718,000</span>. For twelve months ended on December 31, 2024, the Company recognized approximately $<span id="xdx_905_eus-gaap--InterestExpense_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zqbNBFlAQrqi" title="Interest expense">40,000</span> interest expense. In addition, the Company entered into a new lease agreement with the landlord and entered into an employment agreement with the store manager.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_gL3SOBABATB-CXW_zWltB9zsGJKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zfjnh3OQXEG6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PURCHASE PRICE ALLOCATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_z4zxwdUAP2vh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">October 1,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left">Purchase Consideration</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 80%; text-align: left">Cash consideration paid</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireBusinessesGross_c20231001__20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_za23xXrqTK77" style="width: 16%; text-align: right" title="Cash consideration paid">750,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Promissory note</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--NotesPayableToBankNoncurrent_iI_c20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zOpFTkfuKeAb" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note">718,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231001__20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_z7jFcXD4t9Wi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Purchase Consideration">1,468,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-weight: bold">Purchase price allocation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_zxn9GkxuiaAf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">851,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zQUgeJFDmNXk" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Property, plant, and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_zXSqcf5GbK31" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">291,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_iI_zgfWxnBMrwui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Right of use asset - Operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,325,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iNI_di_zrRDX3ZJOS1b" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Other liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(31,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_iI_z9CCj9mPx2qi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Operating lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,325,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--Goodwill_iI_ztGKpt1Tvpz4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">357,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zvNWiHKMgqxc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,468,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left">Finite-lived intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zk7VJZqVFZ0l" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Trade Names (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20231001__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_ztBsQTnykah" title="Useful lives (years)">8 years</span>)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">291,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_zbsjWsBLHuV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">291,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_z9bxy94KrhEc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquisition is structured as asset purchase in a business combination, and goodwill is tax-deductible, and amortizable over <span id="xdx_90D_ecustom--BusinessAcquisitionGoodwillTaxDeductibleAmountAmortizationPeriod_dtY_c20231001__20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zDUt6wMd5iba" title="Amortization period for goodwill for tax purposes (years)">15</span> years for tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>GreenAcres Market</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 18, 2024, the Company through its wholly owned subsidiary, Healthy Choice Markets VI, LLC, entered into an Asset Purchase Agreement with (i) GreenAcres Markets of Oklahoma, LLC, an Oklahoma limited liability company, (ii) GACorp, Inc., a Kansas corporation; and (iii) the group of equity holders owning the majority interests of the Sellers. Pursuant to the Purchase Agreement, the Company acquired certain assets and assumed certain liabilities related to five GreenAcres Market’s grocery stores in Kansas and Oklahoma. The Company continued to operate the grocery stores under their existing name.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cash purchase price under the Asset Purchase Agreement was $<span id="xdx_905_eus-gaap--PaymentsToAcquireBusinessesGross_c20240718__20240718__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zRat9gxRyVs" title="Cash consideration paid">5,475,000</span>, and a promissory note provided to the seller of $<span id="xdx_903_eus-gaap--NotesPayableToBankNoncurrent_iI_c20240718__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zEZVUOkbzEz1" title="Promissory note">1,825,000</span>. In addition, the Company entered into five new lease agreements with the landlords of the grocery stores.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0E_gL3SOBABATB-CXW_zsTdhcrhoioe">The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:</span></span></p> <div id="xdx_C0D_gL3SOBABATB-CXW_zJxAKPERPDD4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_309_134_zPwk5I5DTRvg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20240718__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zDcpY6cY1Fed" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">July 18,</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left">Purchase Consideration</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 80%; text-align: left">Cash consideration paid</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PaymentsToAcquireBusinessesGross_c20240718__20240718__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zI3yDBhMhAhi" style="width: 16%; text-align: right" title="Cash consideration paid">5,475,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Promissory note</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableToBankNoncurrent_iI_c20240718__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zYaAxDhf44Ji" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note">1,568,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20240718__20240718__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zyMisV7lMJP9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total purchase consideration">7,043,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-weight: bold">Purchase price allocation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_zjDuX8MwO6u8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,400,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_z1MxuoPqFbL5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Property, plant, and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_zO52hcaWBhJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,304,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--Goodwill_iI_zKJTj0IYwga" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,212,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zcWAG8CavMJh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,043,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left">Finite-lived intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPyLqCSFqV2g" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Trade Names (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20240718__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zDM0Z5uACcF9" title="Useful lives (years)">13 years</span>)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,584,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteAgreementMember_zLFvgNJKFhHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-Compete Agreement (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20240718__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zLbRp9g1x7ob" title="Useful lives (years)">5 years</span>)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">720,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_z8tkw9P1WDU" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,304,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_C0F_gL3SOBABATB-CXW_zyB3EBEhhW4i"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue and Earnings</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zCw5AQ8tgbWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following unaudited pro forma summary presents consolidated information of the Company, including Ellwood Thompson’s and GreenAcres Market, as if the business combinations had occurred on January 1, 2023, the earliest period presented herein:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zh5QG1nmtqud">SCHEDULE OF UNAUDITED PROFORMA INFORMATION</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zcUQ3n7lkSw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zZHTHBh3CCr2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessAcquisitionsProFormaRevenue_z7CKq30QxVf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Sales</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">77,762,430</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">80,173,326</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zyirDuHHXsgc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net loss</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(4,791,021</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,401,315</td><td style="text-align: left">)</td></tr> </table> <p id="xdx_8A8_zH7MBi4OAzq7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The pro forma financial information includes adjustments that are directly attributable to the business combinations and are factually supportable. The pro forma adjustments include incremental amortization of intangible, fixed assets depreciation and lease amortization. The proforma data gives effects to actual operating results prior to the acquisition. These proforma amounts do not purport to be indicative of the results that would have actually been obtained if the acquisitions occurred as of the beginning of each period presented or that may be obtained in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 750000 750000 718000 40000 <p id="xdx_890_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_gL3SOBABATB-CXW_zWltB9zsGJKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zfjnh3OQXEG6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PURCHASE PRICE ALLOCATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_z4zxwdUAP2vh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">October 1,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left">Purchase Consideration</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 80%; text-align: left">Cash consideration paid</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireBusinessesGross_c20231001__20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_za23xXrqTK77" style="width: 16%; text-align: right" title="Cash consideration paid">750,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Promissory note</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--NotesPayableToBankNoncurrent_iI_c20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zOpFTkfuKeAb" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note">718,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231001__20231001__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_z7jFcXD4t9Wi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Purchase Consideration">1,468,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-weight: bold">Purchase price allocation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_zxn9GkxuiaAf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">851,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zQUgeJFDmNXk" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Property, plant, and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_zXSqcf5GbK31" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">291,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_iI_zgfWxnBMrwui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Right of use asset - Operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,325,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iNI_di_zrRDX3ZJOS1b" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Other liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(31,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_iI_z9CCj9mPx2qi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Operating lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,325,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--Goodwill_iI_ztGKpt1Tvpz4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">357,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zvNWiHKMgqxc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,468,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left">Finite-lived intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zk7VJZqVFZ0l" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Trade Names (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20231001__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_ztBsQTnykah" title="Useful lives (years)">8 years</span>)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">291,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_zbsjWsBLHuV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">291,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_309_134_zPwk5I5DTRvg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20240718__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zDcpY6cY1Fed" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">July 18,</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left">Purchase Consideration</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 80%; text-align: left">Cash consideration paid</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PaymentsToAcquireBusinessesGross_c20240718__20240718__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zI3yDBhMhAhi" style="width: 16%; text-align: right" title="Cash consideration paid">5,475,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Promissory note</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableToBankNoncurrent_iI_c20240718__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zYaAxDhf44Ji" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note">1,568,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20240718__20240718__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zyMisV7lMJP9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total purchase consideration">7,043,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-weight: bold">Purchase price allocation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_zjDuX8MwO6u8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,400,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_z1MxuoPqFbL5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Property, plant, and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_zO52hcaWBhJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,304,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--Goodwill_iI_zKJTj0IYwga" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,212,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zcWAG8CavMJh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,043,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left">Finite-lived intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPyLqCSFqV2g" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Trade Names (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20240718__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zDM0Z5uACcF9" title="Useful lives (years)">13 years</span>)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,584,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteAgreementMember_zLFvgNJKFhHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-Compete Agreement (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKFBhcmVudGhldGljYWwpIChEZXRhaWxzKQA_" id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20240718__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zLbRp9g1x7ob" title="Useful lives (years)">5 years</span>)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">720,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_z8tkw9P1WDU" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,304,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> 750000 718000 1468000 851000 291000 1325000 31000 -1325000 357000 1468000 P8Y 291000 291000 P15Y 5475000 1825000 5475000 1568000 7043000 2400000 127000 2304000 2212000 7043000 P13Y 1584000 P5Y 720000 2304000 <p id="xdx_890_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zCw5AQ8tgbWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following unaudited pro forma summary presents consolidated information of the Company, including Ellwood Thompson’s and GreenAcres Market, as if the business combinations had occurred on January 1, 2023, the earliest period presented herein:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zh5QG1nmtqud">SCHEDULE OF UNAUDITED PROFORMA INFORMATION</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zcUQ3n7lkSw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--EllwoodThompsonMember_zZHTHBh3CCr2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessAcquisitionsProFormaRevenue_z7CKq30QxVf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Sales</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">77,762,430</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">80,173,326</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zyirDuHHXsgc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net loss</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(4,791,021</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,401,315</td><td style="text-align: left">)</td></tr> </table> 77762430 80173326 -4791021 -11401315 <p id="xdx_809_ecustom--LongLivedAssetsHeldForSaleDisclosureTextBlock_zsIfKpsLgjg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9. <span id="xdx_824_zcbGGhhL3k38">ASSETS HELD FOR SALE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 7, 2024, the Company closed the operation of the Saugerties, NY store. The decision was based on management’s plan to maximize the profitability of the grocery segment. The Company transferred all operating assets and liabilities to other neighboring stores. The building, which is owned by the Company, has a net carrying value of approximately $<span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentOther_iI_c20240207__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zEKeBzWXzzO5">544,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and was put up for sale in February at its fair market value. The Company has classified the building as held for sale in accordance with ASC 360, “<i>Property, Plant, and Equipment</i>.” The building was previously classified as property, plant, and equipment (PP&amp;E) and included in long-term assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 24, 2024, the Company finalized the closing of Saugerties, NY building sale with all parties involved and received net proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromSaleOfBuildings_c20240724__20240724__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zbFbkAghiJ72" title="Proceeds from sale of building">695,000</span>. The building was sold at fair market value of $<span id="xdx_90E_eus-gaap--AssetsHeldForSaleLongLivedFairValueDisclosure_iI_c20240724__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zw9ZxCuOT2ik" title="Fair market value">749,000</span> and the Company paid approximately $<span id="xdx_90D_eus-gaap--LegalFees_c20240724__20240724__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zc1EiHMN6MA1" title="Legal fee">54,000</span> in legal fees, commission and other miscellaneous expenses. The title and deed were transferred on the closing date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 544000 695000 749000 54000 <p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zHubWJ4G60Lh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10. <span id="xdx_824_zdw90QRUN3U3">PROPERTY, PLANT, AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_zygGedQz1eoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant, and equipment consist of the following as of December 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zXaBwabiLzha" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20241231_zbOKU9rUlA99" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20231231_zoDJVzRaSEmc" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DisplaysMember_zBfwax7NXNv5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Displays</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">312,146</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">312,146</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze76vqCtHpaf" style="vertical-align: bottom; background-color: White"> <td>Building</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0896">-</span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">575,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zKmaoC3PQnM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">720,657</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">505,436</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zQYASTqj4mA2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,991,953</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,925,385</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zLQ0zrWzbvIb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer hardware &amp; equipment</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">209,029</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">141,682</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OtherMachineryAndEquipmentMember_zSpc1vzwNmA5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">710,682</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">680,718</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz9Wk_z50y9VpsSeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant and equipment gross</span> </span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,944,467</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,140,367</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz9Wk_zBfaZDQvIx3f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation and amortization</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1,967,998</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,463,728</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz9Wk_zmTG7xUD701j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total property, plant, and equipment</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,976,469</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,676,639</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_z3VlmaifAgzi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred approximately $<span id="xdx_90D_eus-gaap--Depreciation_pn5n6_c20240101__20241231__us-gaap--FairValueByAssetClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zz47cqWxp1d5" title="Depreciation"><span id="xdx_90F_eus-gaap--Depreciation_pn5n6_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zqr8ZqDSbiX" title="Depreciation">0.5</span></span> million of depreciation expense for the years ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_zygGedQz1eoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant, and equipment consist of the following as of December 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zXaBwabiLzha" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20241231_zbOKU9rUlA99" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20231231_zoDJVzRaSEmc" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DisplaysMember_zBfwax7NXNv5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Displays</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">312,146</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">312,146</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze76vqCtHpaf" style="vertical-align: bottom; background-color: White"> <td>Building</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0896">-</span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">575,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zKmaoC3PQnM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">720,657</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">505,436</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zQYASTqj4mA2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,991,953</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,925,385</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zLQ0zrWzbvIb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer hardware &amp; equipment</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">209,029</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">141,682</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OtherMachineryAndEquipmentMember_zSpc1vzwNmA5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">710,682</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">680,718</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz9Wk_z50y9VpsSeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant and equipment gross</span> </span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,944,467</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,140,367</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz9Wk_zBfaZDQvIx3f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation and amortization</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1,967,998</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,463,728</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz9Wk_zmTG7xUD701j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total property, plant, and equipment</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,976,469</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,676,639</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 312146 312146 575000 720657 505436 1991953 1925385 209029 141682 710682 680718 3944467 4140367 1967998 1463728 1976469 2676639 500000 500000 <p id="xdx_80D_eus-gaap--IntangibleAssetsDisclosureTextBlock_zbZ9R6Eue8Sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11. <span id="xdx_825_zuWMv31S4Fx2">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zZeYMcK8C6eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net consist of the following as of December 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zyszxCMe4wYg" style="display: none">SCHEDULE OF INTANGIBLE ASSETS, NET</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">December 31, 2024</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Lives</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Years)</b></span></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying<br/> Amount</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying<br/> Amount</b></span></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Trade names</td><td style="width: 2%"> </td> <td style="width: 10%; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__srt--RangeAxis__srt--MinimumMember_zDYfzGZhBtAe">8</span>-<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__srt--RangeAxis__srt--MaximumMember_zOtaFhK0n2Ml">13 years</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zQ5sNVSXVeQ7" style="width: 12%; text-align: right" title="Gross Carrying amount">4,444,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zk8j3gK4JIY2" style="width: 12%; text-align: right" title="Accumulated Amortization">(1,427,798</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zcblYZSB7d17" style="width: 12%; text-align: right" title="Net Carrying Amount">3,016,202</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember__srt--RangeAxis__srt--MinimumMember_zcGmmgbMUOK8">4</span>-<span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember__srt--RangeAxis__srt--MaximumMember_zsulPspaRflg">6 years</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_z9eah5q1IJW8" style="text-align: right" title="Gross Carrying amount">2,669,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_zTXdKhoclID1" style="text-align: right" title="Accumulated Amortization">(1,628,639</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_zfKBrMUzhOD9" style="text-align: right" title="Net Carrying Amount">1,040,361</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Non-compete</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember__srt--RangeAxis__srt--MinimumMember_zdlSK2Jerin1">4</span>-<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember__srt--RangeAxis__srt--MaximumMember_z9wKHa8AjvH9">5 years</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zOtZBXA5ZBWd" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying amount">2,322,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zZIiNU2Ysdw5" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(937,085</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zlQMpNogGurf" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">1,384,915</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231_zeCsQBIgwPn" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Gross Carrying Amount">9,435,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231_zr0ZMbFYXm5a" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accumulated Amortization">(3,993,522</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20241231_zaybrCQWttM5" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Net Carrying Amount">5,441,478</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid">December 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Lives</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Years)</b></span></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying<br/> Amount</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying<br/> Amount</b></span></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Trade names</td><td style="width: 2%"> </td> <td style="width: 10%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__srt--RangeAxis__srt--MinimumMember_zxBCydB3Aem9" title="Useful lives (years)">8</span>-<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__srt--RangeAxis__srt--MaximumMember_zFRb7TYVE0Sd" title="Useful lives (years)">10 years</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zdXksdSDwg7g" style="width: 12%; text-align: right" title="Gross Carrying amount">2,860,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zNk812wPwjC2" style="width: 12%; text-align: right" title="Accumulated Amortization">(1,035,443</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ztpezWWXrMdi" style="width: 12%; text-align: right" title="Net Carrying Amount">1,824,557</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember__srt--RangeAxis__srt--MinimumMember_zmLmT3TkuWWd" title="Useful lives (years)">4</span>-<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember__srt--RangeAxis__srt--MaximumMember_zIuZ3K0BuwKe" title="Useful lives (years)">6 years</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_zWgpgYreHdce" style="text-align: right" title="Gross Carrying amount">2,669,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_zAuv3lnHDt99" style="text-align: right" title="Accumulated Amortization">(1,330,972</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_z5kx3u1cOll3" style="text-align: right" title="Net Carrying Amount">1,338,028</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Non-compete</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember__srt--RangeAxis__srt--MinimumMember_zYGhYF7Pqvv2" title="Useful lives (years)">4</span>-<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember__srt--RangeAxis__srt--MaximumMember_zUb5fOMlVEsg" title="Useful lives (years)">5 years</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zLX96NCkgESh" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying amount">1,602,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zisIpviQEdp4" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(586,066</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_z6BmnAyHOgVf" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">1,015,934</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20231231_zcSloGlJ6UM" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">7,131,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20231231_zoR5XHW4tE98" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(2,952,481</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20231231_zwC2g4TRe57e" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">4,178,519</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zxSmK0LICmQ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are amortized on a straight-line basis. Amortization expense was approximately $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20240101__20241231_zt5EyOmwduwf" title="Amortization of intangible assets">1.0</span> million and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20230101__20231231_zAm2gCkwuCvi" title="Amortization of intangible assets">0.9</span> million for the years ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted-average remaining amortization period of the Company’s amortizable intangible assets is approximately <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_c20230101__20231231_zVHakjL9KqTf" title="Weighted-average remaining amortization period">5 years</span> as of December 31, 2024. The estimated future amortization of the intangible assets is as follows:</span></p> <p id="xdx_892_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zYII66N1oOei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zTJt1w2RO2M" style="display: none">SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">For the years ending December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20241231_zLGnqnPWwIS5"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzuie_zNNIPKf1Hzi7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold; text-align: left">2025</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">1,180,613</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzuie_zPiuqqoAUQ7c" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">2026</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,103,576</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzuie_zFvcNn1Cf35k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2027</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">964,771</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzuie_zYEjH04hfrte" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">2028</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">655,332</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANzuie_zagxqJQMvEA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2029</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">302,221</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANzuie_zgZvAeAlkSM3" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 1pt">Thereafter</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1,234,965</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzuie_zUA5YVtDqD5g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,441,478</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zLAWZtJGf0i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zZeYMcK8C6eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net consist of the following as of December 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zyszxCMe4wYg" style="display: none">SCHEDULE OF INTANGIBLE ASSETS, NET</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">December 31, 2024</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Lives</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Years)</b></span></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying<br/> Amount</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying<br/> Amount</b></span></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Trade names</td><td style="width: 2%"> </td> <td style="width: 10%; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__srt--RangeAxis__srt--MinimumMember_zDYfzGZhBtAe">8</span>-<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__srt--RangeAxis__srt--MaximumMember_zOtaFhK0n2Ml">13 years</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zQ5sNVSXVeQ7" style="width: 12%; text-align: right" title="Gross Carrying amount">4,444,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zk8j3gK4JIY2" style="width: 12%; text-align: right" title="Accumulated Amortization">(1,427,798</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zcblYZSB7d17" style="width: 12%; text-align: right" title="Net Carrying Amount">3,016,202</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember__srt--RangeAxis__srt--MinimumMember_zcGmmgbMUOK8">4</span>-<span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember__srt--RangeAxis__srt--MaximumMember_zsulPspaRflg">6 years</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_z9eah5q1IJW8" style="text-align: right" title="Gross Carrying amount">2,669,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_zTXdKhoclID1" style="text-align: right" title="Accumulated Amortization">(1,628,639</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_zfKBrMUzhOD9" style="text-align: right" title="Net Carrying Amount">1,040,361</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Non-compete</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember__srt--RangeAxis__srt--MinimumMember_zdlSK2Jerin1">4</span>-<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember__srt--RangeAxis__srt--MaximumMember_z9wKHa8AjvH9">5 years</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zOtZBXA5ZBWd" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying amount">2,322,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zZIiNU2Ysdw5" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(937,085</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20241231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zlQMpNogGurf" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">1,384,915</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231_zeCsQBIgwPn" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Gross Carrying Amount">9,435,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231_zr0ZMbFYXm5a" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accumulated Amortization">(3,993,522</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20241231_zaybrCQWttM5" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Net Carrying Amount">5,441,478</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid">December 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Lives</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Years)</b></span></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying<br/> Amount</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying<br/> Amount</b></span></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Trade names</td><td style="width: 2%"> </td> <td style="width: 10%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__srt--RangeAxis__srt--MinimumMember_zxBCydB3Aem9" title="Useful lives (years)">8</span>-<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__srt--RangeAxis__srt--MaximumMember_zFRb7TYVE0Sd" title="Useful lives (years)">10 years</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zdXksdSDwg7g" style="width: 12%; text-align: right" title="Gross Carrying amount">2,860,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zNk812wPwjC2" style="width: 12%; text-align: right" title="Accumulated Amortization">(1,035,443</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ztpezWWXrMdi" style="width: 12%; text-align: right" title="Net Carrying Amount">1,824,557</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember__srt--RangeAxis__srt--MinimumMember_zmLmT3TkuWWd" title="Useful lives (years)">4</span>-<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember__srt--RangeAxis__srt--MaximumMember_zIuZ3K0BuwKe" title="Useful lives (years)">6 years</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_zWgpgYreHdce" style="text-align: right" title="Gross Carrying amount">2,669,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_zAuv3lnHDt99" style="text-align: right" title="Accumulated Amortization">(1,330,972</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerRelationshipMember_z5kx3u1cOll3" style="text-align: right" title="Net Carrying Amount">1,338,028</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Non-compete</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember__srt--RangeAxis__srt--MinimumMember_zYGhYF7Pqvv2" title="Useful lives (years)">4</span>-<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember__srt--RangeAxis__srt--MaximumMember_zUb5fOMlVEsg" title="Useful lives (years)">5 years</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zLX96NCkgESh" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying amount">1,602,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_zisIpviQEdp4" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(586,066</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--NonCompeteMember_z6BmnAyHOgVf" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">1,015,934</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20231231_zcSloGlJ6UM" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">7,131,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20231231_zoR5XHW4tE98" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(2,952,481</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20231231_zwC2g4TRe57e" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">4,178,519</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> P8Y P13Y 4444000 -1427798 3016202 P4Y P6Y 2669000 -1628639 1040361 P4Y P5Y 2322000 -937085 1384915 9435000 -3993522 5441478 P8Y P10Y 2860000 -1035443 1824557 P4Y P6Y 2669000 -1330972 1338028 P4Y P5Y 1602000 -586066 1015934 7131000 -2952481 4178519 1000000.0 900000 P5Y <p id="xdx_892_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zYII66N1oOei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zTJt1w2RO2M" style="display: none">SCHEDULE OF ESTIMATED FUTURE AMORTIZATION OF INTANGIBLE ASSETS</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">For the years ending December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20241231_zLGnqnPWwIS5"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzuie_zNNIPKf1Hzi7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold; text-align: left">2025</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">1,180,613</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzuie_zPiuqqoAUQ7c" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">2026</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,103,576</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzuie_zFvcNn1Cf35k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2027</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">964,771</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzuie_zYEjH04hfrte" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">2028</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">655,332</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANzuie_zagxqJQMvEA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2029</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">302,221</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANzuie_zgZvAeAlkSM3" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 1pt">Thereafter</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1,234,965</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzuie_zUA5YVtDqD5g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,441,478</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 1180613 1103576 964771 655332 302221 1234965 5441478 <p id="xdx_80A_eus-gaap--GoodwillDisclosureTextBlock_z8y0185q1Ntj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12. <span id="xdx_829_zoYvy9HKtnQ1">GOODWILL</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company tests goodwill for impairment annually on September 30 or more frequently if there are indicators that the carrying amount of the goodwill exceeds its estimated fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the impairment test in 2023, the entire $<span id="xdx_908_eus-gaap--GoodwillImpairmentLoss_pn5n6_c20230101__20231231_zYsA1X7aC3p2" title="Goodwill impairment charge">6.1</span> million carrying value of goodwill was recognized as a non-cash impairment charge in 2023. There was <span id="xdx_904_eus-gaap--GoodwillImpairmentLoss_dxL_c20240101__20241231_zV98uzA8kD6f" title="Goodwill impairment charge::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1020">no</span></span> impairment of goodwill during the year ended December 31, 2024 based on the annual impairment assessment for 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfGoodwillTextBlock_zpEBGbpjaMtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The changes in the carrying amount of goodwill as of December 31, 2024 and December 31, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zgkVN1Oknmy8" style="display: none">SCHEDULE OF GOODWILL</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iS_c20240101__20241231_z4LqJhzU2D91" style="width: 16%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iS_c20230101__20231231_zJex4EBhQU09" style="width: 16%; text-align: right" title="Beginning balance">5,747,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Acquisitions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98F_eus-gaap--GoodwillAcquiredDuringPeriod_c20240101__20241231_zOS2SUbU7iGh" style="font-weight: bold; text-align: right" title="Acquisitions">2,212,000</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--GoodwillAcquiredDuringPeriod_c20230101__20231231_zbLfQzDWOYU3" style="text-align: right" title="Acquisitions">357,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Impairment</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_di_c20240101__20241231_zo34fLCt1zNh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impairment"><span style="-sec-ix-hidden: xdx2ixbrl1032">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--GoodwillImpairmentLoss_di_c20230101__20231231_zBOPNh9JAcO8" style="border-bottom: Black 1pt solid; text-align: right" title="Impairment">(6,104,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--Goodwill_iE_c20240101__20241231_zIA3MPGTN716" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending balance">2,212,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iE_c20230101__20231231_zflkceCk4KPg" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1038">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zvXEslPZapS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6100000 <p id="xdx_896_eus-gaap--ScheduleOfGoodwillTextBlock_zpEBGbpjaMtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The changes in the carrying amount of goodwill as of December 31, 2024 and December 31, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zgkVN1Oknmy8" style="display: none">SCHEDULE OF GOODWILL</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iS_c20240101__20241231_z4LqJhzU2D91" style="width: 16%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iS_c20230101__20231231_zJex4EBhQU09" style="width: 16%; text-align: right" title="Beginning balance">5,747,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Acquisitions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98F_eus-gaap--GoodwillAcquiredDuringPeriod_c20240101__20241231_zOS2SUbU7iGh" style="font-weight: bold; text-align: right" title="Acquisitions">2,212,000</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--GoodwillAcquiredDuringPeriod_c20230101__20231231_zbLfQzDWOYU3" style="text-align: right" title="Acquisitions">357,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Impairment</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_di_c20240101__20241231_zo34fLCt1zNh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impairment"><span style="-sec-ix-hidden: xdx2ixbrl1032">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--GoodwillImpairmentLoss_di_c20230101__20231231_zBOPNh9JAcO8" style="border-bottom: Black 1pt solid; text-align: right" title="Impairment">(6,104,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--Goodwill_iE_c20240101__20241231_zIA3MPGTN716" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending balance">2,212,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iE_c20230101__20231231_zflkceCk4KPg" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1038">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 5747000 2212000 357000 6104000 2212000 <p id="xdx_801_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_ztTOetpuUKIj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13. <span id="xdx_822_z4Gjz5ftFEn9">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zAPNvF1z00dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2024 and December 31, 2023, accounts payable and accrued expenses consisted of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zYeNeybhAVg7" style="display: none">SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20241231_zpV3PDNiJhRf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20231231_zIGPIyafShg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_maAPAALzbb0_zO4fwFd59z3c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Trade creditors</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">5,133,782</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,406,299</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_maAPAALzbb0_zOUXidgNh1Qa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued expenses</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">997,752</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">514,112</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iTI_mtAPAALzbb0_zsk6XXBOEsu7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">6,131,534</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,920,411</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z6PGDmeBwaZ" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zAPNvF1z00dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2024 and December 31, 2023, accounts payable and accrued expenses consisted of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zYeNeybhAVg7" style="display: none">SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20241231_zpV3PDNiJhRf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20231231_zIGPIyafShg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_maAPAALzbb0_zO4fwFd59z3c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Trade creditors</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">5,133,782</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,406,299</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_maAPAALzbb0_zOUXidgNh1Qa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued expenses</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">997,752</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">514,112</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iTI_mtAPAALzbb0_zsk6XXBOEsu7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">6,131,534</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,920,411</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5133782 4406299 997752 514112 6131534 4920411 <p id="xdx_807_eus-gaap--DebtDisclosureTextBlock_zoZJhq22geQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14. <span id="xdx_827_zy3EoGD5Kxzb">DEBT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zMZXpl0l3eMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a breakdown of the Company’s debt as of December 31, 2024 and 2023 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zzT4q37lWIF5" style="display: none">SCHEDULE OF DEBT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20241231_zpWF5dhBJr31" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20231231_zKoEE6cszaO5" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--DebtInstrumentCarryingAmount_iI_maLTDzrty_zrZhyNlc0Ir8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Promissory note</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">11,623,392</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,106,508</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msLTDzrty_zuPtYtxTemX1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Debt discount and issuance cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(284,283</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1061">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iI_mtLTDzrty_maLTDNzTsu_zsuJEYGzYr69" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total debt, net of debt discount and issuance costs</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">11,339,109</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,106,508</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtCurrent_iNI_di_maLTDNzTsu_zyVv024z8eCh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current portion of long-term debt</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,200,210</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(702,701</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_msLTDNzTsu_zFpRGK8DDdm5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Current portion of debt discount and issuance cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">68,873</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1070">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtNoncurrent_iI_mtLTDNzTsu_zSeFfEiYsyXg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Long-term debt</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">9,207,772</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,403,807</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_z5tOnlAiL7M5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory Note</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Green’s Natural Foods acquisition, on October 14, 2022, the Company issued a secured promissory note (the “Greens Note”) in the principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20221014__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zb9GKvsmVucf" title="Principal amount">3,000,000</span> as a portion of the purchase price. The Greens Note has a five-year term, an interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20221014__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zpji5arZziC7" title="Interest rate">6.0</span>% per annum and is secured by the assets of the Green’s Natural Foods. The outstanding balance was approximately $<span id="xdx_90B_eus-gaap--ShorttermDebtAverageOutstandingAmount_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zCgrTBxP5EFl" title="Outstanding Debt">1,809,000</span> and $<span id="xdx_902_eus-gaap--ShorttermDebtAverageOutstandingAmount_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zKUQQLrC3wwh" title="Outstanding Debt">2,378,000</span> as of December 31, 2024 and December 31, 2023, respectively. The Company incurred approximately $<span id="xdx_90E_eus-gaap--InterestExpenseDebt_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zSSs3oRGKzp4" title="Debt interest">127,000</span> and $<span id="xdx_90A_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zTNlaXsPblF6" title="Debt interest">160,000</span> interest expense for the year ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Ellwood Thompson’s acquisition, on October 1, 2023, the Company issued a secured promissory note (the “Ellwood Note”) in the principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20231001__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zfUlmCR47FFf" title="Principal amount">750,000</span>, and discounted present value of $<span id="xdx_903_eus-gaap--DebtInstrumentFairValue_iI_c20231001__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zrlqzhS4mMnl" title="Debt fair value">718,000</span> as a portion of the purchase price. The Ellwood Note has a five-year term, an interest rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231001__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zDqx69PBarBa" title="Interest rate">6.0</span>% per annum. The outstanding balance of the Ellwood Note was approximately $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zUpdDMGL7Xqd" title="Outstanding Debt">595,000</span> and $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zqzHR2Cb5MN6" title="Outstanding Debt">728,000</span> in principal amount as of December 31, 2024 and December 31, 2023, respectively. The Company recognized interest expense of approximately $<span id="xdx_90D_eus-gaap--InterestExpenseDebt_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zG4DCxq1WO2e" title="Debt interest">40,000</span> and $<span id="xdx_90A_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zlsqhO1NBjh1" title="Debt interest">39,000</span> for the years ended December 31, 2024, and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2024, HCWC entered into a Securities Purchase Agreement (the “Bridge Financing”) with institutional investors whereby (a) HCWC issued a total of approximately $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240118__20240118__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNJh3IxcsnAk" title="Aggregate subscription price">1,889,000</span> in unsecured promissory notes (the “Notes”) and (b) on the date of the pricing of HCWC’s initial public offering (“IPO”), HCWC would deliver shares of its common stock equal to approximately $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240118__20240118__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember_zXQKoWLOQA9h" title="Aggregate subscription price">1,889,000 </span>divided by the IPO price (“Bridge Shares”). <span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20240118__20240118__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGAc4vUpJy89" title="Debt instrument description">The aggregate gross proceeds received from the investors in connection with the Security Purchase Agreement (“SPA”) was $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240118__20240118__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zva8gvY3Cz64" title="Aggregate subscription price">1,700,000</span>. The Notes were issued at a <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240118__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember_zZ8oUCmw80M7" title="Interest rate">10</span>% original issue discount (“OID”) and accrue interest at a rate of 10% per annum beginning 60 days after issuance of the Notes. All accrued and unpaid principal and interest shall be due and payable upon the earlier of (1) the closing of the IPO, (2) January 18, 2025 or (3) upon an event of default as defined in the Notes.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 8, 2024, HCWC and the institutional investors entered into an amendment to the January 18, 2024 agreement whereby HCWC agreed to issue warrants (the “Bridge Warrants”) exercisable at $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240408__us-gaap--ClassOfWarrantOrRightAxis__custom--BridgeWarrantSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zrAK3qnwxhyk" title="Warrant exercise price">0.01</span> per share to purchase <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240408__us-gaap--ClassOfWarrantOrRightAxis__custom--BridgeWarrantSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGvTvPe3mqC3" title="Warrant purchase">188,889</span> shares of Class A common stock (the “Bridge Warrant Shares”) in lieu of Bridge Shares. The parties agreed to terminate any existing obligations of the institutional investors to acquire HCWC Bridge Shares as part of the IPO transaction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Spin-Off Date, after the NYSEAM market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock was traded on the NYSEAM under the stock symbol “HCWC.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the completion of the IPO, HCWC paid in full the principal amount of Notes and OID. At December 31, 2024, the outstanding principal balance of the Notes and debt discount related with the Notes were at $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMai2eTPTwug" title="Debt discount">0</span>. HCWC incurred approximately $<span id="xdx_90B_eus-gaap--DeferredFinanceCostsNet_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqhWBwTECKe9" title="Debt issuance cost">23,500</span> of debt issuance costs in connection with the issuance of the Notes, which, together with the OID of approximately $<span id="xdx_903_eus-gaap--AmortizationOfDebtDiscountPremium_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zjPVDpQBk313" title="Amortization of debt discount">189,000</span>, was recorded as a debt discount and was amortized over the life of the Notes using the straight-line method since such method was not materially different from the interest method. For the year ended December 31, 2024, approximately $<span id="xdx_902_eus-gaap--InterestExpense_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxD3BDwuVA2l" title="Interest expense">298,000</span> of interest expense was recognized in the accompanying consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company used the intrinsic value model to determine the fair value of the Bridge Warrants on April 18, 2024 and remeasured the fair value on September 16, 2024, and concluded that the fair value of the Bridge Warrants at September 16, 2024 was $<span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240916__us-gaap--ClassOfWarrantOrRightAxis__custom--BridgeWarrantSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJhxvbTH8ZQb" title="Warrant purchase">1,887,001</span>. Due to the fact that Bridge Warrants exercise was contingent upon the IPO, the Company did not recognize the warrant liability until the Spin-off date. The Bridge Warrants were exercised on September 17, 2024 by institutional investors. Upon warrant exercise, <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240917__us-gaap--ClassOfWarrantOrRightAxis__custom--BridgeWarrantSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zwLRQ7H4hCT4" title="Warrant purchase">188,889 </span>shares of Class A common stock were issued and the warrant liability was eliminated against the loss on debt extinguishment in the amount of $<span id="xdx_90B_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240916__20240917__us-gaap--ClassOfWarrantOrRightAxis__custom--BridgeWarrantSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zMtI1MVQacz3" title="Gains losses on extinguishment of debt">1,888,889</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 18, 2024 (the “Loan Effective Date”), the Company entered into a loan and security agreement with a private lender for a $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20240718__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_z9HcVEAMaxo9" title="Face amount">7,500,000</span> loan (the “Acquisition Loan”). A portion of the Acquisition Loan proceeds were used to acquire GreenAcres Markets. The loan is guaranteed by all of the subsidiaries of the Company (the “Guarantors”) and secured by all of the assets of the Company and the Guarantors. The Acquisition Loan has a term of <span id="xdx_906_eus-gaap--DebtInstrumentTerm_dc_c20240718__20240718__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zW0cU3LJ2jNg" title="Debt term">three years</span> and interest accrues at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240718__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zk7zhyZdty9i" title="Interest rate">12</span>% on amounts borrowed. The Acquisition Loan may be prepaid at any time at a premium in the amount of ten percent (<span id="xdx_905_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240718__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GreenAcresMarketMember_zebdWUtoQhLe" title="Acquisition percentage">10</span>%) of the principal amount of the Acquisition Loan outstanding prior to such prepayment. Payments on the Acquisition Loan are required to be made as follows: $<span id="xdx_902_eus-gaap--RepaymentsOfLongTermDebt_pid_c20240718__20240718__us-gaap--AwardTypeAxis__custom--FirstAnniversaryMember_zVqMgQh44JS9" title="Payment of long term debt">1,125,000</span> on first anniversary of the Loan Effective Date, $<span id="xdx_908_eus-gaap--RepaymentsOfLongTermDebt_pid_c20240718__20240718__us-gaap--AwardTypeAxis__custom--SecondAnniversaryMember_zDCcDBYF9tNf" title="Payment of long term debt">1,875,000</span> on the second anniversary of the Loan Effective Date, and the remaining outstanding principal balance of principal and accrued interest on the third anniversary of the Loan Effective Date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the GreenAcres Market acquisition, on August 23, 2024, the Company issued a secured promissory note (the “GreenAcres Note”) in the principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20240823__us-gaap--TypeOfArrangementAxis__custom--AcquisitionLoanAndSecurityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zeltsySOLoyi">1,825,000</span> as a portion of the purchase price. The GreenAcres Note has a five-year term, an interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240823__us-gaap--TypeOfArrangementAxis__custom--AcquisitionLoanAndSecurityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zlUxYXvixwJ8">6.0</span>% per annum and is secured by the assets of the GreenAcres Market. The outstanding balance was approximately $<span id="xdx_902_eus-gaap--ShorttermDebtAverageOutstandingAmount_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AcquisitionLoanAndSecurityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zD2iFFEzb9Je">1,720,000 </span>and $<span id="xdx_900_eus-gaap--ShorttermDebtAverageOutstandingAmount_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AcquisitionLoanAndSecurityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zh4XD3puRFdd">0</span> as of December 31, 2024 and 2023, respectively. The Company incurred approximately $<span id="xdx_901_eus-gaap--InterestExpenseDebt_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AcquisitionLoanAndSecurityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zUNL2O83wSY" title="Interest expense">36,000</span> and $<span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AcquisitionLoanAndSecurityAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_z6KlmcLJeHu5" title="Interest expense">0</span> interest expense for the years ended December 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may, at its option, at any time or from time to time prepay the outstanding principal amount or any accrued but unpaid interest, in each case in whole or in part, without penalty or premium, provided that any such prepayment of any outstanding amount of principal shall be accompanied by the payment of all accrued but unpaid interest on the amount of principal being prepaid, plus any costs and fees incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DebtInstrumentRedemptionTableTextBlock_znWVCAt3bVU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIERFQlQgUkVQQVlNRU5UIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentTerm_dtY_c20240101__20241231_zfuMYTutJ1oh" title="Debt instrument repayment term">5</span>-year repayment schedule:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span><span><span id="xdx_8B4_zsZINCV6jAzk" style="display: none">SCHEDULE OF DEBT REPAYMENT</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">For the years ending December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20241231_zi1o4PoaCHh3"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maDICAz7vH_zpJUj3LCuSr7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold; text-align: left">2025</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">2,200,210</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maDICAz7vH_zV1hGL3Oitfi" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">2026</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,016,526</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maDICAz7vH_zORYfN4VLX7j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2027</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">5,595,359</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maDICAz7vH_zlqTmZgsn9e6" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">2028</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">534,923</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_maDICAz7vH_zOag1YuvTfq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">2029</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">276,374</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DebtInstrumentCarryingAmount_iI_mtDICAz7vH_zsDf7q7wWIOh" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,623,392</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zH61CgjARMAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zMZXpl0l3eMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a breakdown of the Company’s debt as of December 31, 2024 and 2023 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zzT4q37lWIF5" style="display: none">SCHEDULE OF DEBT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20241231_zpWF5dhBJr31" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20231231_zKoEE6cszaO5" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--DebtInstrumentCarryingAmount_iI_maLTDzrty_zrZhyNlc0Ir8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Promissory note</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">11,623,392</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,106,508</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msLTDzrty_zuPtYtxTemX1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Debt discount and issuance cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(284,283</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1061">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iI_mtLTDzrty_maLTDNzTsu_zsuJEYGzYr69" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total debt, net of debt discount and issuance costs</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">11,339,109</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,106,508</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtCurrent_iNI_di_maLTDNzTsu_zyVv024z8eCh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current portion of long-term debt</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,200,210</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(702,701</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_msLTDNzTsu_zFpRGK8DDdm5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Current portion of debt discount and issuance cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">68,873</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1070">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtNoncurrent_iI_mtLTDNzTsu_zSeFfEiYsyXg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Long-term debt</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">9,207,772</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,403,807</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 11623392 3106508 284283 11339109 3106508 2200210 702701 68873 9207772 2403807 3000000 0.060 1809000 2378000 127000 160000 750000 718000 0.060 595000 728000 40000 39000 1889000 1889000 The aggregate gross proceeds received from the investors in connection with the Security Purchase Agreement (“SPA”) was $1,700,000. The Notes were issued at a 10% original issue discount (“OID”) and accrue interest at a rate of 10% per annum beginning 60 days after issuance of the Notes. All accrued and unpaid principal and interest shall be due and payable upon the earlier of (1) the closing of the IPO, (2) January 18, 2025 or (3) upon an event of default as defined in the Notes. 1700000 0.10 0.01 188889 0 23500 189000 298000 1887001 188889 1888889 7500000 P3Y 0.12 0.10 1125000 1875000 1825000 0.060 1720000 0 36000 0 <p id="xdx_897_eus-gaap--DebtInstrumentRedemptionTableTextBlock_znWVCAt3bVU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIERFQlQgUkVQQVlNRU5UIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentTerm_dtY_c20240101__20241231_zfuMYTutJ1oh" title="Debt instrument repayment term">5</span>-year repayment schedule:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span><span><span id="xdx_8B4_zsZINCV6jAzk" style="display: none">SCHEDULE OF DEBT REPAYMENT</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">For the years ending December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20241231_zi1o4PoaCHh3"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maDICAz7vH_zpJUj3LCuSr7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold; text-align: left">2025</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">2,200,210</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maDICAz7vH_zV1hGL3Oitfi" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">2026</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,016,526</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maDICAz7vH_zORYfN4VLX7j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2027</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">5,595,359</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maDICAz7vH_zlqTmZgsn9e6" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">2028</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">534,923</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_maDICAz7vH_zOag1YuvTfq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">2029</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">276,374</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DebtInstrumentCarryingAmount_iI_mtDICAz7vH_zsDf7q7wWIOh" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,623,392</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> P5Y 2200210 3016526 5595359 534923 276374 11623392 <p id="xdx_807_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zOrsuK7xlTC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15. <span id="xdx_827_zInWZwAdSfZ9">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legal Proceedings</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 31, 2024, one of the Company’s subsidiaries, Healthy Choice Markets IV, LLC, was served with a lawsuit filed by a former employee alleging violations of state and federal wage and hour laws. The Company believes the claims are without merit and intends to vigorously defend against the lawsuit. While the outcome of this litigation cannot be predicted with certainty, the Company does not believe that the lawsuit, if adversely resolved, would have a material adverse effect on its financial condition, results of operations, or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time the Company is involved in legal proceedings arising in the ordinary course of our business. We believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of December 31, 2024. With respect to legal costs, we record such costs as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z0dYlEvTPfn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N<b>OTE 16. <span id="xdx_829_zGV65Gt2ndd3">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Spin-Off</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HCMC announced on August 22, 2022 that its Board of Directors approved separation of the Grocery business, including wellness business, into an independent, publicly traded company (the “Spin-Off”). Prior to the Spin-Off, HCWC was a subsidiary under HCMC, which operated the Ada’s Natural Market, Paradise Health &amp; Nutrition, Mother Earth’s Storehouse, Greens Natural Foods, Ellwood Thompson’s, and GreenAcres Market retail brands, as well as licensed wellness centers and Healthy U Wholesale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Spin-Off Date, after the NYSEAM market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock was traded on the NYSEAM under the stock symbol “HCWC.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HCMC distributed all the outstanding shares of Common Stock held by it on a pro rata basis to holders of HCMC’s common stock. For each <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240908__20240909__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zklidCmEHJxe" title="Number of shares issued">208,632</span> shares of HCMC common stock held as of 5:00 p.m., New York City time, on September 9, 2024, the record date for the Spin-Off (the “Record Date”), a HCMC stockholder was entitled to receive one (1) share of Class A common stock and three (3) shares of Class B common stock. The Distribution was made in book-entry form by a distribution agent as soon as practicable after the date of the Distribution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024, <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20241231_zAeHR1b8KnFe" title="Common stock shares outstanding">9,815,749</span> shares of common stock are outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized to issue <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zfFGtMTK2J6i" title="Preferred stock, shares authorized">40,000,000</span> shares of Series A convertible preferred stock with par value of $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zkDXyt9C0cz9" title="Preferred stock, par value">0.001</span>, none of which have been previously issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HCMC has secured binding commitments of $<span id="xdx_907_ecustom--EquityFinancing_iI_pn4n6_c20240913__dei--LegalEntityAxis__custom--HealthierChoicesManagementCorpMember_zdMAHsJRzRfk" title="Equity financing">13.25</span> million in equity financing for HCWC from the same group of investors that invested $<span id="xdx_907_eus-gaap--Investments_iI_pn4n6_c20240913__dei--LegalEntityAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zFt4npNI7egg" title="Investments">13.25</span> million in HCMC Series E Preferred Stock. Pursuant to the Securities Purchase Agreement for the HCMC Series E Stock (“HCMC Series E SPA”), the purchasers of HCMC Series E Stock will also be required to purchase Series A Preferred Stock of HCWC in the same subscription amounts that the Purchasers paid for the HCMC Series E Stock (regardless of whether or not such HCMC Series E Stock has been converted into HCMC common stock).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 208632 9815749 40000000 0.001 13250000 13250000 <p id="xdx_802_eus-gaap--LesseeOperatingLeasesTextBlock_zd2x8oNhTTd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17. <span id="xdx_824_zTYv5KYj7zya">LEASES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has various lease agreements with terms of up to <span id="xdx_90C_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20241231_zhLRIoAnUEKd" title="Lease term">20</span> years, including leases of retail stores, headquarters and equipment. All the leases are classified as operating leases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zTcbzyIWBxe5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zUDt3mIWSWB6" style="display: none">SCHEDULE OF MATURITY OF LEASE LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Maturity of Lease Liabilities by Fiscal Year</td><td> </td> <td colspan="2" id="xdx_492_20241231_zG1IcXq1xr82" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPz2P5_zzmjALdQsIC" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,221,590</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPz2P5_zd2D1mEvyz6d" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,923,741</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPz2P5_zIwMElAAj0Te" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,956,171</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPz2P5_zilsbEWvGaD2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,280,186</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPz2P5_zTT6b3ul9BPe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2029</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,617,808</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPz2P5_zBm7fzHqBm79" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">824,585</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPz2P5_zTxjVcai8Vh7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total undiscounted operating lease payments</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">15,824,081</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zv6cdI3GOjv1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,642,663</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iTI_zqSkVbodFKNg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Present value of operating lease liabilities</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">14,181,418</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zgCGuSX6A8l4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfCompanyOperatingLeasesTableTextBlock_zA6oS8b2bG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes the Company’s operating leases:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zvXnNvpIANpd" style="display: none">SCHEDULE OF COMPANY’S OPERATING LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic">Balance Sheet Classification</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20241231_zyU5hLJW5Fl8" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20231231_z1cTaYg0xhFa" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zyxQHrASMXVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Right of use assets</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; font-weight: bold; text-align: right">14,232,240</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">11,412,562</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maOLLztOx_zcUqBG7C8Ea5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, current</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">3,596,987</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,748,824</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_maOLLztOx_zxPvdidBCqPa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Operating lease liability, net of current</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">10,584,431</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,461,182</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iTI_mtOLLztOx_zshUYAF9pVvh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">14,181,418</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,210,006</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zCCg9rKacNta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amortization of the right-of-use asset of approximately $<span id="xdx_90B_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3d_c20240101__20241231_zKx687b5JVIi" title="Amortization of right-of-use assets">3,274,000</span> and $<span id="xdx_90C_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3d_c20230101__20231231_zMTsufwM7RHj" title="Amortization of right-of-use assets">2,570,000</span> for the years ended December 31, 2024 and 2023, respectively, were included in operating cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--LesseeOperatingLeaseLiabilityLeaseTermTableTextBlock_zNMQxjv1GDCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a summary of other information related to the leases at December 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z7BfcElTq4hg" style="display: none">SCHEDULE OF OPERATING LEASE TERM</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic">Other Information</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2024</b></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2023</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term for operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zz0FCY8PYMV9" title="Weighted-average remaining lease term for operating leases">4</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zMPb4FBamU74" title="Weighted-average remaining lease term for operating leases">5</span> years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left">Weighted-average discount rate for operating leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20241231_zSqhs3yoHvyd" title="Weighted-average discount rate for operating leases">5.19</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_zJBHbOCB1vwh" title="Weighted-average discount rate for operating leases">3.98</span></td><td style="width: 1%; text-align: left">%</td></tr> </table> <p id="xdx_8AC_zrrw0GZVTgG1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent expense for the years ended December 31, 2024 and 2023 was approximately $<span id="xdx_90F_eus-gaap--PaymentsForRent_c20240101__20241231_zuAiOFpgR31h" title="Rent expense">4,196,000</span> and $<span id="xdx_904_eus-gaap--PaymentsForRent_c20230101__20231231_zwOvaO5rmIG" title="Rent expense">3,435,000</span>, respectively, and is included in selling, general and administrative expenses in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--LeaseCostTableTextBlock_z4cuhstVCAQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represents the components of lease expense are as follows for twelve months ended December 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zGkpsyQuShn" style="display: none">SCHEDULE OF COMPONENTS OF LEASE EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20240101__20241231_zD4kJLbSfF3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseCost_maLCzsUv_z5xOo9Pntee1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Operating lease cost</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">3,273,563</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--VariableLeaseCost_maLCzsUv_zPLcEKMT4px2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Variable lease cost</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">922,282</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ShortTermLeaseCost_maLCzsUv_znIo1NwG85k8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Short-term lease cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LeaseCost_iT_mtLCzsUv_zlCVb7IEQZHa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total rent expense</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,195,845</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zUhgmx8MURQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate cash payments under the leasing arrangement was approximately $<span id="xdx_90C_eus-gaap--OperatingLeasePayments_c20240101__20241231_zZatcH0Vl1Rg" title="Cash payments">3,122,000</span> for the year ended December 31, 2024 and was included in operating cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P20Y <p id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zTcbzyIWBxe5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zUDt3mIWSWB6" style="display: none">SCHEDULE OF MATURITY OF LEASE LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Maturity of Lease Liabilities by Fiscal Year</td><td> </td> <td colspan="2" id="xdx_492_20241231_zG1IcXq1xr82" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPz2P5_zzmjALdQsIC" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,221,590</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPz2P5_zd2D1mEvyz6d" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,923,741</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPz2P5_zIwMElAAj0Te" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,956,171</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPz2P5_zilsbEWvGaD2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,280,186</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPz2P5_zTT6b3ul9BPe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2029</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,617,808</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPz2P5_zBm7fzHqBm79" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">824,585</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPz2P5_zTxjVcai8Vh7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total undiscounted operating lease payments</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">15,824,081</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zv6cdI3GOjv1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,642,663</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iTI_zqSkVbodFKNg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Present value of operating lease liabilities</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">14,181,418</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 4221590 3923741 2956171 2280186 1617808 824585 15824081 1642663 14181418 <p id="xdx_892_ecustom--ScheduleOfCompanyOperatingLeasesTableTextBlock_zA6oS8b2bG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes the Company’s operating leases:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zvXnNvpIANpd" style="display: none">SCHEDULE OF COMPANY’S OPERATING LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic">Balance Sheet Classification</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20241231_zyU5hLJW5Fl8" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20231231_z1cTaYg0xhFa" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zyxQHrASMXVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Right of use assets</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; font-weight: bold; text-align: right">14,232,240</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">11,412,562</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maOLLztOx_zcUqBG7C8Ea5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, current</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">3,596,987</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,748,824</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_maOLLztOx_zxPvdidBCqPa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Operating lease liability, net of current</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">10,584,431</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,461,182</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iTI_mtOLLztOx_zshUYAF9pVvh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">14,181,418</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,210,006</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 14232240 11412562 3596987 2748824 10584431 8461182 14181418 11210006 3274000 2570000 <p id="xdx_893_ecustom--LesseeOperatingLeaseLiabilityLeaseTermTableTextBlock_zNMQxjv1GDCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a summary of other information related to the leases at December 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z7BfcElTq4hg" style="display: none">SCHEDULE OF OPERATING LEASE TERM</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic">Other Information</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2024</b></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2023</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term for operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zz0FCY8PYMV9" title="Weighted-average remaining lease term for operating leases">4</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zMPb4FBamU74" title="Weighted-average remaining lease term for operating leases">5</span> years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left">Weighted-average discount rate for operating leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20241231_zSqhs3yoHvyd" title="Weighted-average discount rate for operating leases">5.19</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_zJBHbOCB1vwh" title="Weighted-average discount rate for operating leases">3.98</span></td><td style="width: 1%; text-align: left">%</td></tr> </table> P4Y P5Y 0.0519 0.0398 4196000 3435000 <p id="xdx_894_eus-gaap--LeaseCostTableTextBlock_z4cuhstVCAQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represents the components of lease expense are as follows for twelve months ended December 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zGkpsyQuShn" style="display: none">SCHEDULE OF COMPONENTS OF LEASE EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20240101__20241231_zD4kJLbSfF3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseCost_maLCzsUv_z5xOo9Pntee1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Operating lease cost</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">3,273,563</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--VariableLeaseCost_maLCzsUv_zPLcEKMT4px2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Variable lease cost</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">922,282</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ShortTermLeaseCost_maLCzsUv_znIo1NwG85k8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Short-term lease cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LeaseCost_iT_mtLCzsUv_zlCVb7IEQZHa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total rent expense</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,195,845</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 3273563 922282 4195845 3122000 <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ztLEhrJiljV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18. <span id="xdx_829_zFb16g77Eiqj">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to the Spin-Off, the Company has not historically operated as a separate, stand-alone company and, accordingly has had various relationships with HCMC whereby HCMC provided services to the Company as noted below. Related party transactions prior to Spin-Off include allocation of general corporate expenses and advances from parent.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Allocation of General Corporate Expenses</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HCMC provided human resources, accounting, payroll processing, legal and other managerial services to the Company prior to the Spin-Off. The accompanying consolidated financial statements include allocations of these expenses. Following the Spin-Off, HCWC and HCMC entered into a TSA, under which both companies agreed to provide certain transitional services to one another to ensure smooth separation. These services are provided on a transitional basis and will continue for a period of up to one year following the Spin-Off.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management adopted a proportional cost allocation method to allocate HCMC expenses to the Company. The allocation method calculates the appropriate share of overhead costs to the Company based on management’s estimate that the sum of management time and resources spent managing the Company is approximately equal to the amount of time and resources spent managing HCMC and its subsidiaries. As a result, 50% of HCMC overhead on a weighted average basis was allocated to the Company based on the fact that management spent equal amount of time managing HCMC and the Company. The Company believes the allocation methodology used is reasonable and has been consistently applied, and results in an appropriate allocation of costs incurred. However, these allocations may not be indicative of the cost had the Company been a stand-alone entity or of future services. HCMC allocated approximately $<span id="xdx_903_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn5n6_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_zdD70lmwhO44" title="Allocation amount">2.1</span> million and $<span id="xdx_900_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_z2Rftbfh0kxg" title="Allocation amount">2.5</span> million for the years ended December 31, 2024 and 2023, respectively. The pre-Spin-Off allocated amounts will not be cash settled and are included in the Net Parent’s Investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investment by Parent</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the thirty-six weeks ended September 13, 2024, the net operating expenses of $<span id="xdx_900_eus-gaap--OperatingExpenses_pn5n6_c20240101__20240913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_zCXQ97pFcxCb" title="Net operating expense">1.7</span> million incurred by HCMC on behalf of the Company was included in the Net Parent’s Investment. For the year ended December 31, 2023, the net operating expenses of $<span id="xdx_905_eus-gaap--OperatingExpenses_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_zAbVuxEuyAK6" title="Net operating expense">2.5 </span>million incurred by HCMC on behalf of the Company, $<span id="xdx_90A_eus-gaap--Cash_iI_pn5n6_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_zlYt8IG1gMci" title="Cah advance">0.8</span> million cash advance attributable to the Ellwood Thompson’ acquisition and $<span id="xdx_909_eus-gaap--PaymentsToFundLongtermLoansToRelatedParties_pn5n6_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_zvSf4FVVQXjb" title="Due from affiliates">0.1</span> million HCMC loan payment on behalf of Green’s Natural Foods were included in the Net Parent’s Investment. Upon Spin-Off, the Company wrote off the net parent investment balance to additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intercompany Receivable and Payable</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to Spin-Off, there was no intercompany agreement between the Company and HCMC. Management has determined those intercompany receivables and payables will be settled within twelve months after the balance sheet date. As a result, the Company’s intercompany balances are reflected as “due to” or “due from” accounts in the consolidated balance sheets. At the time of Spin-Off, the Company had a net payable balance to HCMC in the amount of $<span id="xdx_909_eus-gaap--OtherLiabilities_iI_pn5n6_c20230913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember_zc2WQhBQeN1k" title="Net payable">1.2</span> million, and the Company paid the balance in full to settle on the Spin-Off date of September 13, 2024. The Company had a net intercompany balance of $<span id="xdx_906_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20241231_zTN0TLRP3Hba" title="Receivables, net, current">0.2</span> million and $<span id="xdx_908_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20231231_zig9A7H3wzLb" title="Receivables, net, current">3.8</span> million from HCMC as of December 31, 2024 and December 31, 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Agreements with HCMC</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into several agreements with the former parent that, among other things, effect the separation and govern the relationship of the parties following the Spin-Off. These agreements include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Separation Agreement that will set forth HCMC’s and the Company’s agreements regarding the principal actions that both parties will take in connection with the Spin-Off and aspects of our relationship following the Spin-Off;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Transition Services Agreement (“TSA”) pursuant to which HCMC and the Company will provide each other specified services on a transitional basis to help ensure an orderly transition following the Spin-Off.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Tax Matters Agreement (“TMA”) that will govern the respective rights, responsibilities and obligations of HCMC and the Company after the Spin-Off with respect to all tax matters and will include restrictions to preserve the tax-free status of the Spin-Off; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an Employee Matters Agreement (“EMA”) that will address employment, compensation and benefits matters, including the allocation and treatment of assets and liabilities arising out of employee compensation and benefits programs in which our employees participated prior to the Spin-Off.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the transition services agreement, the HCMC will provide to the Company, on a transitional basis, certain services or functions, including information technology, accounting, human resources, and payroll functions. Generally, these services will be provided for a period of up to one year following the Spin-Off. Consideration and costs for the transition services will be determined using several billing methodologies as described in the agreements, including customary billing and pass-through billing. Costs for transition services provided by the former parent are recorded within the Consolidated Statements of Operations based on the nature of the services. Following the Spin-Off, the Company recognized costs of $<span id="xdx_90F_eus-gaap--OtherExpenses_pn5n6_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--TransitionServicesAgreementMember_z8rEiRe1TN6e" title="Other expenses">0.4</span> million for services provided by the former parent in 2024 pursuant to the transition services agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2100000 2500000 1700000 2500000 800000 100000 1200000 200000 3800000 400000 <p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zbVzfW1Erctg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 19. <span id="xdx_826_zkU7klzyDhia">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to September 13, 2024, the date of the Spin-Off of HCWC as a stand-alone entity, separate tax returns were not filed as they were included in the consolidated tax reporting of the former parent entity HCMC, within the respective entity’s tax jurisdiction. On September 13, 2024, HCWC completed its separation from HCMC through a tax-free distribution of HCWC common stock to HCMC shareholders. The Spin-Off was structured to qualify as tax-free under Sections 355(a) and 368(a)(1)(D) of the Internal Revenue Code (IRC). Pursuant to the Tax Matters Agreement (TMA) executed with HCMC in December 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Spin Liabilities: HCMC retains responsibility for all taxes related to HCWC’s operations prior to September 13, 2024, including audits of HCMC’s consolidated returns.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-Spin Liabilities: HCWC is solely responsible for taxes attributable to its operations after the Spin-Off.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification: HCWC indemnifies HCMC for taxes arising from post-Spin actions that jeopardize the transaction’s tax-free status (e.g., violations of IRC Section 355(e)).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For periods prior to the Spin-Off, HCWC’s tax provision was calculated using the separate return method, as if HCWC had operated as a standalone taxpayer. Deferred tax assets and liabilities, including net operating losses (NOLs), were allocated to HCWC based on the carryover tax basis of assets and liabilities transferred in the Spin-Off. This method preserves the tax-free nature of the transaction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024, all amounts related to the Company’s tax positions are recognized on the Consolidated Balance Sheet. Income taxes are accounted for under the asset and liability method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zAxqXd5rEdyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not have expected tax expense (benefit) at the U.S. statutory rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIElOQ09NRSBUQVggRVhQRU5TRSAoQkVORUZJVCkgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20240101__20241231_zthx7TY6ZJKa" title="Federal statutory income tax rate">21</span>% to the actual tax expense (benefit) reflected in the accompanying statement of operations:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zn20AFBOf8Ta" style="display: none">SCHEDULE OF INCOME TAX EXPENSE (BENEFIT)</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20240101__20241231_zKm06mnpr6Kh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20230101__20231231_zRbtlokYqVy5" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maOTEBzL5M_zfZzLXvzFMd6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">U.S. federal statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><p style="margin: 0">(946,354</p></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"></td><td style="width: 16%; text-align: right">(2,085,850</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maOTEBzL5M_z8dWRekDlv61" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State tax benefit net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">(243,330</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(557,568</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maOTEBzL5M_zmh5XffdViu5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">1,358,776</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,496,515</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maOTEBzL5M_zSPtEQ9Z3veb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">True-Up &amp; Deferred Adjustment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">(32,683</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(73,814</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--IncomeTaxReconciliationOtherPermanentItems_maOTEBzL5M_zrR7Eh3GTDW8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other permanent items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">(119,803</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">209,444</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--IncomeTaxReconciliationChangeInTaxRate_maOTEBzL5M_zsR1V9zeO4La" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Change in tax rate</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0">(16,606</p></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,273</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_mtOTEBzL5M_z9CZFkF9QRJk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><p style="margin: 0">Income tax provision/(benefit)</p></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1295">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1296">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zpLEec24UwT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zuqHX5hPmbkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024 and 2023, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zYkbALiJH3Gk" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-left: 10pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20241231_zhDQAoAimhRc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20231231_z2v8IUtN6Bs5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt; text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_zHqZ4Q1riro" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; width: 64%; text-align: left">NOL carryforward</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,129,808</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,449,401</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_z7zHUisUmu0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,958,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,995,960</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--DeferredTaxAssetsTaxDeferredExpenseReservesWarrantLiability_iI_zZPGED4kWHAe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">498,740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1307">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--DeferredTaxAssetsTaxDeferredExpenseReservesInterestExpense_iI_z2Xs7ugRIPxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">227,272</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1310">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction_iI_zSdALW9pWCog" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">ASC 842 - Lease Accounting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,309</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,172</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_zVyizEXBuZFj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Charitable contributions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,586</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOther_iI_zkMPeaXbBo3g" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">UNICAP 263a Adjustment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,823</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">53,284</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_iI_zaQyYur23dH5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; padding-bottom: 1pt">Allowances</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,485</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1322">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_zgaXeRNHycH1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Total deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,938,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,567,403</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_di_zLHQTRfDWT68" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net book value of fixed assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(32,905</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21,083</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_di_zDsvEAwBfU47" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Total deferred tax liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,905</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,083</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zu41NUPtejvd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Net deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,905,097</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,546,320</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z4farJ59ZQR5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,905,097</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,546,320</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_zIHLKUYOuq0a" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1339">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1340">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zPTnf85AAW9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the positive and negative evidence available, management has determined that a valuation allowance is required at December 31, 2024 and 2023 to reduce the deferred tax assets to amounts that are more likely than not to be realized. The Company’s valuation increased by approximately $<span id="xdx_903_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20240101__20241231_zkcSzaSY6RFb" title="Increase in deferred tax valuation allowance">1,358,700</span></span> and $<span id="xdx_90B_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20230101__20231231_zzDkfc0cYAS3" title="Increase in deferred tax valuation allowance">2,496,500</span> for the tax years ended 2024 and 2023, respectively. Should the factors underlying management’s analysis change, future valuation adjustments to the Company’s net deferred tax assets may be necessary. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2024 the Company had U.S. federal and state post-2017 net operating loss carryforwards (“NOLs”) of $<span id="xdx_90C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsForeign_iI_pn6n6_c20241231_zvPXqglsSYPf" title="Federal net operating loss">12</span> million and $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pn5n6_c20231231_zl86kD5yKsj7" title="State net operating loss">12.2</span> million, respectively. Tax Cuts and Jobs Act (TCJA) allows NOLs incurred in tax years beginning in 2018 to be carried forward indefinitely subject to 80% of taxable income under Internal Revenue Code Section 172. Florida, Kansas, and Oklahoma net operating losses generated in taxable years beginning after December 31, 2017, are carried forward indefinitely until used and never expire; however, Oklahoma NOLs are subject to an 80% taxable income limitation per year. New York, New Jersey, and Virginia net operating losses expire after twenty years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. Among other provisions, the IRA includes a <span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20220612__20220612_z9VhOMstG3Uc" title="Corporate alternative tax">15</span>% corporate alternative minimum tax on applicable corporations and <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20221231__20221231_zWzy7Ve3Dc73" title="Corporate alternative tax">1</span>% excise tax on stock repurchases made after December 31, 2022. The IRA is not expected to have an impact on the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had no uncertain tax positions as of December 31, 2024, and 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company files a federal income tax return and income tax returns in various state tax jurisdictions and the Company is generally no longer subject to examinations by federal and state tax authorities for years before 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zAxqXd5rEdyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not have expected tax expense (benefit) at the U.S. statutory rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIElOQ09NRSBUQVggRVhQRU5TRSAoQkVORUZJVCkgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20240101__20241231_zthx7TY6ZJKa" title="Federal statutory income tax rate">21</span>% to the actual tax expense (benefit) reflected in the accompanying statement of operations:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zn20AFBOf8Ta" style="display: none">SCHEDULE OF INCOME TAX EXPENSE (BENEFIT)</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20240101__20241231_zKm06mnpr6Kh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20230101__20231231_zRbtlokYqVy5" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maOTEBzL5M_zfZzLXvzFMd6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">U.S. federal statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><p style="margin: 0">(946,354</p></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"></td><td style="width: 16%; text-align: right">(2,085,850</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maOTEBzL5M_z8dWRekDlv61" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State tax benefit net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">(243,330</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(557,568</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maOTEBzL5M_zmh5XffdViu5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">1,358,776</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,496,515</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maOTEBzL5M_zSPtEQ9Z3veb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">True-Up &amp; Deferred Adjustment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">(32,683</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(73,814</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--IncomeTaxReconciliationOtherPermanentItems_maOTEBzL5M_zrR7Eh3GTDW8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other permanent items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">(119,803</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">209,444</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--IncomeTaxReconciliationChangeInTaxRate_maOTEBzL5M_zsR1V9zeO4La" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Change in tax rate</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0">(16,606</p></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,273</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_mtOTEBzL5M_z9CZFkF9QRJk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><p style="margin: 0">Income tax provision/(benefit)</p></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1295">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1296">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0.21 -946354 -2085850 -243330 -557568 1358776 2496515 -32683 -73814 -119803 209444 -16606 11273 <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zuqHX5hPmbkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024 and 2023, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zYkbALiJH3Gk" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-left: 10pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20241231_zhDQAoAimhRc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20231231_z2v8IUtN6Bs5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt; text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_zHqZ4Q1riro" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; width: 64%; text-align: left">NOL carryforward</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,129,808</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,449,401</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_z7zHUisUmu0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,958,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,995,960</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--DeferredTaxAssetsTaxDeferredExpenseReservesWarrantLiability_iI_zZPGED4kWHAe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">498,740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1307">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--DeferredTaxAssetsTaxDeferredExpenseReservesInterestExpense_iI_z2Xs7ugRIPxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">227,272</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1310">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction_iI_zSdALW9pWCog" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">ASC 842 - Lease Accounting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,309</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,172</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_zVyizEXBuZFj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Charitable contributions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,586</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOther_iI_zkMPeaXbBo3g" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">UNICAP 263a Adjustment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,823</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">53,284</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_iI_zaQyYur23dH5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; padding-bottom: 1pt">Allowances</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,485</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1322">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_zgaXeRNHycH1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Total deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,938,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,567,403</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_di_zLHQTRfDWT68" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net book value of fixed assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(32,905</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21,083</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_di_zDsvEAwBfU47" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Total deferred tax liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,905</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,083</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zu41NUPtejvd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Net deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,905,097</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,546,320</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z4farJ59ZQR5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,905,097</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,546,320</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_zIHLKUYOuq0a" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1339">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1340">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 3129808 2449401 1958875 1995960 498740 227272 89309 65172 30336 3586 -3823 53284 7485 5938002 4567403 32905 21083 32905 21083 5905097 4546320 5905097 4546320 1358700 2496500 12000000 12200000 0.15 0.01 <p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zslRq71qB6V1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 20. <span id="xdx_828_zoeBCflSUonc">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required disclosure in the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 2, 2025, subsequent to the fiscal year ended December 31, 2024, the Company entered into an agreement with certain note holders to exchange $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20250302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqtOdbeG77f6" title="Face amount">450,000</span> of outstanding principal under its existing Loan and Security Agreement dated July 18, 2024 for <span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20240718__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_z0aiGCXGHNE3" title="Face amount">750,000</span> shares of the Company’s Class A common stock. The exchange price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20250228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zISbAvQD0Io2" title="Price per share">0.60</span> per share equated to the closing bid price of the Company’s Class A common stock on February 28, 2025. Following this transaction, $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20250228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zO2ShncPtOM7" title="Face amount">7,050,000</span> in principal remains outstanding under the Loan and Security Agreement. The conversion strengthened the Company’s balance sheet by reducing its debt obligations.</p> 450000 750000 0.60 7050000